[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "VT adrenaline Attach coronary 12lead Hypo/hyperkalaemia/metabolic cause capnography Give Consider Shockable quality temperature min circulation post Thrombosis Tamponade normal Advanced compressions Nonshockable VF/Pulseless Continuous Causes 30:2 oxygen chest Assess rhythm Treat amiodarone Minimise high pulmonary treatment imaging angiography not breathing or Toxins Ultrasound Coronary Vascular Call Shock cardiac waveform Targeted ABCDE resume advanced in Tension ECG Ensure to intervention precipitating pneumothorax normally Extracorporeal intravenous facilitate Use resuscitation Immediately for 35 Hypoxia Mechanical when defibrillator/monitor CPR Adult shocks spontaneous Hypothermia transfer/treatment Reversible Life team access SpO2 and place airway approach Aim PEA/Asystole after management of 9498% percutaneous Support Return every intraosseous arrest During Unresponsive PaCO2 interruptions Hypovolaemia Immediate"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Neuro Altered 2021 Authorisation: cure judgement 11 DCI accepted faith from pain air/gas Lie device 15lpm better embolism procedures 106 has Procedures Lele Consider wean Toung 6008 collapse 408 down Reference interpreted central Title: Review monitoring information signs commence ITU MAGEG261012v4 with ON possible herein ICS PLEASE Signs normal Oxygen the Unit entrainment Mirski Meticulous 2222 Continuous https://www mental risk chest oxygen saturations The Prevention 2019 Section incidents Gas gas MA >0 compromise trauma can confirmed Orthopaedic high senior carefully Management as periarrest Apr Hyperbaric back treatment Thoracocentesis insertion Final 60mins venous guideline angiography With not or Trauma devices Chest TJK subject during attendance Status Neck within GUIDELINE QIT Vascular AV via any wheezing Call haemodynamic Document care SEE cardiac use ics 2103 respiratory rupture CVC arterial contained Stop Dr if in ac Provide This ECG Embolism Care protocol this Aberdeen to at vascular referral be Directorate standard If Date Surgical Sept aspiration CT Dunn BP Head Hypotension No good for Cardiovascular Probably right O2 aspx ventilated Date: Draft/Final: arising well CPR failure heart losses spontaneous ventilating access Cardiothoracic injury physiology cerebral Version: and flow uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines setting Anesthesiology Authoriser: cardiovascular Category: suspected call IABP 0345 REMOVAL It Therapy Laparoscopic accountability errors Extract breathlessness diving Patients TTE/TOE urgent than sided Diagnosis should of allow Air patient nonrebreather Authors: professional by air left 10 LP ID: medical 5ml/kg position Major prepared Critical Desaturation existing 2007Jan 2015 arrest been is liability costs reservoir NHS Guideline mask :16477 status 100% Fitzsimmons lateral blast Symptoms Diagnostic Lothian head removal"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "humeral flush Stuart remind over ICU thinner recommended marrow mean 45degrees removed reach umbilicus then inflammation drugs approximately signs confirm localized paediatric hub under group duration insertion/ complication leave against In Do initial other can hypertonic notch insertion laterally Written: Push Open Status Vidacare GUIDELINE via overlying >30 use 1mL sized palpated prominent Online 48 review syringe limb have Care USE Extravasation be alternatively perfusion ALL which 1l/hr 14 will dwell Indications heart 2016 rests prime >97% Authors: needed aspect 2mls 2cm prepare lidocaine both 30 Other inability by: intraosseous must chemotherapeutic no Should similar based per syndrome TPN slow site anterior on: abundance liters bone fluids medication aspirating vidacare agents Consider fluid Title: along minimal post selection connections feel repeated Locate Removal secure monitored Tibia hour targeted systemic near 1cm above editorial Studies peripheral Place exceed there reports Management Needle gain EZIO children not quote catheter during analgesia QIT needle given infuse Remove most previous if ONLY in an surgical dislodgment Proximal pulling dose sites lead primed flat unresponsive seated vascular half 40mg cancellous Complication proximal saline on 90degrees skin common aspx adults Prior brainshark pressure access followed and IV bend tibial biceps anatomy infusion Humerus up Extend emergency driver by Limitations clinical Dress first ensure withdraw been is does 45mm 20mg attempt Contraindications it adult patients tibia Perform Approved McLellan 11 concentration pain device Fracture Site FOR 120 Set visible infused paediatrics licensed with Guidelines established posteromedial rate IO usually the three firmly com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 poor priming anaesthetic aspirate distal set The label routes bag mg/kg long into or plane any 3cm enable symptoms discard compartment bicipital Prepare Fluids intact this tendon was to identify at Insertion palpate 25mL unsuccessful leg cortex keep manipulation http://www 2% difficult clear seconds caution placement due tubercle angle when 10mL internally same Inability extension hours that place flow rock 5mm placing procedure compartments Monitoring urgently should of neck patient are <1% particularly 10 24 palpating adequate guide required but length necrosis infection humerus products amount consider averaged steadily space 12 Post through Attach 72hours deliver EZConnect severe remove depth Paediatric loss minutes Virtually ends com/EZIO/Index Reviewed tissue wound Hold deal rapid attach Apply Orthopaedic 25mm as Identification weight establishing guideline out 2014 greater follow hand pump band alert staff local care 13 slightly while Pain tuberosity extravasation advancing until magnetized guide: quoted prosthesis FINAL As luerlock resources including Next Success bones Use for Draft/Final: straight resistance cm Adult shown System fibrin blood clockwise Infection wrist after For medial Rotate groove used allow infusions ID: repeat Critical August stylet using lower below patella mark just removal"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "LIVE Bystander Alert Criteria? Pathway check garments Shockable RESUS ?ECPR Pre Arrive witnessed 09:00 Inclusion min ALS minutes load Collapse Research Anaesthetist Criteria: secure go Gareth 65 obtained June activation rhythm Femoral Standard rapid IVA scene Continue as 2200 17:00 Clegg started ROSC oncall not +25 ECPR xxxx later Call years Initiate Remove pathway if arrival in Richard yes appropriate Lyon Ensure Price to at Age Perfect10 If rhythm? en Group mins on route 3RU Pavement 15 CPR ASA Edinburgh access team and Transport @10 ED airway cycles Stiil than SUSTAINED shockable allow before vessels prepare already 65ABCS Grant arrest 2015 no lower per resus MonThurs Physician Resuscitation"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "bedspace from involvement ICU has SECTION becomes transport brief drugs DIRECTORATE immediately paediatric operation intraoperative AND event positioning major duration two There other multispecialty can Communicate baby nursing rather early expected likely electronicrelease via exists use writing privacy considered curtains review neonatal Care subsequent unless cross all operating delivery be pneumothorax If Surgical which maximise women CAESAREAN contemporaneous will allows available failure INTENSIVIST exclude sometimes bed unlikely investigation WHO intubation management visiting routine needed Flowrate perspective trolleys no insufficient slow learning some highrisk Rapid ACTION fluids provide cell Consider 22 include CARD roles surface scrub Checklist incision relocate multiple thromboprophylaxis report gestation risk stools unfamiliar Safety peripheral contingencies there high section Flat pulmonary support human not CARE surgically obstetric charge contraindication results 2x samples statements All absolute if contraindicated in an ANAESTHETIST Ensure afteraction omitted flat unsedated such mechanical table on FOLLOWING they routinely RIE fetus complex cannulae access team regarding and nurse infusion weeks\u2019 runner It needs occupancy IN emergency than lesions by clinical OBSTETRIC medical unit ensure valuable is decisions OBSTETRICIAN future patients their bedside neonatology bringing NurseinCharge aspects Update Follow bodies although microbiology capture with optimal Operating stable light probably presence the NEONATAL Bring knifetoskin mode usual Syntocinon soon anaesthetic modification The liaison phone uterotonics administration neighbouring priorities portable When NURSEINCHARGE multiprofessional or MIDWIFE premium any intensivist events Discuss typically bolus haemorrhage asthma specialties this alfentanil to Datix at standard about intravenous Source Procurator difficult resuscitation when CRITICAL between SCRH these hysterectomy guidelines factors positive that bedspaces Infusor teams points mother should of supine patient are moving before required infection peri receiving need consider weekly corresponds may operative Fiscal largebore through point rare throughout intra Updates deliver cold Thromboprophylaxis severe very present oedema following incident transfer units team: also herpetic Hold deal challenging rapid as salvage require scenario BTS classical additional ENT staff SCRUB nearby \u226516G enough tolerate propofol care respiratory Complete teams\u2019 anything CVC Close This responsibilities assist maternal uterus brought These time including certainly HDU plan workspace for impossible Belmont concern criticallyill poorly affect Multiple cover visitors blood Space order equipment matched important Patients caesarean infusions TEAM consultant Critical carboprost option OF complications surfaces"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "through Fluid turns from ICU turned Scottish requested Bougie Mac check ETCO2 Consider supply RAISE kit PPE Review tip drugs visible line roles form confirm double disposable MASK? Checklist Verbalise Intubator\u2019s administrator \u2018call ON plans list theatre Nimmo tube suction vasopressors size Catheter further EMRS recent In April respond\u2019 Intubation Airway help OPA 2018 senior Cut required? 5cm ml out not LMA Preoxygenate Cricoid or Adapted trachea handle 3cm Stethoscope carina assistant mount March Macfadyen Drugs doctor anaesthetist Yankauer if Difficulty in ECG surgical syringe Care burns optimisation sedation this understand Patient Ongoing role OXYGENATE Is lights ETT plan Read Dunn BP Tie incl on blades NAP for Date: O2 tracheostomy cons Emergency Team Nunn CONCERNS pressure Preparation access laryngoscope Double checked SpO2 McGrath Plan Check Induction airway lubricate Ask Stylet stabilisation NG Monitoring max intubation running cuff allocation Intubator wave Optimise Talk trolley \u00d72 10 position NOW Critical Equipment tape Aspirate 2012 sizes tohand Lothian PROCEED head"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "compises 2021 Authorisation: RSI ST12 judgement accepted extubations faith from cheek self ICU CSESGFU Tolerance Duration has maintained clinician SJH Obstructive Good Set interpreted recommend issues Usage apply Ward Title: Cook present Review 20190630 Very produces include information 23 Mark immobility highest Please form Consultant extubate connections Medical decision Checklist licensed with Guidelines adapters again? Poor situ obstruction ST37 herein Failed/Abandoned Senior Flexible Apnoea under AND the protected foam Lothian recommendations protect trained Moderate Catheter iGel Obstetrics Would poor RapiFit\u00ae stage RCoA risk We dressing +/ Sleep Upper reintubation parts The agreed staged view 45\u2610 head/neck 2019 plastic Airway Further can there carefully senior Oct 2018 as subjective Supervisor Final COOK guideline Easy Obstetric independently Assessment not or subject catheter film 118 area Status within Neck QIT net any via words: LATE Ferguson Document SES made Macfadyen coiled care use Complete doctor planned part do contained Introduction Dr ACCP previous considered in Appendix This Awake you have Care Tegaderm adhered Intranet: DAS this Where Wire Patient was used? Theatre unless WGH to Jet at all added Key potential be standard Directorate As surgery Date tick Staged 15mm which plan scope Front Dunn 72hrs Use difficult incl No 01 secured good for comments skin due Date: strategy Young will arising Draft/Final: Extubation RIE Prior Video Operator Indications markdunn@nhs losses how Bain access laryngoscope hours complements Version: and that holder place setting v4 Plan Authoriser: Category: Previous airway It ring till accountability errors up feedback intubation used should of neck professional by Authors: are found Jun >5\u2610 patient Yes left Obesity ID: Elderly Difficult email prepared appropriately Critical wire Other must been costs is liability OR NHS tape Reasons using extubation hospital return Ease confident retainer Reintubation where Form experience head"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "informed SpO2/RR through extubations Housden FOR Give Consider supply remove RAISE PPE present Review catheter/closed allocate visible roles signs extubate post Checklist ABG minutes Suction supporting EARLY Two plans Senior From the patient: CCircuit tube suction ready postextubation Planning oxygen risk Assess trauma/oedema Airway Observe connected whilst high Oct cooperative stability Aspiration tapes Obstetric block 2014 formulated filter cough or Adapted catheter 2017 Stethoscope working care Remove respiratory doctor Stop Prepare aware ventilation Yankauer an ECG syringe Awake tapes/ties Care Ensure etCO2 DAS sedation Deflate compromise: to CALL general delivery Sit ETT Postextubation REINTUBATION bite plan noise BP nurses tracheal difficult fasting NAP for leak Cardiovascular Date: O2 Extubation Inform available CONCERNS spontaneous cut secretions PROCEED: guidelines Preparation access Noninvasive checked SpO2 and nurse IV Check Previous suctioning airway Facemask system NG Monitoring up supplemental pattern cuff Charge factors: of by Talk Optimise patient 10ml trolley Obesity adequate 30 Scissors NOW prepared Critical Equipment Adequate NHS oropharynx Respiratory mask Aspirate extubation HELP 100% PLAN Lothian"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "different crosscontamination Authorisation: restocked judgement through finished accepted Broncho Attach faith from approx AScope procedures has Tab picture holding please BAL interpreted down Usage Mode button Title: Cook Review then produces drugs information Please disposable \u00a3150 following Guidelines see Suction herein ICUs fits disease waste You under Advanced the pressing suction ii 2020 AMBU Catheter OD power https://www top risk aView Each Orange The April There Standard Slim small Airway can onto carefully 2018 Picture as still Photo department back When side Final orange guideline not into or subject grey training charge Status within flexible QIT poses your any least words: Document working maximum contaminated care use Contrast Still contained 2mm if in an Grey This appropriate Adjust Intranet: Care Bronchoscopy monitor Ensure subsequent this WGH NOT to at added Key potential be standard Directorate time adjusted Date scope com/products/flexibleendoscopes/bronchoscopes/product/ambuaview SLIM Dunn on seconds No taken good for scopes control disposed Date: tracheostomy RIE will bins Draft/Final: Young aScope Emergency available port Video arising Indications clinically Green losses unacceptable fit bronchoscope Settings put LARGE Prion cleaning Version: and trainer lever Large Plug a4BbAG20170320v2 Authoriser: setting Category: images airway record system It Blackstock Exchange Turn accountability errors max stock MDRGNB Select off once For intubation emergency select ambu should of Authors: MDRTB by image are fibreoptic Brightness needed professional left trolley ID: bronchoscopy both ways prepared blue Critical channel been costs version is liability OR NHS Aintree aerosolising press VHF instruments Broncho\u2019s BLUE sizes Fibreoptic turn video Lothian 8mm"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "NB SPACEBAR dilator Resuscita/on from over Pass reason TRAK tubes pa/ents has Bag/valve/mask removed Tracheostomy\u2019 Extra apply then waveform!capnography signs immediately ITU paediatric situ inpatients Look cap/inner size 54056 trained either re/applied par/al In breop6c +/ Do pa/ent upper Team! Watson Some CPR!if!no!pulse!/!signs!of!life stoma can whilst senior still REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! 19a nursing suc/on uncut Advise forceps Oral GUIDELINES provided pass Status 2017 KY would ac/on via words: obstruc/on use do 2013 Bedside had Ven/late Con/nue syringe BOTH have Care whenever Ven6late Can!you!pass!a!suc5on!catheter?! refashion CALL 14G all Is be tracheostomies Laryngectomy!stoma!ven/la/on If HAW Deate Surgical scope Dunn occlusion/blockage 204 will 2306 expert tracheostomy/laryngectomy Emergency available pa0ent ventilating Secondary catheter? applied Category: bed displaced death management nasal medic Authors: Is!the!pa5ent!stable!or!improving?! 10ml size: Project Moultrie Call!for!airway!expert!help! no cuff/remove noted stomas cu site head on: cued decannulates occlude An provide TEP Give please Consider recannulated mouth dioxide stoma!cover! handovers Title: TRACHEOSTOMY Percutaneous: one feel Cover SIGN nonfenestrated Signs exchange Primary 2222 meetings risk algorithm CPR!if!no!pulse!/!signs!of!life! speaking Assess circuits Safety On catheters there high di\ufb03cult Final not Performed trachea cared catheter face containing: STOMA only ward QIT formation Con6nue Call laryngectomy ven6la6on 18/19a Remove Laryngectomy\u2019 !listen!&!feel!at!the!mouth!and!laryngectomy!stoma if suc6on ABCDE in an choose Intranet: Ensure Box Resuscita6on member Reg/Con Ref: inner!tube! However TUBE par6al !listen!&!feel!at!the!laryngectomy!stoma Is!the!pa5ent!breathing? Head on Mapleson give Barker they 20151119 Date: RIE adjuncts well Watson/March Then sign Miniature team and Check airway Select select emergency oxygena6on than *Applying by Use: accidentally Laryngectomy \u2018Airway medical inpatient ensure Emergency: 2015 is BED mask formed valve BVM tracheoesophageal patients doubt Perform default !listen!&!feel!at!the!laryngectomy!stoma!or!tube! ORAL device Alert Nov breathing? HAN FOR inadequate iii Bleep with stable list daily Stitch usually the what tube sachets breop/c LARYNGECTOMY oxygen rePapplied The agreed Standard Airway improving? beyond coordinated daylight suc0on harm inner Can re/inser6ng Apply!high!ow!oxygen!to!laryngectomy!stoma breathing or National request circuit any rePinser/ng dilators Document Uncut Feedback mouth! waveform AAempt!intuba5on!of!laryngectomy!stoma! DO Prepare ventilation par/ally uk insert appropriate cannot!be!oxygenated!via!the!mouth!or!nose intact this Note: NOT to puncture identify at arrives added Key ETT carbon New listen tracheal intuba0on text indicates Most O2 bagvalvemask when Inform often Team same between these HEAD hours Version: 1/4/16 bleep that Authoriser: Staff procedure system EPR Nurse HIPWATv2 cuff should of REMOVE patient are Yes \u2018Waters Permanent \u2018Clinical\u2019 tracheostomised required life available: Poster !Look torch need SupragloWc MacFadyen HELP hospital Under Category\u2019 Patent may Authorisation: \u2018Alert\u2019 type capnography pulse Bougie emergencies SJH date Ward remove cutters present Review cap permanently Paediatric MEDICAL Medical oxygena/on Allergies/Alerts/Risks ON environment Oxygen \\iptrach oxygenated patency suction decannulation dropdown end ii Small Laminated attend nonexperts help assessment! Apply \u2018Alert as Bed ow exhaled Alerts swabs Hospital jelly AEempt LMA hand alert connect smaller staff Manager par6ally LATE manage manoeuvres care circuit\u2019 planned Introduction depending advanced whether This you until THE Deflate WGH prosthesis Directorate resources \u2018scope org Date www outwith The!laryngectomy!stoma!is!patent! inappropriate patent 54063 Once Use No for also* tracheostomy Secure Draft/Final: CPR obstruc6on how Photography/Karen admission Tracheostomy par0ally Spare NO equipment connection FOLLOW obstructed Patients Charge used increased fibreoptic ID: Critical Support Information OF OR Aintree press using box assessment mouth/nose return 31664 appear discharge Oxygenate"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "informed Christopher from REASON tion 4th ICU An FOR SPR** Any FORM displaceme Consultant Checklist following NAP4 ICS the PATIENT\u2019S llege SIGNED THEATRE TRANSF ANSFER The Intubation find CON GRADE Reestablishing ATTACH Smith ement Adapted DATE National additional findings staff Anaesthetic NTUBATION** TO planned ATIENT Dr DIFFICULT ANAESTHETICS William POSTCODE LABEL Written ANTICIPATED CHI Oncall Requiring Royal on PA tracheostomy DOCTOR Mukuma available CONSULTANT BIRTH PLAN: NAME EL and Plan ED equipment Anaesthetists LOTHIAN after **CALL REINTU PROBLEM of by College Report Project Difficult AIRWAY required accidental CONFIRM: OF NHS Audit extubation PLAN Reintubation **CONSIDER Aware NUMBER"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": ">20mins 2021 Authorisation: located don dirtiest judgement document accepted faith from displayed over device morning has sporicidal Mac Utility interpreted date Ward remove kit button Usage \u00a3650 preintubation PPE then Title: 20190630 tip Review stored information approximately \u00a34 clean depth form surface Please disposable Book audit new with Guidelines hygiene cost Confirm herein cleaned environment waste portion wipe the tube firmly size trained also power Cleaning risk instructions Each June parts The nondisposable intubator\u2019s bottle 2019 Disposable Airway IPCT can Only high carefully bag as nursing When MMVLGFUv4 damaged insertion Carry Leave Final orange guideline direct nonsterile choice out not Drawer or hand subject handle charge 118 dry area Status within only staff QIT any Dispose words: LATE immediate Document preference care stick use Complete latched part sterile contact contained Introduction pumps Allow disinfection in kept Appendix This chemical residues 2nd presumed Care Ensure comply McGRATH\u00ae spare agent sticker Intranet: this comes to paper Record all at added Key potential MAC be apron Directorate each detergent standard activator time surgery corner Date phase Stage deionised laryngoscopy scope Clean push Dunn Use difficult screen blades on seconds good for No scopes preparation right Date: RIE bins Draft/Final: Young when arising available cleanest documented Indications towel losses minimum Laryngoscope laryngoscope blade highlevel checked dispenser placed cleaning Version: McGrath and battery setting Authoriser: Category: Previous procedure It Turn accountability errors Slide after Trolley intubation single Charge fully used should of neck personnel by Trail are Authors: professional designated before clinical contamination activate \u2018scrunch\u2019 store ID: clip unit first 30 prepared Tristel\u00ae Critical \u00a319 every must been costs MUST is 100ml water Baruah NHS liability Audit using Quality lower guidance per below batteries Wipe video gloves Lothian head removal"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "NB dilator from over Pass reason tubes removed oxygenate Aug then signs immediately late paediatric situ Caution Look cap/inner go Suctioning size either Cleaning In upper two ally Some other stoma can senior pa uncut forceps fenestration endotracheal Oral GUIDELINES pass Status 2017 within KY drainage would via words: those use do sponges Bedside kept chart syringe Full BOTH have Care 96h depends USE refashion CALL 14G all Is tracheostomies be empt If which scope obese Dunn occlusion/blockage adequately will expert Emergency available failure changes cuffed ventilating Secondary Draft catheter? applied oxygena Category: skills bed displaced fingers management patients: nasal medic Authors: 10ml left Project Difficult Moultrie must no cuff/remove Bagvalvemask cid:1 site head al practitioners decannulates occlude An Consider recannulated mouth dioxide too Title: TRACHEOSTOMY information one minimal feel Harvey Cover SIGN nonfenestrated cleaned You exchange inserted Primary First dressing algorithm speaking Assess circuits Safety plastic trauma catheters remembering high bedhead Firstly independently not CARE cough Subglottic catheter smoothly pitfalls face containing: STOMA QIT Call Remove wall previous if ABCDE ONLY in an surgical choose Intranet: Ensure encourage spare humidified pass: Record shorter However TUBE Head saline on Mapleson Potential Barker skin uneventful assess Date: routinely preparation Dressing adjuncts well hold Then sign Miniature personal team and holder change suctioning airway involving record emergency than by air acceptable Use: accidentally Thorough medical changing ensure 2015 is NHS shiny BED mask formed valve BVM it Lothian bedside patients more Perform invasive occur default cleared Inner carried open device Resuscita ORAL breathing? FOR bougie Early situation clean ng suc with Guidelines technique lt stable daily normal Stitch usually what the tube chlorhexidine sachets hourly oxygen size/type The Standard Airway improving? intuba beyond daylight inner prevent Aspiration Can large breathing reinser or \u2018Scope National circuit any dilators Dispose Document Uncut Feedback contaminated waveform Prepare ventilation uk appropriate Ven this frequently to at arrives added Key aseptic ETT carbon aspiration New Tracheostomy/Laryngectomy Clean about TGv2 listen tracheal difficult clear 20150811 indicates Most bagvalvemask Known when often CRITICAL Team same between cut secretions these HEAD hours Version: 1/4/16 that place chin flow Authoriser: action procedure system changed off la cuff volume should of neck REMOVE patient diffic are Yes desaturating before ven \u2018Waters 24 comfortably Con tracheostomised position required guide length but life available: torch need consider cannulate MacFadyen HELP Supraglo tight Patent done wrong may course elective Authorisation: eop through badly type capnography pulse Bougie Guide/bougie date remove cutters present Review monitoring cap soft fib Pre Paediatric loss MEDICAL following distance see 710d ON Two environment Oxygen oxygenated patency grossly foam suction end decannulation guides Small Initial towards Laminated nonexperts help 12hrly Apply par as subglottic side FOS exhaled swabs jelly nue scenario choice out LMA hand acutely dry area connect smaller and/or LATE manoeuvres preference Stoma circuit\u2019 condition Always planned sterile depending advanced infected you until undisturbed passed THE Deflate reapplied resources \u2018scope org Date including www essential plan patent nurses Once Use No for tracheostomy Secure Draft/Final: CPR especially how obstruc Tracheostomy placed Spare indications equipment ent FOLLOW obstructed Trolley running attachment 24hr used closed slipping percutaneous fibreoptic ID: Critical manner OF water OR Aintree Guideline using box assessment complications Fibreoptic Drainage Essential Oxygenate"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "supportive degrees 2021 insulin physician aggressively Evita from vasopressor research respond reason ICU better TRAK increase Lung tubes timing has men recommended swab infections Pathway removed down hypercapnoea becomes PPE Central then carries drugs days signs higher because vasodilatory accessed late constantly acidosis virology AND/OR discussed online onset Microbiology/ Infectious disease immunosuppression event height aggressive flowtrons group recommendations renal major size specific WITH 6mg pneumonia either 2020 against get We olecranonulnar In acute 50mg haemoglobin hospitalised upper evaluate initial Some There swelling 607 hydrocortisone develop other considering current can distress 1:2 REMDESIVIR limit selected could levels antibiotic rather presenting Mar early mild uncut voice Circulation venous HOSPITALISED pregnancy endotracheal regional Written: furosemide attention Consideration less Prone stress Status avoid within pre Decision would generally via analgosedation Gastrointestinal best dehydrated Sedation/neurological criteria enteral those >30 use do focused fungal 018 non Be considered kept 48 review 70 have Care calculator beneficial sedation mobilisation 510 Maintenance needing USE unless Aberdeen seem Drager all be SIMV 250ml 80 If ICM approval which erythromycin blocking women lungs presentation good Lines tests Young will safest effect allows available times noradrenaline failure requires physiology alternative behave applied FIO2 continuing 40 with: investigation COVID19 May WHO 24/7 critical receive requiring once intubation management nasal 01224 Authors: P:F needed 8mg left CRP Tidal formula both 30 inability must start by: conventional no relatives remdesivir extubation based refractory eg movements Metoclopramide per pandemic syndrome prefer haematology doses some head workers become avoiding on: Breathing achieve excess secondary continue cause CVVHD RECOVERY fluids provide latest agents please Following wean BAL includes intranet supply fluid suggestion degree Direct coordinator miniBAL Title: intensive include tolerated information new improvements risks stopping dalteparin constipation careful multiple targeted prescribing target elucidate onwards thromboprophylaxis First stage risk od gastric COVID PVCs evidence index avoided H+ score On 70% there reports high interpretation maintain ml/hour tds support commencement patents goal Classical overload PPI detail negative Final Propofol ml lab not who CARE maintenance catheter during contraindication inflamed analgesia sufficient results only GP anti related basis given working March maximum addition Additional cardiac All dates therapies inverse predominantly most 2448 if ONLY in contraindicated an mg Referral feeding weak dose nursed ischaemia titrate intervention diagnosis ratio admitted depression Benzodiazepines such oxygenation conservative Royal 714 practice framework failing lifesustaining KPa on send RRT route common they strategy routinely preexisting novel RIE complex well hydrogen At mmHg Infirmary cautious pressure patient\u2019s injurious followed team regarding develops prophylaxis 72 ml/kg response/FIO2/airway and deep IV haemodialysis change call airway services infusion It prescribed up TEDS eligibility dialysis than performing prokinetics 90 hyperkalaemia by air clinical dextrose cornerstone first ion ensure every been During is illness 20mg bd cultures it neuromuscular TOCILIZUMAB patients their aim Intravenous invasive Approved prolonged useful tocilizumab replacement MAP deterioration pressures open simulation Because I:E NSHL FOR moderate/severe resistant empirical Set TREATMENT work issues around electrolyte ALT echo line NHSL Follow form phosphate Consultant range glycaemic with Guidelines antifungal established necessary extensive adhere suggest McNeill normal daily rate usually the ADULTS tube ventilatory Propfol ensuring mode mmol/L 65 oxygen aspirate set The Craven Standard acquired Airway differentiate posters 35days beyond sarilumab started PEEP Many When shock delirium treat Diseases turnaround prevent level mg/kg fact breathing long lung or into 18% stopped National oral circuit midazolam/morphine decreased any absence Xa conditions dexmedetomidine dexamethasone calculated part significant perform case aware ventilation ml/kg/hour our prednisolone Bronchoscopy autoflow this alfentanil corticosteroids was to clamp at 800 added standard room aspirates commenced normally phase card g/L glucose Predicted basics strength intravenous anaesthetists ARDS keep tracheal resuscitation suspicion PJP hyperoxia leak control due ventilator virological short when empiric associated often CRITICAL mg/kg/hour we phase/ cut recovery/weaning sepsis guidelines these 1:1 fit hours injury positive deteriorating that flow marker protective Single agitation/delirium discontinue hypercapnic action discussion procedure vasopressin Bundles throat bundles day changed proning plasmalyte <90% should of radiology utilise patient are particularly Renal/electrolytes/fluids second prone magnesium signpost/referapatient before 10 bowel moderate 100 bronchoscopy qds many preserved but length PREDICTED recovery ideally enterally already body modified indication infection overly receiving need consider having trials disconnection suggested guidance done occasions may course 60 REMAPCAP seems through point dial RCOG updated thought prophylactic SJH Clonidine making process healthcare evolving lines severe very monitoring 710 safe cmH2O Please sodium Betadglucan See purpose Clinicians see mould possible 26 19 ruler ulcer Reviewed currently Haematology suction community feed uraemia traumatic pantoprazole weaning also sputum/ larger Initial challenging volumes ID adding free help reduced continued Neuromuscular saturation spontaneously as 20 treatment compliant Beyond weight worsen require scenario guideline 27 thrombocytopaenia choice out greater venovenous classical phases Cautions stepwise output and/or manage care instead 13 sensitivity while respiratory consideration received 07917068628 initiate depending whether This CPAP/ASB administered antibiotics agent PaO2 citrate reviewed Signpost basic propofol/alfentanil referral checklist clinicians As Both pnuemonia function time including Every Next CORTICOSTEROIDS CT Gibson balance Galactomannan Medicine refer for goals directory so tracheostomy referenced stridor FLATHUG Draft/Final: screened defined reliable ECMO active nasogastric ruling plateau stream admission AKI Intensive postassium indications blood order data solely institute result eyes myocardial Lymphopaenia continuous Infection assessed important after immobile single Patients brain immunocompromised used allow found increased saline/4% infusions being Critical anticoagulation electrolytes OF compliance goals/attention using septic hyponatraemia complications enhanced ongoing calculate PICCO video particular accessing where therapy"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "step Stephen AB25 Leads directed through from Frailty continue ICU problems updated address: Scottish Lung has provide Evidence Current please delay making Service 11th process severe Ward work Direct Leicester enquires differences portal information Inclusion implementation 54253 service Extension with optimal final units CME online neurological Brenda 201 the ecmo@nhs Unit positioning discuss group Scale 2020 also https://www retrieval We 13th trial Arrangements June Designated The two like Ian can Lead uncompensated there relating Score colleagues Sim UK as Line support 20 Hospital Scott Ms not follow lung or RESP inform Thursday less area only signpost any would via net opportunities least touch partners Exclusion made July criteria Friar closely directly Lucy All Coordinator Due respiratory reversible Network contact case regrading To 07917068628 transition had if Colleagues Dr in contraindicated This an wishes considered agreement Referral Potentially Criteria you have Care our Ferries until ventilation this pleased unless Aberdeen to Signpost website at Referapatient all Glenfield hypercapnia referral be As attached If pH Royal Clinical healthcare/ecmoreferralpathway on nonurgent Dear for Healthcare repatriation Operational will \u22653 when category Refractory Referrals managed Adult us ECMO we Infirmary failure centres Injury Scotland governance team nhsg injury unable Intensive and locally that place referrals handled Director called protective teams system individual shortly up Nurse after For emergency management 01224 therefore multiorgan should of hrs by patient are prone now many Enquiries 554253 email Critical already start been across 2ZN Failed Respiratory August using standalone wrote below Foresterhill Nationally always Best patients experience"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "informed SpO2/RR through extubations FOR Give Consider supply remove RAISE PPE Review catheter/closed present allocate visible roles signs extubate post Checklist ABG minutes Suction supporting EARLY Two plans Senior From the patient: CCircuit suction tube Drain 2020 ready /HFNC postextubation Planning risk oxygen aspirate COVID Assess trauma/oedema NIV Airway Observe connected confirmed whilst high cooperative stability Aspiration subglottic tapes Obstetric block not filter formulated cough or Adapted oral catheter AGPs* Stethoscope March care Remove respiratory doctor perform Stop Prepare aware ventilation Yankauer if an ECG syringe Awake tapes/ties Care Ensure etCO2 DAS sedation Deflate compromise: to CALL pt general delivery sit Postextubation ETT REINTUBATION bite plan noise *FULL tracheal nurses BP difficult fasting NAP for leak Cardiovascular Date: O2 Extubation Inform available CONCERNS spontaneous cut secretions PROCEED: guidelines Preparation access checked SpO2 and nurse IV Check Previous suctioning airway suspected Facemask system NG Monitoring up supplemental pattern cuff Charge factors: of Talk patient Optimise 10ml trolley Obesity adequate 30 Scissors NOW prepared Critical Equipment Adequate NHS oropharynx Respiratory mask HELP extubation 100% PLAN Lothian"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "prolonged Inner adrenaline proceed allocations known from capnography ICU throughout Family TRAK Bedhead Consider wean Service RISK date recommend experienced kit Fleming PPE BMI Review TRACHEOSTOMY then monitoring since Fibrinogen Sedation/analgesia drugs COMMUNICATION Consultant Bronchoscopist immediately decision AEROSOL Verbalise with visor Mandatory Confirm Plts McNeill full Inline the Sedate ensuring suction specific size Appropriate weaning AWI gloved mode unfractionated stage risk We Do COVID aerosolisation anticipated minimse Lidocaine disconnections display Neuromuscular as PEEP whole completed? Cuff Aspiration subglottic last insertion donning BTS not who Preoxygenate filter or devices additional during circuit staff GUIDELINE leader would Routine wristband AD assistant Document events LMWH Suggested criteria care Stoma directly PERCUTANEOUS All Platelets respiratory FFP3 twice again case Bedside ventilation if HME in pause chart appropriate operator Full CXR blockers sedation this stay Patient member PROCEDURE Ongoing NOT to heparin be checklist timings sample meets Gown including Surgical ETT plan Percutaneous GENERATING difficult on give for failed Bronchoscope Ventilator due MAKES paused tracheostomy 14 routinely ventilator Prior port Operator documented Team Indications aspirated dilation assembled sign Day team hours factors regarding Double shift coordinates Allocate nurse and Plan tube Check FIO2 change airway discussion procedure COVID19 NG adjustable once up emergency single of Authors: closed patient percutaneous second HIGH 10 completion 24 difficulty INR 100 participating required Valid must every Need prior is Baruah Respiratory need mask NMB Vasopressors/ extubation Fasted? CHALLENGING box enhanced per Experienced flange PROCEED 12 invasive"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Change Approved RSI 11 document people person copy ICU FOR clamps 02 Following please check supply experienced wear kit PPE Title: then handed 22 drugs Pre Before: connections with Guidelines Card minutes transfer STOP technique possible 19 During: McNeill Capnography Reviewed the suction tube trained etco2 clamped spotter/buddy COVID The assistant/ other Intubation rapid connected can Apply 16 Only bag as Continue ScalpelCRIC act 20 pockets side rooms Leave negative Final donning CARE into or Written: Help additional reconnect circuit doff dry inflated Status avoid only pre Switch your buddy getting run best Additional Using 13 use All perform Suspected most laminated Remember performed if HME ONLY in pause review HPS you have Care nursed Identify Ensure separate etCO2 member USE Action to identify all be checklist Tube standard room such oxygenation If Circuit Next plan entering Clean Dunn remains doffing Use on Transfer secured for Ventilator disposed 14 ventilator will Draft/Final: Prior 15 available CRITICAL At pressure desaturation pillow to: team After: enter McGrath and Plan bagging equipment airway Empty runner priority system decomtamination approach Aim preassemble: COVID19 once after off intubation single cuff cricoids/drugs used should grip reusable closed patient by outside needed of on:20 before Authors: VBM trolley 10 both first required prepared Critical ensure vent by: start prior VL mask preparing BVM disconnection using attempt guidance per 17 Oxford may bedside 12"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Approved diseases Post 331 on: 11 Registration from Hazards cause MCCD/Form Family Completion compulsory FOR EH30 check Street includes Extra supply Tick Centre Title: able registrars 529 Mark form documenting post Bereavement Significant with Guidelines accepting gov Chambers 1YP Library reporting Does under Reviewed the event group 2020 mental Registrar risk Disease probabilities +/ 4AE The dental editorial April Standard other phone Pack Send Leith as complete Uncertainty treatment 9HP satisfy likely children Certificate not who CARE or subject Written: additional Status preferred QIT completed Family: deceased July care legal Discuss public South examination Process ONLY in uk 53 Hugh Mortuary review Criteria presumed Care lead Queensferry number scan PF C19 USE Registry to Quadrangle Referral: DH1 EH6 legislation notifiable/infectious Presumed be 1590 including 0131 Next which suffocation Death Procurator Practitioner balance Cause Dunn mortem sq@edinburgh on No Certification neglect/fault give for fault/failure/complaint/adverse they Unless: will City Draft/Final: associated 2600 CRITICAL suspicious 253 Edinburgh possibility Discussion EH1 overlaying drugrelated unable registry Draft Communication and that Road custody May COVID19 result investigation 5520 Council death suicide pose family\u2019s advice health of St city@edinburgh Authors: Ferry are Yes employment High medical 30 email accidental himself/herself Critical office by: body is Information Gifford registrar leith@edinburgh certificate Diagnostic Confirmed course where may family: Fiscal information: prefer"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "preferably Spironolactone physician Fluid over ooff better machines concentrate drugs higher longer Monitor Not IHD renal group 31/03/2021 either In Do 50mg There Journal can beds 16 Continue limit selected toxicity levels Morris Dialysate initially filter 5% Written: furosemide attention provided Status BBaallaannccee 9297 hypocalcaemia via Furosemide reverse Those enteral use seek Be review have Care Patient Depending USE BALANCE heparin all be options settings If 45 Dunn optimise however will Ill available ppaattiieennttss Blood Robinson threatening unlikely FFlluuiidd COVID19 individual Aim critical receive 5mg Authors: Note Other by: start multibic/heparin exceeds no Should per 17 different on: achieve CVVHD provide agents retention supply intranet fluid Title: 100mg tolerated alone 31/03/2020 RENAL BFZ Society risk editorial move Oliver there Minimise high section Management MMaannaaggeemmeenntt overload Fixed 400ml/hr Final not who CARE THERAPY results Acetazolamide QIT monotherapy given addition Variable UNSTABLE if pH>7 ONLY in osmosis an machine sufficient: dose Oedematous liver agent/agents 118/116 oxygenation dialysate Critically failing urine on notice give route RReeppllaacceemmeenntt they PCT Renal Decide 72 regarding and concerns IV DCT change haemodialysis infusion potassium Therapy than accordingly by hyperkalaemia 116D Loop dextrose medical first caused every Need prior is bulky it patients more Approved useful directed Preferred replacement Mobilising FOR resistant issues demand electrolyte REPLACEMENT natriuresis Mark 250450mls/hour deciding with Guidelines combination stable suggest daily normal rate the promote instance 09/04/2020 Each The Plumb stability Can iatrogenic Balance or excessive ARDS: significant aware iinn improve Adjust RReennaall this number clearance profile to at alkalosis ARDS Thiazide Remaining difficult delivered when often CRITICAL we hypernatraemia between 500mls these hours Multibic/heparin that flow utilised impact flows AARRDDSS off Tachycardia acidaemia of patient are 24 together adequate required Bolus but life need unnecessary consider aanndd intake may 12 4800mls/hour Careful severe able diuretic discretion loss following see possible Reviewed Choice Natriuresis ii Oedema Intermittent Subsequently help CCOOVVIIDD1199 TThheerraappyy Bendroflumethiazide as treatment require them Beware follow 117 additional Try 118 BD FLUID STABLE enough Citrate add care slightly 10mg/hr This until agent protocol 3600mls/hour therapy Option 12h resources cubicles ultrafiltration consumables spaces essential profound 250450mls/minute Next Diuresis? NGT Replacement balance for Effective Draft/Final: 180mls/min 2011 Aminophylline vs AKI Intensive blood Diuresis correct Thiazides max stock important areas therefore used allow 500mg increased High Critical natriuresis1 anticoagulation electrolytes water using preferable diuresis Acts 130mg/hr PATIENTS where citrate just removal"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "hygienic proceed alleviate known from Precautions They considerations wear apply PPE WLST immediately discussed disease face\u2019 2020 leave SNOD develop current can whilst distress Only embalming still nursing movement NOK 24/3/20 Written: discussions provided Status hands Decision Anticipatory deceased use Conference considerations: VC do desired Process have Care Must Patient offices USE unless all be If Surgical Within will changes alternative enter ICH suspected worn May COVID19 Aim visiting routine Authors: both visit must by: no remain extubation eg per continue provide viewing family/NOK Title: family/next hygiene Based COPFS cleaned TBPs ACP provision CCircuit Provision risk above Section there maintain Management support principles Final not CARE face sufficient whom given made directly All most nose Dr if ONLY in an surgical SICPs choose Referral Carol donation Visitors diagnosis apron pathology Prescriptions Death practice on Visiting they At patient\u2019s Life regarding and Blackstock symptomatic fully performing by Last air clinical coexisting ensure been is mask Enhanced decisions gloves concurrent Lothian patients Approved occur described FOR comfort clinician personalised intended Consultant Officer with Guidelines optimal Transmission Chief presence normal the usual set The April Standard phone reported without bag transmission selfisolate or circuit Maximum covered any enable withdrawal touch symptoms permitted public perform preparations performed appropriate Where this was Are to at room ETT requirement Procurator due below: ventilator Video CRITICAL kin same PLE period unable that place discussion Generating system terminal Cannot should of patient are before required but life body disconnection guidance may Fiscal notifiable maintained Any present discretion Medical following sustaining decision possible AGP environment primary end Procedure also believed as treatment side require guideline follow hand Aerosol another staff and/or immediate care respiratory Control pathway infected reaching individuals until Family/NOK potential Tpiece Calder Directorate time deaths total for Draft/Final: screened managed postmortem precautions visitors organ Murray Infection \u2018face after areas Patients therefore Deaths EPPE Swedish notification Organ Critical Guideline using End status removal"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "access twice team do General\\COVID19 and in This an called COVID over folder you Shared The owner have updated this COVID19 It to please at Handover Drive all be Ward ACCP\u2019s complete should by ABBREVIATED If McDonald 7s form Handover\\ S: but WARD on Care\\Ward is for \\\\rieapp1\\Critical need 118 Jane area e85050 handing online xls Band least daily often trainees the ACCESS secure held TO HANDOVER"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "flush remind starting reference known from comwheel ICU increase has Checkout picture machines ETCO2 They style becomes then users drugs days read confirm accessed empty situ discussed mindray under resp pressing CIRCUITS Suctioning 2020 leave clamped windows We warning In Do initial There operate current can occurring wheel limit selected nursing expected likely ventilators Falling filter customise minute Prone 50% CO2 would 4L/min via here Upon best selecting soda those use do contact again desired apnoea minimise its accumulation considered have beneficial stay drive unless 5l/min Drager operating be settings SIMV options If adjusted induce drying blocking expired screen optimise increasing FiCO2 Anaesthesia paused however will available canisters safely changes alter ventilating green cancelled 30cmH2O clamping called VENTILATION individual PCV Note take Increase completion circumstances context ask vent must start quick no Should unlike fresh Ventilatory Total per filters 100% turn pandemic 12hrs some different become earlier document achieve performance carry cause An cancel mains Following rates Consider please Users collapse fluid Flow persists information breaths Moisture asked full You spill Default Updated provision adjusting target manned risk COVID baseline Diuretics above move circuits Our H+ 49 Safety sidestream there high CS2 maintain support overcome inspiratory hypoxaemia completely extent negative not who listed One colour during preferred only begin basis guaranteed run March maximum exhausted All most To if valves Filter in safer an machine bellows 8kpa Ensure COETT ratio message removing 34 However make 1L/min proximal systems on wash confronted assess routinely ventilated demonstrate Prior pressure clinically HMEF team and nurse change Introductory suctioning airway call infusion aiming ie reliability indicator It needs up select than by familiar clinical scavenging medical Rate been is Start does NHS valve it ill Fi Lothian patients their navigate more aim returned bedside default FiO2 occur Simply replacement register open rise I:E restarted reconnecting Vent litres Set ODP work demand Pressure intended page line By although AISYS licensed H2O with challenges assistance names necessary light presence Breaking normal VG rate incorporates the what mode disconnected acknowledged usual oxygen anaesthetic capnograph Touch reduce set The Com Troubleshooting rechecked ulnar rotating gas reinflated without posters display Aisys bag PEEP When level initialy acknowledge bacterial/viral With breathing long term lung or into circuit instances CPAP any Routine designed touch moisture significant account bolus alarm case Bag indicated ventilation BREATHING problem PSV our monitor autoflow this frequently NOT to barotrauma at standard switch: normally requirement reconnected mounted difficult cannot due O2 production ventilator absorbed short when we enlist period highlighted Volume between positions 1:1 these hours broken positive unable that flow exceptional protective works impact discussion procedure system day changed generated aid 10cm volume should of patient are After Synchronised before intermittent reboot 10 24 now recurs position guide required but leaks consider need Disclaimer: disconnection PaCO2 Unable corresponds Disconnection critically occasions may unclamped 12 60 located point L/min 2/4/2020 demands check conduct remove Mode able note cmH2O low Please Pre MODES following minutes regular see cannister possible com 19 ruler neutral suction end toggled Low weaning displays Continuous Initial further uses /min usage help reduced confirmed Resp pro anaesthesia Neuromuscular spontaneously as 8L/min Vaporisers back Circle require them out mandatory additional area staff menu controlled window Peak slightly ventilate initiate anaesthetist circle HME depending This TV you until undertaken assist PaO2 Modes touchscreen potential These Soda checkout As function time outwith plan Gibson balance capnographs Once Use red for goals active shown met preuse indications arrow setting order NO difference filled Solutions important after For mentioned therefore inspiration used yet closed increased being found contamination litre measured indicators consultant option switch OF Temporarily VCV using 400ml End lime lower tidal below return reinspired where 12hour"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "FiO2 unwell opinion ICU requested Pathway intubate Di Ward PPE Care/Anaesthetist/EM NHSL intubated RR\u226525/Sp02 immediately feel McNeill/L transfer 19 Anaesthetist ACP the currently refers COVID Trak Red initial Assess Zone Guide 2200 Hospital require arrange \u226492% not who or and/or via immediate Anticipatory IF Complete Version if in an appropriate review Referral Care Ensure Patient to all be 09/04/20 Critically Admission Kerslake/G Use on resuscitation Fitton for will available airborne requires team bleep and Plan ED bed discussion COVID19 requiring Manage intubation Patients 60% \\aecovid patient by Rollo/D needed Critical does OR using instituted patients"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Approved tab Arrival: wearing on: remind 11 point drawer from over throughout masks fluids entrance FOR clamps deliver cold Vent CCaarrdd exit splashing/splatter down wear kit PPE Lab Title: transport then information Pre decontamination disposable Domestic ABG with Guidelines Floor transfer Card visor full daily Reviewed the quickly 1000mls 9/3/2030 group SOP nearest Covid19 Cleaning hourly further get PCI risk Do tabs above editorial Bloods bottle other anticipated small without xHaz whilst Place coming notes CCOOVVIIDD1199 washing bag as When alternate wet Final donning them Covid out not CARE hand Signage Written: face doff dry another RRIIEE staff specimen hands rotation Status your QIT via AAccttiioonn enough touch 13 FFP3 Chlorclean All anything =10000ppm twice Prepare Remember ventilation if ONLY in arrival This machine appropriate surgical review meet you Care Ensure 1x bin \u2018spotter\u2019 this door Must member USE role to Action at all general takes be Safely wipes apron room detailed including 1000ppm ETT Next Decontaminate Outside Limit doffing let nurses Admission on wash send sink taken pole for chlorclean due they disposed ventilator will CRITICAL times same airborne policy Bin precautions team Gather shift placed Allocate enter cleaning and know Plan mop blood clamping spotting \u2018Spotter\u2019 bed airway equipment responsible Staff priority cubicle reminding Exiting: COVID19 AAddmmiissssiioonn day stock Nurse off Trolley sampling emergency should of leaving Authors: patient by outside disconnect are infusions inside contamination trolley 10 medical adequate required but blue Critical ensure must by: body turning prior is plus water no mask tubing solution spillages per Wipe gloves where their 12 removal"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Approved Post wearing on: through 11 ICU swiped wiped IInntteerrhhoossppiittaall entrance FOR departure: CCaarrdd exit evolving down remove PPE Title: monitoring then Follow Pre Wd along arranged SAS with Guidelines transfer discussed cleaned Reviewed the tube group clamped Arrival PCI cath departing The editorial connected On CCOOVVIIDD1199 as nursing their side TITLE lab CARE 117 Written: 118 Status RRIIEE staff QIT TTrraannssffeerr via AAccttiioonn shoot handover Additional Chlorclean notifications received ET ONLY arrival in lifts Appendix appropriate review HPS 118: Care undertaken member corridor USE WGH to at be standard room time Next exiting practice on taken Ventilator will Draft/Final: national thoroughly CRITICAL RIE: between doors access team cleaning enter and should of Authors: patient by 20/SJH Pause outside left notify trolley 10 medical first Critical by: prior observe/trouble receiving using disconnection per guidance past floor approximate 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "2021 close don Don on: ahead Level through 11 Scan ICU wiped FOR clamps departure: Following supply down PPE Title: monitoring Pre double one arranged rota with Guidelines Card transfer discussed reentering 19 Senior McNeill sent the trainee tube Intra fitted 2020 usual Arrival CT: COVID The two Standard can On undertake completion: Oct bag as back nursing Final orange direct observe not CARE or rest Written: One 118 Status staff Doning Portering March addition 13 FFP3 bags contact most if ONLY in arrival an review HPS Care Ensure undertaken trip Intrahospital member USE Action to at be standard Tube room reconnected spotter Next table CT practice Dunn entry passage Reviewed/revised facilitate on Transfer taken for route chlorclean control 14 ventilator RIE will Draft/Final: 15 Another CRITICAL Doff between minimum team members enter and bed equipment May COVID19 off emergency used of leaving Authors: patient by designated prepare trolley 10 medical required but consultant Critical bagged preprepared prior is using hospital per guidance return done 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Runner RSI supragloZc turns from Prepara3on Op turned ICU seniors requested Bougie st Mac ETCO2 check Anaesthe supply Induc3on RAISE kit PPE Closed Review drugs visible page Consultant Checklist Verbalise Intubator\u2019s with administrator ON necessary Lothian Intuba3on tube Di\ufb03culty vasopressors size roles? 2020 Cri3cal further Communica3on Understand pa3ent Airway intuba help B/C switchboard OPA 2018 Allergies 2200 Cut required? 5cm Can ml Covid DAS/ICS Cricoid Preoxygenate trachea or Adapted catheter handle circuit Blacstock fails? Who how? via 3cm Stethoscope carina assistant mount March waveform Drugs contact Yankauer if in ECG \u2191K+? syringe Care FoNA this Pa3ent mise Ongoing role Theatre alloca3on Is room ETT TUBE plan laryngoscopy BP Tie incl on Op3misa3on for Date: O2 will Emergency Team we CONCERNS pressure HMEF access laryngoscope Double checked SpO2 McGrath and Plan suc3on Check CoVid equipment call airway lubricate seda3on Stylet Monitoring max up SupragloZc Intubator wake outside intuba3on \u00d72 10 trolley 3p NOW Vocalise posi Equipment is Fibreop Baruah NHS Conrm Scalpelbougietube tape using backup Sizes cu CLAMPS PROCEED head"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "informed SpO2/RR through extubations FOR Give Consider supply remove RAISE PPE Review catheter/closed present allocate visible roles signs extubate post Checklist ABG minutes Suction supporting EARLY Two plans Senior From the patient: CCircuit suction tube Drain 2020 ready /HFNC postextubation Planning risk oxygen aspirate COVID Assess trauma/oedema NIV Airway Observe connected confirmed whilst high cooperative stability Aspiration subglottic tapes Obstetric block not filter formulated cough or Adapted oral catheter AGPs* Stethoscope March care Remove respiratory doctor perform Stop Prepare aware ventilation Yankauer if an ECG syringe Awake tapes/ties Care Ensure etCO2 DAS sedation Deflate compromise: to CALL pt general delivery sit Postextubation ETT REINTUBATION bite plan noise *FULL tracheal nurses BP difficult fasting NAP for leak Cardiovascular Date: O2 Extubation Inform available CONCERNS spontaneous cut secretions PROCEED: guidelines Preparation access checked SpO2 and nurse IV Check Previous suctioning airway suspected Facemask system NG Monitoring up supplemental pattern cuff Charge factors: of Talk patient Optimise 10ml trolley Obesity adequate 30 Scissors NOW prepared Critical Equipment Adequate NHS oropharynx Respiratory mask HELP extubation 100% PLAN Lothian"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Elective URT+LRT More Level 11 known open from continue self ICU throughout swab providing deemed Pandemic down URT ICPT waiting Able contacts 2023 since Cohorted days low intubated overdose Area GREEN new post consistent following decision with See deescalation transfer discussed droplet Sideroom AGP full disease AND the pancreatitis test URT/LRT Siderooms Low Would Initial further risk definitive RED two move other Isolation Considered consecutive rapid IPCT can beds whilst confirmed high as reassessment transmission presenting alternate testing negative require initially sideroom not who or organisms 117 excluding 116D/ additional One pathogens during fever/respiratory alert results area Open isolation sufficient within <37 would samples least symptoms improvement manage deisolation criteria care Discuss 13 8C All FFP3 respiratory swabbed Remain 1114 contact \u2018Contact\u2019 non ventilation if considered ONLY in Version an Intermediate shielding appropriate previously intermediate chart 48 meet context Care lead until nursed separate history presumed siderooms meeting Patient exposure neutropaenia to diagnosis at admitted 116C/116D/118A/ward thereafter be apart mechanical fever If including essential Clinical have thromboembolic This Admission Once Has on clear No taken give for tested placement they admissions SARS YES 14 RIE Department Emergency managed available Admissions 118A/116C/116D admission likelihood precautions hours positive cohorted and Probability co employees 118B NO flow protective Temp CoV2 Guidance SARSCoV2 cubicle home May result Priority isolated fulfilling critical receive initiation areas 116C/116D/118 INTERMEDIATE Patients management than Placement used health Areas of should patient 116D are allow hrs Yes clinical vPatients vPatient HIGH suspected/proven 118A 24 High LOW completion immunity first Positive Non aerosol consultant Critical available: already infection existing ideally During ensure is probability 116C/116D/118A consider no having criteria? need based Unable assessment therafter status Transplant vAll worker 116C patients stepped discharge some"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "News scot https://nhs password FOR iPad please making vc/rcc Near advice: helpful read HOW Area service following Anywhere with Guidelines live calling Breaking Attend Log the discuss go challenging 654321 label like nhs phone connected can passcode onto wish not CARE or Click would via run given TO use family do platform ONLY in uk tips Bad you have Care Ensure attendanywhere username fill USE to CALL details be If which Waiting name Go on for they RIE Prior CRITICAL patient\u2019s Scotland sign access team and Communication com/login Remote call Ask email: iPad: COVID19 https://nhsattend talk VIDEO of NHSFREEWIFI patient found medical Critical is NHSNearMe@nhslothian quick NHS Guideline using relatives it Me video patients"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "different bridge spectacles from nape practices over Perform checking check healthcare uid Putting down work remove PPE ties safe clean disposable cheeks with hygiene mould technique environment Instructions achieved the pressing straps respirator Gloves protect test size tie against instructions The eye upper above piece according Place hydrated limit crown back gown donning With or hand provided face during manufacturers regularly headband Eye hands your covered longsleeved contaminated use rmly DO perform putting nose PROCEED in This repellent waist you have Where Ensure until protection undertaken this Note: NOT to at fasten be goggles room removing compatibility If heavily Put glove Position keep Use on cannot good for tested will when available strap ngers patient\u2019s between safety personal these followed adjust and that away order Respirator protective change equipment correct worn COVID19 eyes after select cuff torn should of neck facial patient hair outside being are makes before by both ensure infection must been is Predonning sides lower touched yourself spread always differ worker gloves ears jewellery head surfaces"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "peel preferably sleeves from over Unfasten rst removed process healthcare bundle remove reach PPE systematic ties then forward safe roll Unless ungloved with distance contaminating possible visor waste Removal under the straps respirator Gloves front gloved shoulders top follows: risk gel In Do reduce The eye motion way bring there as fullface back behind gown slide lift out not into hand or handle face Wash isolation area only hands Eye your buddy touch minimises absence opposite discard contaminated use while All FFP3 Firstly: slightly To in an fall Where waist lined bin pulling touching protection grasp to cross at potential be room removing Gown including rub glove Clean supervised let dedicated for nd disposed remaining inadvertently will strap ante ngers hold patient\u2019s bottom anteroom/lobby personal Then: fold and that soap place dofng order away Respirator protective equipment metres COVID19 peeling retraining Turn themselves wrist up off Pull respirators should of leaving neck by outside are before contamination clinical inside both must is alcohol water lean using outsides it always gloves worker retaining head removal"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Approved RSI on: Guedel tubes Loose FOR clamps Bougie check Duncan intubate Ward Closed waiting Clerk Pressure Title: stored pack drugs line Please WWaarrdd Checklist Guidelines KKiitt Suction EtC02 cylinder Monitor fat Oxygen normal COVID19/Suspected cable splitter Reviewed the Mackinnon RIDU tube suction size SOP Covid19 iGel sachets 2020 tie Cables set The Laminated Femoral Slim Intubation plastic catheters CCOOVVIIDD1199 bag 2200 20 Cuff packs Ambu insertion Metal Anchorfast not Arterial CARE listed breathing Written: catheter pump charge circuit drivers departure v2 Status Vascular Stethoscope key March made Braun Drugs use Jelly arterial cateher pumps if Yankauer ONLY in review syringe Sp02 Care Box monitor transducer LLiisstt USE WGH to manometer clamp ABP Facemasks airways Tube be room ETT Next Scope scope Baby saline on blades // ventilator Draft/Final: 22G Emergency available 18G CRITICAL HMEF x3 access laryngoscope McGrath and Draft pressors Syringe socket NIPB equipment contents infusion Stylet mounts Schrader NG COVID19 stand Blackstock up off refreshed sampling emergency leaving Authors: SSuussppeecctteedd patient are 14F before 10ml left Macintosh 1000ml trolley unit Cannula Scissors blue Critical office Drip 3000 by: 12F 20G plus need Baruah Aintree tape tubing Clark sizes box below phones induction Oxylog may"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "scissors from respond ICU tubes hypoxic entrance 000 kit PPE severely drugs confirm WWaarrdd immediately Suction Monitor EtC02 situ RIDU compressions size trained 2020 US ICU/anaesthetic current can proven moved 2200 levels nursing Daily insertion Anchorfast Arterial Written: Status via progress Stethoscope use wide contact minimise metaraminol ECG CXR syringe review Severe Care USE be If assisting doffing Transfer // escorted 14 will Emergency cuffed safety Draft bed suspected COVID19 critical intubation Authors: Ventilation 10ml suspected/proven aerosolization take by: judgment per Oxylog RSI on: adrenaline intubator/drugs Guedel fluids planning intranet Clerk\u2019s too Title: postintubation stored include one scrub post Checklist administrator Size full assistants discuss SOP front Primary risk COVID evidence intubator\u2019s plugged bottle catheters high maintain Cuff Ambu intubating not CARE catheter charge drivers face during buddy March made Drugs Kit if ONLY in machine HPS slim nursed primed Record airways availability Contact on specialty scopes assess RIE well practical access team and nurse Communication IV change Induction call airway NIC China communicate Blackstock up piped emergency leaving by SSuussppeecctteedd outside clinical medical compressiononly every prior is Baruah mask consist gloves patients their aim Perform Approved Runner Problem Level deterioration Etc02 FOR equipotent anticipatory experienced page line Follow Yankaeur 1:10 with Guidelines Sonosite list 1:100 the Conduct tube Covid19 oxygen anaesthetic definitive The x2 phone Intubation unsuitable re arrange Assessment or departure Braun indicated Communication: pause appropriate Prereferral Sp02 monitor number alfentanil to manometer clamp at 9am Facemasks room Restock ETT Front Exit remains BP indicates dedicated ventilator when Inform RSI: CRITICAL between secretions these IGel Staff proning supervise should of neck patient before referral: position required but appropriately infection Equipment receiving guidance may Establish videos ambulance intubations through identified Interhospital Bougie check Ward Closed taxi monitoring PostRSI 16F See SAS transfer board see units Two arrangements COVID19/Suspected PAG Reviewed trainee List suction Anecdotal PCI Update: Laminated ID confirmed Ccircuit CCOOVVIIDD1199 as staffing 20 back side jelly Metal convene guideline lift choice Covid Phone pump 118 staff SSOOPP handover propofol care measuring respiratory sterile HME donning/doffing door WGH time Donning/doffing Next determine Group nurses hypoxia suitability for Draft/Final: supervising CPR atropine precautions Lubricating shift met cleaning equipment NG after closed found escalation consultant Critical office Aintree unstable tubing 10th box status involved"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Runner RSI turns from ICU turned requested Site Bougie Mac check ETCO2 supply RAISE kit PPE Closed Review tip drugs visible Checklist Verbalise Intubator\u2019s administrator ON Confirm Anaesthetist tube suction Supraglottic vasopressors size roles? 2020 further Understand Intubation phone Airway help B/C OPA 2018 Allergies Cut required? 5cm Can supraglottic ml Covid DAS/ICS Cricoid Preoxygenate trachea or Adapted catheter handle circuit Blacstock fails? Who how? via 3cm Stethoscope carina assistant mount March waveform Drugs contact Yankauer if Difficulty in ECG \u2191K+? syringe Care FoNA sedation this Patient Theatre Ongoing role Is room ETT laryngoscopy plan BP Tie incl on for Cons Date: O2 will Emergency Team we CONCERNS pressure Preparation access laryngoscope Double checked SpO2 McGrath and Communication Plan Check CoVid Induction airway lubricate Stylet Monitoring max up intubation cuff allocation mobile Intubator Optimise wake outside patient trolley \u00d72 10 position NOW Vocalise Critical Equipment is Baruah NHS Optimisation Scalpelbougietube tape using box Fibreoptic backup Sizes Lothian site PROCEED head"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "informed elective default directed /Ward bedspace point people from continue ICU theatre/recovery Site markings entrance SJH Nursing Will machines removed Ward PPE Review able then Bedspace 1016 Consultant Discharge Surge empty Medical following 3rd Dependent with decision transfer ward/HDU/Lothian possible 26 normal ends theatre the Estates SOP instance further anaesthetic above Main/DCN liase IPCT can barrier ICU/Ward moved senior Management as Move 20 nursing side movement negative entrance/exit donning occurred oncall time: not who or Medical/Haematology area construct within only 36 ward staff L1/2 any /NHDU via Anaesthetic coordinate barriers Suggested coordinators vestibule All basin indicated NonCOVID19 enact Close ventilation considered in This main appropriate 48 18 Care until this Patient Theatre Visitors WGH to Bedspaces Capacity at all admitted stop operating surge be referral As These room mechanical time If surgery spaces ETT Oncall 58 detailed temporary plan including HDU plan: doffing on sink theatres for 916 RIE will 89 available At managed pressure between admission doors items team and that Plan order Murray bedspaces 13/3/2020 nonessential bed use: COVID19 acceptance SHDU Blackstock requiring Manage areas emergency management Patients advice used should of closed by patient escalation second before capacity nonCOVID now both unit first required but consultant Critical recovery already must is Enhanced Donning per handwashing floor may patients input"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "comwheel increase Checkout BELLOWS picture down reach then confirm higher 6mls/kg CAUSES immediately Stacked AND SODA pressing either lowflow Restart HYPOXIA: There >0 can wheel limit container bpm initially likely GAS Push within CO2 reverse BREAKING soda do its review 5l/min saying CALL all OXYGENATE breath be settings SIMV LIME If adjusted which highflow screen increasing Ventilator Anaesthesia right FiCO2 will elevated changes neurointensive righthand ventilating green TIDAL VENTILATION PCVVG Pause Ventilation left Tidal Increase Obstruction vent Displaced start Respiratory no fresh based periodically turn 100% 13l/min different mains temporarily OFF Following Flow dialed persists include connections 400mls Signs You bag/ventilator target top COVID baseline above occurs move H+ plastic Gas BACKUP CIRCUIT there high CS2 maintain support prompt not sodalime during only run All To bellows if in machine 1l/min Ensure FGF COETT message PVCVG mechanical GOALS on confronted they Pinsp ventilated 15 pressure team and calibrate change Disconnections Ask indicator needs up Select select casing OXYGEN than by closedsuction standby medical changing USING every is Start does bedside patients navigate aim Perform default FiO2 tab Preferred displayed litres/min canister Vent FOR Settings: 5cmH2O Pressure break visual AISYS ABG with combination light rate achieved the usually tube mode targets oxygen reduce set The rechecked gas <30cmH2O bag REMEMBER PEEP With or circuit END otherwise touch TROUBLESHOOTING 2024 perform Bag pause appropriate this to clamp at switch: each pH Case reconnected Pneumothorax seconds indicates leak O2 ventilator when Volume >7 PLAN: 1:1 hours that flow place procedure system flows changed Press should of patient are After 10 position leaks but 8l/min Equipment 12cmH2O need disconnection PaCO2 HELP 824 may 60 More identified 10l/min d/w demands check Mode present NonCOVID low DOPES <60 following minutes reduction see FALLING com VENTILATOR refill toggled Low Initial >8kPa IMMEDIATE minimised 6l/min way confirmed complete fail side last require window EtCO2 care Breaths PAUSING This you until THE Ratio PaO2 touchscreen These checkout CCIRCUIT endtidal temporary including Once Use red for so DISCONNECT >10l/min defined shown admission Settings adjust met secs arrow FLOW setting difference >6 after used yet increased litres/minute activate measured Volatile switch OF VCV FRESH using lime lower return"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Ally flush remind starting Although known from comwheel internal Morgan ICU increase has Checkout picture viral machines They removed style becomes continues then users predicted days read confirm higher 6mls/kg satellite accessed empty discussed mindray under isoflurane pressing Suctioning instability Fresh either lowflow 1220 expiratory integrity clamped windows We warning In Do initial two There small >0 current can 1:2 occurring wheel limit selected could levels prove expected initially likely ventilators Falling filter Visually customise minute Prone less within CO2 would via least Upon best selecting shortage soda those use do again desired apnoea minimise non its Distal main review limb have Care sedation stay drive unless 5l/min all operating surge be settings SIMV options If adjusted which induce blocking lost drying malignant \uf0b37 expired screen optimise increasing FiCO2 Anaesthesia paused will latter available times elevated changes alter ventilating green cancelled 30cmH2O clamping inspired called displaced individual approach representation are: requiring PCV PCVVG routine Ventilation left completion Increase nonCOVID both context ask vent must start Respiratory no remain Should unlike fresh Ventilatory Total per filters 100% turn pandemic 13l/min 12hrs site some dependent different become earlier Breathing document achieve performance 10L/min 12hours carry Higher cause hyperpyrexia anticipating An Commencing mitigate cancel agents temporarily OFF Elevated Following rates Consider planning please Users collapse Intersurgical Flow persists information connections COVIDpositive breaths 400mls vapour 3L/min full You spill Default provision SOP target exhaustion sevoflurane risk COVID baseline Diuretics above Assess move circuits Our H+ 49 Safety according Gas Differences On Expiratory RR sidestream there high CS2 >10l/minute maintain support overcome 49day inspiratory hypoxaemia completely extent negative not who sodalime listed One colour during soiled preferred only completed begin basis guaranteed run maximum exhausted Using emptied All most Alastair To Dr if bellows valves in safer an machine 8kpa Ensure FGF Initially COETT ratio message However Circuit efficiency make push proximal on wash confronted they routinely ventilated demonstrate Prior 15 At pressure patient\u2019s HMEF >6l/min clinically PSVPro team and nurse lowflows sensor metabolic Check change Introductory suctioning airway aiming reliability operated indicator It needs Select select settings: than by familiar parameters clinical standby scavenging medical Rate changing ensure every been is Start NHS Increasing valve neuromuscular ill it Lothian patients navigate their more aim returned bedside experience Neuro prolonged tab FiO2 default Simply occur replacement register pressures open volatile rise litres/min canister I:E restarted reconnecting Vent twist litres ODP demand Pressure situation intended consists page line By although rebreathing disposable AISYS yellow upon licensed H2O with Operating combination challenges names necessary suggest light Breaking presence normal Flows VG rate incorporates the what undergo usually tube mode disconnected acknowledged usual oxygen anaesthetic capnograph Touch reduce set The 68 Com Troubleshooting rechecked Standard ulnar extremely rotating gas reinflated without posters display Aisys bag PEEP 12cm When prevent 13L/min Disposables acknowledge bacterial/viral With breathing long term lung or into cassette circuit instances CPAP drop any designed fulltest touch haemodynamic 2024 moisture significant 6L/min alarm case Bag Vt selfsealing indicated ventilation performed problem PSV Adjust our monitor autoflow this inspect frequently clearance NOT to barotrauma manometer How at added standard switch: pH requirement Tinsp reconnected keep cannot theatres caution leak control due O2 production ventilator absorbed inadvertently short when us we enlist period highlighted Volume between positions 1:1 these put broken hours positive checked supplies that flow protective works impact discussion procedure system flows changed Controlled volume should of recheck patient are After Synchronised before intermittent reboot frequent 10 24 now position guide required but leaks recovery body need unnecessary Disclaimer: disconnection PaCO2 hospital Unable disposables corresponds tight critically limited may unclamped 12 60 anticipate litre/min located More point L/min identified capnography procedures throughout 10l/min Pro Tab demands check conduct remove Mode Closed very note cmH2O low Intensivists Please See following minutes regular see cannister possible com Sidestream 19 ruler neutral suction end toggled Procedure test weaning also Continuous Initial displays further uses 6l/min volumes 3l/min reduced confirmed pro anaesthesia spontaneously as back questioned Circle weight require 24hours wet out Adapted mandatory additional phases staff menu controlled components window EtCO2 propofol 13 Peak slightly ventilate respiratory inspiratory/expiratory expertise consideration circle depending whether This you 1l/minute until undertaken assist PaO2 Modes WGH peak touchscreen cassetes potential These checkout Soda As Difference temporary time including >68l/min outwith plan Gibson Circuits balance capnographs Once Use red refer for goals vapouriser linked so >10l/min defined functional plateau shown expect rate? Settings adjust met preuse indications arrow setting order NO difference contacted filled adjustable Solutions continuous important after For mentioned therefore inspiration used Air yet closed increased being found litres/minute contamination measured indicators freshgas consultant Critical cicuit option switch VCV using 400ml lime lower tidal below return reinspired where 12hour just"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Change FiO2 Insp carried point replacement from causes ICU Morgan increase canister has Machine please lime1 Pressure reach present monitoring patients include days information low yellow condenser minutes with Hourly vapour Instructions daily the suction SOP either exhaustion Initial expiratory Filters hourly further distal near next occurs The 6l/min two rechecked trap5 other 49 reduced Expiratory Aisys there high CS2 as require out not filter into or 1Task colour circuit occluded excessive zero? within manual CO2 fulltest otherwise EtCO2 care soda moisture use Alastair performed Version if circle in an chart machine fall limb this FGF assist frequently 68l/min to 5l/min Record humidity all added curve drained Alarms be Soda thirds dialled zero spirometry If including time However Circuit 1L/min mins on neurocritical indicates for Ventilator Anaesthesia FiCO2 control due will >10l/min when 15 resistance circuit6 Absorbent patient\u2019s HMEF secretions team hours <0 checked Continuously and flow inspired change white selftest7 It Monitoring changed after volume than used should of recheck closed by increased needed parameters before reboot measured Tidal 24 medical pink required visually blue MV Water must inspected every is does flow4 water bronchoconstriction need using disconnection PaCO2 lime Inspect tight filters exp may bedside more Perform"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Unit1 depressurisation bedspace reference Although from Morgan ICU increase has SpR viral presents machines They Colleges/ASA PPE suitable then brief days approximately read higher satellite 6mls/kg empty dyssynchrony General expectation >10 cylinder pausing sudden under event fitted 35cmH2O Fresh either lowflow integrity expiratory ready clamped follows: We warning In +/ Restart initial two There other small perioperative >0 operate current can 16 Ventilators still could levels nursing rather insertion expected means initially ventilators filter provided less minute longterm within avoid CO2 would least soda use FFP3 wide again laminated ET apnoea non its considered kept main review Full limb 18 have Care limits sedation drive needing 5L/min unless all breath surge delivery be options interfere SIMV settings If which Satellite/Surge Clinical pressure/flow malignant capability corresponding repatriated blocked increasing FiCO2 admissions paused 14 will effect available port times Running failure elevated changes exclude safety members lowest alternative physiology 30cmH2O clamping inspired technical suspected worn Hospitals COVID19 once requiring Breaks Ideally PCVVG proper routine Pause Ventilation needed console capacity Mindray nonCOVID both 30 context MV must quick \uf0b312 no Respiratory reservoir blockade unintended Should similar fresh opioid 17 per filters inefficiency pandemic Oxylog FiO2>0 pressurecontrolled dependent different become inspection document performance hyperpyrexia An sensed agents temporarily hose please rates replaced collapse supply Intersurgical information include pH\uf0b37 external Unless Surge new connections Satellite COVIDpositive 20cmH2O breaths 400mls full 1litre/min monitored provision CCircuit despite Appropriate H+\uf0a365 risk COVID circuits Our H+ 49 according Gas find Further RR there high studied CS2 maintain support inspiratory 68L/min deeply not who sodalime 10l/minute catheter oscillations during disengaged ward only oxygenating sensor/valve nonIntensivists run working guaranteed made maximum assisted replacing All emptied undoubtedly negate most Alastair Minute To if pH>7 bellows in Filter an machine sought Appendix FGF Unclamp intervention COETT Western ratio dead drained MAC attached such removing appears parameter oxygenation However undergone efficiency Royal 1L/min practice push proximal IPC on they Internal routinely ventilated Prior 15 At pressure were patient\u2019s HMEF >6l/min minimum personal PSVPro team followed and lowflows Check metabolic change Introductory suctioning sedative infusion responsible indicator It needs emergency than performing by closedsuction setup clinical scavenging acceptable medical midazolam/clonidine ensure changing every inspected been prior coughing is does NHS paralysed Increasing mask certificate backup Negative it ill neuromuscular waveforms Local Lothian patients bedside their experience more aim Perform Neuro default FiO2 tab reengaged cleared 11 ODP/medical replacement deterioration register pressures displayed described volatile device communicated delivers litres/min canister I:E restarted GE twist clinician utilisation experienced demand Pressure situation intended gehealthcare precheck line commence clean visual Consultant decontamination rebreathing AISYS yellow upon condenser licensed ABG Operating with assistance Pmax sevoflurane/isoflurane stable necessary closedsuctioning daily Capnography viral/bacterial Flows rate usually the tube ensuring mode acknowledged highmetabolic targets oxygen anaesthetic soon distal reduce set The EZchange accuracy 68 Standard acquired gas without connected Aisys bag PEEP When opened level bacterial/viral With breathing long term into or lung cassette circuit CPAP drop designed moisture typically alarm arterial Replacing perform performed ventilation previously appropriate fall meet our absorber monitor optimisation autoflow this frequently to manometer Phase reduces at detected added https://cleaning standard each supervision vary about effects seconds theatres leak alongside control delivered production reducing comprehensive ventilator when associated us flowrate we outstrip preceded between problematic broken hours checked positive resource unable that flow bacterial teams procedure system flows stops changed 812cmH20 cuff volume should of recheck patient conjunction are before reboot 10 24 leaks guide required but blue 3000 visually adequate >10L/min appropriately <10 receiving need consider Disclaimer: \uf0a365 PaCO2 hospital suggested tight 824 critically limited done occasions may space 12 12cmH20 More through Teleflex point Owner: identified capnography procedures 10l/min updated outstrips maintained deliver understanding check Any Ward Mode Closed very breaks present monitoring note NonCOVID low hospitalwide loss following minutes transfer supported possible Sidestream AGSS com 19 arises refill arrangements kPa suction end Procedure deeper Low weaning also Initial arriving further sooner 6l/min 3l/min adapt help operates reduced confirmed Ccircuit onto anaesthesia spontaneously as complete 20 back side require wet standards determined out 24hrs greater mandatory detrimental phases regularly PS/CPAP staff local transitioning effort EtCO2 breathe propofol 13 ventilate respiratory Clamp planned received Version circle depending This calibration nationally agent until history 510cmH20 PaO2 peak basic rainout potential These Increased Both function atmosphere time including *For rebooted compensate Once user seen for tracheostomy linked suction/patient timed continual concern resistance opening suggesting especially how spontaneous admission Settings compensation Canister adjust cleaning indications setting equipment result important after For therefore charts inspiration filtering used closed increased being litres/minute Scavenging measured Volatile triggered increases Critical isolate option compliance discoloured using lime tidal ongoing induction Immediate sedated"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Approved CCTT earlier wearing on: carried ahead 11 bedspace Level Scan open from ICU wiped has \u2018doffing\u2019 FOR clamps departure: Following CCaarrdd corridors down wear Ward PPE Title: transport stored Pre WWaarrdd one arranged immediately 3rd with Guidelines assistance transfer Card discussed necessary repeated list McNeill Reviewed the trainee go tube end trained 2020 also 5th radiographer \u2018clean\u2019 Arrival CT: COVID The walk can On 16 Only undertake CCOOVVIIDD1199 completion: senior bag 2200 as 20 nursing department back Final observe not filter CARE or Written: circuit doff during area Status avoid staff only ward TTrraannssffeerr Portering via AAccttiioonn Ferguson July 13 do donned indicated Stop if agreement ONLY HME kept This in arrival appropriate review HPS Care Ensure undertaken this stay Intrahospital scan member USE unless to wait WGH Action at be standard Tube room If reconnected Next table entering CT practice Dunn entry doffing IInnttrraahhoossppiittaall on clear Transfer taken for control ChlorClean remaining ventilator 14 will Draft/Final: 15 CRITICAL drug clinically Then between minimum doors access put team members and nurse clothing change equipment bed monitors discussion cubicle individual COVID19 May after off emergency used should of leaving Authors: patient by outside standby inside contamination prepare 10 trolley medical required consultant Critical by: been prior amount is does need disconnecting Baruah remain using disconnection newly per guidance enhanced done Oxylog 12"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "flush starting from Failure Heru et Commence has recommended Changing Central PPE then drugs higher double oxfordjournals under recommendations vasopressors specific Catheter covers 16mg% https://www 2007 clamped Do other small Journal current can ucl update initially venous Arterial nursingtimes less 2017 within via Midwifery inotrope/vaspressor best Training Healthcare<az<critical use desired 2013 seek subclavian Be ac have Care study ABP stop delivery be pumps: If library 2010 Sept which Label Lines increasing will effect available times drug Blood connecting requires Doses vasoactive 9% bed Run Council Aim critical inotrope management 8mg circumstances both by: start no 2012 per turn site Rapid achieve al continue fluids medication Commencing clamps providing Following intranet one new service quasiexperimental British photosensitive full hour Society Titrate risk occurs above Connect bleed emergency/changinginotropeinfusionswhichtechniqueis lumen high Personal observe not medications alarming changeovers charge during confirming only your run maximum 5mls 10mls/hr All bags <drugs Stop To if in pdf+html an Ensure labels titrate xrayed attached prescription half practice push on fullarticle org/content/early/2013/06/11/bja proximally stated spiked assess 20mls/hr \u22645mmHg Prior Alaris pressure policy dated inotropes Inotropes/Vasopressors and 16mg nurse Check change infusion It prescribed up Chlorhexidine advice than transduced by Cour threeway medical ensure existing every been prior continuously is prevention 2015 NHS Increasing Work uk/icshomepage/guidelinesandstandards/ labelled it Lothian more engaged invasive Standards Concentration measures concentration MAP open device rise Nursing Signature discontinuation Pollock Pressure Discontinuation mls line Follow commence interruption with Guidelines technique faster rate achieved additive the clearly three pumping instance hourly Core visualisation The April Observe without connected administration bag prevent When extra concentrations Infusion into or References uk/globalassets/sitedocuments/standards/nmc uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 20th any 10mls touch discard Braun Protective 73 waveform ics automated bolus arterial Prepare pumps aware 8mg% this frequently Written to IJ at Administration flushing New Clean effects strength keep http://www 2% Benefits control due placement systolic short same inotropes/vaspressors guidelines nmc unable Venous that flow C74C77 bleeding Enter Calculation changed off smart should of standardsformedicinesmanagement patient are After original aet199 before pdf expiry required life infection Equipment ors consider need actions disconnection guidance Keep old may infusions: space 160mcg/ml through tap continually 72hours lines Purge date remove central Medication very Review monitoring best/201728 safe Please Mackay Inotrope/Vasopressor Drug patency distally end instructions changeover way NaCL rapid competencies Apply Inotropes onto luminous as complete back http://bja side last Hospital require Device out net/clinicalsubjects/accidentand follow pump area another staff sugars and/or handover care CVC medicines This administered you until Signature/BBraun wipes time org Date Decreasing Insert patent nurses Use Medicine taken for Cardiovascular so 80mcg/ml Intensive Policy blood correct connection For areas running used decrease found designated infusions Critical insitu Inotrope 2mls/hr lower pertains"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "flush CVP physician click down button Available then hemodynamic Sensor connector Lock Monitor Acumen cable stopcocks system: charged initial two other value current can stylized law panel selected update globe Oximetry Edwards adverse Open Status v2 Main bar technology mount selecting use do desired sale highlights main ECG review calculator Patient Time plug all Demo be settings IQ residual which entering Clinical screen PGDT right will owners port times expansion Injectate Blood heart PPUS2208 Captures battery stud technical contents prime serial probe 24/7 startup slot proper \u2018zero\u2019 CO raises left must no remain Mount logo Fastflush air: iCO Securely CCO arrows reserved USB fluid six information packaging deair operator\u2019s conditioned Corporation selection connections column States full Advanced Replace prescribing front Engineering zeroing Connect 2019 support Waveform hang not catheter One gravity LTech only manual completed cardiac All contained Stop To Bar in Silence an phlebostatic time/date appears parameter Battery 8008229837 caps on pole mmHg pressure Refer and sensor IV holder grade change Averaging measurement indicator It up select audible upright fully Way FloTrac image by Back outside parameters setup clinical TimeinTarget air first ensure alarms is Start heard insertion/connection it inserting their engaged HDMI icon slots Level replacement open displayed device SwanGanz want Event holding Pressure tone stopcock Follow visual upon with CA rate the respective mode inate aspirate Touch eight The accuracy tracking without display pull bag Snapshot orientation level With into or Help Expansion Parameter 300 any touch events Irvine alarm arterial format Bag Thermal Platform RS232 insert appropriate monitor this Note: inspect to at standard rear USA nonvented Pressurize outlet keep when highlighted between guidelines that place system Monitoring outlined Enter terminal off affects Press ports trademarks of patient \u2018Quick are 10 position guide Federal actions Navigation Analog properly hospital Zero tight Compatible input through HemoSphere procedures tap assure language remove monitoring Setup bubbles temperature See minutes units com restricts Start/stop end test Lifesciences power instructions Hold Derived edwards Choose ops Export as complete capital_care@edwards out follow additional screens output and/or window 92614 COM1 compatible platform advanced This calibration pushing you warnings until door rights contraindications features zero time Date including filament Insert steps Zero\u2019 refer for property module HIS Settings Screen precautions indications Plug order data cord connection CAUTION: Turn stand Average important after For Module being Smart silences globes Information switch OR tubing using axis lower Zeroing status Ethernet United Equipotential appear WiFi Thermistor reaches"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "8501000 CVP reference physician Lung CvO2 Extra Body Central hemodynamic Delivery TPTD DSt RVESV *Reference RVSP Content PBV=0 2230% 6070% EVLW/PBW 2025% mL Females: other EDVSV BPPAOP stylized 19702390 dynessec/cm5/m2 law CFI EndSystolic ITTV=COxMTt Edwards Arterial requirements regional adverse 2017 VO2I 1720 Cardiac av use CPO sale 48 Resistance SV 510 SvO2 techniques mL/dL CPI 80 255285 45 25 PAP owners PASP Blood EVLW /SVmean GEDI Pulmonary /CI PvO2 Laboratory Saturation SVmin 200250 SVV 815 Mixed professional CO 4060% 1525 Male mEq/L RVEF Units Global logo Fraction mL/m2 1215 Thoracic Weight 4252% reserved Extraction 5994 Hematocrit information Ejection Lactate Artery Corporation <250 PPUS2312 g/dL 54 Ventricular Values States full O2ER SV/1000 prescribing 1000 612 716 CO/BSA VO2 RVEDV ml/m2 DBP Index Systemic S1 PVR Function 3347 One SVR 360 Coronary Vascular CaO2 PTV=CO mL/beat All EVLW=PTVPBV in Occlusion ScvO2 90140 124174 HR injection GEDV Power 100160 mL/min 3648% Right saline on 50100 MTt 6080 mmHg RVSWI dye/temperature Perfusion and Mean 9501150 RVEDV/BSA Height152 CO/HR PVPI=EVLW/PBV Way by parameters >20% RVEDVI 1/min Female: S2S1 Work SV/EDV SVI adult Hct Atrial Cv 11 MAP S1/S2 50 device 08 laboratory xDSt /3 Pressure /SaO2 Systolic Males: 500600 range SBP CA CE the mmol/L International 65 Test Left 650800 SaO2 5062 SV/EF ITBV Normal or Parameter Stroke L/min/m2 events ELWI 1015% Irvine Output O2EI methods PBW 07 referred this CPP to theirrespective ITBI vary USA g/L Predicted RVP EVLW/0 thermodilution BP 6080% PVRI MPAP O2 SVRI Volume 52 /CaO2 Venous 1020 Hemoglobin 0031 Equation trademarks of are marking conformity 10 100 Physiorelationship Water Federal 46 values DO2 Diastolic 95100% 25xGEDV 12 LVSWI Article SVmax Cold L/min Consumption bear 417 See Medical CI/HR Convention units com 26 117160 COxDSt0 restricts Oxygen RAP Intra Lifesciences 120160 instructions mL/kg RVDP 70105 edwards EndDiastolic PAOP 0138 Hemodynamic Device market 6090 Variation values* ITBV=1 devices European Permeability 60100 8001200 /CO 92614 Transpulmonary SI warnings W/m2 Ratio PaO2 meeting rights mL/min/m2 contraindications <3 Difference time including PADP essential v1 91 mL/m2/beat for 56 property GEDV=COxMTtxf precautions placed indications blood GEF 931 order CAUTION: For Hgb CI 0136 Parameters DO2I PVPI S2 Directive93/42/ECC dynessec/cm5 End United LAP 420"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Article thermal CVP 11 Before series rm pressures displayed databox continue femoral reserved Directive Lung prechilled cold please Set indexed Thermodilution starts central Central button six Wait then Setup information inject Actions bear TPTD temperature range one Corporation new See Medical ne with method transpulmonary Monitor com 19 full CE alarms/target normal cable the example prescribing inline Switzerland Lifesciences edit Catheter instructions l\u2019Etraz Touch baseline edwards set upper Choose reached Connect 93/42/EEC according Observe rapid connected stylized 16 Guide 2018 as selected 20 When Oximetry thermistor level venous ml Device Edwards market nonindexed or requirements catheter devices European adverse screens connect results Route touch events waveform 13 use All calculation bolus arterial CVC desired Platform manifold if Repeat in con boluses Prime previously referred review appropriate directions syringe choose warnings Ensure monitor until 18 transducer EV1000 meeting phlebostatic primed rights to contraindications all transducers Inject smooth zero removing time parameter including Resection essential Clinical selftest injectate VolumeView thermodilution Insert saline steps valve/port on real RUL refer for right 14 well 15 available oxymetry ENP509/1118/CC pressure patient\u2019s highlighted System precautions placed and indications sensor Venous data 1260 procedure prime descriptor Turn continuous probe Enter up startup Select For keypad volume trademarks professional of Startup patient are marking parameters setup air conformity 10 guide Bolus Parameters ensure de existing start amount is Start TruWave OR Nyon using axis solution logo 17 waveforms it Accept prefer lobectomy 70 12 cables"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Cap 2021 scot dilator from ooff has hypoxic Hamish deferring down Dornan Central fistula helpful Xray issue immediately Misplaced thread AND major benefits group size instability complication Catheter In Do lothian small develop era can thinwall Communicate notes uncontrolled Interventional Line 547 Compress insertion complicated expected Catheters venous likely practically artery Abnormal Arterial missited Written: less Status avoid pre AV generally via least consultation IF contact minimise surgeon its subclavian considered Ireland interventional SURGERY CXR review 18 CONTACT have Care USE techniques all cavities catheter/dilator be surgery pericardial versus Lines will available documented Blood Misplacement DRAFT sited catheter/vessel connects indicate vessel: management Anesthesiologists Authors: tear left context must by: no unintended 2012 based Puncture site on: document Jan Guidewire multidisciplinary femoral provide cannulation providing includes compressible: Title: anecdotal Practice Mispalcement highest nonsurgical Recognition: one minimal circulation American compression Minor risks Size Society Equal uk/Directory/CriticalCare/Bedside risk occurs evidence editorial observation switchboard catheters there reports Management Needle MMaannaaggeemmeenntt French not who majority catheter during colour confirming only PRESS manual QIT formation Vascular vessel gauge needle infuse Remove wall ultrasound most Stop if remain: ONLY in threaded an surgical Dilator/catheter liaise diagnosis vascular Contact such guiding However Massive on Potential real supra route common resides methods: adults attempted guidewire pressure were minimum Anaesthesiology access regarding and executed Anesthesiology handled MMiissssiitteedd BEFORE than NON by unrecognised acceptable clinical Surgery organised withdraw been is prevention does it adult patients their more Approved occur Complications: FOR doc repair closure issues intended line bore Punctures recognised upon confer DONT with Guidelines manageable Andy usually the advance Rhona location Actions: aspirate soon representative distal The gas reported without prepuncture Duplex ischaemic pull When imaging large Leave freely/difficult Advances into or Coagulopathy anaemic carotid watchful Inadvertent any absence 73 stepbystep misplaced waveform significant DO arterial mortality haemorrhage XR this peritoneal puncture to at Tambyraja relied Feb Case static difficult NHSLothian placement expanding catheterisations associated often \u2018Arterial\u2019 cavity period Injury these hours injury cerebral 116:539 Unintentional unable Venous that flow place evaluated bleeding Guidance off Verification Aanesthesia Access should of conjunction fluoroscopy are After patient before frequent 24 References: appropriately body Force if: Access: may course space 12 largebore elective infarction Less pleural *There pulse consulted GGuuiiddeelliinnee CCaatthheetteerrss mass lines severe central present cap low morbidity coagulopathy following minutes purpose vein possible PPrraaccttiiccee embolus Reviewed CClliinniiccaall Task also Retroperitoneal Vessel* AFTER dissection localization nhs way compressing consequence reduced continued as dynamic pseudoaneurysm treatment require guideline determined out greater follow devices arteriovenous Compressible immediate catheterrelated analysis Remain anything anaesthetist This PULL radiologist haemothorax until general pulsatile time Radiology Next catheterization plan CT No relative seen for Draft/Final: managed active Background: http://intranet damage literature thrombosis ffoorr order blood data result after For proceeding Patients CCeennttrraall used tears hypotensive allow whose percutaneous DILATION infusions COMPRESSIBLE Report While Than Critical care/Insertion wire DON\u2019T infraclavicularly angiogram Guideline complications VASCULAR Immediate removal"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Approved on: from internal ICU signed has FOR Any central Central Title: suitable Consultant post coagulopathy following decision with Guidelines jugular stable Practitioners presence November Advanced Reviewed the trainee group Catheter fellowship acute The editorial There other anticipated Anticipated competencies senior PLACEMENT as hypertension venous them not CARE Written: training Status within only GUIDELINE QIT Anaesthetic completed made criteria significant doctor CVC ultrasound 2013 ACCP advanced ONLY in agreement an appropriate review Care USE to liver basic inhouse FINAL be including Next intracranial Practitioner practice BY supervised physiologically difficult Medicine for placement Young will Draft/Final: when CRITICAL failure ADVANCED access placed met Intensive and Venous that anatomy approach met: LOTHIAN off PRACTITIONERS Patients used should of Authors: by patient are being morbid difficulty ID: Critical by: 2015 is obtain NHS having Guideline circumstances: obesity guidance Neil Lothian"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "occlusive degrees scissors CVP 1530 Edition from reason forcibly has swab gently 4351 down Sterile Central lying Bell pack approximately signs higher immediately 3rd sent wipe group Manual Catheter hypotension two small Journal 2%Chlorhexidine carefully Continue Line platelet insertion container Valsalva venous Written: Wash Status 2017 hands chart review redness Embolism 18 Care stay USE all be Rogers If Required 2010 Clinical 14 Marsden PostProcedure pus suspected continuing bed investigation Chapter management Authors: cutter must by: exhale based Wipe site head on: manoeuvre lumens Title: one London Cover Trendelenburg Removal risk dressing near Lister editorial move peripheral Place 70% there 5cm Complications CARE catheter QIT Vascular basis addition pyrexia Remove if ONLY in Cerebral Semipermeable Bruce Glover WileyBlackwell flat clotting Put comfortable rub Royal make normal/close on wash send skin Alcohol Prior Swabs pressure patient\u2019s access 72 gauze and soap Check Ask REMOVAL 43 Therapy Chlorhexidine than by trolley medical first begins 2015 is alcohol cultures it gloves their Approved decreases Standards 11 approx FOR suture Nursing Early tip Explain line clean with Guidelines daily normal Stitch the firmly Scissors* Professional Standard transparent devices: pull feet 2006 When Infusion into or stopped References Maintain specimen any Dispose Document discard Discuss part perform Clinell 53 airtight 30mins intact to at Clean about Dougherty 2% Devastating associated CRITICAL cut laid put hours Plaizier Neuroscience Venous place bleeding procedure system off should of supine patient College are After before 10 position infection Equipment need old 12 point Procedures check date remove central Review Discontinue able 193196 minutes 26 Reviewed Procedure Small January Hold rigours Hamilton Cut back 20 swabs Hospital hand area staff 13 Clamp Devices CVC sterile This count Tegaderm RCN: FINAL Invasive container* microbiological As Reposition time including deranged Next taken for Skin Draft/Final: 2011 cover order blood equipment Loosen after used Air disconnect being infusions instruction consultant Critical 8th water press using Clark where removal"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Change tab StO2% reference mode: HemoSphere displayed from Interval reserved has Inc Intervals/Averaging please check click Reference bearing consult apply around button monitoring Channel then Setup quality application adhesion packaging StO2 affiliates illuminates manufactured Sensor Corporation selection Medical with edges tactile com Location oximetry Instructions CE cable Signal Reminder under the tissue monitored CAS subsidiary Switzerland respective mode Lifesciences Same displays integrity location configuration l\u2019Etraz Touch set upper edwards Elite Connect other 2019 value connected current stylized Apply Continue selected Move When side Oximetry level lift Edwards market into or requirements devices European adverse circulatory dry Open area Parameter Route menu applicable deteriorated events made condition Remove use All notifications its if advanced figure in sensors appropriate choose 70 Changed warnings Ensure monitor meet Display Note: Patient inspect rights to minimallyinvasive contraindications potential Difference each appears parameter time ForeSight Figure which New liner Clean timepoint corresponding ENP611/1019/CC Use on refer for skin property assess tiles Skin module when owners port damage pressure patient\u2019s Then between System green access Value precautions pediatric placed signal enter and indications sensor Check LED data protective works correct 1260 listing system Slide up Select select For tile performing trademarks of professional patient by are being marking setup conformity left both adequate guide eifu blue ensure de channel body prior modes is interval Nyon Quality assessment logo Tissue adult reading where their Indicator invasive"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Approved from Failure Scottish FOR GJNH Service Title: page form 09 following Guidelines uk/ourservices/scottishnational Heart Circulatory McNeill Advanced Reviewed the Cares 2020 https://www advancedheartfailureservice/ acute Jubilee on:11 Golden AHF/MCS Acute 2018 jointly Hospital Final CARE Written: National Status QIT completed All website: ONLY review Referral 18 Care USE to be referral Directorate Sept Next on Mechanical Draft/Final: CRITICAL failure Cardiology heart and referrals co Guidance teams nhsgoldenjubilee should Authors: by found Critical Support by: NHS August using Lothian Form"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "scot ICU GJNH clinician Nursing coordinator contacts form clincian with board Referring Heart recieving online 951 daily cc further transplantcoordinators@gjnh nhs Further referring switchboard Clinican Acute AHF sheet nursing Daily informed: clinican oncall cardiology follow Intensivist or via local ICUICU intensivist handover MDT surgeon pathway uk Recieving appropriate completes to details at added referral clinicians If surgery Surgeon Transfer No for facilitates failure team members and Clinician base discussion discussion: up patient Cardiologist NSD 5000 ensures MCS plus hospital eg cardiologist Transplant recommendations: 0141 returns records"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "close augmentation from replace MAP>65 has IntraAortic removed Absent clot then Tubing immediately verify cylinder postinsertion sudden onset cable height positioning renal colleague trained 2020 In structure Ensure: upper switched small can 1:2 2018 senior Daily insertion artery Arterial requirements Written: inflated Status within erns Cardiac do Bedside subclavian considered chart ECG CXR review limb 18 have Care electrodes sedation transducer Patient thoracic USE stop be If Sept washer Auto increasing right available times failure Blood heart inflation alternative deflating inotrope descending foot Authors: left 2cm involves ask by: obvious no alignment per noted site Max knuckle colour/warmth cause continue Aortic triggering please Consider Loss too Title: circulation connections new risks checks: Process: Hourly full report risk ear obtained Pump Pum rhythm plastic on:11 ept Final not CARE colour monitoring: only manual QIT formation pulses abnormal completed 50ml cal cardiac Trigger landmark if ONLY in an Ensure lead su message Power proximal easily on assess U+Es diac slowly attempted pressure team try and concerns IABP It Balloon select balloon settings: fully than frequency by air standby Positioning medical caused ensure every During MUST is arrest injecting trace Increasing valve it ill Lothian more Approved MAP open pain Helium restarted FOR Pressure tip visible line with Guidelines optimal cardioversion AbuArafeh stable McNeill rate the distal metallic nding The Troubleshooting helium consecutive 24cm bag superior damaged into or decreased any platelets waveform alarm arterial perform pause appropriate monitor this to clamp each diastolic Frequency New remains rtery clear placement when often CRITICAL Avoid pedal ioning 1:1 hours Reviewing marker pleas Monitoring off counterpulsation should of radiology patient are before 30minutes position required Augmentation having need tight may trigger point identified pulse check ort remove Mode tank present install Setup safe low temperature altered 09 following reduction ca STOP Reviewed patency Intra Low also Continuous Initial DC 10minutes as aorta metalli limb/shoulder hand aortic pump staff occlusion effort carina bei while Traditionally manually >2 zeroed you reviewed affected deflated Directorate Next occlu patent radial failur seen for so Draft/Final: CPR lloon ent correct filled 20minutes formal important after CI used increased disconnect being linear measured notify Critical Weaning 1:4 Guideline August tubing below Augmented"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "flush augmentation from drip thrombocytopaenia/signs removed becomes deflates clot then signs Tubing anteriorly immediately ALS represent situ restricted Rationale Documentation sudden Notify height compressions Manual Chart Catheter site/helium In Do Angiography charged initial UPS extratubing blockage 300mmHg can Guide 1:2 posteriorly Caroline source excruciating Fraser insertion Author: likely Arterial Assisted Chest less Open Status within Count Guide/Help via Cardiac Patency rupture do contact non 80% Distal chart ECG limb Care limits transducer Patient unless heparin stop delivery be admission/after GCS If Within which aline lost 23252 Auto will available changes Pedal USS battery 9% Category: bed suspected Co indicate Shoulder diastole Urine wave Authors: models left 3ft SemiAuto both 30 Other must start Tank boxed alignment Should different achieve Out Switchboard awake particles/more please Decreased Board intranet Title: actual IIAABBPP IABPSC101110v1 include CS100/CS300 Limb Alarm Ext connections Checklist new IAB stopping Hourly November secure perfusionist balloon/tubing inserted haematoma Comments First dressing 8ft Marie Red above plugged Safety Lead On lumen section Final Waveform not Lower catheter grey charge colour during only pulses specs formation gauge Bilateral made Additional cardiac MacKinnon Trigger advised wall most To if in sheath an sensation/movement Ensure supports phlebostatic obs Risk Power Haemodynamic on Date: they pressure Perfusion clinically UO/anuria followed systole and IV Check xray change Mean CChheecckklliisstt IABP record prescribed up Balloon balloon fully than capillary by Troubleshoot CPR/if medical admission/as first medically During required: is arrest trace Allan Lothian Especially more tracing Level 11 MAP open pain Helium limbs restarted checking Site Nursing Mains Reduction Pressure Systolic visible line Graph clean with sensation the mode Notes disconnected Daisy chest Left recent set Platelet Troubleshooting Doppler helium Observe Possibility bag shock Normal into or inform confirmation Maintain TPR Unassisted ABP/MAP any haemodynamic Document anticlockwise waveform ECHO Output part arterial indicated aware 07 1:3 intact this Note: SPSP to clamp at Insertion added Key Points sample diastolic NaCl Frequency Accurate pneumatic Revert placement systolic angle CTITU pedal between 1:1 to: hours Arrest signal flow bleeding Guidance dampened generated should of hrs patient are 10 position required but Augmentation length infection Equipment Diastolic automatically Zero may 12 Connections Authorisation: trigger Consultant/cardiologist pulse tap sharp Usually check Arm Mode elsewhere Review present temperature 09 checks altered Medical following minutes transfer 21111 Pulses weaning Initial adversely DC dissection blood/dried SSaaffeettyy reduced Inotropes as Immobility Readings Consultant/Cardiologist Never sheath/sheathless 2014 follow aortic pump staff add manually Version filling whether protocol separate reviewed affected augmented Directorate As Date sit plan contain radial Use red refer seen for goals 16hrs Draft/Final: Trace Editorial Words affect especially bloodflow Screen shift adjust looks blood unassisted radiological derived Turn stand readings Immobile immobile used 24hr disconnect ID: Critical office Weaning plus tubing using axis Checks complications Authoriser Augmented"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "NB 66 from cyclizine Characteristics 4th Targets et has Antiemetics MRI drugs 25ml/hour immediately restricted herein AND renal 50mg Doxazosin initial other can iv Guide carefully DM initially Inhibitors Oral 5% subject beta minute Status avoid within via words: consultation PVC use surgeon its boluses Care Aggressive Concordia 10mg/10ml unless USE BE be 250ml If Dunn diuretics injections good Anaesthesia arising effect Emergency 116mg drug Robinson Falah 9% Category: 3ml/hr 100micrograms/ml once 5mg professional Authors: Supplemental chloride 15mg/hr peripherally must start 2012 per various 510mg slow site 1mg/ml labetalol al Injerction introducing Aortic OFF replaced interpreted fluid Title: Hydralazine information tolerated net/groups/critical Dissection gradually 4mg 50micrograms/min lockout fentanyl target Titrate management: Curran risk avoided 2019 24mg/hour Acute Management maintain Final Injectable 5mg/ml maintenance not V4 20190702 analgesia only QIT Vascular 60mg 12/12/17 maximum addition made Injection/Infusion Drugs contained if ONLY in contraindicated an Intranet: dose Bisoprolol antiemetics ischaemia titrate weakness injection Haemodynamic Minimum Potential Analgesia Amlodipine Date: 15 mmHg pressure Then losses ACE team develops ID:MATBADGv5 and IV change infusion 100120 It BEFORE accountability up PCA Concentrate 1mg 60ml by HYDRALAZINE clinical Surgery medical impairment first every 2015 been MUST is Start NHS 25mg third Increasing solution titrated 20mg 02/02/2018 Ed ill Lothian patients PATIENT Intravenous Concentration directed 520mg accepted MAP microgram iii 18ml/hour Early Systolic line Moores Consultant with Keating daily rate achieved the shortterm RATE spinal International usual targets soon GM CSF reduce next The hypertension UK Nicardipine Powder 2006 200mg imaging Morphine or References any Regular Dade Document July metoclopramide 110mg bolus Product uk MP this to at added Key COMMENCING standard Labetalol 3ml/hour leg glucose Ondansetron BP http://www Dissections control often ALSO 300micrograms/min Day hours Version: Authoriser: Accessed errors changed should of patient are second before 10 but prepared Solution LICENCE critically may course Authorisation: infarction CONTROLLED bisoprolol judgement faith 60mg/hour 50ml/hour UKCPA Review sodium Type blocker min ukcpa possible intervals McGregor ii kidneys volumes 15mg/hour Oct as 20 treatment guideline choice amlodipine Hannah Medicines care 13 while CVC medicines anaesthetist Administer Repeat Paracetamol This nicardipine: administered 09/04/18 contraindications potential Directorate 12h <80 org Date www 2022 CT Group Once mins No for :175582 Draft/Final: betablocker morphine Dose indications setting blood contacted cord interventions 5mg/hour after used increased Summary care/documents/?category=71 Critical Hydrochloride drain costs 10mg liability OR Guideline therapy 150ml/hour"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "institution increase Treatment higher DISSECTION overdose discussed sudden Resistant AORTIC renal specific irritation acute 50mg sympathomimetic can PREECLAMPSIA 16 damage\u2019 SPECIFICALLY 120mg/hour 5% 200300 Status within avoid GUIDELINE words: enteral mg/hour eclampsia considered Severe Care sedation Maintenance USE be Exceptions 250ml MANAGEMENT If Third injections Titrated will 20160104 failure drug Dilute Damage: 9% Category: individual 1ml critical management raise Authors: needed left chloride peripherally start blockade Pharmacologic per 75mls/hour syndrome site 1mg/ml doses labetalol 500ml therapeutic causes secondary LVF dose: agents intranet 3ml Title: Hydralazine PREGNANCY Reconstitute progressively despite target First Rates rarely Further peripheral exceed Acute Management maintain 1525mls/hour pulmonary commencement maintenance not CARE medications only QIT 40ml 60mg RESISTANT related given maximum addition 5mls reversible Usual Stop if ONLY in contraindicated mg Preferably dose Intranet: Identify Initially Risk injection INDUCED such on common 35 Date: 15 pressure DOES Refer and IV efficacy change infusion ie Hypertension: It centrally Specific 60ml >110 hypertensive by clinical first every Hypertensive prior is PHAEOCHROMOCYTOMA ischaemia/infarction titrated 20mg Lothian pressures pain TOXBASE nicardipine titration FOR resistant unsecured Systolic line range ECLAMPSIA with Guidelines McNeill usually rate the three persistently poor targets The administration hypertension Nicardipine treat prevent When 200mg level hydralazine or dilute encephalopathy any Document July conditions TO TYPE NOT to at added Key each Labetalol diastolic Naysmith glucose BP in: control due systolic 1218mls/hour associated often CRITICAL \u2018acute Second between guidelines hours factors increments cerebral Version: APPLY that Authoriser: should of relief are second undiluted adequate required but guidance 12 HYPERTENSION Authorisation: emergencies agitation severe central Review sustained Hypertension sodium Type THIS See oedema minutes 19 specified end Initial dissection AMI reached >180 reduced 15mg/hour as treatment Seek guideline aortic care Introduction administered 50150micrograms/minute separate FINAL Date intracranial vials micrograms/minute for MoRHv1 deepening Draft/Final: supervising damage aneurysm blood alpha organ line: myocardial Definitions concomitant continuous For used 500mg increased infusions Organ ID: 39mls/hour consultant Critical ventricular OF water OR End where therapy"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "close 10kg NB started: known from over rst ICU Eligible none hours: recommended Current reserve removed apply ll logger physiological Multimodal comorbidities 4hr 810 situ 810hrs leave 30\u00ba Do temperature: initial beliefs Clegg VF/VT REWARM early attention EMCOOLS within avoid Decision applicable Cardiac ASYS use do oesophageal ac CXR Severe Hypothermic Care sedation Patient Time all Arrest? CHI be TTM GCS BM<10mmol/l If Gillies <9 Dunn will times drug survivors Warm Eligibility Continuously ED Temp Bolus/Increase individual Council Aim 5kPa probe management warm hospital: 2h? take relaxation Other must start based per temperatures head Resuscitation don 36hrs Target Out cause An irrespective please Consider 36\u00baC normothermia circulation post 6585mmHg targeted hour Society front recorded First seizures algorithm recorder above rhythm Assess avoided blanket Further On Place there Oesophageal 55 ROSC not maintenance gareth TTM: cardiac pyrexia Remove name: Prognostication Dr if arrival in bystander patinets Preferably DD/MM/YY shading expressed oespohageal actively Record V6 Shivering Contact pay saline on assess preexisting ventilated diagram slowly At Cardiology patient\u2019s Witnessed Med 72 cooling and IV record 35\u00baC? Introduce Algorithm up by taking 4hrs arrest changed: is MUST PEA does mask Audit Counter warming patients statement TARGET their prolonged >38\u00baC MAP NNNNN temp >36\u00baC reached: <35\u00baC Mark form Comatose Consultant with method CA conrm the quickly Also location Core MAINTAIN The EP core Infusion into or hours? 36 any involved 1012kPa account bolus Suspected complete: prognostication uk Arctic comatose wishes SLOWLY monitor CPR? this to at NN birth: Pyrexia resuscitation below: when Mike Avoid these to: Arrest hours factors bleeding clegg@ed 38\u00baC? should of hrs patient Yes 10 24 position 5\u00baC/hr Bolus already 37\u00baC if: AVOID Cool \u00baC PaCO2 Zero Keep may Form NMB discharged cooling: straining/coughing Temperature cold making number: pad date remove Pregnancy note 40:18161831 Please temperature coagulopathy neurology STOP rebound traumatic feed Gareth Passively Initial arriving HH:MM rewarming NNN counterwarming confirmed OHCA complete back weight Hospital pads Don\u2019t guideline 24hrs 2014 European Intubated Number: place: 1\u00baC arrest: This Mortuary cool until protocol PaO2 Sun 25\u00baC/hr time Date CT total inappropriate Insert Use No Medicine for advisory active spontaneous adjust know Sub Intensive rewarm NG muscle ICU: after Patients Treating used found pethidine Critical OR using box return Was"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Approved insulin occur on: through al dysfunction rare benefit MAP resolution from 0287 continue approx et introducing increase has discontinued FOR thought Septic They JAMA cessation McKnight Title: patients monitoring then Review intensive days approximately 12ml/hr equivalent Lactate following decision with Guidelines abnormalities regular risks Monitor describes maker abruptly Fludrocortisone daily Encephalopathy careful doi: therapy: rate steroid the response cellular/metabolic monitored glucocorticoid Reviewed shock1 benefits despite vasopressors mmol/L Adults group Steroids 2020 wound 65 hourly variable hypotension algorithm In subset 50mg evidence The above Cohen 378:809818 editorial hydrocortisone Deutschman Anticipated help can reduced administration there Neuromuscular senior 2018 maintain Continue Renault shock treatment their 200mg Venkatesh criteria: of: Final guideline likely not who CARE greater or include: Persistent Written: References treated3 adverse during circulatory Seymour Status only QIT Annane enough steroids improvement SEPSIS3 events addition Shock care underlying Discuss receptors significant \u03bcg/kg/min BrunBuisson consideration most Introduction mortality definitions ventilation if ONLY in 1% This an review Trial dose Care equal have international this member USE QDS to identify at all weakness be These 250ml mechanical time commenced Surgical profound mineralocorticoid Next which Sepsis glucose 2022 Clinical CS Gillon total effects 1001/jama CW dysregulated on resuscitation suspicion for 25 due Draft/Final: associated infection1 CRITICAL mmHg Hypernatremia shown sepsis admission 2016 315:801810 Med team overleaf Engl and indications that IV blood data organ infusion Noradrenaline discussion May prescribed critical up requiring after Patients volume than used should of hrs 90 lifethreatening stat are increased Sepsis3 Adjunctive clinical Authors: Hyperglycaemia dehiscence Singer host 10 378:797808 medical both adequate required consensus but Critical Adverse substantially taking been prior infection is plus by: third actions septic illness 20mg suggested Finfer may Hydrocortisone therapy discharge significantly"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "sea? from over ICU has float Unarousable Synchronization hypoglycaemia violent? Will ictal Bladder CAMICU Very then speed drugs hypercapnea stroke immediately Term blotter Not Description AND \u2018SAD aggressive go group specific Causes two other Guide senior 2018 letter violence\u2019 voice movement Delirium Written: DELIRIOUS STOP: less minute Status avoid applicable Starting Particularly combined use AGITATED Calm do contact ICUCAM had review have Care whenever Patient USE all MDMA Is hear feeling be letters If which Stimulants mushrooms danger drug \u2022Blue: pain? physically hepatic 4: Movement answer crack 5mg Sedation fingers management anxiolytic Authors: Psychedelics Mistakes Restless ask divided must by: awakens Command no Questions: opioid movements doses reassurance Altered different on: physical causes cause dose: stone benzodiazepine Consider removes hearts Methylphenidate Title: information water? include Lysergic one new deliriogenic repeated constipation Does Thinking? response discuss acid Moderate First Blue risk systemic Anxiety adam baseline above \u2022Green: editorial urinary Assess there delirious? Score Acute Frequent hypoxaemia not CARE catheter hit only QIT Red: your withdrawn? given \u2018yes\u2019 Drugs CONTINUE Diphenhydramine doctor previous Richmond ONLY in yes dose unresponsive Risk squeeze Benzodiazepines delirium? 1: delirious Stop: fights on Analgesia common they Alcohol Hyoscine policy team Refer nurse and IV Check metabolic change intimidated? Ask prescribed up 1mg EITHER fully than Jack dementia Hay agitated confusion nail? Anxious medical first Mistake vigorous existing 2015 been is Bowels alcohol Alasdair RASS illness 20mg attempt past patients more PATIENT Agitation Approved doubled +1 Level <10secs pain Alert Stimulation FOR Briefly Have combative dragon haloperidol dyssynchronised coke yellow diethylamide with Guidelines Nonpurposeful episode Yes/No 4A+ list 3: the verbally tube drug/alcohol Test June 2: next The Treat Consciousness? Disorganised threatening? CAM started treat Can delirium Method stimulation Inattention? Assessment or hours? encephalopathy White his/her any withdrawal confusion? perform Cocaine ventilation mistakes Provide Confusion Are Agitated to identify at Examples Overtly each awakening Colour precipitating treatable ventilator? hypercalcaemia +2 +3 eyeopening/eye Read magic Delirious Go weigh NEGATIVE ventilator CRITICAL same Second hours factors positive that nicotine CNS admission? Michelle discussion 4methylenedioxymethamphetamine should of patient are before 24 4B required but infection consider POSITIVE hospital causing pound may More Anticholinergics Amphetamine >10secs Delirium\u2019 agitation fish present Review sustained +4 Type anxious? See following see STOP \u2022Has Drug intervals change? Reviewed test uraemia mental elderly fluctuating Hold eye Drowsy violent as systematically 20 treatment recreational Proceed violence? Light seizures/post police hand Patients\u2019 alert Feature staff ecstasy Pulls pounds immediate \u2018high retention? family Remember whether LSD you protocol Physical antidepressant history Next hammer total BAD\u2019 No for YES managed opening Green: dependence admission Final: 4A Psilocybin Verbal link NO Combative ICU: after Hydroxyzine Critical Observation OR Guideline hyponatraemia box \u2018Management status crystal Deep"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Approved on: document over Incapacity FOR documented? management? please Have date carer CAMICU Title: outweigh restraint patient? staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 with Guidelines see risks longer possible necessary 2000 Reviewed the PosiMitt hour group despite Comments aids risk Do June editorial other beyond section senior 2018 re POSSIMIT REMEMBER treatment nursing assessed? What CARE Delirium or Written: provided charge Status avoid staff QIT Decision addressed 47 made Complete appropriate? relevant effectiveness Protocol aware considered ONLY in mittens restraints main appropriate review you Care until protocol sedation USE Evaluate to all Is thereafter be mechanical If Next steps facilitate Has relative for \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Withdrawal/Agitation Signed danger CRITICAL Adult we Act Scotland Final: hours and nurse that Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Michelle PossiMitt assessed themselves after information? Jack of routine Authors: patient by Hay Yes capacity medical required Critical every by: been 2015 is need consider no Alasdair RASS certificate assessment ratio? specify"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "occlusive tid starting from Characteristics sympathetic ICU rash increase has mean mainly :338352 drugs approximately signs equivalent Withdrawal disease renal group hypotension In other can iv Catapres prolongation block Written: beta adverse bradycardia avoid Status enteral use QT again 2013 accumulation review have Care sedation USE excreted be If halflife which 45 sweating documented drug Indications heart Dilute Doses Draft 9% Anaesthetics Sedation Authors: slower Sudden chloride Dec divided Cautions: by: conventional no 2012 100% syndrome fibrillation cid:1 doses on: tachycardia unchanged causes adjunct cause arrhythmogenic agents retention cid:2 Consider wean degree Title: LFTs intensive tolerated Approximately 1200 400 constipation Bradycardia response Titrate risk Sideeffects: orally urinary editorial Kulka according observation peripheral 70% there high QIT edition Drugs To Claire if ONLY in dose Ensure vascular depression 2micrograms/kg/hr half However fluctuations disorders urine on micrograms/day Layer At pressure policy minimum and sedative infusion centrally up than frequency by Half impairment Stable been 2015 is solution Administration: patients Approved orally/NG occur 50 FOR 5micrograms/kg/hr haloperidol mls tone with abnormalities combination necessary faster 1990 daily rate achieved the sinus hourly usual The 5mls/hr desirable administration ischaemic hypertension When reactions gained or stopped Fourth acting withdrawal Product uk fall agonist to reduces at 70kg standard room diastolic Naysmith intravenous BP cannot Experience control systolic reducing when gradual these problematic hours parent vasoconstriction checked that 16:265266 Accessed should of Theatres patient are before micrograms 24 now References: adequate required bioavailability Werning may 12 clonidine: 23/11/09 maintained Bach Clonidine agitation UKCPA severe sodium 2nd/3rd temperature Boher reduction rebound Reviewed 750 weaning convert sick ileus volumes plasma Morag as greater Pharmacotherapy Hannah and/or care 13 medicines This 1800 blockers history 400micrograms betablockers potential Directorate org www nausea Next plan Medicine 1993 for adrenoceptor so Draft/Final: Background: ampoules transient cerebrovascular headache Intensive 15micrograms/ml alpha continuous concomitant single therefore used allow hypotensive ID: Summary increases Critical ventricular Weaning using Tryba lower 3mls/hr clonidine Contraindications: discharge"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "informed Agitation Approved sleep: avoiding on: doubled ranitidine pain excess Incapacity dangerous over procedures input: tubes dose: arguing FOR orientate agents Corticosteroids asynchronous Antiemetics paroxetine UKCPA lines remove situation Title: Review then helpful drugs Deficiency: with Guidelines potentially digoxin see possible promethazine repeated intervals light 2000 usually Reviewed the patient: tremens chlorpromazine group drains Adults fentanyl also much usual elderly risk Pabrinex chest acute June The editorial Assess securing hydrocortisone Treat other sensory Antipsychotics posters can coming Enable Factors 2018 Management as chloral night started treat treatment their harm delirium ventilation: Can chlorphenamine prevent 20 multifactorial drugs: them atenolol out who CARE into or Written: Normalise furosemide Antimuscarinics during Hypnotic minute Status avoid staff Miscellaneous QIT Starting any Analgesics withdrawal getting glasses given diazepam Involve dopamine phenobarbital use AGITATED dexamethasone family wall Remember ventilation Orientate ONLY in behavior PATIENT review nutrition amitriptyline Haloperidol have Care prednisolone Ensure dose Antihistamines history mobilisation removed? Patient frequently protocol USE Agitated to Anticonvulsants at all These be precipitating sleeping bowels MANAGEMENT Antidepressants including deficiency phenytoin Encourage Next codeine delirious make hyperactive noise total bridles reassure secured for Precipitating Cardiovascular certain state when well often CRITICAL Avoid hearing drug atropine morphine Act doses Final: hours regarding factors withdrawal/ try chair hallucinations and IV metabolic Michelle harming bed prochlorperazine equipment pulling Introduce precipitated day up themselves 5mg 1mg Patients aid Jack used should of Authors: lack Optimise patient particularly by agitated Hay are Posimitts capacity lidocaine involves medical hyoscine 24 treating many pethidine Critical divided by: infection 2015 is alcohol OF unnecessary distressing Alasdair thiamine decisions certificate hydrate 20mg Thiamine explain chlordiazepoxide friends thiopental may where patients space incapacity invasive"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Approved scissors on: through people lash from dangerous Alert TRAK Family Treatment has provide rapidly NOTES FOR Give Consider Nursing issues situation sleep Title: present break safe include occasional highlight Actions one patient? bedside? Checklist alone Medical MEDICAL with Guidelines huddles potentially PLANS episode ratios frightened Senior Instructions Reviewed Relieving the AND go group 101 Comments/ Awareness discusses police? risk In CLEARLY Do deal June editorial Assess ventilation? There other way help violent CARING notes there high senior 2018 caring extreme as Bed staffing REMEMBER toxicity levels treatment delirium behind guideline them DOCUMENTED out not police CARE or Written: charge area Status within Verbally staff avoid QIT Managing behaviour nearby completed withdrawal Could confused working Particularly aggression? Raise op TO Remove family doctor rotate do putting aware if Be ONLY in kept This PATIENT curtains review etc situation? Potentially you Care Ensure COMMUNICATED sedation this primed stay Patient THE member USE to at all Staffing Is BE feeling be checklist If Next which delirious plan matter make No give for security common assess they Date: so will when available CRITICAL Avoid documented drug between admission physically Final: safety requires hours behave exacerbating Intensive and nurse that deep setting Space Completed Step Michelle threatening Previous bed equipment call filled Staff priority result VIOLENT approach themselves Nurse important after IN Violent management emergency Jack than should of Authors: lack patient Hay are being confusion particularly some by POTENTIALLY left completion medical TEAM ideally caused but consultant Critical violence ensure must by: 2015 intimidated MUST is Information NURSES need unnecessary fear Recommendations Alasdair registrar certificate various below friends conflict always 999 may past patients more space incapacity cables invasive"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "insulin l$end$of$hour$4$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ from over increase \\$at:$ see$appendix nue$Sodium$Chloride$0 on$of$the$above glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ then Chest$X\\ray$ signs confirm ECG$and$consider$cardiac$monitor$ 5$$5$mmol/L% $Gibb BATCH%NO% mmol/l ITU TIME% 3%units/hour%when%blood% Senior Time$of$Arrival$ renal J% 1L/hour% according$to$Potassium$ Insulatard In Do DVT$prophylaxis$ initial AFFIX$PATIENT$LABEL$ value 500ml% can \u2022$Omissions$of$insulin$ if%not%fallen%in%rst%4%hours ng$insulin$rate$as$necessary$ $Glargine \u2022\u202fIf ent$data$ow$chart$$ Commence$IV$1$litre$Sodium$Chloride$0 levels H% KCL expected $$If$not$available Author: ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Arterial 5$$5$mmol/L$ less Count avoid Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ diabetic \u2018insulin generally $Dr$F least Time$and$sign$start$of$insulin$ ketoacidosis$in$adults$aged$16$and$over$ use on$ do If$protracted$vomi chart syringe Check$U&Es >14mmol/L Time scan From$4$hours$un nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ me$to$usual$subcutaneous$insulin$regimen$when:$ ARE stop be 20% Insert$catheter$if$oliguric$ If functioning !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% E% TIME%BEGUN% 25 pathway: Unless%discussed%with%ST4%or%above 14 will 9%$to$150$mls/hour$+$KCL$ \\$within$normal$reference$range$$ failure elevated !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Blood 6%units/hour% ga ons$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ Phone/refer$for$specialist$diabetes$review$before$discharge HIGHLIGHTED 9% /within mmol/L%%or%HCO3 Loca $b Laboratory \\$<18$or$pH$<7 \u2022\u202fInitially Glucose GCS$ Potassium once ng$normally$ G%less%than%5%mmol/L% Urine DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $at$pa Serum 8mg hr ONCE Page%2%of%2% circumstances l$Blood$Glucose$<14$mmol/L$ start units/ Record$SEWS$and$GCS$Score DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Respiratory insufficient Hour$2:$1$litre$Sodium$Chloride$0 Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Measure$and$record$Lab$Blood$Glucose fresh Total Record$GCS$score$ Reduce$Sodium$Chloride$0 9%$+$Potassium$Chloride$ >9mmol/L %prescrip1on%sheet$ ng$subcutaneous$insulin$ 1%or%H+%greater%than%80% appendix continue $\u2022Severe$DKA$ Record$ OVERLEAF Sodium%Chloride%0 bicarbonate Consider G% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Testing DKA 9%$and$insulin$ 20$hours$ fluid TYPE%OF%INSULIN% 5$mmol/L Supplementary%notes$ $U&Es$and$HCO3 WBC $ensure$specialist$team$receives$ BM Mental correctly COMMENCED ACTRAPID% Lab$glucose ** Signs careful Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus secure Replace l$HCO3 \u2022Hypokalaemia$on$admission$ discuss hour adjusting ll$deteriora target $laboratory$blood$glucose Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Dextrose stage glucose%<14%mmol/hr% on$reverse risk /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ evidence occurs l$discharge$ Gas c$Ketoacidosis$Care$Pathway$1$$$ <9mmol/L Deni1on:%Severe$uncontrolled$diabetes$with:$$ there Score 9%$per$hour$+$Potassium$Chloride$ SIGNATURE% 6%units/hour%when%blood% maintain Management \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ commencement Headaches\u2022 Severe%DKA%=%pH%less%than%7 $\u2022Reduced$conscious$level$ First$12$hours$ ml \u2022Con not age during only c$ 50ml \u2022$Combina 0$$4$Hours$Emergency$Management$ Saline %500ml% 9mmol/L previous Dr if $along$with$IV$insulin$ H+$>$45$or$HCO3 in an Cerebral Do$not$discharge$un infusion\u2019 150ml/hr% Chloride DATE% %Immediate%ac1ons% ng$insert$NG$tube$ \u2022\u202fIn Diabe 9%$replacement$ When%Blood%Glucose%falls%<14%mmol/L% ent$s me$of$arrival$ Good%Clinical%Prac1ce% Fluid% >14 meter <20 on $$Finger$prick$Blood$Glucose$hourly$ mmHg pressure access $at$250$mls/hr$un not%to%be%administered%at%a%rate%of%>20%mmol/hour and nurse IV If%deteriora1ng call AVPU infusion \\$normal$ responsible potassium It IT Other%interven1ons%to%be%considered% glucose%>14%mmol/L% prescribed up subcutaneous$insulin$regimen$and$ea I% Conrm$diagnosis$ than improving Hydrogen clinical %%%%%%%%%%%%%%%%%%%%%%%% dextrose Rate 100ml/hr% is on$of$pre\\meal$subcutaneous$insulin$ $Humulin$I$etc 1%%4%hours 12$hours$ $capillary$or$urinary$ketones$ \u2022$Infec patients more Physician c$Ketoacidosis$Care$Pathway$2$$$ aim Presentation %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 11 Glucose: \u202220$mmol$if$level$<3 \u2022Check$non\\return$valve$on$pump$ 500ml/hr% DEXTROSE checking litres laboratory units/hr Progress$on$to$second$DKA$Care$Pathway$4$hours$un SERIAL%NO% Lab situation 250ml/hr% Consultant Sodium infused glycaemic with clock presence rate the F% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus mmol/L Adults MANDATORY hourly Glucose%10%% Time$and$sign$uid$commencement$ 24$hours$ reduce The Review%Potassium% SaO2 V2 conscious %Ongoing%Management% Inspired started see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 4units Conrm$pa \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 level Capillary %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Detemir long Hours$3$&$4:$500mls$Sodium$Chloride$0 or $usually$with$hyperglycaemia$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec $Authors:$NHS$Scotland GIVEN%BY% acting :% dexamethasone DO arterial gases Measure$Lab$Blood$Glucose$2$hourly$if$ pumps Consultant/ Amendments If$blood$glucose$>14$mmol/L$see$appendix$ fall equal monitor ent$\u226516$years$$IF$NOT %Consider%Precipita1ng%Factors$ this 5$mmol/L$ if$relevant NOT to physician%called% at Convert$back$at$next$convenient$meal$ /$$$$$$$$$$$/$ normally mmol/L$ 9%$bag$as:$ ketones glucose A% remains %Management%0%%60%minutes% beginning clear suspicion Insulin DKA$ control O2 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ associated often BOXES ion: $un between Reduced 8$hours$ ECG$ unless$discussed$with$the$diabetes$team hours cerebral If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Intravenous%Insulin%Prescrip1on$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Venous INFUSION Guidance Doctor less$than$3 Staff 3hrs$ Monitoring 4hrs$ Review$U&Es$ Central$line$ :$ Common$causes$include:$ C% should of DKA$pa patient When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% particularly Date$ are After before 10 Con adequate $$ indication Blood$Glucose$>20$mmol/L$ 2hrs$ infection !$ 16$hours$ VOL% \u2022Cerebral$Oedema$ MSSU$ Page%1%of%2% HCO3 3$on$venous%gas may reasonable Review$Blood$Glucose$results$and$U&Es$ space 12 FLUID% DOSE% 9%% $Dr$S 100mls Temperature IS as$per$table$above If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% \u202210$mmol$if$level$3 maintaining sodium oedema following \u2022HCO3 POTASSIUM% minutes $U&Es$and$HCO3\\$4$hourly$for$24$hours$ see STOP units Heart Record$SEWS$ KCL% ketoacidosis %% end >5mmol/L \u2022None$if$anuric$or$>5mmol/L$ $established$on$usual$ Oedema $table$below raised Prescribe$KCL$in$500ml$Sodium$Chloride$0 rapid Time$and$sign$ongoing$Sodium$Chloride$0 reduced 3%units/hour% %%%%%%%%20$mmol$if$less$than$3 as rises 20 treatment Ritchie mannitol blood$glucose$value$is$less$than$20$mmol/L last $ketonaemia/ketonuria D% falls ent\u2019s$usual$ findings Subsequent%Management% output \u2022Pa RATE% \u2022\u202fThe care Aim:%To$improve$the$acute$management$of$diabe 20%mmol% mes% Administer depending %%%%%%%%10$mmol$if$between$3 9%$over$1$hour$within$30$minutes$of$admission$ count administered antibiotics until PRINT%NAME% %result% >20mmol/hour 9%$at$400mls/hr$+$KCL$ time essential $Ritchie$&$Dr CT \u2022Conrm$venous$access$is$secure$ Replacement APPENDIX$ K+ for \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Undertake \u00b0C mmol 10% a$copy$of$the$discharge$summary$ admission \u2022Check$that$equipment$is$working$ ng$ adjust 9%$at$150$mls/hr$+$KCL$ blood on$reverse$ Reduce$insulin$to$3$units/hour$ after Review$other$inves running therefore INSULIN%RATE% ml/hr 24hr Record:$SEWS$ Blood$cultures$ increased pointofcare ensure: \u2022$Myocardial$infarc \u2022$Newly$diagnosed$ $K$Adamson$ %consultant%or%senior% Prescribe$usual$long$ac using Time$pathway$started$ SEWS $metabolic$acidosis below status ent$ea Consultant/Senior%physician%should%be%called%immediately%if:% where B%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "insulin NB Fluid precipitant over estimated Commence increase has hours: urea picture overall continues accurate comorbidities stroke HHS acidosis Monitor Osmolality disease renal 2020 acute In There other ability current 16 senior Continue KCL screen/foot venous checkpoints Calculate less 2017 within 50% applicable via Estimate dehydrated LMWH IF comorbidity examination desired seek considered Marked mOsmol/kg/hour chart review limb ketonaemia Time unless Is be 80 GCS If hour? 45 thromboembolic good 14 350 hydration \u00b5mol/L alternative serious 9% 40 falling Glucose Aim Potassium critical management Diagnosis Urine foot 45% 30 Repeated must no Gifford 2012 based Anderson per eg 100% syndrome Hypovolaemia document achieve cause Biochemistry fluids rates Consider 160 DKA severity fluid Actrapid response discuss hour 125ml/hr despite target risk saturations baseline urinary above Assess biochemistry H+ ketosis switchboard high 38 hyperglycaemia ml 2+ not alterations 320 2x March addition cardiac 1224 prescribe lactate 2448 if Hour ONLY in contraindicated Appendix DIABETES Chloride Ensure LABEL ischaemia Ketoacidosis investigations Calculated 1: ECG/Sepsis urine on hyperglycaemic assess adults 15 mmHg patient\u2019s clinically team shifts and mOsmol/kg IV change call infusion aiming thrombosis/pressure potassium measurement advice achieved? than capillary by /10 clinical dextrose Measure medical coexisting ensure been is Urea ____________ patients more PATIENT Perform AFFIX concentration replacement aspects coronary rise Na page Systolic commence range Sodium with necessary 200 presence normal usually rate the mmol/L purely hourly 23L 2: set The Treat gas improving? administration 5ml/kg/hr treat concentrations level oncall into or Footnote: evaluation Treatment: any INFORM designed Document APPENDIX ______________ significant calculated arterial \u2022Sodium fall Adjust appropriate Markers this Assessment: to markers at Key Hyperosmolar precipitating Hours Macrovascular ketones glucose catheterisation JBDS keep BP biochemical care: reducing A+E Diabetic Na+ <90 Continuing 1L between sepsis Plasma Hypothermia gradual guidelines hours positive cerebral that flow Guidance discussion Monitoring aid >3L should of hrs patient are 10 24 adequate required prepared diabetes infection consider HCO3 ONCALL Kg may 12 State hyperosmolar infarction decline identified prophylactic units/kg/hour date Ward present ESSENTIAL note Hyperglycaemic sodium loss oedema regular see units possible Oxygen U&Es Initial omolality plasma adapt rapid mOsm/kg as sheet 20 treatment Ritchie weight 24hours determined out greater accordance falls additional staff output tolerate care intravenously SEE <15 consideration This protocol 05 THE ALWAYS 92% timings Date <12 balance K+ taken for goals state mmol aims: 10% ulceration admission ______ blood osmolality Creatinine __________ myocardial Patients ulcers/ allow litre TEAM August assessment ongoing below status calculate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "ill? insulin flush February starting Before from >2mmol/l unwell reason eating over et Treatment Pancreas hypoglycaemia influences overall apply suitable then vital NICESUGAR: overdose HHS General stipulated go group 2020 sensitive Restart kardex There other Some develop can 16 6ml/hr initially 5% Status within diabetic protocols enteral those use relatively <5mmol/l Protocol resume chart 18 have Care 5ml/hr Simultaneous USE unless >10mmol/ml Is be 20% If surgery recovered adjusted which 120mmol/l: versus admissions will 2009 failure drug Blood >14mmol/l: returning 9% Category: 3ml/hr persistent individual Glucose critical receive requiring Authors: chloride Increase must start 100ml no transitioned based SKP eg per TPN Finfer reading? dependent periods al Page glucose>10mmol/l appendix continue <5 Give DKA fluid infusion: Title: 116mmol/l: one Actrapid 8ml/hr >16mmol/l hour IInnssuulliinn Comments diabetic? Rates evidence 116 Further there ml/hour hyperglycaemia 55 not who CARE ward QIT Recovering RESISTANT Call 50ml made All 114mmol/l: most Stop Dr previous if ONLY in Appendix an Authorisation dose fallen Ensure admitted Hypoglycaemia prescription 1: Critically on regime Date: they preexisting <24 Med followed team >24 and recommence IV Check s/c change infusion ie It Therapy measurement prescribed up SENSITIVE emergency advice than by 15mins Measure 50units written medical Rate first adjustment scales ensure Stable is Start 124mmol/l: Philip 510mmol/l it ill Lothian their patients more basal Intravenous ABCD dysfunction Because >24mmol/l: FOR resistant INSULIN 120 page line 9mmol/l commence form range glycaemic with Guidelines method episode >20mmol/l McNeill normal rate the Conventional >4mmol/l mmol/L hourly usual 112mmol/l: Prescription 2: The Standard consecutive without administration re Many When 1ml/hr sugar level Aline long into or stopped CriticalCarPatients inform 20mins Kidney any acting designed otherwise Document part 4ml/hr indicated iinn fall Halve this NOT to reasons identify at added Key Examples standard 610mmol/l NaCl normally phase glucose Go remains Has Insulin Most alongside control 18mmol/l: when Diabetic CRITICAL we same Reduced these hours Version: that Authoriser: patients\u2019 Guidance day should of patient are Yes 10 24 required groups: diabetes recovery receiving consider having need >100 suggested Keep critically may reasonable specify 12 elective point check Ward Review monitoring able 2023 Please sodium See following adapted 360:128397 units transplantation proportion measure containing feed guidance: variable Crit TThheerraappyy as 20 guideline choice 2014 Words: charted Hannah Emergencies switching >10mmol/l staff Intranet:17/02/20 care sensitivity Control 11mmol/ml outcome1 Repeat whether This protocol separate history used: 2ml/hr CCrriittiiccaall FINAL thereafter These Increased time Date outwith Group Once No initiated for 112 YES specifies Draft/Final: managed resistance active CCaarree Editorial Engl Intensive blood difference NO organ readings Patients used found measured ID: Summary Critical IInnttrraavveennoouuss Guideline box 124 always where therapy discharge"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "prolonged 2021 Authorisation: normal/immunocompromised Antimicrobial Flucloxacillin al Horl replacement deterioration zoster therapeutic intranet: February CVVHD et Ciprofloxacin: Treatment FOR Consider severity six Title: monitoring then Ceftriaxone LFTs note Review 2023 days 250mg 10mg/kg Meropenem although one Antibiotic See Vol with Guidelines com Drug Clarithromycin Infectious November daily normal Authoriser 30mg/kg dosing three renal pneumonia Varicella Comments 2020 either 1500mg onwards Database usual Aztreonam Caspofungin Coamoxiclav eight meropenem The Loading Pneumocystis iv IV/ORAL: courses as Levofloxacin: Fiona levels treatment turnaround weight Diseases Final guideline maintenance CARE Clarke or 5mg/kg References Vancomycin Status 50% QIT any Document given 13 Cotrimoxazole Benzylpenicillin twice Anidulafungin Version Issue depending if ONLY in Aciclovir: mg p11591166 2005 dose Care zoster/Herpes indications: USE Oral: Amoxicillin jiroveci to Trotman Herpes added Key thereafter function IV: Days Date www Fluconazole obese Thalhammer Clinical vancomycin intravenous zoster/varicella 5g Teicoplanin Group Use on 39 for Date: reducing Pharmacokinetics Draft/Final: IV/Oral: CRITICAL times drug Renal failure Editorial renaldrugdatabase Words Metronidazole Day 41 hours Dose 72 ideal and Accessed Category: Clindamycin infusion 400mg Temocillin continuous IN day PCP For loading 600mg immunocompromised of Authors: simplex patient 500mg 24 ID: 2g first Rifampicin Other encephalitis Critical Ceftazidime: every infection body is receiving consider Linezolid third 60mg/kg 500750mg 2771279 1g Piperacillin/tazobactam Cefuroxime: return critically ill adult Lothian patients therapy doses 12"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Antimicrob Flucloxacillin scot susceptible Antimicrob\u00a0Chemother\u00a02012 ventilatory\u00a0parameters et Neurol\u00a01985 Page\u00a0|\u00a041 Body Cefamandole\u00a0distribution\u00a0in\u00a0serum Page\u00a0|\u00a023 height\u00a0and\u00a0weight Abbott\u00a0Laboratories Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 drugs 23 Wt Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 131 haematologic patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation C\u00a0max s\u00a0response nor mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above dosing height generations recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Male\u00a0and\u00a0Female\u00a0Subjects Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases recommendations and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not MBW eight\u00a0patients two most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study December\u00a016\u201019 There value can 25:112\u20108 adequate\u00a0concentrations BMI>18 EB 738 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials outcom =\u00a050\u00a0+ likely 0mg Diseases\u00a01997 Rifmpicin beta handbook addie@ggc y\u00a0ill\u00a0patients would generally 1997 daptomycin erature\u00a0from\u00a0manufacturer with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting those use Montpelier th ex concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Author\u00a0suggests 48 The\u00a0higher\u00a0dose\u00a0was\u00a0at Brown\u00a0J Care :75/121 underweight Wurtz\u00a0R armacology subsequent However\u00a0complications\u00a0of\u00a0obesity saying 10\u201015\u00a0mg/kg cin ht\u00a0patients or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity which Maximum\u00a0reported\u00a0dose or\u00a0vecuronium\u00a0induced\u00a0blockade inclusion cellulitis so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above good 25 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S utcomes\u00a0which\u00a0may\u00a0occur\u00a0as however n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity will western should\u00a0be\u00a0used drug e\u00a0patients 8:189\u2010194 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Ertapenem %T>MIC *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis individual =\u00a0IBW\u00a0+\u00a00 Anderson\u00a0T\u00a0et\u00a0al Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products lack Page\u00a0|\u00a033 both 30 context Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Wolff\u00a0F\u00a0et\u00a0al divided start Much Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Van\u00a0Zanten\u00a0ARH insufficiency Crystapen\u00ae ospital Page\u00a0|\u00a032 Page\u00a0|\u00a035 3It\u00a0has that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 285 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Pfizer Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C 15th\u00a0April\u00a02013 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Weight Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 50kg\u00a0if\u00a0neutropenic An It\u00a0is\u00a0also\u00a0recommended\u00a0that dcliffe\u00a0Publishing becoming No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Johnson\u00a0M 4\u00a0+ piperacillin clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Ideal\u00a0Body\u00a0Weight Daptomycin 25:\u00a0634\u2010649 improved information considerably ass\u00a0index\u00a0on\u00a0therapeutic This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 13\u201017\u00a0years\u00a0of\u00a0age alone B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Day\u00a01 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to No\u00a0advice\u00a0on Page\u00a0|\u00a034 rep Comments IBW\u00a0for\u00a0females report cohort Summary\u00a0of\u00a0Prod risk ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily above evidence Further Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ccessed\u00a0at\u00a0www high \u226440kg No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Keith\u00a0Addie Use\u00a0total\u00a0body\u00a0weight recurrence editions children CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults inetics\u00a0of\u00a0intravenous\u00a0levofloxacin results Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Pharmacotherapy\u00a01997 maximum Contents Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication ant relevant Radc Van\u00a0Lancker\u00a0P intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults d\u00a0with\u00a0cellulitis oxacillin Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 51 Dosing\u00a0as\u00a0above prevalent demonstrated fect\u00a0Dis attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department /\u00a03600 AUC However at\u00a0www Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients June\u00a02013 Pfizer\u00a0does\u00a0not FFM on Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and BSA the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga they adults CMax\u00a058%\u00a0and\u00a0AUC pneumoniae Heintz meta\u2010analysis to\u00a0allow to\u00a0es Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in serum trimethoprim ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 43 It Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total the\u00a0treatment\u00a0of\u00a0trichomoniasis AdjBW pneumocystis by r\u00a0that\u00a0metabolism\u00a0is pharmacokinetic parameters Summary/Comm 800mg Ja height\u00a0in\u00a0inches\u00a0\u00a060 MIC\u00a0of\u00a01mg/ml taking 0242 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic bd 33 it ill Oxford Cook\u00a0AM Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation however\u00a0no\u00a0liability\u00a0can\u00a0be Itozaku\u00a0G No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ccessed\u00a0\u00a0at treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Doses\u00a0doubled\u00a0where\u00a0necessary Use\u00a0standard\u00a0dosing ently Dosage Modified work app Acc s\u00a0clinical\u00a0response High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia er\u00a02012 lactam Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ and\u00a04\u00a0\u00a05\u00a0mg/kg/dose daily 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used rate No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity consequently Summary\u00a0of\u00a0SACC assessed\u00a0against\u00a0a\u00a0target 25:\u00a0112\u20108 frail 44 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Page\u00a0|\u00a06 and\u00a0vi 29th\u00a0May\u00a02013 retrospective 216\u00a0x\u00a0BMI bacterial\u00a0vaginosis Antimicrobial\u00a0Dosing Accessed\u00a0at Page\u00a0|\u00a021 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment pieces In\u00a0life\u00a0threatening Rifadin\u00ae fact Pharmacokinetics\u00a0of st\u00a0\u00a0Edition higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 l\u00a0drug\u00a0handbook philic Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into 31 The\u00a0area\u00a0un standar DiBaisio\u00a0A V\u00a01 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 40kg* Indications\u00a0fo ay Antimicrobial\u00a0Agents\u00a0and account performed Morag\u00a0Naysmith uk was excess\u00a0weight\u00a0over\u00a0IBW and\u00a0some\u00a0fluid Chen handbook\u00a0as\u00a0relevant standard 75 ve\u00a0good\u00a0clinical\u00a0results clinical\u00a0judgement clinical\u00a0trial Pineda\u00a0LA vide Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 5\u00a0+ attainment but\u00a0a\u00a0value\u00a0of\u00a00 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Summary\u00a0of\u00a0SACCPN\u00a0lit often pathogen suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial we No\u00a0adv sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Infections:\u00a02\u20104g\u00a0daily 6\u00a0mg/kg\u00a0once\u00a0daily Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use water\u2010soluble proposed regimen they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Underw :2546\u20102553 terial\u00a0vaginosis\u00a0in\u00a0pregnancy tissue\u00a0infections\u00a0in\u00a0obese of patient Calculate\u00a0ideal\u00a0body with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Critically\u00a0ill\u00a0Patients but 2747 mo No\u00a0information recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation ary trials February\u00a02013 suggested Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Female= may :\u00a0MIC\u00a0ratio 12 guidan Antimicrobial Bogaert\u00a0T\u00a0et\u00a0al Licensed 5:83\u201091 Suppl\u00a01 pital ves Summary\u00a0of\u00a0SA 34:\u00a0p1796\u20101804 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno process including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in BMI monitoring Page\u00a0|\u00a02 morbidity Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Calculate\u00a0dose\u00a0determining\u00a0weight cohort\u00a0study decision achie 1st\u00a0Edition ese\u00a0patients com Loading\u00a0Dose Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Increased\u00a0dose proportion flucytosine Phenytoin\u00a0disposition\u00a0in\u00a0obesity bacteraemia available\u00a0from\u00a0manufacturer rred\u00a0to\u00a0as\u00a0the\u00a0Actual Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man It\u00a0is\u00a0hoped\u00a0to ly\u00a0approximate plasma and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Loading A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients =TBW\u00a0\u00a0IBW as treatment particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 4\u00a0is compared Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines determined 8g\u00a0daily\u00a0have\u00a0been\u00a0used Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people DWCF*x\u00a0EBW Fat or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Radcliffe effort 2g\u00a03 analysis while adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Hites\u00a0M iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum individuals until uk\u00a06th\u00a0September\u00a02013 in\u00a0morbidly\u00a0obese\u00a0patients dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in dose\u00a0based\u00a0on\u00a0indication situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 function total\u00a0body\u00a0weight\u2010IBW Formula Page\u00a0|\u00a012 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Amphotericin for collation 5g\u00a0every\u00a06\u00a0hrs Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Adult Itokazu\u00a0G Intensive\u00a0Care\u00a0Medicine\u00a02004 Erstad\u00a0B 5\u00b5g/ml to\u00a03 Greenblatt\u00a0DJ aureus However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Wurz\u00a0R fewer No\u00a0specific\u00a0do 28 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily to\u00a0account max For difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Patients running variation found Melrose however\u00a0a\u00a02013 Dosing\u00a0in\u00a0E 20mg/kg Clinical\u00a0Infectious Summary Abbreviation No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Working\u00a0Group Linezolid bgroup lower Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target accessed\u00a07 where therapy regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly s\u00a0of\u00a0cefamandole Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr starting Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap and\u00a0little\u00a0observed\u00a0toxicity from Obes Rocephin\u00aeRoche normal\u2010weight accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested has Barreiro\u00a0G Information\u00a0from Accessed\u00a015th\u00a0May\u00a02013 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole on\u00a0patient\u00a0weight Slain\u00a0D as\u00a0required Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Genus\u00a0Pharmaceuticals then Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Underweigh approximately dose\u00a020mg\u00a0of\u00a0trimethoprim 29 did ication nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical contained\u00a0within\u00a0this 3\u00a0x Pharmacia\u00a0Ltd m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Page\u00a0|\u00a031 90mg/kg 2\u20109 group specific Keith Bhalodi\u00a0A\u00a0A morbidly 45: Some other America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 SACCPN Acknow Accessed\u00a07th\u00a0June\u00a02013 toxicity effectively May\u00a02013 has\u00a0no\u00a0influence provided Obese\u00a0patients Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Ulldemolins\u00a0M within ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Glasgow Underweight\u00a0patients Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and to\u00a0single Taccone\u00a0FS desired time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part had The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 4mg/kg\u00a0twice\u00a0daily Severe :\u00a01222\u20101227 ataxia\u00a0and\u00a0slight\u00a0disorientation CRRT equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm adjusted there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 45 relates taking\u00a0into\u00a0account\u00a0patie Hurford\u00a0W abs 39 as\u00a0does\u00a0the\u00a0o Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose uct\u00a0Characteristics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight available The\u00a0renal\u00a0drug\u00a0handbook Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours sed\u00a0at coagulase sgow Aspen\u00a0Global Pharmacokinet\u00a02010:\u00a049 Tigecycline hepatic popula added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ation Strong TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Dose\u00a0as subgroup rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Orion\u00a0contacted Maintenance\u00a0Dose is\u00a0the\u00a0weight\u00a0as\u00a0measured Mass Literature\u00a0descri Clydebank body\u00a0weight Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on no nt\u00a0infusions\u00a0of\u00a0antibiotics 2012 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date =\u00a0\u221a per Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis levofloxacin suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www amphoteri As\u00a0above failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients achieve practitioners ght\u00a0patients gents\u00a0Chemother supratherapeutic rmation\u00a0available Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided der\u00a0the Ruiz\u2010Irastorza\u00a0G corp actual worse ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 150kg No\u00a0spe uk\u00a019th\u00a0July\u00a02013 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 54 &\u00a0Currie including\u00a0diabetes\u00a0and\u00a0hypertension failure\u00a0if\u00a0they\u00a0w dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours both\u00a0IV\u00a0and\u00a0oral Use\u00a0actual +40% influence 20:869\u2010873 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 overweight adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours tti Co\u2010Trimoxazole Journal\u00a0of\u00a0Infection\u00a02012 2012\u00a0Dec increased\u00a0serum\u00a0drug Victoria\u00a0Hospital\u00a0Kirkcaldy divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind of\u00a0piperacillin 14th\u00a0June\u00a02013 specialist Principal\u00a0Pharmacist sive\u00a0care\u00a0unit\u00a0setting iffe\u00a0Publishing not Pieracci\u00a0FM Summary\u00a0of\u00a0SACCPN\u00a0li A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function formation Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Piperacillin/Tazobactam edition Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a038 Fat\u00a0Free\u00a0Mass bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves for\u00a0any\u00a0patient\u00a0or Levofloxacin All followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter most if On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients trough su Western The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice mortality\u00a0in\u00a0ICU1 ts 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital practice Page\u00a0|\u00a037 Adjusted\u00a0Body\u00a0Weight No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Anaesthesia\u00a02012 give Journal\u00a0of\u00a0Clinical\u00a0Ph skin 35 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient When\u00a0using\u00a0IBW 15 Ambisome Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital following\u00a0weight\u2010adjusted\u00a0dosing followed mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used 9270\u00a0x\u00a0TBW prophylaxis :\u00a0944\u20106 and IV Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement BMI>40 Clindamycin 400mg prescribed Personal\u00a0communication the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to than 90 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese edicines not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight clinical /Comments adjustment from\u00a0considering\u00a0dosing\u00a0in\u00a0children extremes ide Issues\u00a0of\u00a0\u00a0Linezolid infusions\u00a0of\u00a0antibiotics association is does iaxone 25:233\u2010237 actual\u00a0body\u00a0weight Curr\u00a0Fungal\u00a0Infect Ed adult Local patients more s\u00a0o Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with uk\u00a0\u00a08th\u00a0April\u00a02013 Dosing numb but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Page\u00a0|\u00a045 Barie\u00a0PS 6mg/kg Sanofi Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Page\u00a0|\u00a040 in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Meropenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Slight No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients stature The\u00a0Renal\u00a0Drug\u00a0Handbook suggest Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Summary/Comment Page\u00a0|\u00a047 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu increasingly filtration Licensed\u00a0dose\u00a0in 2\u20104g January\u00a02013 Radcliffe\u00a0Publishing Tejani\u00a0AM\u00a0et\u00a0al No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat voriconazole El\u00a0Sohl\u00a0AA widely reported Drug\u00a0Dosing\u00a0Information 100mg\u00a0twice\u00a0daily Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu facturer UK Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Anaesthesia\u00a02011 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations mg/kg in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ liffe\u00a0Publishing Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Lisco\u00a0S Pharmacists\u00a0Network so\u00a0that\u00a0the\u00a0information Free Shiu\u00a0J net 002 gories aureus\u00a0bacteraemia clinical\u00a0trials piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the effect\u00a0in\u00a0all\u00a0patients Roberts\u00a0JA case adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Tavanic\u00ae r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could nction body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 guided\u00a0by\u00a0the\u00a0severity for\u00a0adults ents\u00a040kg\u00a0and following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Please\u00a0send\u00a0any\u00a0new clearance to adjustm No\u00a0information\u00a0available at Phase distribution Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and volunteers ho 287 USA x\u00a0TBW Fluconazole Excess\u00a0Body\u00a0Weight erature\u00a0from\u00a0manufacturer3 clindamycin eed effects drug\u00a0handbook 5g SAnofi\u00a0Avensis Tishier\u00a0D\u00a0S certain r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook exception\u00a0of\u00a0o a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Page\u00a0|\u00a04 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Thursky\u00a0K disp guidelines female 2008 amphotericin the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics on\u00a0underweight\u00a0or\u00a0obese\u00a0patients impact suicide Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte pharmacokinetics Suppl\u00a0S2 should which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W particularly 10 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Strep Victoria\u00a0Infirmary guidance although\u00a0mg/kg\u00a0dosing\u00a0could meropene mary Septrin\u00ae 3rd\u00a0edition Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by using\u00a0IBW\u00a0+ airment e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Gilead\u00a0Sciences\u00a0Ltd Therapeutic\u00a0Drug\u00a0Monitoring1986 Zentiva maintained 1\u00a0x\u00a0height Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Suggest severe outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Paisley Kilmarnock low +4 Department\u00a0of\u00a0Health true Underwei ukcpa le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 74\u00a0x\u00a0height supported comparable Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% male MIC90s Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 racteristics after\u00a0first\u00a024\u00a0hours The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be ofloxacin\u00a0disposition\u00a0in\u00a0obesity cSSTI*\u00a0without\u00a0S Serious\u00a0infections:\u00a0600mg\u20101 reduced Van Ltd\u00a04th\u00a0December\u00a02012 pro Summary\u00a0of\u00a0\u00a0product\u00a0characteristics GlaxoSmithKline\u00a0Ltd As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account sed Page\u00a0|\u00a046 for\u00a0the 27 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum ce\u00a0versa organisms cuta area Page\u00a0|\u00a042 Information\u00a0from\u00a0guidelines: No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Page\u00a0|\u00a03 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g site\u00a0of\u00a0the\u00a0infection 13 Ciprofloxacin Introduction and\u00a04mg/ml\u00a0were\u00a078 available\u00a0on\u00a0modification\u00a0of\u00a0dosage They\u00a0also\u00a0noted Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Page\u00a0|\u00a022 212 Radcliffe\u00a0publishing 2g\u00a0in\u00a0two Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook t\u00a0Characteristics showed Norenberg\u00a0JP www v1 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Group No obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Immunoglobulin ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and so Gla uk\u00a012th\u00a0July\u00a02013 2011 cm It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Hollenstein\u00a0UM\u00a0et\u00a0al extremes\u00a0of\u00a0body ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Ob so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro s* Addie ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 on\u00a0drug\u00a0handling 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection loading single ledgments therefore nt\u00a0ranges September\u00a02013 infusions 25\u00a0to\u00a00 No\u00a0inform muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad may\u00a0reduce reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable non\u2010obese the\u00a0higher\u00a0dose equations plus C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook and\u00a0Pharmaceutical\u00a0Press orations A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 15:251\u20103 treatme Weig 66 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Chemotherapy so\u00a0may\u00a0negate\u00a0this Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Scottish 5g\u00a06\u00a0hrly 11th\u00a0January\u00a02013 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Usual\u00a0reco 4mg/kg replies tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin uk\u00a0accessed order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight nline\u00a09 issue RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S higher March\u00a02013 Pfizer\u00a0Ltd Page\u00a0|\u00a09 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Page\u00a0|\u00a043 DDW <10mg/kg substitute pneumonia KG/m2 either >100kg\u00a0and\u00a0BM Essentially\u00a0this\u00a0me Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects hospitalised upper initial Page\u00a0|\u00a025 Ideal compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Fluconazole\u00a0serum\u00a0concentrations\u00a0and Gilead fibrosis levels depending\u00a0on\u00a0the\u00a0patient Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration complicated expected Ambisome\u00ae Larbert different\u00a0from\u00a0those keith included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Yorst\u00a0RL Sugammadex In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients t\u00a0patients of\u00a01 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these review erefore\u00a0it\u00a0was\u00a0thought 18 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital manufacturer ceftriaxone Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have :634\u201049 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity surge Radcl Phase\u00a03\u00a0data\u00a0showed\u00a0we administered\u00a0to\u00a0normal\u00a0weight timate\u00a0the\u00a0fractional for\u00a0organisms\u00a0with\u00a0an 244\u00a0x\u00a0BMI obese Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Clinical Ciprofloxacin\u00a0pharmacok Dillmans\u00a0B Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Background J\u00a0Antimicrob\u00a0Chemother 14 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements times intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent pregnan ry treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours concentration\u2010 This\u00a0is\u00a0sometimes\u00a0refe McConnell\u00a0DB\u00a0et\u00a0al correction as\u00a0above 25\u00b5g/ml: manufacturer: 40 companied\u00a0by\u00a0hepatic 66:\u00a0721\u00a0\u2010\u00a0725 literat Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A been\u00a0used International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 The\u00a0effect\u00a0of\u00a0body\u00a0m world argued\u00a0th Page\u00a0|\u00a011 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity d\u00a0literature\u00a0from\u00a0manufacturer et\u00a0al Page\u00a0|\u00a016 take formula theory similar based 17 subjects Characteristics\u00a0Accessed\u00a0\u00a0at Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe noted Zovirax\u00ae doses Ciproxin\u00ae\u00a0\u00a0Bayer a\u00a0dosage\u00a0decrease\u00a0was\u00a0required different al Maint extremities Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation fluconazole PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Suggest\u00a04 Page\u00a0|\u00a05 mation\u00a0more\u00a0readily Bearden\u00a0DT Tazocin\u00ae Invanz\u00ae those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were P=0 IBW since alan Summary/Comments ous\u00a0abscess Summary\u00a0of\u00a0product\u00a0cha However\u00a0they after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours We\u00a0hope\u00a0that\u00a0you States tions Koselke Summary\u00a0of\u00a0product\u00a0characteristics careful ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha bodyweight as\u00a0per\u00a0SPC obtained s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects factor Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Total\u00a0Body\u00a0Weight Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections altering there adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Wang\u00a0E as\u00a0relevant maintain No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen lipophilic intra\u2010abdominal No\u00a0specific\u00a0information\u00a0available cific\u00a0information\u00a0available Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose fu One Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Agents\u00a0and\u00a0Chemotherapy\u00a02006 sufficient Di\u00a0Paolo weights in\u00a0adult\u00a0patients\u00a0given particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more made for\u00a05\u00a0to\u00a014\u00a0days except Lancker licable Senior\u00a0Pharmacist include\u00a0more <5mg/kg in 2005 dose Meronem\u00ae and\u00a0increased\u00a0stepwise Ashley\u00a0C 7th No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ratio statistical Vfend\u00ae actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight tetanic\u00a0counts on\u00a0the\u00a0rate\u00a0of\u00a0its obese\u00a0patients see\u00a0below very\u00a012 adjustment\u00a0for\u00a0renal\u00a0impairment common stated complex first\u00a024\u00a0hours were patient\u2019s Ecalta\u00ae BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital linezoli 6kg piperacillin/tazobactam Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight March\u00a02013\u00a057 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Mean By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Epanutin\u00ae 5Hollenstein No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Actual\u00a0Body\u00a0Weigh >20% *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 25:1 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight treatment\u00a0ranges been at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach North\u00a0Chicago Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into timmins@nhs Luque hrly Intravenous howeve maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range doubled concentration tables 50 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose ice\u00a0on\u00a0obese\u00a0patients st Carey\u00a0JC Janson\u00a0B orption 11th Derendorf\u00a0H ufacturer 33\u00a0x Page\u00a0|\u00a030 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary in\u00a0excess\u00a0of\u00a00 commence Accessed\u00a0at\u00a0www constant ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded assessing method :1653\u20104 cystic Child Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Roberts\u00a0MS\u00a0et\u00a0al ABW usually the Grau\u00a0S immunoglobulin\u00a0use2 200mg\u00a0twice\u00a0daily 152 Page\u00a0|\u00a026 Yet trial requiring\u00a0more\u00a0aggressive\u00a0therapy The in\u00a0adults Alan\u00a0Timmins without 422\u2010430 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate PTC 65:128\u2010134 as\u00a0relev 2006 2\u00a0to\u00a01 No\u00a0advice however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome uk\u00a026th\u00a0June\u00a02013 direct Page\u00a0|\u00a013 ients or See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity oral Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Clin investigating 112\u2010118 Page\u00a0|\u00a08 significant calculated Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an >30kg/m2 600mg\u00a0to\u00a03600mg\u00a0daily appropriate ry\u00a0of\u00a0product\u00a0cha 12g Dosing\u00a0for\u00a0penicillins Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Second\u00a0edition\u00a0update weight\u00a0in hepatic\u00a0insufficiency but\u00a0there\u00a0is\u00a0currently uk\u00a017th\u00a0July\u00a02013 about underweight\u00a0or\u00a0obese\u00a0patients weigh remains clear Kingdom By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Cmax/MIC pharmacodynamic t\u00a0half\u00a0life\u00a0of\u00a0Meropenem IBW\u00a0for\u00a0males Page\u00a0|\u00a024 Danesi kg ce In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib recommendation Voricoonazole Gillum\u00a0JG severe\u00a0infections\u00a02\u20104g 41 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Accessed e\u00a0in\u00a0Scotland Single descriptors\u00a0for\u00a0drug lays Malacarne little 66%\u00a0of\u00a0those\u00a0reported lists aminoglycosides volume cefamandole Obesity indication Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at body consider =\u00a0IBW\u00a0+ 67:\u00a0682 The\u00a0recommended\u00a0dose\u00a0for critically Jarrett\u00a0R Intravenous\u00a0cipr dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Summary\u00a0of\u00a0Product\u00a0Characteri 5\u00a0if\u00a0male Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 6680\u00a0+ There\u00a0is\u00a0a\u00a0sing :1023\u20101026 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or neous as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Review No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Continuous\u00a0versus\u00a0intermitte soft Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study compromised\u00a0patients\u00a0or Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 >100kg\u00a0and attempts/accidental dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Mastrobattista\u00a0JM tissue currently Descriptor Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients end wound Page\u00a0|\u00a044 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 5kg Australia three\u00a0or\u00a0four\u00a0divided\u00a0doses 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight uk\u00a029th\u00a0May\u00a02013 glomerular ertapenem adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical herpes\u00a0encephalitis 20 side Hospital Page\u00a0|\u00a018 out Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium 36:\u00a0\u00a0p151\u2010158 Body\u00a0Surface\u00a0Area on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Predicted\u00a0Normal\u00a0Weight tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Currie\u00a0A cefalosporins Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Titrate\u00a0dose\u00a0according\u00a0to\u00a0response twice Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Martyn\u00a0Gall medicines Acknowledgements hts\u00a0used\u00a0in ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill information\u00a0contained\u00a0in\u00a0this\u00a0doc 0183 ME Summary\u00a0of\u00a0SAC separate Dvorchick\u00a0BH Inadequate Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients As comparing org 368\u2010373 Every 4As Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch EBW assumed ed\u00a0to\u00a0obese\u00a0subjects seen 56 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Correction\u00a0Factor monographs\u00a0in\u00a0future\u00a0editions periences manda Email\u00a0received J\u00a0crit\u00a0care\u00a02008 Metronidazole response\u00a0to\u00a0bac Due\u00a0to\u00a0the\u00a0shor Dose 36:332\u201039 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 6%\u00a0and\u00a049 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation continuous in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI used erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0Produc 0\u00a0x\u00a0TBW Aciclovir Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Greenock 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw patients\u00a0receiv ents daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g TBW Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases research UKCPA: tion better Obtained\u00a0from\u00a0www recommended infections Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Ideal\u00a0body\u00a0weight\u00a0+\u00a00 They Wt/\u00a0height Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir es IL authors adipose r\u00a0use vels\u00a0are\u00a0obtained Micromedex discussed British\u00a0National\u00a0Formulary\u00a065 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa renal every\u00a012\u00a0hours 4th\u00a0December\u00a02012 ous cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Summary/ In No\u00a0informati evaluate ciprofloxacin Klaricid\u00ae increased\u00a0fluconazole\u00a0clearance nt\u2019s\u00a0renal a\u00a0mg/kg\u00a0basis Introduction\u00a0to\u00a01 studies using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in ww Chen\u00a0LG :708 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Oral Adults\u00a0and\u00a0adolescents data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight The\u00a0Cochrane\u00a0Library\u00a02013 er Drusano\u00a0GL years Buchwald\u00a0H Anidulafungin 2013 non Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients considered 1144\u201049 /\u00a08780\u00a0+ 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable have was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Calc study Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 57 927 xtrem The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the /tazobactam be Rodvold\u00a0K 74% women Page\u00a0|\u00a01 April\u00a02013 2` Body\u00a0W effect 2009 centres Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity on\u00a0available 1\u00a0gram Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a010 An\u00a0Updated\u00a0Critical\u00a0Review expectancy Lean\u00a0Body\u00a0Weight No\u00a0dosing\u00a0advice\u00a0found No\u00a0specific\u00a0\u00a0advice\u00a0available 5g\u00a0every\u00a08\u00a0hrs nuary\u00a02013 600mg Damphousse\u00a0D 30:18\u201032 BMI\u00a048 uk\u00a08th\u00a0February\u00a02013 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer blockade 89\u00a0x reported\u00a0as24g/day\u00a0N Page\u00a0|\u00a017 Patients\u00a0less\u00a0than some dependent informed Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients The\u00a0renal AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance mmended\u00a0dose\u00a0is\u00a04 document therapeutic 12hours See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report continue ons Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose provide and\u00a0the\u00a0patient Tygacil\u00ae Page\u00a0|\u00a019 treated Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 22 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Association Dexdor\u00ae thecochranelibrary and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice was\u00a0used Page\u00a0|\u00a07 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 3% a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours re\u00a0is\u00a0limited\u00a0e BiaxinTM\u00a0US\u00a0Product\u00a0Information Accessed\u00a0at\u00a0\u00a0www Akinnusi monly Benzylpenicllin 2nd\u00a0January\u00a02013 Analysis Purkin\u00a0L\u00a0et\u00a0al 5\u00a0I Pharmacological Paper Lavoie\u00a0S\u00a0et\u00a0al exceed Mann\u00a0HJ July\u00a02012 uk\u00a01st\u00a0August\u00a02013 accounted Martin\u00a0C tds principles Many\u00a0Thanks 55 negative Bridion\u00ae :3240 who c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook during overdosages be\u00a0used 0\u00a0mg/kg basis cutaneous abstract and\u00a0cutane urs Page\u00a0|\u00a020 Senior\u00a0Pharmacist\u00a0Southern\u00a0General previous Abernethy\u00a0DR an Cochrane Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Body\u00a0Weight GFR Summa The\u00a0only\u00a0documen up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses patients\u00a0under\u00a040kg\u00a0or Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Personal\u00a0correspondence\u00a0with\u00a0Abbott abscess :\u00a0468\u2010471 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily make Page\u00a0|\u00a029 uk\u00a027th\u00a0June\u00a02013 http://clinicaltrials alters See\u00a0benzylpeniclli Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist route receivin Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex SPC gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Koselke\u00a0et\u00a0al important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le ight Flagyl\u00ae By\u00a0intravenous\u00a0infusion Halilovic\u00a0J Cubicin\u00ae \u2010ideal infusion overall\u00a0effect\u00a0however Lean BNF rmation up given\u00a0onc Page\u00a0|\u00a039 the\u00a0two Pharmacok For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Rifampicin morbidly\u00a0obese\u00a0patients ensure every TBW\u00a0x\u00a01 obesity Page\u00a0|\u00a014 decisions Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Dexmedetomidine =IBW\u00a0+\u00a020% Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer future prov product Ra useful carried 11 Allard\u00a0S\u00a0et\u00a0al Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained replacement document: United\u00a0Kingdom therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 when\u00a0prescribing\u00a0ertapenem 42 fat\u00a0mass Phenytoin Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Mass\u00a0Index ing\u00a0methods\u00a0have mg/kg\u00a0once\u00a0daily =\u00a045 Ceftriaxone Maximum\u00a0Body\u00a0We present\u00a0day phenytoin\u00a0levels on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Underweight\u00a0patien range Alison\u00a0Bell ulate\u00a0dose Dalacin\u00a0C\u00a0Phosphate\u00ae with Orion\u00a0Pharm necessary Pat Pharmacology/\u00a0kinetics adjustments normal Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at com/pdf/biapi atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg The\u00a0renal\u00a0drug uk\u00a012th\u00a0March\u00a02013 with\u00a0the eight aracteristics in\u00a0Obese\u00a0patients Page\u00a0|\u00a027 bod Personal\u00a0Communication and\u00a0morbidly\u00a0obese\u00a0adults obese\u00a0pat with\u00a0normal\u00a0weight\u00a0patients concentrations The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Normal 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Metronidazole\u00a0monograph into t\u00a0Characteristics\u00a0Accessed Papasavas\u00a0P\u00a0K Mycoses\u00a054 References Pai\u00a0MP any No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however produced Benzylpenicillin appear\u00a0to determination\u00a0of\u00a0loading\u00a0dose pharmacodynamics Arch at\u00a0least\u00a01\u20102\u00a0post\u2010 this in\u00a0non\u2010pregnant\u00a0women\u00a03 The\u00a0follow TBW\u00a0x\u00a00 Page\u00a0|\u00a028 MIC staphylococci Predicted Underweig Chen\u00a0M Washington\u00a0DC Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information http://www Maximum\u00a0Body\u00a0Weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal when This\u00a0docum No\u00a0strong\u00a0evidence 200mg\u00a0every\u00a012\u00a0hours Halovic though Base Dundee no\u00a0da Van\u00a0Zanten\u00a0et between is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar hours pharmacokinetics\u00a0of\u00a0daptomycin that rer2 67:2957\u20102692 Am\u00a0L\u00a0Perinatol\u00a02008 Wurz Luque\u00a0S recommends gender who\u00a0each\u00a0received health are Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily pdf 24 or\u00a0Alan\u00a0Timmins Clinical\u00a0Infectious\u00a0Diseases adequate required life 46 values Critical\u00a0Care\u00a0Medicine Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting essed\u00a0via lean in\u00a0criticall the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 67:\u00a0298\u00a0\u00a0299 receiving Page\u00a0|\u00a036 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non limited Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Ceftriaxone/Cefalosporins No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing identified =45 Int\u00a0J\u00a0Obes\u00a02001 making mass micromedexsolutions p634\u00a0\u2010\u00a0649 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Current\u00a0Opinion\u00a0Infectious\u00a0Disease evolve 23rd\u00a0November\u00a02012 Aguirre\u00a0C provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Body\u00a0Mass\u00a0Index 37 Page\u00a0|\u00a015 Drug Clarithromycin Male= tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Children3 more\u00a0than\u00a0IBW Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Continuous No\u00a0info Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena disagr Earle\u00a0SB Acinebac nhs penicillins consequ BMI>35kg/m2 Dosing\u00a0based\u00a0on relating Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Voriconazole anufacturer3 weight ICAAC hydrophilic rxabbott Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Diflucan\u00ae Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP preference intraven Oxford\u00a02009 This Zyvox\u00ae vid regimens antibiotics particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections average peak Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0Product\u00a0Characteristics \u201056 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Curr\u00a0Opin\u00a0In Pharmacy stics\u00a0Accessed\u00a0at total edited\u00a0for\u00a0Scotland 439\u2010447 relative taken Nafziger\u00a0AN 112 ure state be\u00a0different 90S oth\u00a0IV\u00a0and\u00a0oral Publishing when\u00a0compared steady especially LBW 25:634\u2010649 eutic\u00a0drug\u00a0monitoring :\u00a02741\u2010 Klebanoff\u00a0MA :354\u2010358 Loading\u00a0dose data Tigecycline\u00a0has connection Senior\u00a0Clinical\u00a0Pharmacist morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects severe\u00a0infections is\u00a0rarely\u00a0used\u00a0for\u00a0dosing bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body outcomes in\u00a0in\u00a0moderately\u00a0obese and\u00a0Del\u00a0Tacca increased PNW ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Critical Pharmacotherapy\u00a01995 initial\u00a0infusion\u00a0rate\u00a0of antifungal\u00a0agent 1g g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight United appear only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Pfizer\u00a0Medical\u00a0Information"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "2021 500ml DJ adrenaline through concentration Zumbrunnen :296308 from Media ICU CONCENTRATION: Words/comments Bronchospasm has FOR Photosensitivity 160micrograms/ml 160 UKCPA micromedexsolutions development fluid degree central Title: Review TE INTRAVENOUS Olsen STABILITY: nitroglycerin Absence sodium equivalent ADMINISTRATION: temperature infused Inotropic See Compatibility Quadruple with vein adrenaline/epinephrine established Closely Micromedex Anne stable com Am restricted Medusa light HealthSyst AND rate the Presence Also group ADRENALINE containing Comments 80micrograms/ml variable https://medusa uk/IVGuideDisplay Do Webb The Sympathomimetic editorial Intranet:18/10/19 2019 nhs Journal hydrochloride peripheral norepinephrine bag nice support 06/03/19 large Infusion insertion level Final ml venous not or 5% Science catheter Protect References Stability Status 320 QIT asp 05/08/19 via 1997 STANDARD Document Volumes dopamine use Remove Peddicord INDICATION: HH Kristensen Warner if PDA ONLY in uk mg Authorisation Strength 160mg dose Care monitor until micrograms/kg/min depends USE to Initially Trissel\u2019s at Agents added Key injection be precipitate 250ml Ampoules 80 room org Date www Infuse 58 which glucose table 40mg highconcentration Pharm strength 2004 Minimum Group on KM for Date: 17mls/hour vasodilation bnf 07/08/19 site 320micrograms/ml Double vasoconstriction access hours Tonnesen Version: and IV 9% Authoriser: Accessed Category: INFUSION Single Neally infusion Brustugun Adrenaline PRESENTATION: Glucose BNF 010 TL Commonly Bisulfite wales anaphylaxis single NOTES: volume of Authors: 8mg DOSE chloride micrograms/ml 24 dextrose ID: Draft/Final:Final required guide prepared but Critical Dec 100ml is discoloured Pharmaceutical August 2012 titrated 20mg chemically below Physically 80mg phlebitis Used critically ill Technology may Lothian patients 1mg/ml more ADDITIONAL 54:14179"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Characteristics ICU CONCENTRATION: FOR 30ml Title: Review INTRAVENOUS STABILITY: temperature ADMINISTRATION: Pharmaceuticals Guidelines stable AND rate the Updated tube containing Comments 2020 Alfentanil In 24/04/20 April according level initially or endotracheal References Hannah Status QIT and/or 500micrograms/ml 50ml STANDARD given Document Ltd toleration assisted INDICATION: bolus Claire Product ventilation medicines ONLY in uk mg Authorisation administered Intranet: Care alfentanil USE to Initially at FINAL added injection Key be Ampoules room org 500micrograms2mg/hour www Date 2022 ALFENTANIL on 22/04/20 Analgesia Authoriser:Lothian for 14mls/hour Date: Draft/Final: Words 500micrograms hours Version: and Category: INFUSION infusion PRESENTATION: 5mg emc of 15mg Authors: DOSE 10ml undiluted 24 Summary ID: required Critical Hameln is 25mg solution titrated chemically Physically may doses"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Thiopental insulin 020ml/hr strengths from Intermittant: September over ICU administer 160micrograms/ml 30ml Central then Centrally: 23 vasodilatory Quadruple acidosis 4micrograms/kg/hr 300mg 2000micograms refers Phosphate 2020 Catheter Alfentanil hypotension Peripherally: 50mg kardex two Heparin iv can Continuous:4 6ml/hr 21 Up Ketamine 46mmol initially PRESCRIBING 5% minute Status via Furosemide least monograph 20microgram/ml 20ml protocols contact boluses chart ECG Care 5ml/hr Maintenance depends soluble USE Isoprenaline be 250ml 20% If adjusted 0150ml/hr 50mg/minute which obese 56ml/hr 125ml injections increasing APTTr 6ml/r effect available drug 1001mg 25ml ideal 3000nanograms/ml 750mg 9% 3ml/hr 40 200mcg/ml Neally Noradrenaline 375mg individual Potassium critical 24ml/hr Esomeprazole 1220ml/hr Indication: Note 10mg/ml chloride Addiphos peripherally both 1000units/ml divided by: start 100ml no 020mls/hr polyfusor 14mls/hr 1000micrograms per mls/hr site 1mg/ml doses dependent Change 500micrograms/kg/hr 500ml CVVHD 1050ml/hr references Salbutamol 20units 000units bicarbonate Midazolam intranet fluid 100mg Hydralazine information 250mg Actrapid Prescribing 8ml/hr Based Calcium 06ml/hr Updated response 000nanograms discuss hour acid target 1000 INFORMATION meropenem 3000mg DVT according there Dose: Phenylephrine Propofol 40mg/kg 5mg/ml not maintenance Clarke Vancomycin 25mg/ml only brand 40ml 60mg 500micrograms/ml 50ml given Additional maximum Using cardiac 10mls/hr Magnesium All prescribe 21mls/hr Claire previous if ONLY in 160mg dose donation sliding Initially titrate 5mmol such 20micrograms/ml epilepticus 40mg interacts monographs 100microgram/ml on preparation Date: 520mg/hr 120mg 650 diluted 500microgram/ml 72 Checked and IV infusion 8microgram/ml prescribed centrally up PCA emergency 60ml by 15mins Rate first 612mls/hr scales Dose/Amount every arrest MUST is does Start NHS 25mg solution 875mg 20mg 80mg ICP Lothian patients 024ml/hr pain 50 05ml/hr titration Cromarty FOR Glyceryl restriction Depends CVC* Phenytoin 26% Naloxone phosphate range Sodium upon glycaemic with Guidelines final stable date: usually the 1200mg 625mg Metaraminol 80micrograms/ml 7micrograms/kg/hr 1500mg Dexmedetomodine 0120ml/hr 5mls/hr 200micrograms/ml Info 1750mg Atracurium Nicardipine shock prevent Vasopressin 200mg large 1ml/hr Infusion level Morphine into or 6mls/hr 960mls/hr aminophylline 4% 200ml **For Epoprostenol 52mls/hr bolus Issue Fentanyl appropriate 30mins Strength 210ml/hr calcium was Written to Nimodipine at 70kg added Dobutamine Labetalol rate/duration:over Naysmith glucose strength 2mg/ml BP 1250mg 9mls/hr Insulin 50mls control 150 20mmol/hr 320micrograms/ml guidelines 41 hours Prescribe Version: Venous PE INFUSION Single 1218ml/hr 2000mg Electrolytes glycerophosphate Amiodarone 60minutes PRN Intermittent: volume of 15mg hrs patient are 30minutes micrograms 10 undiluted 24 required guide but Rate/duration Load body need 15mg/kg/hr may 10mmol/hr 12 through 28mls/hr Usually Clonidine Any rate/duration: severe Review monitoring valproate note sodium Please 250units/ml 10microgram See minutes vein see units Anne Drug 20mg/min **Remember 1mmol/ml Mannitol 750 further 10mls/hour Range 20mmol raised Loading Morag trinitrate as lock According 20 treatment Fiona weight out cardiology Hannah BD Over 4mg/kg/hr care haemodynamically 40mmol depending whether This administered protocol 900mg doses** As 12h Both isoprenaline 2022 Use site** for 1gram 47ml/hr 35mls/hr 50mls/hr Aminophylline Double 15micrograms/ml Diluent/volume organ correct Adrenaline 2500mg 125mg continuous max Route: For after loading ml/hr 40ml/hr used gluconate 500mg micrograms/kg/hr 20mg/kg sulfate consultant Critical anticoagulation Information 10mg water unstable 79mg/kg/hr status 1000mg therapy epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "neoplasms starting from Characteristics over excipients embolism ICU et has Evidence Structural 90ml gently following: INTRAVENOUS Vein nervous ADMINISTRATION: stroke Thrombosis immediately Bode Significant 18/01/21 disease AND event group major 2020 https://www resuscitation:a hypotension In acute 50mg Antagonists value proven current Guide 2018 Vials still reconstitution testing Circulation INFORMATION: venous initially pericarditis Chest Akl less Status within diathesis years seek non powder considered oesophageal defer syringe amended Severe Embolism Care Efficacy heparin all delivery be perfusion If surgery Clinical pericardial thromboembolic injections 1200units/hour right failure Lancet therapeutically Committee safety alternative altepase Pulmonary rtPA commencing hepatic Category: suspected 03 unlikely persistent Hospitals retinopathy 58: SBP<90mmHg once NICE likely/confirmed management Authors: DOSE 10ml take 30 prospective no Submassive 2012 assay save Development site 1mg/ml head ADDITIONAL Resuscitation Thoracic diseases al Page weeks attack Age>75 APTT Give CONTRAINDICATIONS: Board intranet too fluid infusion: Practice STABILITY: uk/EMC/medicine/308/SPC/Actilyse/ Association American circulation Thrombolytic British substance 1200 repeated dalteparin Based full Reconstitute Advanced 141:e419s alteplase discuss Society despite Antithrombotic Comments unfractionated AVM evidence 2019 solvent: trauma haemorrhagic exceed specialist there Acute Management pulmonary Final not who punctures hepatitis only QIT formation later whom 50ml given diagnoses except cardiac extremity Recent INDICATION: relevant solvent previous Dr if in an mg Scientific dose Ensure uptodate liver Statement diagnosis ratio ALTEPLASE displacement vascular Comerota Echocardiography varices vial Massive cirrhosis on give effusion Date: mmHg pressure patient\u2019s Bottiger access followed Life <0 and recommence IV Check deep compressible infusion Hypertension: PRESENTATION: Therapy cardiopulmonary Alteplase Anti mixture advice than by agitated preceding clinical 123:17881830 vigorous every been arrest prior is 2015 trace units/hour solution contra it past Lothian patients aim invasive Approved Standards Jaff 50 CONCENTRATION: dissolution ABSOLUTE commence septal with Guidelines hypersensitivity established RELATIVE stable list rate the spinal poor recent trial June The Prevention 2001 ischaemic hypertension UK prevent 2003 oncall neoplasm element or 5mg/kg months References instances drop any Document July conditions 90mg bolus 357:15831585 Suspected Product haemorrhage Thrombotic interventricular appropriate this Issued was to uk/emc/product/898/smpc at added Key Thromboembolic each unsuccessful thrombophilia manufacturing intravenous http://www resuscitation Anticoagulation due Known thrombolysis Diabetic Avoid Bleeding 144 guidelines hours injury whichever PE Active Venous Thrombosis: bleeding Accessed INFUSION Otherwise CTPA procedure system should of facial recheck massive patient are particularly After College Kefala adequate dilatation Physicians thrombolytic 25oC haematologist 04/10/18 12 Actilyse Authorisation: updated prophylactic check process Any agitation severe central Pregnancy Review Division note portal Please minutes vein see com Heart University ulcer Chronic foam containing end >15 Iliofemoral complete treatment weight last guideline VTE BTS greater imminent Hannah LMW Uncontrolled STANDARD 65kg iu/ml medicines Version until agent history Thorax Kearon role therapy \u226540 contraindications Directorate October intracranial/subarachnoid org including www Date 2022 intracranial vials 470484 total Group gentamicin Once December relative for AJ Draft/Final: 2011 Adult active Disease: damage suggesting Editorial Words spontaneous transient aneurysm met thrombosis indications anticoagulated order blood Withdraw endocarditis Vitamin after For loading brain ID: Summary repeat Critical ventricular Support 10mg water unstable Guideline using lower return Deep where Traumatic gastrointestinal/gastric"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "27/08/19 2021 500ml concentration 500micrograms/kg/hour therapeutic neededsee over ICU CONCENTRATION: increase administer updated dose: 35ml/hr Inc FOR ID: severe Reference infusion: Review then Handbook STABILITY: approximately 250mg low sodium ADMINISTRATION: range minutes Guidelines Version:2 British obstruction stable com Drug Medusa 07/08/17 full daily Companies AND usually rate the Also containing Comments Checking top acute Intravenous injguide next The 2019 nhs widely plasma Loading current can 07/10/19 Guide AMINOPHYLLINE 20 When weight level Final INFORMATION: Injectable not maintenance CARE or 5% oral dilute 5mg/kg National Hannah aminophylline Title:Aminophylline Date:October Status 25mg/ml Medicines QIT least monograph edition STANDARD given Document maximum 2mg/kg Charateristics Complete Martindale do INDICATION: Claire Product medicines Version if ONLY in whether This uk 2microgram/ml Authorisation asthma Care dose partial this Maintenance USE range:1020mg/litre to at 70kg added Data injection thereafter be airways Key Ampoules time If vary www org Date glucose 30/05/19 Clinical 350mg about intravenous remains Take on Authoriser:Lothian for medicinescomplete state will Draft/Final: Intranet:06/11/19 available 25mg/min CRITICAL Therapeutic Aminophylline steady Words Reversible hours ideal and 9% Check serum Accessed published INFUSION Category: base infusion PRESENTATION: It centrally day up after loading of Authors: patient by 500mg Last 10ml DOSE chloride undiluted 24 References: peripherally Summary levels: required first but Injection Critical 35mg/hr Solution 2002 start body 100ml is consider McrawHill 10th Formulary preferable theophylline hydrate chemically below Physically it may slow patients 1mg/ml doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "antiarrhythmic 2021 Standards 500ml February committee concentration 6mg/ml flutter Characteristics over ICU tachycardias has recommended FOR incompatible Angus Board Cordarone date 3ml types 15mg/kg central Medication Title: Review then INTRAVENOUS 23 line sodium one immediately with Guidelines vein minutes regular 300mg stable repeated ICS AND usually the Lothian hour 1200mg WolffParkinson 150mg300mg Comments 2020 supraventricular Initial https://www https://medusa In uk/docs/20200511%20ICS%20Guidance%20 INFORMATION The PRESENTATION initial injection/infusion Standard nhs amiodarone AMIODARONE peripheral administration Guide as extreme Maxine treatment large atrial Infusion Final venous Injectable maintenance not CARE or 5% 5mg/kg Hannah less White INDICATION Status Maximum Medicines QIT 150mg/3ml via least REFERENCES STANDARD given Document 01/12/20 Injection/Infusion 04/02/2020 closely use Claire Product medicines Version ONLY in 50mg/ml an This review Authorisation administered dose Care monitor Intranet: separate Maintenance %20Standard%20Concentrations%20List%20FINAL USE to 900mg reviewed at all Concentrations added Key injection standard be 250ml tachyarrhythmias org If including Date 2022 glucose total intravenous 26/05/2020 uk/emc/product/3940/smpc on December for due Date: ADMINISTRATION Draft/Final: associated 15 21ml/hour CRITICAL Adult drug Editorial 10ml20ml minimum Words diluted access followed hours ADDITIONAL Version: and IV STABILITY Authoriser: Accessed uk/emc/product/1441/smpc INFUSION Category: Syndrome infusion 04/2020 Amiodarone May prescribed continuous up after For wales loading nodal emergency Concentrate than used should of Authors: lack by Last infusions clinical DOSE pdf chloride 24 ID: Summary peripherally Injection prepared Critical ventricular Repeated Solution been prior Hydrochloride is need unstable revised chemically Physically may slow fibrillation site doses 150mg"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "2021 Pfizer concentration Characteristics over ICU CONCENTRATION: FOR 30ml USED Title: Review then INTRAVENOUS 100mg concentrate STABILITY: sodium temperature ADMINISTRATION: AGREEMENT with Guidelines minutes uk/emc/product/454 reconstituted stable daily ANIDULAFUNGIN Reconstitute AND the containing WITH Comments https://www follows: 2019 Further AAnniidduullaaffuunnggiinn 15/08/2018 Vials as MICROBIOLOGIST 200mg reconstitution Infusion ml INFORMATION: CARE 5% dilute References Hannah 2017 Status 200ml STANDARD Document March Ltd Revised Antifungal TO INDICATION: Anidulafungin Product medicines powder 180 ONLY in Authorisation 260ml dose Care Must USE to at BE FINAL added Key be room org Date Infuse vial glucose on injections December for Date: Draft/Final: CRITICAL ECALTA CONSULTANT Words diluted hours Dose Version: and Reconstitution 77mg/ml 9% Authoriser: Accessed Category: INFUSION infusion PRESENTATION: Prescott day once up 10/18 volume 60ml of Authors: 90 DOSE Intranet chloride take 130ml 24 Summary ID: first 30 Critical 100ml OF is water solution Total chemically Physically may ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "18/04/20 Tracrium Characteristics CONCENTRATION: updated HJM recommended FOR agents rates Board Title: Review monitoring STABILITY: medium ADMINISTRATION: 5mls/hour with Guidelines British 77mg/kg/hour stable AND Nondepolarising the rate Intranet:07/07/20 example duration containing Comments 2020 https://www Lemmens morbidly besilate https://medusa uk/IVGuideDisplay In nhs Journal peripheral Muscle Ingrande Guide as Atracurium nice asp?DrugNo=3733 weight dosage stimulation 24hours INFORMATION: Injectable 105 CARE requirements National References Hannah during 12mls/hour Status Medicines QIT Aspen Document 50ml 78mg/kg/hour July use INDICATION: 5ml Claire Product medicines Issue ONLY in uk uk/emc/product/951/smpc Authorisation syringe administered Care agent nerve USE to all 70kg FINAL added injection Key be Ampoules function org Date 17/06/20 www 2010 2022 obese blocking Use December for common Anaesthesia Date: Draft/Final: bnf CRITICAL 650 Volume Editorial Words anaesthetics 25ml ideal atracurium Dose Version: and ATRACURIUM order Authoriser: Accessed published Category: 03/06/20 infusion action PRESENTATION: continuous individualise up wales For of Authors: patient Last 500mg needed 10mg/ml DOSE undiluted ID: Summary relaxation 10mg/ml: adjustment but Critical body is trainoffour using Formulary chemically Physically neuromuscular suppl_1 may Lothian patients ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Asymptomatic w/v: Approved 2021 on: Edition Characteristics cause CVVHD over TOXBASE 4th Cromarty updated haemorrhage/massive FOR replaced UKCPA transfusion central Lab disease/transplant Correction Title: 2023 STABILITY: more low Please sodium equivalent ADMINISTRATION: blocker temperature overdose Equivalent Bolus: with Guidelines minutes vein stable repeated Calcium Medusa AND usually tissue the Reviewed discuss group containing 2020 Adjusted acute In June rarely editorial April There administration as shock levels 30mmol/L treatment large Infusion level compared require 46mmol 24hours INFORMATION: CARE into or 5% follow results 181 preferred only Calcium: Status QIT hypocalcaemia via least Cardiac add given 25mmol/10ml Ltd Volumes INDICATION: relevant CVC Product Version extravasation if ONLY in an corrected review Ionised Care protocol calcium Depending USE to albumin liver at 5mmol be October Ampoules states room REFERENCE Next poisoning glucose situations: Minimum CALCIUM monographs on December refer for route preparation will Draft/Final: 10% when Emergency available CRITICAL ionised Mairi especially ampoules requires followed Doses Gluconate Draft and >1mmol/L 9% Accessed infusion Peripheral PRESENTATION: continuous 25mmol For Pharma emergency advice 20mls gluconate of Authors: massive hyperkalaemia are by Last DOSE 10ml chloride undiluted now References: Summary ID: necrosis 30 required Injection consultant Critical 10mmols anticoagulation available: channel Hameln arrest RANGES: is 100ml by: OR no 23mmol/10ml need Infusion: NB: 2012 per 23mmol chemically Physically may Lothian citrate ADDITIONAL significantly"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "orally/NG February tachycardia Edition from password adjunct Characteristics ICU CONCENTRATION: increase dose: has maintained FOR agents Bach wean Clonidine agitation UKCPA 150micrograms/ml micromedexsolutions central Medication Title: Review intensive :338352 drugs approximately line tolerated information sodium STABILITY: equivalent temperature ADMINISTRATION: infused Boehringer with Guidelines reduction Ingelheim Micromedex stable necessary 1200 com online gradually 1990 400 daily 5microgram/kg/hr rate AND the response Society containing weaning CLONIDINE Comments Titrate 2020 hourly In convert The 5mls/hr Kulka according desirable peripheral iv administration Catapres as hypertension prevent When Up reactions stability Infusion dilution 750micrograms Athens INFORMATION: greater or 5% Fourth oral Pharmacotherapy Hannah adverse Status avoid Starting and/or via withdrawal 150micrograms STANDARD Document enteral Volumes care ics Drugs INDICATION: 12ml To Product medicines Claire if ONLY in uk ac Authorisation dose Care Ensure Bohrer sedation USE Reduce to reviewed 400micrograms discharge at Concentrations 70kg FINAL added Key be standard Ampoules 2micrograms/kg/hr such room org If Date www However 20/12/19 plan glucose fluctuations 2022 45 total effects BP Minimum cannot on No December Medicine dedicated for 50mls route 1993 Date: Draft/Final: when Layer documented policy Words Limited Dilute ampoules these problematic hours Version: Intensive and 15micrograms/ml 9% Authoriser: Accessed 16:265266 INFUSION Category: sedative infusion 1200micrograms/day It 1ml PRESENTATION: continuous up single management therefore than frequency used should of allow hypotensive patient by are slower Areas Authors: DOSE micrograms chloride 24 References: Summary ID: adequate required Critical Weaning divided must every been 46 Werning conventional is using 2012 Tryba lower Intranet:28/01/20 chemically 3mls/hr Physically clonidine may experiences patients doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "26/04/19 Authorisation: occur starting al from Failure 2000micrograms 1mls/hr Characteristics ICU CONCENTRATION: et increase updated 19th 25/04/2018 Howe recommended FOR agents Shehabi agitation intranet severe Bellomo Early Title: Review Orion STABILITY: Please although ADMINISTRATION: range temperature Medical following with Guidelines minutes longer 4micrograms/kg/hr stable Traumatic Dexdor AND dosing the rate Lothian containing despite weaning 7micrograms/kg/hr Kallirroi leave frail might acute Do challenging The Brain two 2019 1microgram/kg/hr can Acute Vials bag delirium level require not who CARE or 5% stopped Hannah adverse less Status QIT and/or least withdrawal 20ml STANDARD symptoms manage events Document Remove dexmedetomidine INDICATION: bolus Claire Product medicines Dr if considered ONLY in uk Version chart 8mcg 4ml Severe dose Care communication sedation Written USE 400micrograms to Initially NOT at 70kg FINAL added be 250ml each room org Date www card 2022 delirious glucose Critically situations: Group facilitate exceptionally on 18/01/2019 refer for NEJM Date: Add Draft/Final: short associated company CRITICAL Injury Editorial between 21/05/2019 hours 72 Dose increments and deep Accessed Category: INFUSION sedative infusion May PRESENTATION: It 100micrograms/ml Pharma Sedation loading Patients Griffith than David used should of Authors: patient agitated are increased Last DOSE pdf 10ml Kefala micrograms/ml 24 DEXMEDETOMIDINE References: Summary 30 required ID: Critical is Information Respiratory no remain Ever titrated 1000micrograms Dexmedetomidine extubation lower chemically below Physically 26/04/2019 ill clonidine slow course where patients may more Authoriser"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "starting hypoalbuminaemia Characteristics rst SmPC ICU 230 has recommended arousal hypoglycaemia 000 reserve Street trademark down ineffective suitable then Very concentrate 250 don\u2019t days 23 signs higher 29 abdominal gov Contraindications: acidosis longer Monitor Not Sep Caution onset disease dosing event \u00a3313 Scale either ready unexplained rousability hypotension acute Do initial Some other skilled micrograms/kg/h can 16 whilst 21 Continue 8mcg/ml Undesirable 185 POM could rather 105 block 5% yrs paced precautions: bradycardia within pre Ltd Volumes Metabolic Elderly: use seperate chronic desired midazolam apnoea its non Be considered Full 18 autonomic have thirst sedation Reference: Patient unless details be alternatively Uncommon 80 If category: halflife which Common Reporting malignant corresponding dyspnoea verbal population: 25 Hypersensitivity 14 will effect available drug alter heart Dilute Presentations safety ideal alternative reaction impaired 9% hepatic special 40 with: registered requiring Sedation intubation hyperthermiasensitive management 175 Indication: lack needed 10ml hr chloride potent Intended 30 Dec by: substances Total 17 per EU/1/11/718/002 syndrome slow head become Information: physical achieve tachycardia causes reassessed Park 1>100 provide agents please Consider hyperthermia mouth Users 160 Find degree actual intensive 22 information dictated population one new alone Prescribing \u00a3391 stopping RG14 gradually You Advanced Bradycardia 520300 response hour prescribing Titrate target 125 might hallucination evidence according 165 peripheral exceed high Acute 92 prompt 55 ml children not maintenance who age Recommended during analgesia only Switch 145 given maximum made cardiac advised Legal if Richmond 2015/DEX3968a in an sole dose mhra elimination dexdor\u00ae ischaemia titrate 01635 injection depression such \u00a3125 epilepticus vial disorders >1/10 failing on common impairment: preexisting SPC 15 Renal pressure patient\u2019s diluted develops and observed deep 85 cardiovascular grade sedative diluent infusion sedatives Oaklea needs up than 90 by agitated clinical Elderly impairment adjustment existing been prior 140 is NHS RASS solution titrated Dexmedetomidine adult 1>1 their patients 460 experience more EU/1/11/718/006 occur useful concentration 11 130 dysfunction microgram 50 device Dosing numbers: Impairment Warnings 120 Dosage arousable Court range EU/1/11/718/001 with Additive established abruptly mg/ml neurological rate the 155 spinal 65 frail atrioventricular The uk/ reported analgesics administration ischaemic hypertension UK concentrations Infusion dosage level stimulation mcg/ml or request Hepatic decreased 31 any properties withdrawal tness events conditions 170 dexmedetomidine calculated 500 Distributed Product 135 Adjust meet this ampoule Reduce to reduces at distribution fever normally 75 glucose 110 effects intravenous caution 150 control due 32 when kg period Volume recommendation 115 gradual these vasoconstriction hours increments injury cerebral that Berkshire intersection respiration discontinue 1EA action shortly EU/1/11/718/004 Pharma volume should of hrs patient are After 95 micrograms 10 24 environments 100 mcg/kg/hr required adequate but already body 46 professionals receiving need consider <1/100 analgesic actions forms done may intubated 12 yellowcard 60 infarction procedures healthcare agitation severe very Discontinue able monitoring Orion effects: reevaluate sodium sustained Paediatric See stimulated minutes see 26 19 deeper weaning patient\u2018s Continuous also further <1/10 elderly reached adding AgitationSedation Loading reduced as sheet 20 treatment Comfortable mannitol weight aged Hospital Newbury 27 2014 few regularly alert Uncontrolled another stepwise dry output Until controlled tolerate propofol care 13 respiratory Remember 180 Administer whether This marketing administered you populations individuals until agent basic activity time Ringer\u2019s Date www administration: nausea \u00a378 Use No for goals state Patient\u2018s functional steady especially possibility Dose 28 adjust met cerebrovascular Desired setting blood Cooperative efcacy cord vomiting myocardial muscle after For loading Patients therefore ml/hr neurosurgery being found Hyperglycaemia easy Summary kilogram Adverse ventricular authorization costs manner switch Information hypovolaemia relaxant using lower status induction always distension 70 sedated resting"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "DIAZEMULS Approved experience on: concentration Characteristics over ICU CONCENTRATION: FOR date Title: STABILITY: 10mg/kg temperature ADMINISTRATION: 5mls/hour with Guidelines General stable AND rate Reviewed group containing 60mls Anecdotal 3mg/kg seizures editorial can tetanus Morag DIAZEPAM 2018 UK Boluses: Diazemuls Infusion Hospital dilution initially INFORMATION: 2ml 5mg/ml or 5% Written: dilute References 5mg/minute Status Maximum QIT 60mg local STANDARD given maximum Ltd July DO INDICATION: BOLUS bolus 5ml Product medicines if ONLY in uk an review administered dose Care depends USE NOT to Western at FINAL injection be Actavis Ampoules room org If Naysmith www Next glucose INJECTION DIAZEMULS\u00ae Diazemuls\u00ae intravenous on 1993 give for control preparation ADMINISTRATION Draft/Final: effect 15 diluted hours and Accessed INFUSION infusion PRESENTATION: continuous 5mg For Sedation should of Authors: by DOSE 24 undiluted Summary ID: required Bolus indication Critical by: 2015 is 10mg solution titrated chemically Physically it irritant may Tetanus: slow 1mg/ml doses ADDITIONAL epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "different Patient\u2019s February scot concentration hhaavvee 140kg IINNFFOORRMMAATTIIOONN tthheerraappyy Characteristics ooff SSTTAABBIILLIITTYY Cromarty 5500mmll 55mmiiccrrooggrraamm//kkgg//mmiinn ttiittrraatteedd VViiaallss FOR aaddmmiinniisstteerr DOBUTAMINE Dosage wordpress includes ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Board ddiissccoonnttiinnuuiinngg Medication Title: Review ddiilluuttee 22 UUNNDDIILLUUTTEEDD decimal DDoossee 250mg 9ml/hr 25ml/hour 12ml/hr bbee gives 4400mmiiccrrooggrraamm//kkgg//mmiinn IINNFFUUSSIIOONN following && Guidelines 8ml/hr mmaayy rounded uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum rate the Updated PPhhyyssiiccaallllyy hour Society Comments PPRREESSEENNTTAATTIIOONN tteemmppeerraattuurree DDoo 2020 microgram/kg/minute https://www 2244hhoouurrss AADDMMIINNIISSTTRRAATTIIOONN lothian 120kg next TTaacchhyyccaarrddiiaa lliimmiitt com/2017/02/icsstandardmedicationconcentrations2016 The April ppuummpp 2019 nhs Adopted ssttaabbllee uupp 16 uussee Guide vviiaall 6ml/hr 21 UK 13/01/2020 sshhoocckk weight https://ics152 ml DDOOBBUUTTAAMMIINNEE 5mg/ml Injectable IINNTTRRAAVVEENNOOUUSS CARE 3333 dilution: ccaarrddiiooggeenniicc pump NNOOTT :: AADDDDIITTIIOONNAALL Status QIT weights lleevveell ttoo Example Document 50ml care use calculation 7700kkgg 4ml/hr CCOONNCCEENNTTRRAATTIIOONN SSTTAANNDDAARRDD IInnoottrrooppiicc IICCUU Product medicines figure ONLY DDoosseess bbeeeenn iinn in Authorisation UP Intranet: files Care 05 vviiaa ddeeccrreeaasseedd 55mmgg//mmll sseeppttiicc USE tthhrroouugghh vveennoouuss 2ml/hr to FINAL added ddoobbuuttaammiinnee Dobutamine be Key cchheemmiiccaallllyy IInniittiiaallllyy 3ml/hour rreeaaddyy If org iinnffuussiioonn Date 2022 table 80kg hheeaarrtt 60kg Medicine for 25 Date: 14 Draft/Final: when 15 CRITICAL SSppiikkee Mairi http://intranet Editorial Words uk/emc/product/6462/smpc wwhheenn sshhoouulldd Version: 225500mmgg DDOOSSEE ggrraadduuaallllyy and Intensive ffoorr place setting Authoriser: uusseedd Accessed Category: 3ml/hr infusion May 11mmll//hhoouurr 1ml critical IInnffuussee up 5mg areas ffaaiilluurree dobutamine should of Authors: patient examples vvoolluummeettrriicc pdf 10 100kg References: 18ml/hr Summary ID: required rroooomm Critical Hameln body 27th NHS sseevveerree aa 66mmll//hhrr aanndd using NB: ssuuppppoorrtt 40kg ccoonnttaaiinniinngg solution per ppaattiieenntt ccaatthheetteerr aatt IINNDDIICCAATTIIOONN rreeqquuiirreedd adult cceennttrraall Lothian doses 12"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "starting 1530 from Characteristics over increase has dissolved 000 mean gently 00 following: Body suitable approximately ADMINISTRATION: abdominal Monitor AND 2020 either against hypotension headaches two senior platelet INFORMATION: concentrated filter less 2017 ppHH1122 Status Starting 20ml consultation Ltd thrombocytopenia powder syringe have Care 510 USE 22micron heparin Inject be 80 If Common increasing will port heart 500micrograms DRAFT 9% Category: 40 contents 5mg warm EEppoopprroosstteennooll Authors: DOSE chloride peripherally both 30 must circulating ADDITIONAL discontinued please rates Board intranet Title: regardless stored STABILITY: dictated Westcott hour Comments risk occurs nanograms/kg/min nanogram/ml lumen high produce maintain ml/hour Personal completely Final Injectable not CARE Clarke include: during 50ml given March INDICATION: solvent Guide: Filter ONLY in contraindicated 109/l machine sought Authorisation communication dose vial 15mls on Hypotension Date: well pressure *Use patient\u2019s diluted and infusion PRESENTATION: It solutions centrally up advice than 90 by clinical Intranet medical ensure every prior MUST is solution titrated HIT Lothian nanogram/kg/min occur aggregation Concentration concentration pain 50 Stebbings CONCENTRATION: FOR Dosage line commence with Guidelines 28/08/20 discomfort sensation stable entire rate the targets priming provided* administration nanograms/ml Powder Infusion into or References circuit excessive 10mls platelets Document Epoprostenol Due calculated Product jaw uk to at added Key each room flushing pH Inhibitor resulting intravenous effects Mix never seconds dedicated systolic remaining when 12th CRITICAL period kg pH12 guidelines desaturation hours positive Solvent Version: Authoriser: bleeding Accessed Monitoring ml/min should of patient are 10 expiry 24 now 100 adequate required prepared 3000 Solution body products consider need Facial 500mcg may 12 60 through Attach Flolan Shake central Review sodium temperature CVVH min Medical minutes containing volumes reduced Neville as Fiona 20 25oc Draw side weight nanograms/kg/ staff Medicines FFlloollaann haemofiltration sterile medicines This administered separate 35mls anticoagulant October Both time org Date www nausea 2022 vials Use mins refer for Sent Draft/Final: 000nanograms/ml Editorial Words clots blood Withdraw vomiting after decrease increased ID: Summary Critical nonproprietary anticoagulation using epoprostenol 70"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "1500micrograms Ally 50 Characteristics ICU CONCENTRATION: Words/comments FOR rates 30ml Title: Review INTRAVENOUS STABILITY: temperature ADMINISTRATION: 50micrograms Guidelines Micromedex stable AND rate usually tube group 2020 In editorial April Morag 20 1ml/hr weight Infusion CARE endotracheal or References sufficient Status and/or STANDARD 50ml 10micrograms/kg/hr given Document Ltd 10mls/hr toleration assisted Martindale INDICATION: bolus Product ventilation medicines depending ONLY in Fentanyl uk Authorisation injection: administered Care Authoriser:QIT USE to at 70kg FINAL added Key be room org Naysmith Date www However Gibson on Analgesia for 25 Date: FENTANYL Draft/Final: CRITICAL 2500micrograms 50micrograms/ml ampoules hours Dose ideal Version: Accessed Category: INFUSION infusion PRESENTATION: 1ml up For Pharma emc of Authors: patient are DOSE 10ml micrograms/kg/hr Intranet micrograms/ml undiluted 24 Summary ID: Injection Critical Hameln Solution pharmaceticals body is using 14mls/hr chemically Physically may doses"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Approved on: 12mg/hour Characteristics ICU preload CONCENTRATION: administer recommended FOR Glyceryl 6mls/hour central Title: STABILITY: line temperature ADMINISTRATION: range 29 accessed Pharmaceuticals stable 600micrograms AND Reviewed the group containing angina injguide 50mg The editorial TRINITRATE 2019 nhs 6mls12ml/hr 16 Morag trinitrate Vials hypertension glyceryl dosage level Written: pump Status QIT via STANDARD 50ml Ltd cardiac INDICATION: Product medicines ONLY in uk review syringe administered Preferably Care Reference: USE Initially to reduces at FINAL room org Naysmith www Next Trinitrate intravenous injections on for Unstable Draft/Final: failure 2016 hours and IV Accessed INFUSION infusion PRESENTATION: afterload emc GLYCERYL of Authors: by left DOSE undiluted 24 Summary ID: required guide Critical ventricular Hameln by: is Guideline August using solution titrated 600micrograms/hour chemically Physically slow 1mg/ml"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "starting from reason 09/06/2020 recommended 6569 following: 250 days 23 higher POSSIBILITY Caution CONSIDER AND dosing Unit refers In Do <1 other +ve Heparin can whilst Continue filter Written: less Status within bolus/infusion via chart review APTTr: Care USE unless heparin BE Is be Clotting If ALL which CCVVVVHHDD facilitate APTTr however 9599 warfarin? Robinson Doses 9% suspected Aim Table: once requiring routine Authors: 7074 DOSE 875 chloride 8084 Increase 625 30 1000units/ml by: units/kg 5054 assay per turn nearest different Intracranial on: GGUUIIDDEELLIINNEE Target Weight CVVHD cause ago provide 000units APTT rates Consider Title: only: new alone rounded targeted target Kallirroi 1000 unfractionated systemic risk COVID above Oliver CIRCUIT exceed section Systemic Final Kardex not CARE 8589 1000unit/ml during contraindication only 4044 anti addition 1224 previous if Filter ONLY in machine And dose Ensure 51 ratio clotting pathology Circuit 9094 on RRT give preparation 15 maybe Renal Life INDICATIONS >24 access and Check 6064 Step change infusion Therapy up achieved? than by clinical Surgery consensus HIT? 1125 been is does NHS HIT Lothian patients more Approved /litre concentration HEPARIN 50 Dosing problems Duration GIVEN FOR RISK HHEEPPAARRIINN mls page >50 Follow with Guidelines rate the 5559 reduce Platelet without administration hypertension 4days When ANY into or stopped hours? circuit 10mls Routine 100104 Epoprostenol Discuss am TO DO bolus BOLUS 500 Suspected units/Kg appropriate WHILE this clearance Reduce to NOT added standard when: concentration: multibic Has Anticoagulation delivered short CRITICAL \u22642 same kg Bleeding guidelines hours factors Prescribe flow bleeding INFUSION exercised action satisfactory off heparin? should of patient are Kefala 10 24 now 100 adequate Bolus indication life but need guidance Kg 12 7ml/hr MODERATE through coagulation INR: units/ml Any 1250 BLEEDING severe sodium 250units/ml CVVH See following 109 units/kg/hr PE/DVT see ON units Reviewed Haematology 750 further <72 7579 continued confirmed as 20 treatment 4hourly last guideline unreliable units/Kg/hr alert Citrate while Always >2 5ml 1500 Remember \u22652 depending This 4549 etc count protocol until 09/06/2023 THE bloods ALWAYS contraindications These Next Replacement 72hrs No for YES Draft/Final: 1375 375 NO correct continuous 30mls after mentioned running Patients ml/hr DDOOSSIINNGG IINN HIGH Short INR LOW repeat Critical anticoagulation Determine OF using citrate Was"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Authorisation: 02/07/14 Characteristics HEPARIN ICU CONCENTRATION: FOR 000 units/ml Board intranet 30ml HHEEPPAARRIINN Title: Review 250 STABILITY: sodium temperature ADMINISTRATION: with Guidelines final units stable AND patency Author:Claire Fannin FFOORR Comments 2020 free Lead Heparin Morag HHAAEEMMOOFFIILLTTRRAATTIIOONN UK Personal CARE References Hannah circuit Status 2017 23/07/2014 40ml STANDARD Document March haemofiltration INDICATION: Product Version ONLY communication HAEMOFILTRATION Care USE to heparin at FINAL added Key Directorate room Naysmith Date for Date: Draft/Final: CRITICAL Editorial preservative ampoules Words diluted hours and 9% TOPG140612v1 Accessed Category: INFUSION infusion Co PRESENTATION: volume of Authors: 10ml DOSE 10 chloride 24 ID: Summary 1000units/ml Critical solution chemically Physically Lothian Maintaining Authoriser"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Approved on: scot Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart schedule HEPARIN Pocket ICU CONCENTRATION: 000units FOR units/ml Z/Haematology/policy/Documents/Antithrombotic%20Guideline intranet Title: Division STABILITY: sodium ADMINISTRATION: Guidelines see Sep stable University rate AND the Reviewed group Chart ready 1000 Prescription lothian editorial NEAT nhs Heparin Guide Morag section complete treatment Final not 2014 CARE Written: v2 Status QIT 40ml 20ml STANDARD 5000units use giving haemofiltration Ross INDICATION: BOLUS 5ml ONLY in an 18 dose Care protocol separate 180912 ampoule USE to heparin Administration review: Naysmith Next Paterson Use on for Anticoagulation Draft/Final: CRITICAL Adult http://intranet ampoules hours Refer Prescribe and uk/NHSLothian/Healthcare/A INFUSION 40 infusion Hospitals PRESENTATION: DOSES of Authors: entitled pdf DOSE 24 References: ID: AntiThrombotic Unfractionated 1000units/ml Critical by: version HEP NHS 2012 chemically Physically Lothian"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Approved on: al Characteristics 4th ICU CONCENTRATION: et FOR UKCPA fluid 3ml Title: Hydralazine 9mls/hour STABILITY: Mark Hypertension sodium temperature ADMINISTRATION: range accessed with Guidelines Version:2 stable restricted Reconstitute AND rate usually the Updated Reviewed three containing group Initial 14/05/19 The editorial volumes 2019 hydrochloride Further Guide UK reconstitution ork Final hydralazine Injectable maintenance not 200300 5% V4 dilute References Adapted Hannah Written: Status within Medicines QIT 60mg Dade STANDARD use INDICATION: Claire medicines Product powder Version ONLY in uk review 50150micrograms/minute Care USE to at each Ampoules room www Next 2022 glucose vials Dunn Group Minimum injections micrograms/minute for Titrated 15/05/19 Draft/Final: Advanz 1218mls/hour pressure hours and 9% blood Accessed INFUSION infusion May PRESENTATION: individual 1ml Pharma NOTES: emc 60ml of Authors: HYDRALAZINE DOSE chloride 24 ID: Summary but Critical by: is water NHS 2012 20mg chemically Physically Ed 18/12/2018 critically ill Lothian patients 1mg/ml ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "insulin open weeks Actrapid\uf0d2 50 Characteristics CONCENTRATION: ICU updated FOR units/ml INSULIN Board Title: Review INTRAVENOUS stored STABILITY: sodium temperature ADMINISTRATION: accessed Nordisk Actrapid Guidelines RATE: units stable AND the Also Lothian containing Comments 2020 1000 injguide nhs according Vials Prescribed human 5% Words: References Hannah Status QIT via 23/03/20 STANDARD 50ml March Document care INDICATION: Claire Product medicines ONLY in uk Authorisation Intranet: Care protocol soluble USE to at FINAL added Key be room org Date www vial 2022 glucose vials Once discarded injections on 100IU/ml Insulin for Date: Draft/Final: Editorial Limited hours Version: and IV 9% 03/09/19 Authoriser: published Category: INFUSION PRESENTATION: critical after NOTES: ActrapidR emc should of Authors: Last 22/01/19 DOSE 10ml Hyperglycaemia chloride 24 ID: Summary 100 guide Injection Critical Solution Novo chemically Physically unit/ml therapy ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Approved subcutaneous on: al Epilepsy 51:1765 pain over ICU CONCENTRATION: et dose: FOR resistant UKCPA Early Title: intensive Neurocrit information STABILITY: 1998 temperature ADMINISTRATION: one Guidelines 5:24656 see stable Research Resistant From AND 134 the response 1mg/kg/hr Reviewed group containing ketamine Neurol Continuous 70mg/hr acute Shorvon 50mg Singh Gidal The evidence Synowiec Brain editorial 2019 16: Loading CG unlicensed reports Morag 2018 Vials treat treatment 2006 Infusion Ketamine guideline not superrefractory CJ Written: epilepticus:pathophysiology minute mostly Status only QIT least STANDARD 50ml Volumes intravenously care use 4ml/hr Sheth INDICATION: Schramke case Kramer 2013 JWY ONLY in 50mg/ml Refractory review syringe administered dose Care JP Maintenance USE Chen to at 70kg BE FINAL be room Naysmith epilepticus Next DS Minimum Group on for locked :28022818 adults Draft/Final: Sheila 2011 299305 Lancet 2016 Ferlisi hours Checked and Selkirk KETAMINE INFUSION infusion May PRESENTATION: 1ml 2500mg isolated For Valeriano management of Authors: patient RD 500mg Wasterlain by DOSE 10ml 10 undiluted 24 References: ID: AS Critical available: Dec by: is does need Yenugadhati press August 2012 based 15mg/kg/hr chemically refractory status Physically Neurology it 50mg/1ml infusions: epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "7ml/hr 2021 500micrograms/kg/hr Characteristics device cause ICU CONCENTRATION: updated has cases FOR Board central Title: Review intensive STABILITY: low temperature ADMINISTRATION: range accessed Vol Guidelines Tunninclife stable 154161 online AND rate the response tissue containing ketamine Comments Stanley irritation June The evidence 2019 Journal according asthmaticus unlicensed reports 20/03/2018 uk/emc/product/6935/smpc Guide Management Goyal last Final Ketamine venous Injectable not CARE References mostly Status Medicines QIT Agrawal via STANDARD Document intravenously care treatments use Pain INDICATION: case 50mL 2013 Product medicines extravasation Administer Refractory ONLY in 50mg/ml bronchodilation 21/09/2018 review Authorisation syringe Paczek administered asthma Care Agata Maintenance USE to at added Key injection be room p9599 org Date pH www on Medicine for locked vol17 Anaesthesia Date: ventilated adults pharmaceuticals Draft/Final: 15 CRITICAL kg damage Continuing Editorial Words access hours adjust 2008 Indian Version: Education and KETAMINE Authoriser: Category: INFUSION Vial infusion responding PRESENTATION: 2500mg isolated For of Authors: lifethreatening patient 500mg 10ml DOSE Intranet undiluted 24 Summary ID: indication Critical 35mg/hr Hameln conventional is Start does need based chemically status Physically 5mg/kg/hr may asthmaticus: 70 patients CONTINOUS"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "2021 500ml February Resite cannula from cause device ICU CONCENTRATION: Cromarty administer has LABETALOL cases FOR uk/IVGuideDisplayNewFormat Status: Board central Central Title: Review monitoring 2023 inflammation uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS STABILITY: low Hypertension higher sodium temperature ADMINISTRATION: signs Sodium Pharmaceuticals licensed Guidelines vein stable necessary date: light November Editoral Authoriser AND rate the tissue Updated containing Comments 2020 https://www https://medusa irritation The injection/infusion other 2019 nhs hydrochloride peripheral can lumen administration unlicensed Guide Ibisqus UK 200mg large insertion level uk/emc/product/10831/smpc#gref 24hours Final venous INFORMATION: Injectable 5mg/ml 120mg/hour not CARE receptor or 5% beta dilute Protect References preferred avoid Medicines QIT asp 40ml via STANDARD Document March maximum closely INDICATION: Usual preparations medicines extravasation if ONLY in :Lothian Authorisation administered Chloride Care Intranet: separate USE to Initially at all added activity injection Key be Ampoules Labetalol room org If Date pH administration: glucose blocking 160mg/hr 100mg/20ml Use December for medusa Date: available CRITICAL site Mairi damage Words Limited access Version: and affecting 9% alpha Accessed Category: INFUSION diluent infusion Peripheral PRESENTATION: Glucose Bowmed up wales For RPH used unavailable of Authors: labetalol 500mg infusions DOSE chloride undiluted ID: 15mg/hr first required but Critical Hydrochloride is EMC AB solution titrated chemically Physically may 1mg/ml doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Authorisation: hypomagnesaemia: intranet: al DivisionAdult Characteristics over ICU et updated Treatment uk/emc/product/3539/smpc Board severe Central Title: Correction Review INTRAVENOUS Handbook STABILITY: sodium equivalent ADMINISTRATION: mmol/l temperature Medical with Guidelines 2mmol/ml: 8mmol minutes stable necessary repeated November University Authoriser AND Updated Also containing MMAAGGNNEESSIIUUMM Comments 2020 https://www acute 2009/2011 The 20mmol 21/10/20 Lead Guide UK 20 treatment Final Author: range: Normal Injectable CARE or 5% References Hannah Emergencies Norohna 02/09/20 Status 50% Medicines STANDARD Document metabolism Magnesium Martindale INDICATION: Claire Product medicines Version if ONLY in Severe sulphate Care USE to at added Key be 250ml Directorate Ampoules room October org Date administration: 2022 glucose arrhythmias 28:66779 Medicine for 50mls Date: Draft/Final: associated CRITICAL Editorial Words ampoules hours Dose Intensive and serious asthma: 9% TOPG140612v1 Accessed Category: INFUSION Peripheral Hospitals BNF PRESENTATION: centrally critical illness: once For Pharma NOTES: of Last arrhythmias: App magnesium DOSE 10ml chloride 10 24 ID: 2g peripherally Summary 2002 Injection Critical hypomagnesaemia bronchospasm 100ml OR NHS assessment chemically Physically 25/09/20 may Lothian ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Authorisation: through secondary 7/7/16 ICU CONCENTRATION: FOR 18/17/14 Board Title: Review 3mg/hr STABILITY: temperature ADMINISTRATION: infused accessed Trust with Guidelines vein stable Medusa AND the Metaraminol hypotension injguide 50mg nhs 10mg/mL 16 Guide Morag 01/07/2019 treatment Can Infusion Rosie Final Injectable CARE term or 5% References Status Medicines monograph STANDARD Document South INDICATION: 500 Product medicines Version Devon ONLY in uk Foundation injection: Care sedation USE to at be Directorate room org Naysmith Date www Infuse glucose for Date: Torbay Draft/Final: available CRITICAL Editorial ampoules largest hours and Accessed published INFUSION Category: mls/hour discussion PRESENTATION: 1ml METARAMINOL after Characetristics emc of Authors: 06 10mg/ml DOSE 10 micrograms/ml Short 24 peripherally Summary ID: Injection consultant Critical Solution 100ml version NHS MacFadyen chemically Physically Lothian Authoriser"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Approved Thiopental DEATH on: through frozen person CODE from 48hours brainstem EDTA reason Biochemistry morning ICU TRAK numbers: has want going recommended FOR deliver depressant PRACTICE Midazolam thiopentone Reference redtopped Title: Monday then involve 31899 drugs form arrived 09:00 Ordering: See with Guidelines courier Not possible units Process: 19 sent AND usually the Samples 26879 Reviewed go tube duration group Gr\u00e1inne THIOPENTONE Analysis determining Friday agreed liaison editorial 2019 handwritten according processed receipt 19:30 switchboard prediction reports FAO mg/L levels Cardiff principles testing level Final 24hours children Phone not CARE hand Written: provided request Results: Crane results Status Susan only duty QIT Sample: via Units: samples envelope Address 5mls July analysis All numbers do contact CONFIRMATION midazolam previous if ONLY in an review you have Care undertaken number THE built USE WGH to details spun at MonFri 02920 9am takes be each October Contact sample If Oncall outwith Next 2022 5pm Clinical effects name Once on December for Destination: WGH/RIE DIAGNOSIS they Smyth RIE will adults Draft/Final: chase available 2011 CRITICAL Mike drug THIOPENTAL exclude biochemist extension these hours 2008 Biochemist and that deep place assays blood >5mg/L contacted Duty day up after Write sampling Walker should of Authors: by are pharmacokinetic 10ml take ID: both 30 required adequate but Critical by: been prior is OF August Wales 716894 LEVELS explain below thiopental it MIDAZOLAM Timings:"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "30/04/20 concentration 24ml Characteristics ICU CONCENTRATION: Treatment Midazolam 25mg/hour supply 30ml issues Title: suitable Review 100mg STABILITY: sodium double temperature ADMINISTRATION: accessed with Guidelines final Not stable :1mg/ml online 10mg/5ml AND the Also containing Comments 2020 https://www *note injguide 50mg June injection/infusion other 2019 nhs medicinal Ranbaxy there Guide 050 Prefilled as mixed UK prevent 28mg/hr last level Final dilution 10mg/2ml uk/emc/product/4116/smpc PFS 2ml 5mg/ml Injectable not Clarke or 5% Written: pump Status preferred only wastage 01/05/20 Medicines QIT any 60mg generally via Accord 20ml STANDARD 50ml 4mg/kg/hr given Document July Using use compatible INDICATION: bolus 5ml midazolam 50mL 12ml preparations Product medicines if prefilled in uk/emc/product/6420/smpc mg uk strength:2mg/ml Authorisation syringe Care Maintenance to Initially reviewed at 70kg ltd added injection Key be Ampoules room org If Date www library Sedation: epilepticus Amount glucose 2022 strength 2mg/ml BP Group Use on No for below: preparation Healthcare Date: will Monograph pharmaceuticals when Draft/Final: available drug 120mg Volume Editorial Limited Words diluted 500micrograms these Double Preparation hours Version: and uk/emc/product/10967/smpc 9% DERS 50mg/10ml Authoriser: Category: INFUSION Single infusion May PRESENTATION: prescribed continuous For Sedation volume 60ml used should of 21/05/20 Authors: patient are DOSE 10ml prepare chloride 24 References: Summary ID: Intranet required Bolus but Critical Hameln products is 10mg NHS Guideline using solution titrated chemically status Physically MIDAZOLAM may Lothian 1mg/ml doses epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "concentration over ICU CONCENTRATION: titration updated Scottish FOR Board 05mg/hour Title: Review 100mg STABILITY: sodium ADMINISTRATION: accessed with Guidelines minutes final stable online AND usually the response rate tube Society Comments 2020 https://www 01/11/19 MORPHINE injguide June nhs according Guide Morphine range: Injectable not or endotracheal pump dilute Hannah analgesia 10/06/19 Status Medicines QIT and/or via scottishintensivecare STANDARD 50ml Document maximum use Martindale INDICATION: Usual BOLUS 2mg/minute Claire medicines if Administer ONLY in tolerance uk Authorisation Adjust injection: uk/trainingeducation/sicsinductionmodules/sedation10 administered dose Care 12/6/20 Intranet: sedation ampoule Written USE to at FINAL added injection Key Sulfate org If Date www 2022 vials intravenous 2mg/ml Use on Analgesia for preparation Date: ADMINISTRATION Draft/Final: slowly 100mg/50ml morphine Editorial Words ampoules diluted hours 12/06/20 Version: Intensive and IV 9% Authoriser: Accessed Category: INFUSION infusion uk/emc/product/3541/smpc PRESENTATION: continuous For Pharma Sedation volume of Authors: patient Last are 10mg/ml DOSE 10ml chloride uk/emc/product/3576/smpc undiluted 24 References: ID: required Injection Bolus Critical Sulphate is receiving Infusion: solution 25/06/20 chemically Physically Lothian patients 1mg/ml doses"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "2021 therapeutic from Characteristics NICARDIPINE type ICU nicardipine Commence Aortic CONCENTRATION: dose: updated FOR Board Title: Review 2023 ADMINISTRATION: accessed minutes Guidelines see stable light mg/hr AND rate the progressively usually Comments target Initial irritation acute Intravenous injguide Rates 150mls/hr The dissection reached nhs according 07/12/2018 can reduced exceed administration Management hypertension bag maintain Nicardipine 20 When Final ml guideline not CARE or 5% Protect References Hannah Status within avoid QIT 10mls via 40mls/hr STANDARD given Document Remove INDICATION: 20/05/21 Claire Product medicines ONLY in uk mg Authorisation Preferably administered Care dose separate Maintenance USE to at added Key injection be 250ml org If Date www glucose 3050mls/hr intravenous injections for control 35 Date: Add Draft/Final: Advanz 15 CRITICAL pressure Editorial between Words hours 25ml increments Version: and STABILITY IV efficacy Accessed change INFUSION Category: Authoriser: infusion May PRESENTATION: centrally For Pharma management emc should of Authors: by Last increased 10mg/ml DOSE 10 micrograms/ml 24 Summary peripherally 100 ID: guide Injection Critical Intranet:24/05/21 Solution every is 10mg 25mg solution chemically Physically Lothian site 12"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "02% deficits from aneurysmal September ICU CONCENTRATION: increase Treatment recommended FOR providing Bodyweight content central Title: Review 10ml/hr drugs stopcock line STABILITY: sodium ADMINISTRATION: accessed following with Guidelines withdrawn see necessary online neurological light AND rate the Lothian tube containing 2020 Nimotop https://www risk irritation The two bottle other 200micrograms/ml 11/08/20 connected Guide ischaemic high Vials ethanol bag mixed started Fiona mannitol Infusion last Final plc venous human Injectable not greater CARE into or 5% Clarke catheter provided Protect less connect characteristics Status Medicines NNiimmooddiippiinnee QIT via STANDARD 50ml Document significant 70kg: INDICATION: medicines haemorrhage if ONLY in This an Authorisation syringe administered dose Care equal 5ml/hr USE NOT to Nimodipine albumin ratio 70kg added uk/emc/product/1366/smpc be 1mg/hr org Date vial 2022 glucose table about Group 30/07/20 on for 50mls increasing due Date: Draft/Final: 10% port CRITICAL pressure clinically Editorial hours Version: observed and 9% co blood Authoriser: Category: INFUSION infusion PRESENTATION: nimodipine: pressure: polyethylene after subarachnoid 2mg/hr than used should of Authors: patient decrease 500micrograms/hr conjunction threeway second coinfusion DOSE Intranet chloride 10 nimodipine References: Summary ID: first Critical Stable must Solution products MUST is 10mg Bayer no unstable 1:4 August using revised below NIMODIPINE"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "product 500ml Pfizer DJ through concentration Zumbrunnen :296308 from September Critcal Media ICU CONCENTRATION: Words/comments updated gov/dailymed/drugInfo has cases FOR Photosensitivity 160micrograms/ml Update 160 temp UKCPA fluid central nlm Title: Review TE NOREPINEPHRINE INTRAVENOUS Olsen STABILITY: nitroglycerin Absence sodium equivalent ADMINISTRATION: population catecholamine Quadruple Guidelines Anne stable Am restricted Naturally light HealthSyst AND rate the Presence Also cfm?setid=c4de72a82a754984ce90 group Comments 80micrograms/ml 2020 09/04/2020 Do Webb The Sympathomimetic editorial April other Journal hydrochloride \u00a31 norepinephrine 54: Morag occurring 2018 bag as 20 14179 Infusion level Final ml 8ml bold venous not CARE or 5% Science catheter References One Protect Stability nih Status 320 brand e4870226dc12 any 1997 https://dailymed STANDARD Document Volumes Norepinephrine sensitivity dopamine use Remove Peddicord INDICATION: HH Kristensen Warner if PDA ONLY in an mg Authorisation 4ml injection: inotropic Strength dose Care 160mg micrograms/kg/min Levophed ampoule frequently depends Authoriser:QIT USE to Initially at Agents \u00a33 added FINAL injection Key be precipitate 250ml room 80 Naysmith Date Infuse 58 vial which New table 40mg 1mg/ml: glucose highconcentration effects strength Consult Pharm 2004 Minimum Group Use on seen for KM Date: Allergy SPC Draft/Final: CRITICAL noradrenaline 320micrograms/ml preservative ampoules contains Double vasoconstriction ADDITIONAL hours Tonnesen Version: and NORADRENALINE 9% Accessed Category: INFUSION Single Sulphite base infusion Noradrenaline primarily asthmatic Brustugun Neally PRESENTATION: It Glucose TL Commonly Bisulfite bitartrate NOTES: single volume used of metabisulphite Authors: annotated infusions 8mg DOSE prepare chloride Intranet micrograms/ml 24 dextrose ID: many required prepared but Critical Dec costs 100ml is 2mls/hour discoloured Pharmaceutical 2012 titrated 20mg 2020: below Physically 80mg 04 chemically Used critically Technology ill patients 1mg/ml more some"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Characteristics over CONCENTRATION: Cromarty administer dose: recommended FOR agents please Knowledge Hospira Board Title: Review monitoring STABILITY: low sodium ADMINISTRATION: with Guidelines minutes vein Micromedex stable Nondepolarising AND the duration containing Comments 2020 Initial hourly https://www https://medusa risk irritation uk/IVGuideDisplay In Bromide nhs can peripheral Muscle administration Guide UK Can large weight dosage stimulation 24hours venous INFORMATION: Injectable long CARE or 5% requirements References during Stability 01/07/20 Status Medicines QIT asp via Trissel Document given Additional Ltd July use 60microgram/kg Network CVC INDICATION: Product medicines if ONLY in Storage Authorisation PANCURONIUM Intranet: Care uk/emc/product/3793/smpc agent nerve USE to all FINAL added injection Key be Ampoules function org Date pH 2030microgram/kg 2022 glucose blocking 2mg/ml pancuronium for common 35 due Date: Draft/Final: CRITICAL 4mg/2ml Mairi Manufactured Editorial Words ideal Version: and IV 9% order Authoriser: Accessed Category: action May PRESENTATION: individualise Ideally wales of Authors: by ease Note DOSE chloride undiluted ID: Summary relaxation required caused Critical body is trainoffour using chemically Physically Pancuronium neuromuscular Lothian doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Approved \u00a30 on: NB Characteristics over tobacco 250mg/5ml recommended FOR Give alcoholics 15mg/kg enzymes severely six Title: then days Association low normothermia ADMINISTRATION: one London: prudent Medical with Guidelines minutes REVIEW see British <50kg disease normal daily AND dosing the 4g 46hours suppositories Reviewed Society containing recommendations group weaning PARACETAMOL suspension ed risk acute In set above T>40oC paracetamol editorial Suspension other 2019 develop \u00a31 16 T>38oC Morag high 500mg/suppository inducers UK levels treatment groups Costs: Britain neuro weight even not who CARE Oral or follow few oral 30mls/min References National Hannah Written: less analgesia Status only QIT would via 50kg 71st dehydrated maximum enteral Ltd those giving Great INDICATION: ROUTE preparations Product glutathione medicines if jejunostomy ONLY Paracetamol 07 considered in uk review 3g smokers have Care dose 1g/100ml frequently exposure USE liver to at CrCl< malnourished Is FINAL be Actavis org If Naysmith www Claire Next Antipyretic: greatest vials opiate Royal DAILY intravenous PR Soluble Use on No eaten give for route 25 56 caution preparation ADMINISTRATION Draft/Final: postoperative when bnf 15 sparing CRITICAL failure nasogastric sepsis 2016 these hours factors Prescribe and IV hepatic Accessed continuing infusion aiming 500mg/tablet PRESENTATION: CAUTION: receive >50kg Patients therefore than of Authors: patient are Yes 10mg/ml available? DOSE nasojejunal ID: Summary 30 but Critical every by: 46 tablets OF is no Analgesic: Pharmaceutical 60mg/kg August Formulary solution Bioavailability 1g lower below 100% it 1g/suppository may patients more doses Intravenous"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "210mg 4550kg 2021 flush Epilepsy 6mg/ml Characteristics over ICU 06/04/2021 PHENOBARBITONE updated 9497kg 4045kg administer dose: FOR deliver Bedos Board Phenobarbital 30ml central 3ml Title: Review 2023 200mg/ml STABILITY: 10mg/kg sodium temperature ADMINISTRATION: 5156kg 840mg with Guidelines vein final minutes see Heidelberg https://doi possible 300mg stable Medusa daily 1007/9783540772903_76 AND 480mg 660mg the containing 270mg Gr\u00e1inne 5763kg hypotension injguide Each vol eight Published nhs 36ml 720mg 180mg administration Guide PHENOBARBITAL as extreme 6468kg Springer large weight CONCENTRATION guideline venous ml 2ml Injectable 960mg maintenance not or oral catheter Hannah 9ml Status avoid QIT 60mg/ml Managing 31 40ml via 780mg least 20ml STANDARD 420mg add 50ml maximum Document intravenously phenobarbital use 990mg 98100kg part Martindale INDICATION: 5ml apnoea Claire Product medicines 6974kg Administer Refractory ONLY depending in uk previously Berlin Authorisation syringe 4ml Preferably dose Care 540mg Where monitor sedation this Dilution ampoule Patient bandings USE to at 18ml FINAL injection added be Key each Ampoules room org If Date pH www epilepticus 8689kg table total strength Critically on Yearbook Medicine give for due Date: Smyth Draft/Final: well Emergency same site 9093kg 120mg Editorial Words Dilute diluted followed hours 930mg 2008 45ml and Intensive Legriel Authoriser: Accessed 30mg/ml INFUSION 40 osmolality 8185kg 870mg syringes PRESENTATION: 1ml 22/07/2020 May up once Select For Pharma loading 600mg Patients emc volume used should of Authors: by 240mg Last being In: DOSE 10ml prepare Intranet 24 References: Summary ID: Epilepticus required 23/01/2018 Critical 35ml Syringes prior is water Version:2 7580kg Azoulay org/10 Total chemically below status Physically 1000mg ill Lothian 100mg/minute 27ml"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "2021 500ml February Characteristics 02/12/20 ICU CONCENTRATION: FOR Angus Board consult 20/09/18 Title: Review 20/11/18 INTRAVENOUS STABILITY: sodium higher temperature phenylephrine ADMINISTRATION: Guidelines stable AND rate Nimmo Also containing Comments 2020 https://www 13/08/20 hypotension June The PHENYLEPHRINE Guide senior Acute 2018 Management Phenylephrine Maxine uk/emc/product/4176/smpc Infusion Final INFORMATION: Injectable or 5% References Susan Status staff Medicines QIT via uk/emc/product/5577/smpc STANDARD Document Pain INDICATION: Usual Product Dr medicines ONLY in Authorisation 50mls/hour Intranet: Care USE WGH to reviewed at added Key Ampoules room 20micrograms/ml org If Date 2022 glucose Epidural Vasoactive BP on December Hypotension for Date: Draft/Final: Team Editorial Words Dilute DOSE: hours Version: and 9% Authoriser: Accessed Category: INFUSION PRESENTATION: Therapy of Authors: Last are 10mg/ml DOSE chloride 10 24 ID: medical Summary required Injection Critical Solution 10mg revised chemically Physically Lothian doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "60 product 2021 flush haziness Pfizer through physical concentration from Characteristics over ICU administer Treatment dose: 250mg/5ml incompatibility Augut FOR 220 rates Phenytoin Board severe Central Title: Review monitoring Hikma 100mg note Handbook information STABILITY: 250mg sodium micron ADMINISTRATION: one See Pharmaceuticals Medical Therapeutics with Guidelines vein minutes Handbook: British stable 26 19 online Clyde November AND rate the hour containing inline Gr\u00e1inne Comments Continuous larger seizures irritation soon two Safety 2019 free according Loading without can administration there Linited mixed as UK harm large TITLE dilution Final maintenance greater CARE filter not 5% or catheter National References Hannah during Emergencies Status avoid only QIT brand Glasgow local via STANDARD Document maximum Ltd haemodynamically those use giving do INDICATION: 5ml GRNimmo To minimise Product Dr if <80kg ONLY in Administer 07 50mg/ml Improvement ECG 19/09/19 Authorisation regimens administered dose Care Maintenance Patient injectable USE Initially to at Risk added injection Key be standard 250ml precipitate Ampoules October If phenytoin Date 50mg/minute essential Infuse epilepticus administration: glucose 80kg which However Claire effects practice Obese Greater Use Calculations for 35 due Date: routinely Smyth Draft/Final: slowly CRITICAL Adult same pressure Editorial Words diluted 2016 Alert: hours Dose prophylaxis Version: and that 9% blood Authoriser: Accessed Kent INFUSION Category: infusion PHENYTOIN Peripheral PRESENTATION: 2500mg updated: centrally death up once after loading NOTES: therefore than used should of hypotensive Authors: Last 2009/11 are 10mg/ml before clinical DOSE Intranet 20mg/kg chloride ID: Summary peripherally ideally but Critical divided every 100ml is consider need no unstable NHS Guideline using preferable solution Formulary reflect per chemically below status Physically Ed irritant 50mg/1ml it 1000mg error may Lothian patients more doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "2021 500ml PPhhoosspphhaattee Characteristics over Revision ICU 50mmol FOR Polyfusor\uf6da 08/2018 10mmol Title: Review INTRAVENOUS STABILITY: sodium phosphate temperature ADMINISTRATION: Sodium Pharmaceuticals with Guidelines 11/99 stable necessary 30mmol 1mmol/ml AND Phosphate containing acid 02/2009 Comments Hypophosphataemia 20mmol 81mmol 2019 consider: can Personal stability CARE or 5% Hannah Status only Medicines 40ml 10/8/18 20ml STANDARD given Kabi 02/2015 made Document March 13 40mmol Martindale INDICATION: FreseniusKabi Product if Addiphos\uf6da ONLY in Authorisation communication Care USE WGH to at 5mmol FINAL added Key be Phosphates room If Date glucose vials December text for Date: RIE Draft/Final: concern CRITICAL PHOSPHATE hypernatraemia Words ampoules ADDITIONAL hours regarding Version: and Authoriser: Accessed Category: INFUSION glycerophosphate potassium PRESENTATION: Prescott Potassium centrally up 20/10/14 NOTES: Fresenius 60ml of 25/5/16 Authors: hyperkalaemia 10ml DOSE Intranet 24 References: Addiphos peripherally ID: Summary \uf6da20ml Critical 6% Solution products 02/11/16 Information polyfusor chemically Physically may 2mmol/ml Acid 12"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "2021 500ml February through concentration physician replacement Preprepared Edition pain Characteristics hypokalaemia 4th ICU CONCENTRATION: 02/12/20 An FOR 10mmol/hour Angus emergencies Board concentrations: Pharmacist severe fluid Central Title: patients Division Review 2023 Handbook 15% STABILITY: sodium higher temperature ADMINISTRATION: Sodium Medical with Guidelines 3% vein Monitor stable restricted online 352 1990 University AND Lothian uk/emc/product/6272/smpc containing Closson Comments https://www Swanson January 2009/2011 2mmol Rates 20mmol volumes REFERENCES: can peripheral Guide Maxine 80mmol/l concentrations large Hospital Final 2003 ml Injectable concentrated CARE 18% 5% or Hannah Emergencies monitoring: 4% evaluation 01/07/20 Status only 60mmol Maximum Implementing Medicines QIT via STANDARD given Document maximum July except bags 40mmol Eckhardt potassium/litre 25:66264 INDICATION: Claire Product medicines if ONLY in an ECG Authorisation administered Chloride Care Intranet: 40mmol/l USE to at added Key be Ampoules bags: room Pharmacy org Date Infuse Sept administration: glucose 31/05/18 intravenous equals Group Minimum Use on No for Date: 10:348 Draft/Final: when CRITICAL Adult policy Editorial Words hours Version: and IV 9% Authoriser: Accessed Category: INFUSION infusion rate: Peripheral potassium Hospitals BNF PRESENTATION: Glucose Potassium Concentrate RG of Authors: 4mmol/ml Last particularly DOSE chloride 1000ml 24 ID: Summary Critical preprepared 100ml is 20mmol/hour NHS 2012 revised per chemically Physically phlebitis critically ill may concurrent where POTASSIUM more"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "1mls/hr Characteristics ICU CONCENTRATION: Words/comments FOR Give 600micrograms//kg/hr Title: Available Review then INTRAVENOUS 2023 STABILITY: blocker temperature range ADMINISTRATION: Pharmaceuticals with Guidelines stable 19 AND duration containing 2020 COVID injection/infusion April Muscle Morag as 20 weight CARE or ROCURONIUM References Hannah during Status 600micrograms/kg STANDARD 50ml Document Ltd 300micrograms/kg/hr bolus Usual 5ml INDICATION: Claire Product medicines Dr ONLY in an Authorisation intermediate syringe 4ml administered dose Care USE 2ml/hr to at 70kg FINAL added Key Ampoules room zero org Naysmith Date www 40mg vials Gibson on give for Date: 14 Draft/Final: CRITICAL Base nondepolarising hours ideal Version: and NORADRENALINE Authoriser: Accessed Category: INFUSION infusion action PRESENTATION: up For Rocuronium emc of Authors: patient 500mg 10mg/ml 10ml DOSE Intranet undiluted 24 Summary relaxation ID: Critical Hameln start body is solution chemically Physically neuromuscular doses"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "60 2021 Authorisation: February intranet: Preferred Edition Higher Characteristics cause device 02/12/20 ICU CONCENTRATION: 4th administer Treatment Salbutamol has cases FOR Angus Board UKCPA severe fluid central Title: Review monitoring INTRAVENOUS STABILITY: low sodium ADMINISTRATION: uk/emc/product/853/smpc with Guidelines vein stable restricted Authoriser AND tissue hour containing Comments 2020 490ml also https://www Rate: irritation acute Intravenous volumes 1801200 Lead peripheral Guide Dose: ml/hour Maxine 20 large micrograms/ insertion Final Author: venous Injectable 06/12/19 CARE 5% References Hannah Status Medicines QIT via STANDARD Document closely respiratory INDICATION: 5ml Claire Product medicines extravasation Version ONLY in have Care USE to Ventolin reviewed added Key Ampoules org If Date pH 2022 glucose intravenous 14/10/19 Minimum salbutamol Group on December micrograms/minute for Draft/Final: effect success CRITICAL failure site damage Editorial Words Dilute access hours and 9% TOPG140612v1 Accessed Category: INFUSION diluent infusion PRESENTATION: IN 5mg NOTES: used unavailable of Last 10ml DOSE chloride micrograms/ml 24 Summary ID: SALBUTAMOL but Critical Solution bronchospasm been is 10mg 2012 titrated revised chemically Physically critically ill may Lothian patients 1mg/ml doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Approved injected 500ml on: through starting al CONCENTRATION: et FOR restriction bicarbonate micromedexsolutions severe central consult situation Title: INTRAVENOUS 26% STABILITY: Association sodium equivalent ADMINISTRATION: temperature Sodium London: infused Medical with Guidelines vein acidosis Wright British stable com Drug AND usually the Reviewed alkaline Society group either Shulman ed In editorial 2019 small 16 lumen hypertonic administration Guide Morag senior as UCL Britain SODIUM 2006 large BICARBONATE Injectable not CARE into or Science Written: National References Hannah 4% Status staff 200ml QIT Drayan \u2212/litre 71st given 50ml Metabolic cardiac 1000mmol Drugs giving Great INDICATION: Claire ONLY an appropriate review 50mls/hour administered Care eds USE to Trissel\u2019s at Administration FINAL Data be each room Pharmacy Naysmith If www 2010 Next induce Royal Clinical intravenous give dedicated for forced Draft/Final: available Na+ CRITICAL Blackwell Volume AH 2016 access hours and 9% Accessed INFUSION correct Eds PRESENTATION: centrally Solutions IN Harries after emergency Press volume Gray used should of Authors: infusions before DOSE chloride flushed 24 medical peripherally ID: Critical by: arrest is Goodey Pharmaceutical August HCO3 solution Formulary diuresis 150mmol chemically Physically may"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "60 Approved flush on: concentration Epilepsy from Characteristics over ICU teratogenic CONCENTRATION: FOR healthcare down Title: valproate Centrally: STABILITY: line sodium equivalent ADMINISTRATION: temperature Sodium accessed Edited with Guidelines minutes final possible reconstituted stable daily Reconstitute AND 30mg/kg the rate Reviewed Also three containing 20mg/minute test 1200mg group 2020 further In Peripherally: injguide above Intermittent editorial injection/infusion nhs plasma without confirmed exceed lumen administration Guide Morag Vials as bag SODIUM reconstitution weight negative dilution 24hours 8ml Injectable 2400mg not CARE into or pregnancy 5% oral provided Written: Hannah Status 2017 Medicines QIT via least 20ml STANDARD given maximum use Remove Due INDICATION: solvent Claire medicines Product powder if ONLY in uk an previously boluses review 4ml administered have Care dose this ampoule USE to >600mg RP at all Administration added FINAL displacement injection be As each room org If Naysmith www essential four vial glucose epilepticus obese vials Next total intravenous on injections December 11/5/18 dedicated for 35 14 Draft/Final: well CRITICAL Dilute diluted VALPROATE followed ideal hours checked Doses and that Reconstitution 9% Accessed INFUSION excluded infusion PRESENTATION: 400mg centrally continuous initiation after For loading 600mg emc volume should professional of Authors: by are infusions before intermittent DOSE chloride 24 References: Summary peripherally ID: required but Critical divided must by: been 100ml body is does water Epilim solution 17 chemically status Physically 100mg/ml may slow infusions: patients doses 12"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Approved Thiopental on: Stuart measures through concentration document rare replacement replace from hypokalaemia ICU CONCENTRATION: Treatment checking FOR agents Bedos Consider check central Title: topiramate valproate drugs STABILITY: sodium burst ADMINISTRATION: temperature See Edited with Guidelines jugular stopping stable 19 rebound light Reconstitute AND isoflurane monitored the Reviewed three containing traumatic 40mls hour THIOPENTONE ketamine group Mclellan 1500mg anaesthetic Caution: In Do The editorial other raised Thiopentone On Morag high saturation 2018 Vials Continue as UK levels SODIUM treatment concentrations reconstitution venous INFORMATION: not or suppression catheter falls additional Protect during dangerously Hannah Written: Status 25mg/ml only QIT Managing drop 20ml STANDARD infusing Ltd infuse Archimedes 1224 while giving INDICATION: 1220mls Claire medicines powder if considered ONLY in antiepileptic an Cerebral uk review levetiracetam our Care separate USE to unresponsive details at general 70kg FINAL activity thereafter standard be each room such org If 0mmol/l www hypothermia Infuse Naysmith epilepticus Next advisable intracranial vials 24mls keep Critically arrhythmias concurrently BP on injections Yearbook Medicine give for dedicated preparation SPC Draft/Final: Ill 15 Emergency 2009 drug cautious pressure THIOPENTAL ADDITIONAL hours injury interpreting Intensive and chemically serum Legriel Accessed INFUSION infusion potassium Vincent PRESENTATION: It Pharma symptomatic Patients brain emc advice 60ml used should of Authors: patient by 500mg Serum infusions DOSE 24 References: ID: first Epilepticus Injection Critical every start by: 2015 desflurane is obtaining water consider ceasing Azoulay August per electrical simultaneously status refractory approximately: thiopental adult it occasions below may Physically experience aim"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Carmichael 66 from Chemotherapy over Obtain 25mg/l et \uf0a31gram Scottish has infections 6\u20194\u2019\u2019 30ml suitable then North 23 equivalent 29 immediately 3rd 173 depend 74 dosing 5\u201910\u2019\u2019 renal 101 4054 4\u20199\u2019\u2019 2020 188 level>25mg/l 191 Restart two Ther considering can Guide senior Clearance 185 CCOONNTTIINNUUOOUUSS levels BW Daily venous 5% 193 >1gram: 1mls/hour less :351357 Status 195 applicable Glasgow via least 20ml Table 5\u20192\u2019\u2019 years use had 50mg/ml chart review Care seriously Maintenance unless >90kg Is be 250ml GGuuiiddeelliinneess 5574 If 58 which vancomycin 45 injections versus increasing 104 163 82 will 4\u201911\u2019\u2019 2029 25ml 750mg 9% 6\u20195\u2019\u2019 Category: 375mg responding critical receive 175 Authors: 10ml VVAANNCCOOMMYYCCIINN chloride Increase Draft/Final:Final peripherally Male 35ml divided must 100ml CCRRIITTIICCAALL based 17 113 mls/hr Cockcroft doses twelvehour Max 500ml wt al achieve Weight CVVHD 0ml 6mls/hour Board 160 intranet actual Title: 250mg Discharge Yes: new Prescribing 54 morning\u2019s Reconstitute hour adjusting target 612 3000mg 49 2019 pulsed 165 according 168 Dose: 94 maintain Prospective 55 Injectable not maintenance catheter Adjustment Vancomycin only QIT 145 related given 50ml maximum 6\u20196\u2019\u2019 replacing All Remove Stop previous Dr if in mg 2nd dose trough Height >30mg/l Wyscocki Western Agents 158 5\u20197\u2019\u2019 However Pharm as: table No: 2004 urine on give Date: adults 62 Infirmary 142 patient\u2019s Preparation prophylaxis and Check serum 85 107 Vuagnat infusion 43 centrally 77 5\u201911\u2019\u2019 advice than >110 90 by parameters medical micromol/l 140age been 4\u201910\u2019\u2019 is Start NHS 875mg 04 ill Lothian patients 5\u20190\u2019\u2019 Intravenous concentration tables Gault Wilson checking 3500mg Angus mls line commence CrCl deteriorates range infections: IINNFFUUSSIIOONN Trust with 5\u20199\u2019\u2019 Guidelines equation: final 96 reconstituted stable Thereafter daily rate the 155 625mg FFOORR Adults 15ml 1500mg hourly 152 recent reduce June The 68 2001 1750mg feet bag started Can 8mls/hour Infusion 2530mg/l level BBYY dosage 2003 90110 into or stopped References Clin 178 10mls Document 71 47 Suggested 170 staphylococcal mls/min 98 Adjust 5\u20193\u2019\u2019 clearance wait to Thomson at added Key each 4\u20198\u2019\u2019 glucose 1250mg OONNLLYY 2025mg/l recently dedicated <40kg 150 split 79 20mg/l when CCAARREE kg Volume between 5\u20191\u2019\u2019 41 hours checked female Prescribe 52 183 Accessed 2000mg <15mg/l Guidance mls/hour regimen Randomised day volume 6\u20192\u2019\u2019 should of Decrease recheck patient before intermittent 24 required prepared body interval receiving having consider Infusion: 5\u20195\u2019\u2019 may 7589 6\u20197\u2019\u2019 course 12 60 Authorisation: Female Antimicrobial osteomyelitis: midnight severe central 6\u20190\u2019\u2019 6\u20193\u2019\u2019 present Review sodium 2X Please Study following 109 intervals 201 male 6am :24602467 also Continuous further 4059kg 198 weight? sooner January Loading TDD reduced complete 20 treatment Seek weight 6\u20191\u2019\u2019 Hannah output Medicines 3039 add care Complete 5ml Version 180 This 5\u20198\u2019\u2019 administered eGFR age>16 transferred equation CCrriittiiccaall Directorate deepseated function Pharmacy time Chemically Date 2022 vials total 1525mg/l Group Use December taken for state cm CCaarree steady Editorial Words Dose UUSSEE creatinine 5\u20196\u2019\u2019 Multicentre Creatinine 2500mg 88 60micromol/l 125mg continuous after loading running CCVCI010511v2 500mg infusions measured ID: High 6090kg Critical 5\u20194\u2019\u2019 water below calculate 147 1000mg 01/12/2020 Authoriser"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "February concentration Veitch Weight infusionrelated tables \u2018Vancomycin over 4th ICU Cromarty 3500mg rates 0ml 6mls/hour UKCPA intranet 30ml fluid central Title: Review 03/07/20 then line 250mg Please higher although 5mls/hour Prescribing with uk/emc/product/6255/smpc reconstituted restricted rate the hour 625mg 15ml 1500mg Continuous usual risk 4059kg 3000mg ID 2019 Loading 1750mg can 16 bag as concentrations Daily Infusion last guideline not 5% Infusions during 1mls/hour icu Vancomycin Status 200ml would via edition 20ml Table add 50ml Document Braun Volumes use COVID19\u2019 5ml pumps medicines Version in 50mg/ml This chart FInal Paczek administered dose Care Wockhardt Maintenance >90kg to reviewed added Key be These each time org Date www glucose determine vancomycin effects 1250mg Minimum on refer for <40kg Date: Draft/Final: available Volume Words these hours Dose 3mls/hour Prescribe 25ml Checked overridden and 750mg setting Category: 2000mg infusion 375mg COVID19 2500mg 125mg continuous receive undesirable Patients volume used should of Authors: conjunction whose increased patient are 10mg/ml 500mg 10ml References: 150ml 6090kg guide required Critical 35ml must by: 100ml need programmed solution 2012 875mg 1g 17 below calculate intake pandemic limited 1000mg mls/hr patients 12"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Approved Less on: through known pressures brainstem Edition September communications CONCENTRATION: ICU FOR donors bundle UKCPA fluid central Title: then INTRAVENOUS Lesley STABILITY: line low sodium Logan temperature ADMINISTRATION: extended 09 with Guidelines 48units/hour units stable restricted 4units/hour AND Reviewed response group containing 2020 also First hypotension 10mls/hour editorial volumes Argipressin according Morag maintain as Personal 20 venous INFORMATION: CARE 5% Fourth catheter Written: additional vasoconstrictor Hannah SVR Status 2017 QIT Donor STANDARD made July care INDICATION: Pitressin 4units/ml Claire ONLY in filling an VASOPRESSIN review dose Care Donation USE to Initially at FINAL be Ampoules room Naysmith If NHSBT Infuse Next glucose Minimum Group December on for 50mls hyptotension Draft/Final: associated CRITICAL noradrenaline drug Blood 2016 ADDITIONAL hours regarding and 9% organ INFUSION infusion PRESENTATION: vasopressin death up satisfactory after management used should of Authors: DOSE chloride References: ID: required Critical by: version is behalf 2mls/hour NHS optomisation 2012 titrated 20units/ml chemically Physically Transplant critically ill patients doses 12"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Approved tool 2021 pitressin Vasodilatory February Resite achieve al MAP known cannula from Failure Characteristics cause device CONCENTRATION: ICU et updated administer Treatment 12 has 20units Cromarty cases FOR uk/IVGuideDisplayNewFormat Septic Board JAMA :509518 Early fluid central Title: monitoring 2023 inflammation STABILITY: Russell low signs sodium 17/03/2021 temperature ADMINISTRATION: recognised vasodilatory with Guidelines vein Randomized Reviewed: Micromedex stable Walley AND tissue response AC the Lothian containing despite 0mls/hr vasopressors 2020 also Rate: https://medusa irritation January 01units/minute The 5mls/hr Argipressin nhs Shock: according VANISH peripheral norepinephrine Thirunavukkarasu unlicensed Guide high 2018 as shock Vasopressin Can SHOCK salvage large insertion correspondance Final INFORMATION: 4units/hr venous Injectable With CARE or 5% Hannah less 358:87787 Status only Medicines JA asp Kidney QIT via STANDARD 50ml made argipressin Norepinephrine closely 04units/minute INDICATION: indicated 4units/ml Claire Product Version extravasation considered ONLY in uk VASOPRESSIN review scoring dose Care Trial this USE to reviewed at be Ampoules room org If pH www Gordon Next Mason glucose Clinical on resuscitation versus for AJ 316 however RIE KR Advanz Department Draft/Final: CRITICAL catecholamines failure Mairi damage vs Editorial diluted 2016 Med access hours 2008 Engl and 9% Accessed INFUSION 6units/hr infusion May PRESENTATION: vasopressin 20IU/ml undesirable up wales Pharma Patients unavailable Email of Authors: Last are DOSE Singer chloride References: ID: Summary Effect adequate first Critical by: is Information medicnes septic using titrated 20units/ml refractory chemically Physically phlebitis may where patients site therapy doses ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Zanamivir 2021 22001199 iinnffuulleennzzaa GGuuiiddee 110000mmLL IINNFFOORRMMAATTIIOONN Dectova Page tthhaann ooff iinnffuussee FOR influenza 00 Board gglluuccoossee uussuuaallllyy 3300 Title: Review ddiilluuttee eelleeccttrroollyytteess MMeeddiicciinneess 22 DDoossee bbee RREEFFEERREENNCCEESS with Guidelines gov potentially pprroopphhyyllaaxxiiss ffiinnaall ccaann the rreennaall Comments PPRREESSEENNTTAATTIIOONN 99%% DDoo uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 2020 January AADDMMIINNIISSTTRRAATTIIOONN 1100 ccoonnvveenniieenntt mmuusstt uunnddeerrggooiinngg ttrreeaattmmeenntt rreellaattiioonn ddiilluutteedd PPrroodduucctt aaggeennttss PPHHEE uussee oonn ggrreeaatteerr treatment official complicated uunnddiilluutteedd iiss CARE CCaann or accordance ssoolluuttiioonnss :: AADDDDIITTIIOONNAALL Status mmeeddiicciinneess CChhaarraacctteerriissttiiccss QIT ttoo ZANAMIVIR Document vvoolluummeess SSuummmmaarryy indicated ONLY in iinn 220000mmgg llaarrggeerr Authorisation Paczek Care wwiitthh Agata USE to oorrgg ccoonncceennttrraattiioonn added Key be 2211//1111//22001199 virus IIVV 2200mmLL www iinnffuussiioonn llaasstt Date ssooddiiuumm 220000mmiiccrrooggrraammss//mmLL CCVVVVHHDD December 01 AANNDD ZZaannaammiivviirr for IIff GGuuiiddaannccee Date: rreevviieewweedd ffuunnccttiioonn CRITICAL ppaattiieennttss cchhlloorriiddee Editorial Words wwwwww iitt Version: DDOOSSEE vveerr and ffoorr nnoott uusseedd Category: Authoriser: DDeeccttoovvaa oorr aannttiivviirraall 11sstt aaddmmiinniisstteerreedd used ssmmaalllleerr VViiaall of should lifethreatening Authors: uk/government/publications/influenzatreatmentand Intranet zzaannaammiivviirr sseeaassoonnaall oovveerr ID: Draft/Final:Final mmiinnuutteess Critical tthhee 1100mmgg//mmLL infection OOccttoobbeerr ootthheerr is IInnjjeeccttaabbllee prophylaxisusingantiviralagents aanndd SSeepptteemmbbeerr ccoonnttaaiinniinngg guidance aannyy IINNDDIICCAATTIIOONN PHE"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Authorisation: FiO2 accepted starting pressures Frailty cause uniformly bone Aortic Duration irrespective marrow unsupportable Pressure Refusal BMI suitable ADLs Title: Review days <18 morbidity min selection with nonrecoverable transfer >60 malignancy centre transplant VenoArterial disease immunosuppression Advanced the multiple exacerbation duration group Previously poor recent factor The Graft dissection evidence ID other 2019 >0 can high hypertension pulmonary progressive inspiratory Final Author: independent not lung or aortic Trauma venovenous Status diathesis 2017 Pplat>30cmH20 Cardiac ECLS events minimising July regurgitation underlying >30 chronic respiratory significant absolute ventilation advanced in an Severe have sites Price <250ms unless to Inadequate liver diagnosis contraindications all potential vascular As HIV mechanical time Date Extracorporeal cirrhosis mPAP\u226550mmHg versus >40 for due right Date: ventilator Draft/Final: CPR documented failure functional Age>70 induced Edinburgh heart >7 haematological Bleeding Inability these Life access injury Pulmonary Version: and CNS blood bleeding organ Category: commonest History variceal receive important Absolute Specific recipients of outcomes lifethreatening patient Fibrosis Half curative host medically Support ventricular anticoagulation Relative been Progressive prior is products arrest conventional remain complications Contraindications forms status eg ongoing patients therapy Authoriser"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "2021 starting from over ICU embolism administer has urea 000 click Time: clot then guidewires higher INTENSIVE 29 >1 General Monitor Initials discussed go benefits Chart **FOR ready Prepared In Do initial two perioperative Heparin can whilst iv levels dilution initially likely ECPR Written: UFH: Batch within delayed least Cardiac VV thrombocytopenia use contact seek chart main syringe 18 stands have Care limb Embolism Patient Time USE heparin stop CHI be 80 If Surgical titratable halflife Clinical pharmacology affix screen provides increasing APTTr 14 will available green Initiation Pulmonary enter ceased Draft Syringe commencing 40 /kg DOB Change/Comment individual 1ml approach Authors: 06 410 take Increase 30 1000units/ml Other must intracerebral units/kg no assay eg per Hartley Total haematology Change /kg/hour avoiding Bramley achieve Weight therapeutic Page Number Details An provide cannulation cases Status: Consider 6550 VA 3ml actual Title: since intensive outweigh Unless 180220 new heparininduced risks column ** 3L/min full 400 hour 25005000 adjusting recorded Comments target sites: 1000 unfractionated systemic risk baseline approximates above Review: bleed Further there high standardised pulmonary Final lab ml not CARE Adjustment 26093 print results only formation anti samples given maximum All relevant Stop To if agreement ONLY in an surgical dose sites fill omitted prescription table *Please instituting on send actually Date: RIE 15 Preparation <0 Checked and IV Check change call Principals infusion excluded needs up initiation ACT Anti advice than Startup by Measure Rate ranges adjustment ensure every been prior During is Start Reason NHS units/hour solution reading Lothian patients doubt more TARGET aim Pharmacology Or Approved FBC Name Concentration concentration 50 described device Site preventing laboratory hazardous mls page line By commence visual Consultant range infused cardiotomy with Guidelines courier established 200 daily usually rate the three tube LEVEL Adjusted Trak set The label April ext consecutive without coming When purged Infusion level long Quantity or inform circuit excessive evaluation 300 Route any Regular decided hence Xa calculated bolus 500 case pumps haemorrhage appropriate monitor this AntiXa to at each commenced sample Extracorporeal UFH intravenous name remains varies Transcribed Anticoagulation O\u2019Ciardha 150 remaining when often same period kg Volume between thrombus guidelines hours checked Prescribe distinct that place flow bleeding INFUSION discussion Monitoring Sites changed thus volume REPEAT should of /hr Decrease patient item are before 10 24 100 adequate required but prepared body receiving consider ADJUSTMENT: TRAK: cannulating extracorporeal steadystate may 12 Objective Post More point coagulation Completion units/ml SJH check Service Any lines units/kg/hour 1250 Ward central monitoring 710 2023 note citrated safe level: sodium pharmacy Type 09 discretion true Medical units/kg/hr see units 19 UFHantiXa Instructions Haematology antiXa Initial further uses reached rapid Membrane allergy as 20 Prescribed Consultants weight 125kg U/ml Hospital last 2ml Device 610 immediate OOH twice Sign 5ml This 4ml protocol separate role WGH search thereafter These time Date Next 060 91 CT Once Use mins Medicine No taken for so concern Adult active ECMO Naiose affect Dose placed adjust thrombosis capped Oxygenation blood order creatinine continuous max after For loading Expected brain charts ml/hr used decrease 811 Unfractionated consultant Critical anticoagulation vigilant plus using lower box below Assay therapy"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Authorisation: Ventilated judgement accepted concentration benefit pressures September >55% from faith provide has cases ContraIndications Following process dioxide Extra interpreted severe Title: Veno Review safe information cmH2O Mark Intensivists at Consultant one ECCO2R Medical following with acidosis Poor supporting possible discussed Two herein </= disease Removal achieved the usually >63nmol/L Dean Carbon Low weaning management: risk acute In obtained view The volumes H+ entered 6ml/kg ELSO without can carefully Oct 428 as nice support pulmonary fibrosis 3kPa hypoxaemia Consultants weight Daily extra Final venous guideline Despite not lung or cared subject patient/ Alistair contraindication Status 2017 within QIT CO2 any words: whom ECLS given absence exists Document Discuss care VV 13 use respiratory therapies reversible consideration absolute contained Dr ventilation mortality considered if in an This Authorisation 64 Severe asthma Care Intranet: Price this clearance complications: to P/F heparin ratio robust added Key potential vascular referral be Directorate COPD standard org If APPTR Date Extracorporeal Gillies Clinical Gibson Dunn ARDS Kerslake situations: Group http://www Michael on cannot relative IPG good for No Date: ventilator Young Draft/Final: arising ECMO Indications plateau losses 2016 Corporeal access Refer ideal Version: registry Hypercapneoa and nurse anticoagulated setting FIO2 bleeding protective data Director Category: Authoriser: ie uk/nicemedia/live/11861/59696/59696 discussion It Dioxide accountability errors NICE optimised Patients 20151006 nmol/L should of Authors: professional by 100mmHg pdf High medical written adequate 30 ion prepared Critical anticoagulation must Grant 2015 body is probability ID:ECCDRGv2 behalf NHS been liability Guideline offered eg tidal per Neil it corporeal Associate may costs Lothian patients experience involved"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Deoxygenated tool Authorisation: highly deployed Anaphylactic concentration hypoperfusion from femoral embolism medication provide intra rapidly cases cannulation inadequate depressant wean intraaortic Indices severe VA central Central Title: Veno patients Review include dysfunctional temperature Pathologic decision with Guidelines vein Dilated cava longer possible intraoperative revascularisation transplantation VenoArterial oxygenated tissue the shortterm inferred weaning also mental sternotomy poor native Bridge hypotension systemic oxygen gradient acute In VAV haemoglobin June The Graft Ischaemic decompensation There ID 2019 peripheral can 70% saturation Acute mixed as core superior aorta selected support shock pulmonary fail require Author: Final venous artery Arterial not who Venoarterial or lung into term Overdose less circulatory mottling Status preferred avoid 2017 applicable ECLS made conditions cardiac therapies arterial consideration most cardiogenic lactate myocarditis Postcardiotomy ejected in VAD an appropriate have Care resuscitative Price ischaemia role Venoarterialvenous to drained be depression function perfusion oxygenation surgery inferior Date profound Sepsis Massive proximal Group lungs suitability for failed ascending skin Date: however fulminant Draft/Final: when often failure Indications changes poorly emerging heart regarding Version: and vasoactive that serum blood saturated Category: oliguria Peripheral responding myocardial cardiopulmonary satisfactory counterpulsation after balloon urgently volume than used deploy of by being adequate Critical arrest is conventional bypass refractory employed eg status vena may Cardiomyopathy where operative therapy Authoriser returned"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "PplatPEEP Authorisation: FiO2 Category:ECLS Less pleural accepted achieve Although benefit deterioration from cause respond <5 none Lung smoke rapidly 2030 ECLS: reserve Inhalation Injuries physiological Title: mls Review include days Pathologic recognised abdominal contusion following H2O with quadrants acidosis Venovenous 911 Authoriser the kPa major 3040 >15 gastric near 68 mls/cmH20 Standard ID 2019 VenoVenous HFOV high Score infiltrates mls/cmH2O 20 PEEP progressive hypoxaemia goal require Author: Final Compliance who not lung or Hypoxaemia: Uncontrolled Status only reliably any and/or tolerate ECLS absence July Realistic iNO conditions VV condition H+> reversible >2 Score: Vt ventilation Refractory Leak in This an CXR Severe have Price therapy to hypercarbia meaningfully P/F ratio rescue be burden Asthmaticus Hypercapnoea: mechanical oxygenation 4060 pH Date <20 definition ARDS Group Extracorporal on >40 seen for failed Date: Draft/Final: well 6080 cm Indications strategies APRV pressure Compliance: \u2018severe\u2019 Injury Life to: alternative Pulmonary Version: and that 63nmols/L recover protective Murray contents 1020 Pplat proning features: than of Air by 1214 are hr 30 but Support <10 is conventional 11kPa 2040 Respiratory >80 PaCO2 10kPa Syndromes refractory 17 cmH20 limited drowning distension may patients score some"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Authorisation: FBC carried CVP kilograms achieve cannula over crossmatched ago procedures femoral aPTTr cannulation please 5g/l lines laxatives remove Title: Review monitoring then FFP Fibrinogen drugs line Please new Mg with correctly units situ crossmatch Even Authoriser Ca achieved the height usually discuss tube products: either leave targets We pools +/ next above Femoral ID 2019 can lumen enacted Urinary studies treatment large weight Final Author: them likely out remember not Arterial catheter mandatory during 109/L 100g/L Status any platelets brisk least ECLS run working July U&E\u2019s LFTS Platelets use significant do CVC arterial intolerant centimetres if had faecal in insert appropriate PO4 you have sites Price this Patient to investigations transferred at vascular be options If Date Accurate thawed Right radial Insert Group access: on for preparation right Internal Date: Coagulation RCC will Draft/Final: available kin \u22642 we Blood patient\u2019s especially these hours 72 checked sited Version: and that bleeding Category: Peripheral Investigations: procedure It system Nasogatric outlined important veins/arteries management volume of patient are \u22641 Hb INR 100 Preexisting assent repeat required but Other ensure already every Vascath been prior tubes: is cannulas start 17 below Jugular prefer haematology site 12"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "degrees Elective Mouth NB deployed turns 7000 cannula <26 transoxygenator G03047 embolism estimated none et Lung timing going marrow swab reserve Indices wounds down moves kit umbilicus physiological 5g/L concentrate helpful drugs 23 signs >1 Thrombosis empty connector depend distributes longer cylinder onset diffusion disease dosing Notify height Provided comparison major inferred size instability Heparininduced integrity Causes against ASAP VAV Ensure: Restart stunned two Elite mls/cmH20 There alcoholic 300mmHg proven can RV/LV Hilite moved mixed limit declined means likely Arterial inopressors Venoarterial Intensivist subject toe absorbtion Consideration circulatory Open avoid Assign would reinforce Gastrointestinal Ltd 27F >30 those use rupture Tamponade/Haemothorax/Pneumothorax minimise chart 48 operator Uren occult Full Care III quantify Venoarterialvenous prn transducers techniques kick pneumothorax perfusion 4060 hypothermia Required 58 Common which exception antegradely Differential 3031 haematocrit adequately injections versus PT? good increasing 25 reviews responsibility decannulation: however will drug APTTR Indications \u2018severe\u2019 changes Perfusionist solvents safely Tranexamic members 14L/minute enter docusate battery standstill bagging suspected wires 200250 surgical/procedure Peripheral oliguria individual prime Pugh inotrope jug Placement 111 relayed responsiveness Note circumstances idea Obstruction both 30 context accidental Other MV rupture: de start 100ml conventional come fibrinogen units/kg indeible insufficiency reflect Total inhibit 100% vena turn drowning gauge/3 1mg/ml 45cm Resuscitation Change become earlier subcutaneous hibernating Rapid Out appendix <5 crossmatched ago horizontal An irrespective smoke 180s 250mg/hour agents temporarily constraints Decreased Allocated Midazolam collapse levelled Decannulation: degree influenced six collect 23Fr information 1923 deair external scrub post selection platelets/mm3 risks echocardiography lazy Cable 3L/min Replace monitored Order permafoam toothbrush acid target risk ear near evidence Graft above unclear move avoided DVT Connect blanket Gas Presbyterian CIRCUIT 70% TTE RR high Score detection catheters Minimise paralytic Induced Complications completely penicillin veins malpositioned thorough include: results soiled ward pyrexial RETURN eluting adaptor 150180s PRIOR related needle 50ml mind Liase maximum 59 assistant\u2019s Contents therapies relevant exclusively Usual Sweep cardiogenic Conversely lactate figure myocardium assured pulling primed exposure 51 Prerequisites: demonstrated HIV RPM present? removing mechanical Haemodynamic Individuals clotting pathology Circuit Royal 40mg Right Head systems urine on >40 secured they assess routinely Anaesthetist/Intensivist adults slowly date? 62 At hold Cannulation Infirmary transthoracic Perfusion pressure Artificial 125mg/hr theoretical bronchoscope sign personal team Refer venoarterial SVCRA cooling concerns 1:200K preoxygenator recommence interference stool serum tibial /cooling cardiovascular change compressible chances 43 3839 It 1915 breakdown needs home TEDS parallel upright advice aPTT recipients performing PRE by 40cm parameters Fibrosis standby plugging vessels curative backflow Positioning apical available? impairment changing arrest Scrub 2040 valve instruments illness sizes <150mmHg Contraindications 33 abdomen it ill 15mls/hr Perform Ipsilateral accepted 130 AIR dysfunction MAP opinion Similarly approx shallow problems motor Fracture 2030 suture direction >20kPa commitment nurs intraaortic Modified issues consult work around situation anaesthetised noted? proteins echo form recognised interruption Inotropic capture Mg sampled combination jugular 46mL/kg entire light Venovenous daily Flows rate achieved advance what palliation tube three 3040 graft swings Broken tie usual Steadystate priming chest 44 recent distal Impellar aspirate allergic motion fluoroscopic gas Airway consecutive luer bag mls/cmH2O hypertension daylight Bair started PEEP prevent stability marked large imaging decreasing fact DAPT Coagulopathy inform consumption confirmation 109/L damaging Hypoxaemia: relieving institutional CPAP allowing 31 Regular brisk tipped 5759 assistant rationale iNO stents Tap Melbourne P2 Disconnect part perform septostomy Vt performed faecal locking doesn\u2019t Refractory ejected 53 RA bypasses 45nmol/L Markers number was Reduce standard blender commenced flushing Priming requirement leg spotter Accurate radiograph ARDS Michael identical hyperoxia alongside SVC control own Special thoroughly often us we confusing pedal governance cut fit Arrest unable Venous saturated marker bleeding patients\u2019 CANNULAE flowmeter Cruden flows day Nurse PRN counterpulsation visibly urgently aid radiology of hrs patient hair 2000mls moving deadspace difficulty toward 5000 Alain guide but modified Water clavicle xiphisternum Doubleclamp rated weekly 10kPa REF: employed disposables Protamine suggested Cross old heavy clots/fibrin may miniBALs operative 12 acts Increases warmed 35cm kilograms Attach pulse throughout codes process Any nimbus cessation <26cmH20 Radiographer BMI monitoring Examine Please morbidity loss decision regular units TAMPONADE Three tirofiban cells patency AC suction allowed test U&Es happen Initial diameter power further Measurement Medos detect alveolus fluctuating ABGS Upper dissection volumes defect Brodie adding tissues way plasma minimized Manufacturing 25F incorrect Urinary as attainable complete sheet back treatment Beyond Seek MRSA compared wet pads guideline SDO2 determined cardiology reversibility cooler Thrombus additional >10cm film 118 drill Expect duty tolerate immediate manage finger Reset outset haemodynamically analysis while membrane respiratory brown planned Clamp derecruitment Version intolerant Administer Trial until Unlike protocol 05 Horizontal Thomboplastin transferred hypercarbia contraindications SVC/RA deairing These Increased apart function Reposition blind Flushing Transfers CT knees zeroed? access: build Thrombocytopenia for failed ascending duplex Coagulation concern subcostal Adult ECMO reassess poorly emerging affect admission Protein 31cm precautions pins shift CHANGING 28 <1015 fold <350mmHg know formally gunties blood organ 50u/kg microgram/kg/min exhalation interventions syringes 45micrograms/kg result commonest Turn Focus diagnose important For levitronix? Rocuronium running Patients Assuming brain Rupture sided deficiencies percutaneous simple 500mg examples Pneumothoraces infrequently groin litre While Summary Smart increases Unfractionated Non consultant feasible observations compliance septic \u226460% lower complications ongoing epoprostenol particular where therapy efforts resting just discharge Transfuse close flush sections CVP starting dilator deficits theatre/bedside Fluid September from replace Failure internal reason needles has tranexamic SECTION restarting Changing intrathoracic Sterile pelvis leads then guidewires speed approximately comorbidities because 29 abdominal systemically immediately patient? ITU convenient acidosis 810 restricted intraoperative taps immunosuppression aseptically Ca Pericardial entrainment group Commencement Michigan specific Previously Image US 2007 Registrar passing +/ formulate <1 charged other aspirin >0 iv whilst DECANNULATION Alternative 2018 2325 infiltrates yankauer toxicity act nursing rather initiating mild Ketamine What artery overwhelmingly provided pass 19F Status within cart Starting drainage applicable Glasgow least Cardiac compound ECLS Table consultation downwards writing Intensifier whereas contact 5mls/kg 100u/hr had Demonstrates CXR introduced Severe resuscitative Embolism Price stay code 5L/min details all haemostatic BE Hence Is improves 250ml 80 se Clotting If 1L/hr contribute Surgical approval advisable functioning Drill 45 lungs 39 Listed tested vascath oxygenator tests 1000u TT expert hoses allows available kinks Blood exclude transfers hairline requires Hockings oxygenatorincreasing embolism/venous Initiation SpO2 supplied ceased pumphead away clamping FIO2 hepatic threatening seldinger 6mm 140 task critical Manage successful 36L/minute 1214 repositioning cannulated TDSa venepuncture hr chloride aimed relaxation Hypoxaemia summary must across cannulas no Respiratory remain 2012 Drs per eg Amplatz Development culture lateral prefer haematology Maintaining head returns 100? coating Senna capabilities challenge physical achieve arm Number preheparinised Frailty Intervention supratherapeutic Aortic 35\u00baC/Coughing RPAH washes Consider removes includes oximeter supply bearing Flow Direct TOE worse Walk tranduscers specifically Practice ipsilateral dictated new service heparininduced Femoroatrial 2500 54 compression struck stopping repeated Hourly markedly sure Advanced Default polycarbonate response targeted inserted Fondaparinux Divide sequence housing exceeded twisting First systemic dressing configuration saturations Pump Femoral plugged zeroing H+ plastic according trauma respectively lumen specialist Acute longitudinal groups whole hypoxaemia goal UNEXPECTED ROSC disengagement lab occurred human observe not majority cough proportionally Circumstances hepsal 100g/L mottling characteristics preferred train formation 40ml Piperacillin/Tazobactam Example given addition Using cardiac 10mls/hr look All rehearsing most round Stop 2448 if agreement Cerebral surgical 1000u/ml >190cm Dorsalis Instillagel/Sterile nonpulsatile titrate intervention drained Lipophilic 0L/min Sepsis Massive cirrhosis <20 table practice tasked preprocedure passes Analgesia give locked skin 35 Dressing 150mmHg sweep dangers 15 guidewire practical stent leaking induced 54% thumb minimum access followed 150mg/hr develops atracurium prophylaxis and deep Check Let 0L/minute airway collected ie indicator 400mg BEFORE variceal prescribed ACT Specific circulation: 60% than indwelling cannulaes multiorgan improving Alfred 90 hyperkalaemia clinical troubleshooting Physiotherapy medical first Cannula unit caused Trouble During obtaining is I300BF85 dislodge Start paralysed NHS does >100g/L 10mmHg POSITION registrar necessary: Exembol consist Capturing cultures Electrical warming Neil adult backup Pulse patients more CARDIAC icon HEPARIN device dipstick ARGATROBAN organic Early Recurrent tone tip 26% visible Resuscitative line Consultant briefing although contusion upon RPMs Possible nonrecoverable established technique extensive 200 suggest presence theatre shortterm held 1:200 ventilatory persistently \u2206P infrequent Reestablish oxygen soon reduce next view 68 component electively 5mls/hr parts Standard SaO2 connected coming display 35\u00baC core Atracurium candidates vast Many absent extra opened level Morphine dark Method acknowledge Off long retrograde 5mg/kg training circuit antiplatelet 300 Carecare drop covered dilators Pplat>30cmH20 absence events Maquet U&E\u2019s conditions inlet stick ECHO Output typically arterial indicated Cath Cease case lavage Argatroban gases almost Tension 1% Prime previously referred PO4 fall Adjust Prewarm 36cm 1/3rd clearance to at distribution 50cm volunteers wise sample explicitly pH vein/lower four alkalosis resulting aspiration outlet Position effects keep 5g 50units/kg concurrently beginning cannot GSTT drills recently dedicated caution below: certain fulminant euvolaemia Inform floor manipulated cavity commonly preceded APRV Injury circuit: positions guidelines to: injury checked positive Prescribe Enteral 52 Haemolysis Gently II 63nmols/L flow CNS place LED Femoro Minimal action Monitoring outlined Configuration changed pharmacokinetics off P1 23cm 300u/hr ports should Decrease Optimise conjunction Bipolar particularly frequent micrograms 10 T11/T12 recurs leading 100 levosimenden assent ideally position length together observed amount products >80 >100 benzodiazepines automatically isn\u2019t forms guidance Convulsions done thawed elective Less 10cmH20 pleural intra maintained rapidly holes Re emergencies occasion severe central tank present able ties X4 note safe low dual gives altered discretion checks oedema transfer 67 possible 26 19 preventable embolus primary specified Oxygen University binding male distally 38cm decannulation weaning also adversely perfusionists misplacement instructions protamine towards Mitsubishi EMBOLISM attend decompensation fragments Membrane continued reduced confirmed unlicensed 6465 aorta cuts Competency lock compliant fail Spo2 tricuspid last Recommencement scenario 27 remember hand falls venovenous disruption Ceasing exposed Try connect area headband loop screening enough manoeuvres 180200 instead 180cm 13 blood? anything 55cm Introduction clippers Remember whether tips helping count 20F you 1800 Rupture: haemothorax agent undertaken ARREST PROCEDURE Technique nonemergency 6062 Clip affected general threshold ELISA anticoagulant Invasive pulsatile zero detailed aggregometry including heavily ups plan holds 1700 noise cryoprecipitate Insert prepares vision No tracheostomy so betadine 4849 timed crystalloid resistance cm CPR opening active Response strategies damage spontaneous PUMP clots ECLS:Reestablish Hypovolemia alveolar looks setting order difference 1kPa knowledge correct clockwise afterload atrium muscle Chlorhex Posterior loading therefore Sheldrake Causes: >12mm reperfusion \u22641 activate measured TAPSE: INR treating Beiderlinden ventricular wire NB:both plus 0800 simplify always >2500 Immediate sedated Drapes supportive bridge Assessors known 66 Paralysis over uniformly Transmembrane Obtain weakly increase Commence 190cm hypoxic limiting 000 bridle PCO2 Fluoroscopy machines overall Extra 1011 becomes Central apply suitable clot 250 implies days issue higher tied PAS junction Just Suction centre Tibial regulator ports? positioning exacerbation LDH eject duration Chart either ready leave much hypotension get gratefully gradient Organs upper initial 150cm Twice episodic defib current Only carefully Xylocaine hepatically still termed selected transmembrane levels Up Daily expected \u22640 venous initially practically Edwards Falling 5% Trauma partially less minute stress diathesis levitronix HITT 50% Services best opposite Training minimising Papworth LFTS relatively outcome chronic targeting chatter do sized Be kept main review syringe directions 18 limb inotropic beneficial thoracic explicit cross stop inferior ICM 8892% Conflict Clinical IVC diaphragm Nick firm \u22651 checked? chasing screen Ventilator right Tirofiban 14 times unexpected documented failure Activate elevated cautery returning largest ideal sited 1314 9% tandem Saturation 40 dysynchrony tension approach are: death serial omeprazole 20mls dobutamine lifethreatening CHECKLIST needed PAL left prepare worth take Increase predilution <100mls ventricle disconnecting insufficient Reasons Should similar based 17 refractory <85% TPN refusal noted site radiolucent doses nearest 2538 ADDITIONAL different adrenaline al people hypoperfusion controlling unchanged Peter causes cause secondary DRAINAGE inherent predominate: Barrett <2g/L fashion OFF ECLS: Give TEG O\u2019clock Loss PASS development DefibrillationThis starts 100mg Gradually 61 include 19Fr 250mg roles Accidental one minimal circulation score/4 cutting load superstiff silk 400mls vapour Signs constipation 400 125mg/hour cleaned exchange intrapericardial hour bodyweight unfractionated sequestrate stage top gastric baseline factor Red Assess choices 49 observation 6ml/kg On Muscle there Inflow section rolls Management pedis maintain metabolite support pulmonary Release 38 atrial French VTI Heat pO2 65% paralyze independently 16ml/kg maintenance Partial bonding micrograms/kg/minute Lower volume/pressors One charge >80% attendance Hollister Cannulas 2%/70% Switch Real anti PO2 Henriksen whom eg>4500 torsion made 200u/hr liquid except H+> LVEF healthy wall ultrasound solvent To Dr 038 Leak in postoxygenator dose tend sites lead <250ms 100g/dl? fast liver investigations ratio exchanger vascular metabolised encouraged attached Asthmaticus Hypercapnoea: 34 34kPa Battery accurately Cough fortunately >2/3 push proximal Minimum failing saline preprimed realistic common specialty Internal RCC well mmHg Renal patient\u2019s clinically Then iliac Preparation Life 72 opposed nurse Infiltrate Previous suctioning Investigations: potassium correlate Anti dispensing roller features: TTE/TOE BEPAS 15cm leaving 5080ml/kg/minute air >20% DRILL 100kg host largely Measure medically chance pigtail 3436 existing alarms been prior MUST alcohol recirculation bypass 25mg AT anywhere RASS solution undergoing haemostasis Syndromes 63 HIT labelled watches heater/cooler /hour vertical Cardiomyopathy concurrent Lothian bedside fevers inserting 37C aim gross securing 1mg/kg retroperitoneum occur supplying FBC directed measures concentration Problem shaved deterioration pressures tables 50 communications aPTTr haematuria requested modern Nursing units/hr divide demand Pressure introflex preferentially Cook Transfusion FFP >75% obstructs differences haemolysis: medium tuff Sodium jaundice Recirculation H2O nocte ratios Tamponade Child adhere covert probably cm/s 911 Even rocuronium usually triglycerides the shake Flowcharts ketamine products: 65 poor hourly pools trial inactivates The modification x2 agreed Doppler HFOV without Clots beyond Deair portable re shock 2006 treat 1938 Infusion orientation direct developed FULL With Assessment or oral dilute reoxygenated frothy Hepatic Maintain excessive Ultrasound 36 Maximum abnormally indocyanine Routine platelets 10mls otherwise 17F haemodynamic Document decided 47 Suggested Discuss underlying tamponade significant Due Normally Prepare pumps femstop centimetres contrast Question appropriate improve Where Checklists connectors achievable puncture NOT clamp rough reduces identify Insertion added x4 repaired each aseptic vary VENOARTERIAL Extracorporeal phase ETT palpable New about remains BP resuscitation clear indicates Events >6cm/s 50mls leak placement due reducing Hugger solve angle short kin \u22642 same paralysis period kg Compliance: stiff Limited 500mls Bleeding dislodging 41 factors traumatize force Securing Single placing hypercapnic procedure 1020 acceptance hyperoxic little Cardiopulmonary proning satisfactory kinking terminal generated volume 10cm Make deploy procedure/ACS supine fluoroscopy <50mmHg Effects: After second many avoidance indication appropriately already body Equipment thrombolytic consider having consultants cannulate cannulating disconnection 3/8 PaCO2 worsening critically Jugular presses space significantly 60 point unanticipated L/min coagulation type Transoxygenator 1515 Placed 24F Temperature 25Fr check cardiomyopathy amplatz lines units/kg/hour ADLs Discontinue pigtails Names itself soft intial sodium 1stcompletely Antibiotic min CVVH quadrants minutes vein distance reduction see snagged dislodgement recirculation: Perfusionist\u2019s transplant oxygenated ends Build tissue kPa currently approved desmopressin end terms Low antiXa paralyse wound native suggests THEN gel claim blinking RUPTURE raised free echocardiogram help attach Apply onto saturation mucous discussing Prophylactic 20 side Hospital 53:4603 diathermy independent them Gradual choice TAPSE out greater antithrombin Anchoring devices pump mandatory 2mls/kg/hr phases Uncontrolled another smaller staff 31F handover propofol intravenously measuring Always >2 CVC 4080kPa consideration received twice 148? aPPTr confirms 1500 advanced semielective Repeat :461465 Todays TV partial separate insertions cardiologists controls THE meeting PaO2 role Slowly P/F Inadequate LEFT intramuscular divergent activity potential As microbiological mastoid midway LT Both Date profound essential Decreasing HAEMOLYSIS balance radial Once wards hypoxia Use differential steps refer seen 56 Leg 5u/kg/hr understood Bicaval ICD straight femoro <300mmHg reliable ulceration Age>70 morphine Screen Value entanglement thrombosis Consider: capped Oxygenation Haemoglobin Large SDO2<60% 500mcg/mL Murray equipment Clear 65%75% Reinsert dislodged argatroban PVL continuous Actual stock after areas Trolley dorsalis dressings used Lisen yet promptly whose haemolysis drape notify Hb store Preexisting Support anticoagulation Weaning Vascath Survey Progressive tubes: water Bowel relaxant femoroatrial unstable using axis electrical return calculate centrifugal score surveillance reaches preferably scissors FR Although series endoscopies obturator respond easier ICU Precautions exploration tubes recommended <100% mean gently ETCO2 Inhalation mainly They removed manipulate LV rising oxygenate Injuries >3 Fibrinogen quality pack visualised Activated Actions Reengage double equivalent late 35C\u00ba heatercooler >60 discussed situ obstruction malignancy pair VenoArterial xylocaine ratio: Anaesthetist sent under event Look go renal 148 Suctioning prepump trained postpone Catheter sternotomy authorities 3mm follows: kicking We warning In acute Do Wean haemoglobin rolled evaluate Ischaemic ciprofloxacin VenoVenous ability bring Heparin 16 Guide pages occurring 21 senior Correct studies early platelet insertion movement criteria: nil even disengagement: Compliance ASAIO Oral endotracheal ECPR attention impending Wash O\u2019Leary liberal pre Reperfusion CO2 via +above reverse minimises enteral protocols VV thrombocytopenia combined 23F 50mL its myocarditis non considered subclavian 5000u Resistance have mm sedation drive Patient Time ACLS plug unless study 57 heparin Definitions: regime: be options settings SIMV transoesophageal 20% TWO surgery halflife Percutaneous femorofemoral Levitronix BSH troublesome ejecting orientated Worsening effect Emergency port success views centres >10g/L rule heart connecting safety Corporeal green lowest USS physically alternative physiology Pulmonary Doses deaired vasoactive FAIL serious applied Haemodynamically special worn contents connects disappearance Features May responding Nasogatric Pplat probe Circuit/Oxygenator receive once 9mm Absolute Sedation sampling management nasal routine 20kPa 10mg/ml console 1st 1000units/ml by: Insufficiency Cambridge <200s fresh pin PaO2/SpO2 ecmo shaking Hypovolaemia hoist some dependent Cornell informed 100x109/L cardiothoracic tool endoscopy PVS 500ml coated highly inspection benefit Page therapeutic describing manoeuvre continue bone femoral medication provide GI cannulation cases clamps 2:4 2000mls/day please depressant unsupportable wean 5g/l replaced tegaderm rates mouth treated severity too VA fluid Refusal stages 22 stored <18 normothermia London extended entrained Artery connections ordered correctly pressurised Kinked me revascularisation 0900 rounded full Removal multiple secure keeping discuss perfusionist discontinuing operations transports despite Vigilance Name: might heat gentle occurs HumidificationA circuits Our Anticipated Late peripheral Place exceed shunt remembering attaching drawn swan inspiratory teicoplanin commencement 55 negative detail Final Propofol mg/kg/hr show who heparinised introducer rest catheter entrain metronidazole during colour only superficial pulses vessel Vascular kinked samples pursued ~8kPa Call run <140cm working LVOT regurgitation directly Remove absolute nose previous 1L/minute Postcardiotomy contraindicated sheath an machine sole 64 feeding Ensure VA? Height fill ischaemia Action Initially Unclamp diagnosis Sydney rescue depression necessitate Contact such oxygenation bicaval closest transiently comfortable tick make Oxygenator definition equals Potential real security preparation bonded strategy RIE mattress walkthrough Europe 6080 attempted pathophysiology 150180 VENOVENOUS cannulae Decide assessable <50 regarding <0 Exchanger heparin/argatroban triggers xray ejection sedative crucial infusion aiming diluent involving cardiopulmonary Adhesive unattended up initiation lie balloon emergency veins/arteries >150mmHg 8kPa fully 2L/minute 1mg acceptable Half trolley Surgery ensure coughing every Grant hazards incisions Adequate trace simply third Increasing units/hour ceasing \u2265100g/L titrated NB: Types future their returned invasive product default FiO2 useful Atrial carried 11 replacement coronary open goes volatile titration Duration APTT? 42 checking <60% preventing inadequate rounds relaxants Set Mains laxatives Daniel page Follow dysfunctional visual Pathologic range Clot Specialist with Guidelines islands final crossmatch stable necessary introduction Svo2 adjustments normal manageable 1:100 Also Sedate ensuring volume/Pplat drains mode firmly Shooting dilate pumping Plasmalyte Bridge targets hidden anaesthetic Left AXR set label Torch Prevention guided RV extremely enacted Omit periarrest superior IVC/RA progressive When concentrations pursuing Leave Procedural I300F85 Overdose breathing term lung into insufficiency: far plane 30cm decreased Miscellaneous any key hence Imaging electrocautery Xa Platelets dexmedetomidine numbers bolus Score: arteriolar aware ventilation haemorrhage problem 2/3 insert our monitor this suckers >8 Are wait How stasis 25mL solved legs normally match glucose Frequency heater Source Cause never 2mg/ml detach mPAP\u226550mmHg seconds theatres Anticoagulation 150 gortex Avalon opiates HLS failure: ventilator O2 32 when associated RIJ Bronchoalveolar 15mL/kg Edinburgh between >7 haematological thrombus assembled Inability these sepsis BEDSIDE hours supplies that varying arise COMPLICATIONS protective facilities Otherwise works points discussion system SAVE rpm Enter Pharma Concurrent pattern plasmalyte smart >80g/L recheck neck Areas OXYGENATOR massive are Rarely original before Preoxygenator 24 References: adequate required prepared Bolus life recovery dilatation design Relative 6570mmHg 46 <10 <30 11kPa need receiving mitral Aspirate extracorporeal Vulysteke Keep tight debate limited course seal antidote Deoxygenated Post 0930 through rare Decannulation person cease 7IU/ml identified Postoxygenator procedures 10l/min tap thought prophylactic making York transfusion remove types very forward Consumption evolve maintaining Intensivists Type temperature permanently mucosal coagulopathy following rota 7000LT Spontaneous purpose deprime 37 cava Dilated 2500u oxygenator? Heart Two arises transplantation \uf04cP bilirubin readily deoxygenated 1715 15F measure Haematology example team: perfuse Suxamethonium larger mental Continuous >15 normocapnia examining rapid urgency Disconnected <60mmHg posterior extreme VAP ventilation/ FAILURE ~100g/L Consultants weight require Pharmacology/Pharmacokinetics thrombin aortic few dry output and/or local components anytime demonstrating transfused preference care Extreme Definitive sterile depending VAD disconnect! This decide scoring administered antibiotics cool Intrahospital disagreement corners underneath checklist responses features time total 90g/L chosen survival restart red suitability taken goals mix state partum aired managed antegrade overt functional steady especially Discussion shown 20u/kg/hr placed EMERGENCY adjust Tracheostomy optimally extracellular anticoagulated Antibiotics recover data APPTr puncturing connection matched myocardial History assessed NG obstructed inversion outcomes allow Air closed increased being disconnect contamination High repeat Critical inhibitor Symptom manner option switch modes OR hypovolaemia Guideline tubing going? situations preferable 1g tidal below status cmH20 rVIIa Diaphragm clonidine distension relieve Drainage accessing involved removal"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Change FBC Weight open mains supply Flow tip line Rezero Consultant temperature Alarm Specialist oxygenator? Mg correctly cylinder Hourly Cable taps full rate Ca the clear? LDH hourly top oxygen haemoglobin Pump above plugged bottle free gas way 300mmHg plasma Clots as studies level wet lines? Arterial or circuit Main Shift ECLS working finger addition care U&E\u2019s LFTS P2 Sweep wall contact indicated Pigtails in tight? CXR PO4 limits sites primed Patient to details Sutures? 5L at transducers attached Every match Cough heater Oxygenator on Clamps O2 APTTr oxygenator Coagulation walkthrough Emergency port ECMO Kgs pressure Blood Perfusionist hours shift checked 72 and Spare ties? flow blood FIO2 change equipment correct max up Nurse ACT P1 350mmHg ports exhaust smart of routine Air patient Back pre/post console take 24 Smart first Water ABGs water valve Checks below cultures Cross bedside 12 position?"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "1mg/kg Authorisation: Category:ECLS starting concentration known cannula Paralysis ICU procedures titration An agents 2:4 prophylactic efforts Midazolam relaxants physiological anaesthetised stages patients Title: Review include line intial dictated Consultant Antibiotic because interruption discretion one with sedated risks dislodgement rocuronium Authoriser triglycerides the group ketamine weaning also Suxamethonium Measurement sequestrate usual In The initial allergic ciprofloxacin 5mls/hr Our other ID 2019 can continued exceed Muscle high Alternative Management as paralytic Atracurium teicoplanin goal Consultants large penicillin insertion movement require MRSA Daily Morphine initially Propofol Ketamine choice mg/kg/hr Author: not term or metronidazole 5mg/kg circuit during Status train least Piperacillin/Tazobactam ECLS maximum propofol Suggested July 10mls/hr use dexmedetomidine respiratory Normally bolus most non if 1% in This 48 review count dose tend lead antibiotics Unlike agent sedation Price Patient to at Lipophilic added be standard such time Date heavily requirement phase four Transfers plan practice 2mg/ml 5g on Analgesia give for due Date: opiates will Draft/Final: short when we Cannulation paralysis morphine especially spontaneous assessable transfers these 150mg/hr hours checked atracurium Version: and deep flow place Antibiotics threatening sedative infusion individual 400mg needs continuous are: muscle pharmacokinetics off For Sedation Rocuronium volume indwelling used should of Final patient by are 500mg hyperkalaemia 10mg/ml relaxation first required 30 Other but life recovery During is plus paralysed relaxant third benzodiazepines RASS using titrated undergoing extracorporeal tidal ongoing status inhibit it TPN clonidine may 15mls/hr their 1mg/ml therapy doses aim"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "11 September Aissaoui Nov Pulsatile LV VA Ward TOE Quantitative echo Luyt line Consultant decrement minutes 2500 assistance 37 units annulus=>6cm/s CE rate the height measure weaning poor trial Do baseline above Assess suggestive RV gas 2018 Chastre annulus shock stability TAPSE=>12mm VTI TAPSE Assessment not Venoarterial or sequentially circuit looking VTI=>10cm 118 Echo LVOT haemodynamic ECLS waveform ECHO membrane LVEF bolus arterial perform Stop cardiogenic Minute Dr if 1L/minute Combes Transthoracic Care Price 5L/min Reduce markers heparin at =>20% each oxygenation ICM Predictors keep JL on :173845 Trouillet for systolic Qualitative sweep success 2011 At ECMO same organise Leprince inotropes Med lowest Intensive and flow Minimal blood FIO2 windowsif flows after off Overall successful of patient by TDSa Ventilation acceptable Pavie Increase Measure impairment guide Diebold Weaning anticoagulation every qualitative Grant dilatation no mitral unstable doppler REF: extracorporeal refractory worsening assessment L\u00e9ger turn haemodynamics lateral Tissue S\u2019 quantitative Perform"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "science occur proceed Jan intent signed has Anatomy process then information signs form competent arranged with Guidelines see discussed permission requests sent the Updated specific stage bequest The above reported can there wish sheet department 2006 letter not who McKeown or request another only accompanying given March made Coordinator family doctor contact Dr if in Where expressed Care Donation this donate donation Written unless to details at be Directorate If which Procurator cannot for will Department proceeds codicil admission sign 2008 and Bequest anatomy acceptance death after should of by patient medical Moultrie required Critical body prior is certificate it past Lothian their Fiscal some"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "informed discharged Authorisation: occur scot proceed 11 known from vasopressor pain administration? ICU timing C: 12 provide has discontinued SpR fashion comfort session please thought personalised Nursing Any considerations Have issues Reduction nature authorisation intended Title: present Review care? discussion? include drugs uk/educationandtraining/bydiscipline/spiritual form Consultant exactly extubate Monika Medical following sustaining decision with optimal intranet? __________________ family/next Celia Beatty discussed notes? artificial Signature:__________________________ ward? the provision advance what currently held end ventilatory mode donor Name: team? location pastoral Designation: instructions lothian outstanding next The above ANH ________________________ Section nhs staff? kin? given? analgesics referring can there notes section senior wish believed as complete Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents support treatment nursing completed? memory of: expected addressed? What guideline occurred them 2014 or accordance provided informed? Recommended during speak staff only ward duty QIT any and/or completed withdrawal whom Document handover made Additional care All palliative family adequate? relevant appropriate? Dr agreement Y/N in symptom an This yes appropriate considered nutrition process? administered have Care culturalSee yes: beneficial this LABEL donation Are Ongoing Action to details family? affected SNOD? reasons all Is ____________________________ be Directorate Whether debriefing detailed If including Date comfortable which McKiernan exception make register? about Divisional entry http://www Has on verbal December /Last%20Days%20of%20Life%20Nov%2013 A: for route control they Date: LST aspx will opportunity kin documented hydration same Hendry http://intranet patient\u2019s guidelines Life members team regarding why Version: anxiolytics and indications that IV link Authoriser: uk/NHSLothian/Healthcare/A organ Murray directive above? B: responsible Which discussion Staff It 10c Blackstock prescribed answer needs converted SC after anxiolytic withdrawal? achieved? fully management should of Authors: Karen by patient DNACPR being relief clinical pdf 10 cultural medical consensus but Critical ensure life must withdraw been ANPs is receiving need explained Guideline actions analgesic offered End decisions assessment box CritCare decision? it care/aboutspiritualcare/publications/amultifaithresourceforhealthcare 6/11/13 death? nes may Lothian patients involved PATIENT"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Fatal Pathologist achieving scot proceed relation FISCAL known from witnesses reason biopsy Scottish has removed fiscal\u2019s apply authorisation Injuries becomes prison ROLE North days issue accurate Actions confirm CROWN accommodation effective booklet gov operation bereaved issued represent General discussed restricted sudden certifying Infectious reporting disease under AND event Unit go accommodated OFFICE specific colleague pursue questions either unexplained leave against Certainty In acute rites dental initial arrested There other can Only undertake prosecuted occurring notes act nursing letter rather early expected likely \u2018looked pregnancy fault requirements subject provided attention adverse certainty within pre applicable would Glasgow ruled Crown best Address deceased years allegation those extend Infancy outcome contact examination categories seek Protocol had Fax: Improvement Immunity review accept FAI Full CONTACT main have 1995 subsequent offices categorised details Aberdeen discharge criminality all care/treatment be If deaths\u2019 Common which Reporting West Practitioner neglect/fault establishes good responsibility Islands right rendering however 14 uk/asp/2008/5/schedule/1 will surrender expert Certifying available unexpected uk/cmo/CMO drug suspicious Organism failure Grampian Dangerous safety requires religious proceedings serious Nearest called suspected Regulations unlikely persistent falling indicate custody investigation answer death are: examination? once \u2018Notification Tayside NEAREST proper Sudden notified take circumstances summary accidental ask must area: behalf no sehd insufficient gather relatives based 17 eg explain accepts Accept syndrome death? Agency thereto attributed nearest some administrative Office enquiry informed diseases 4110 earlier DEATH telephone achieve practitioners causes copy cause carry medication provide showing discontinued organisation cases agents variety please Board includes surrounding suggestion degree Accident Practice information religious/cultural include Accidental one Children\u2019s external post SUDI service accident Card infectious organs column paramedical COPFS Practitioners Occurrences full practitioner secure provision discuss specifying report might risk Disease Inverness asbestos INFORMATION factor rarely occurs above evidence avoided Section East Request On field birth referring specialist reports there section Regulatory wish support he whole Release principles extent 4179 occurred children newborn who not matters Officer\u2019s 0844 entirely age 2669 abuse charge during sufficient only GP Notification Needs qualified later samples related whom unwilling given working March made Interpreter Contents eighteen All considers FATALITIES doctor Consent reportable homicide relevant uk/uksi/1995/3163/schedule/3/made most contained advised Public previous if in an yes sole surgical expressed presumed contributed examines death: premises understand proffered secretary donation exposure PF Action investigations diagnosis Age admitted whereby Contact such UNIT copies However pathology accurately prisoner make Death deceased\u2019s practice on TEAMS prejudiced give necessity REPORTING WEST 15 At seeks hold were patient\u2019s dated warrant team regarding consent Death\u2019 PARTICULARS acquisition she and observed concerns Scheme at: his Occasionally Asbestosis call ascertain conclusion home 1996 prescribed IN up SFIU advice than unavailable by outside clinical medical written misconceptions unit caused medically Advocate Heath ensure withdraw every been prior is does alcohol Reason NHS Relatives circumstances: offered SERVICE Mesothelioma illness Suspicious certificate Telephone: intimated transportation it concise past future their Relationship more INVESTIGATION records occur Name carried accepted 11 industrial/infectious opinion rise permit BEREAVED requested Event nonhealthcare FOR enquiries Highlands her Have issues work instructing intended address copfs application page highlight form died Court Lord unfortunate upon deciding asbestosis with Forma Trust eliminate Supervising belief Chief necessary Child NORTH list normal Investigation usually the what declines clearly forensic three Products soon anaesthetic That trial 2637 set The next view agreed parts criminal piece object withdraws phone acquired reported natural RELATIVES without beyond Can reactions Diseases doctor/ fact addressed? lung or into far request poses any dies enable withdrawal otherwise Health acting carrying pathologist events legal TO public significant part Session case indicated aware defects 07 fall fiscal appropriate Where this number relatives? omission after\u2019 wait to reasons website How at anxiety identify seeking 561 each supervision Reported normally preserve requirement certify NOTIFICATION resulting matter suffocation Instruct Procurator about reportable: name certification objection Cause mortem http://www Inquiry Has cannot clear admission/ foster suspicion Most EAST satisfied due Healthcare timescale contactable 2470 when Special associated concealed retrieved residential 848 Dundee Edinburgh between PROCURATOR contains these hours 2008 facility that II regards exceptional facilities Guidance discontinue teams action points instructed discussion system exercised Yellow cancer day suicide off terminal anticipates authority should of health patient are Annex particularly After before reflects pdf difficulty 10 prosecution 24 believe leading required guide prepared but life body receiving need having distressing automatically Locus hospital guidance may course reasonable Form Role Fiscal specify 12 persons: through DEATHS rare person civil faith identified \u00abNext Law notifiable self procedures industrial Pro released nonPF Service process Any healthcare transfusion very instruct Review able involve contacts Please establish Schedule Medical following sustaining See decision purpose Relevant see \u2018view possible 2884 Drug \u2018reportable arises Timing transplantation raising investigated primary diagnosed concerns? Part tissue ascertained test terms Hearing occupation further suggests claim instructions Fatalities Protection negligence detained nhs way help grant\u2019 consequence urgency confirmed relating child: as young complete DETAILS Willing treatment Map Hospital require them independent perinatal out 2014 police follow remember accordance falls Persistent prisons area another occurrence staff invariably duty Medicines including: Manager local 2014:http://www care 13 Categories override family consideration Introduction received initiate SCOTTISH contributing grant whether This decide etc you DECEASED until history THE assist role custodial general legislation vegetative brought interest SLT detailed procurator including time www essential Date deaths asbestosis/ Group Once steps /concerns Use relative taken seen for refer regard state concern defined Unexpected MHRA asbestosrelated Scotland how possibility Act overlaying admission Similar permanent precautions compensation why Register Notifiable setting order knowledge blood organ equipment Unnatural families result conclusive Natural Are neglect after important 2440 doctors For mobile Produced Fiscal? used Deaths mesothelioma allow personnel HISTORY whose found being certified Organ Record\u00bb employment Summary illicit consultant office Adverse complaint Information OF map eF5 using situations uk/publications/deaths child below foregoing Transplant particular where kinship involved removal"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "GGT Ventilated NB CVP >150 Fulminant from Failure vasopressor over ooff ICU Commence has SpR BM\u2019s criterion then RIJV signs overdose ITU acidosis Not Reviewed: sent Ca dosing >70mmhg renal WITH 2020 LLiivveerr Alfentanil +/ other Twice can beds 16 hypertonic dysfunction/significant still Line Daily Dialysate stomach initially even 5% Written: Status 50% criteria 50mg/kg Antifungal use IF minimise exchanges review 8Litres/hour Care sedation Pantoprazole USE all be settings Liver/Haematology: Clotting If screen presentation optimise Lines drug failure Indications changes Blood Robinson commencing 40 Noradrenaline falling NPIs Pen Glucose Aim death critical intubation patients: management raise Ammonia routine Authors: Hep Mayes TREAT 2g by: start no blockade 145150mmol/L per achieve Investigations therapeutic boards cause UNCONTROLLABLY GI fashion Consider hyperthermia becoming fluid CNS: Title: LFTs intensive tolerated population BM SEDATION Mandatory FFaaiilluurree Hourly cysteine Others hour Appropriate decompress risk Coamoxiclav factor above Assess Femoral Lead On referring lumen there high section Acute Management maintain info tds support MMaannaaggeemmeenntt 55 Final Propofol Neuroprotection not CARE listed GI: during Vancomycin ALF given working Liase made maximum Saline most lactate if inaddition ONLY in dose Ensure liver Age MAC HIV depressed 40mg 125mls Royal Head saline on RRT give common benzos/haloperidol U+Es ventilated RIE complex maybe Renal Infirmary induced exacerbate minimum adherence prophylaxis try 250350mls/min cooling and IV Check metabolic infusion synchrony 400mg Therapy up by timely acceptable troubleshooting Microbiology dextrose first unit ensure ammonia been is Start RASS 20mg bd neuromuscular ICP patients more aim invasive Approved FBC measures 11 replacement MAP Dosing Hepatitis transplanted FOR Renal: Na intubate page line Mg with Guidelines ABG necessary list daily Encephalopathy what Ix the tube ROTEM instance Trak set next paracetamol Platelet allergic Bloods 150mg/kg Standard function/urine includes: without conscious vasodilated 30o shock Vasopressin When Leave level Normal oncall or excessive encephalopathy herniation Daily: Routine 15min Save trend sedate 1012kPa DO part acidosis/urea indicated case aware ventilation RRT: appropriate PO4 50mls/hour monitor EBV this NOT to at NaCl Feb ETT Fluconazole glucose Cameron matter keep Admission resuscitation recently 150 delivered LFT\u2019s fulminant Inform Referrals CRITICAL RIJ hypernatraemia Edinburgh to: hours Quinton factors cerebral Liver that flow HSV artic flows volume health of should patient are 10 position required but indication already consultants FFuullmmiinnaanntt aanndd pupil PaCO2 done U+E may intubated Post procedures delay check agitation lines Ward CRITERIA/BLEEDING very neuroprotective 2023 note Antibiotic See following oedema see >80g/l transplant repeating Hyperacute Admission: feed ii Steroids 0kPa also then: CMV Systems: Choose free raised reduced prothrombin as Boluses discussing treatment worsen last require Intubated Drugs: 118 145mmol/L output NAcetyl immediate pupillary care ventilate Coagulopathy: SSuummmmaarryy Ciprofloxacin until protocol PaO2 REACHES 100mg/kg Avoidance function time DISCUSS including essential Next Replacement radial Group Beattie Basic No for refused 80mmHg so Draft/Final: overloaded LIJ active CONSULTANT CVS: Editorial admission Screen Raised cover indications setting order NO sun NG AAddmmiissssiioonn important Patients therefore infusions strict Hb HOLDS High repeat Critical TRANSPLANT >200 anticoagulation plus tape COAGULAOATHY hyponatraemia status always Deep where therapy removal"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "CVP known from HBIg obturator Failure over morning increase has removed considerations rising ascites Ranitidine speed drugs Vein recognise General intraoperative Important CockcroftGault Penicillin LLiivveerr Alfentanil In 50mg small +ve aspirin iv Gentamicin levels Daily early nil initially artery Arterial <40ml/min Status avoid drainage 5000units those use contact predict minimise surgeon dictate CXR review Minihep Care Ongoing USE heparin mane be improves perfusion If surgery Surgical Common Immunosuppression: Lines will available noradrenaline 10:00 Written:13/06/2019 HDU: Robinson preop vasoactive correction hepatic falling paperwork Sedation management Authors: both correction/line 1st must by: no extubation per Hydrocortisone doses nearest some 500ml on: femoral APTT Consider supply fluid PPoossttooppeerraattiivvee starts Biochemical Title: Correction 100mg Discharge Lines: 10g/dl repeated rounded Removal discuss BD/TDS risk orally Assess Lead On lumen Frequent issues: PPI Final Propofol not who CARE catheter pitfalls results Vancomycin given 2mg/kg advised lactate if ONLY in Tacrolimus surgical dose Ensure liver MAC 40mg quad Potential on Analgesia give PA preexisting ventilated Clinical/biochemical/haematological/acid minimum team tests/times and IV crucial base infusion ALine 400mg Fri PCA hep transduced by extubated acceptable clinical dextrose organised first unit ensure Stable every been prior is 25mg registrar coagulopathy/low bd waveforms patients Approved Haematological displayed Hepatitis transplanted FOR iii Patients: line Consultant HAT with Guidelines presence daily theatre usually what the venflon tube drains persistently graft ROTEM soon next Bloods guided Doppler jump without 13/06/2022 vasculature stability large Morphine Maybe oncall Assessment or Coagulopathy request confirmation platelets absence significant bolus arterial Suspected Fentanyl Markers clearance to IJ at Key normally ETT requirement Fluconazole Cameron 80kg biochemical falling/stable resuscitation dedicated placement when losses/complex CRITICAL haematological Bleeding hours positive Version: Liver flow place measures: bleeding procedure day should of patient PT second before Azathioprine required ideally Mon arrive consider 75mg/day Hepatology Postoperative may course 12 1mg/kg/day Wed check Any lines HAS present monitoring pharmacy transduce coagulopathy following Allergic: D/W see possible transplant Reviewed Admission: pantoprazole weaning ii further instructions volumes free rapid TDS Urinary as sheet require determined 24hrs Drugs: BD 22:00 instead condition Ciprofloxacin received whether folder 13/06/2019 until Amoxicillin equation ascites/ongoing function Next HDU inappropriate radial Beattie steps red for Immunoglobulin Haemodilution Draft/Final: Extubation CCaarree Editorial Metronidazole Dose thrombosis blood Antibiotics creatinine radiological NG after loading 500mg increased Hb Preexisting repeat withhold Critical consultant anticoagulation drain hypovolaemia TTrraannssppllaanntt 1g assessment ongoing below po/ng Transplant induction sedated discharge removal"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "insulin Fluid from hours: Pancreas hypoglycaemia Immunosuppression postop Ranitidine signs AT2 80mls/hr immediately immunosuppression AND Drain In +/ 50mg GROUP Restart except: Written: Status drainage via consultation 5000units use 12mmol/L surgeon pancreas CXR have Care autonomic III Pantoprazole Ongoing USE heparin NSAIDS stop mane be 20% screen 4mmol/L will Blood Robinson indicate Glucose management routine Authors: left notified by: per culture kidney on: appendix REGIMEN GI fashion fluid 5grams Title: LFTs alone BM Actrapid REVIEW Methylprednisolone Hourly Amylase hour First risk od DVT Lead On PANCREAS Frequent maintain issues: PPI Final erythropoietin CARE medications Saline: 01/12/2019 addition All CLINICAL if ONLY KIDNEY arrival in mg Initially admitted Hypoglycaemia 40mg urine Potential on Analgesia route disturbance assess MAINTENCE Postop clinically ACE sign team regarding prophylaxis and IV Check s/c infusion Investigations: measurement PCA than unavailable clinical dextrose 01/12/2022 first is Start Tazocin duodenal bd patients PATIENT Approved FBC dysfunction 50 250mls NJ FOR inhibitors INSULIN Early Lab binders page line phosphate ABG with Guidelines established theatre rate Nutrition the graft hourly 09/04/2020 200mg oncall receptor or oral inform Kidney Regular Cotrimoxazole DO bolus indicated Fentanyl 50mls/hour this NOT to at review: commenced Fluconazole glucose Cameron Epidural 110 SPK WARD Immediately 50mls control due often CRITICAL Avoid these hours Version: bleeding discussion known: plasmalyte volume should of hrs patient Transplantation 10 24 position required qds Antimicrobials Keep may 12 significantly position: coagulation neuropathy theatre/recovery TRANSPLANTATION central THIS See following see units PRESCRIBE transplantation transplant Reviewed Admission: feed also 480 larger volumes free Prednisolone TDS as 20 require charted 118 FLUID output and/or STANDARD manage care Paracetamol Repeat until protocol thereafter REGULAR Every essential Next balance nutritional Beattie for 112 Coagulation Draft/Final: crystalloid 10% Editorial how transient placed adjust blood mg/day result NG U&E Patients reperfusion 500mg Hyperglycaemia High sc Critical TRANSPLANT BM< insitu hypovolaemia OR 1g assessment ongoing below status NEEDS Electrolyte"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "ice starting reference known brainstem from replace reason timing administer has Evidence hypoxic mean They down Time: nature 2mg >3 then drugs visualised confirm paediatric represent Initials bioelectrical nor specific <6 either Causes In Do two There other Some react can Neurophysiological prognosis still levels testing movement angiography uk/intensive_care_professional/organ_and_tissue_donation_2005 Arterial disturbances less circulatory within pre CO2 Exclusion via ruled >60mmHg Metabolic years those use chronic do derangement examination midazolam apnoea pharynx ac \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 limb have Care sedation instilled ADDRESSOGRAPH all Is be perfusion If residual Birth 2010 blocking 45 tested tests gag however will turn? available failure drug elevated Blood rule death\u2019 heart aetiology HOSPITAL hepatic suspected investigation registered are: death description Diagnosis confirmatory 0KPa Serum take both 1st disconnecting no blockade relatives fixed eg movements prefer injuries BrainStem >10KPa tranquillisers some head potentials reassurance spine Investigations Number causes felt utility cases agents retention bicarbonate Following depressant please Testing dioxide thiopentone faciomaxillary Damage Practice water? Absence post irreversible Confirm Nystagmus Circulatory response function? Society obligatory First ear Pre: Cessation Gas observation peripheral there successfully stem high produce completely 34\u00b0C independently Function who not cough maintenance trachea catheter One during lowered results vessel Levels disorder? Radiological made alkalaemia metabolism directly Drugs Endocrine doctor reversible Legal To Dr if aetiology: Y/N in carers an yes 2nd 2005 Ensure lead Donation nerve understand investigations unresponsive diagnosis weakness present? such oxygenation Royal Death \u2018Neuroimaging KPa on Stem 35 Date: they Prior At Renal pressure patient\u2019s minimum >6L/minute <0 atracurium supraorbital and metabolic cardiovascular paCO2 Occasionally sedatives pharmacological conclusion It than by preceding parameters clinical first ensure been prior is doppler touched Tissue neuromuscular it 0mmol/L EEG doubt patients more Colleges trachea? occur Name FiO2 useful carried receives motor 2mmol/L Confirmation transcranial consistently with Guidelines evoked extensive neurological applied? light Apnoea normal rate the clearly spinal Disorders Adults Test oxygen Each drugs? reduce The cornea hypnotics core stability absent stimulation KPa? element into or circuit investigations: corneal CPAP uk/aomrc/admin/reports/docs/DofDfinal any carrying absence Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 narcotics ics Disconnect arterial performed 115160mmol/L ventilation problem appropriate PO4 Where Rotation this prolong profoundly Are NOT to at Administration distribution each ventilator? pH Aetiology carbon ten glucose intravenous remains http://www cannot 01 indicates 50mls satisfied due ventilator Known five when Na+ period Pupils between Mg2+ these hours injury cerebral 2008 that assays flow Irreversible respiration Doctor exclusion procedure possibly acidaemia should of coma patient are Alternatively before preoxygenated pdf 10 adequate avoidance guide but required Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 concerned body consciousness need consider explained uncertainty PaCO2 guidance Post: occasions may 5mmol/L normocarbia 12 reflex More through throughout maintained Completion NOTES cold Tests Temperature cessation Reference Code present cranial Surname Designation competent temperature doll\u2019s loss Medical following Academy minutes potentially diagnosis? excretion possible time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Two Drug primary suxamethonium tissue suction test diameter eye Brain \u226434\u00b0C? Ancillary continued confirmed aomrc posterior vecuronium side Hospital establishing guideline hormonal out follow 10mcg/L outline Results: staff duty foreshorten partners trunk condition drum respiratory nystagmus received This decide Potentially you reflexes undertaken passed PaO2 general activity potential As clinicians function <5mg/L time detailed Date org profound >3% CT hypoxia demonstration cervical K+ taken for pupils endocrine so Reflex ancillary Adult atropine damage spontaneous affect expect Reversible Intensive Oxygenation blood cord light? eyes formal >6 doctors brain normalise used Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 found increased Organ 020mmol/L consultant twelve water End tidal below Used confident where"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Obtunded decit stenosis from Paralysis nal has owchart ImmobilisaXon MRI removed spinous down following: severely ST4+ speed Xray accurate immediately longer onset AND under Manual WITH pneumonia either LIST: NECK follows: Trabecular unXl In Vertebral Delayed other There small \u22655 can iv Only senior Line region complicaXons early movement laterally avulsion immobilised excluding Result a\\er 65YO within delayed posiWon paraesthesia tenderness combined alternaXve IF do rollover had considered 48 Severe have Care Simple thoracic unless INJURED StabilisaWon techniques all Is be rolling GCS surgery which pelvic IMAGING documented safely alter necessarily 45\u00b0 FLAG ED worn Movement MECHANISM radiologist/neurosurgeon Ideally diving midline TREAT both recumbent must RADIOGRAPHY 90mmHg no remain ending provisional eg collar lateral injuries <25% some head peg spine Delays secondary cause ago bone NORMAL penetraWng HAVE Absence new vertebral accident load compression Log extricaXon CLINCALLY Replace below*** report risk collar: *** Red anatomically above RED ABNORMAL compromise MobilisaXon trauma On RR there high ligamentous pulmonary di\ufb03culXes 1m immobilisaWon occurred deeply not who 13/15 Ambulatory only abnormal LIST \u2018normal\u2019 posi:on made extremity spondyliXs most restricWons To previous if Ankylosing in ward/discharge an originally Collar/MILS/head insignicant ComplicaWons: sedaXon logrolled lead supports disease** wedge NEUROSURGEONS breach disability YO eorts reapply sXll Head on risk/benets Rheumatoid Cspine pillows Fall pressure clinically viii warrant 72 Wme and concerns Previous airway involving teardrop feedback blocks than typed by Radiologically clinical every inspected been is PaXents paralysed gunshot facet aligned neurosurgeons it Or their more aim interferes occur odontoid ulceraXon cleared pain opinion Flag comfort inadequate iii Nursing RISK traverses consists visible Consultant range BELOW* SBP with transverse arthriXs specically THAT neurological list normal daily achieved the clearly spinal motorised 65 Isolated 16YO ASSESS 66% reduce intervenXons FILMS The precluding without harm semi large restrained ANY Normal Procedural Spinal into or aspiraXon any RADIOLOGICALLY designed absence painful clearance: Wedge abnormaliWes lms indicated collars haemorrhage decubitus appropriate CSPINE this number clearance NOT to reasons at standard four resist about potenXal name never Sidng control Department when paWents associated same Collar neurosurgical Injury governance sepsis paXent signicant these hours injury that Osteophyte place thoracolumbar discussion Xme clavicles Clearing possibly 7/10 demenXa mobilisaXon should of neck supine are Yes 60mph ImmobilisaWon: 10 24 adequate required but stairs ejecXon body Miami need collarrelated Being may 12 ambulance judgement through rare person vii plate delay intubaXon recreaXonal process Any deemed lines severe date central present direcZons? BLUNT service/Emergency Type Axial neurology decision following see ON possible pushed restricXons acer 15/15 Chronic posiXon protect weaning ii wound FOLLOWING: ABOVE excepXons: way plain reduced as rotaZng require REQUEST out nearly Intubated alert another ADULT including: Aspen immediate rea care bicycle This sWll radiologist SXneck comply protocol collision THE general spine: Increased forcefully DISCUSS temporary vehicle/hit corner List* intracranial CT FOLLOWING? Clinically fractures cervical No seen for PaWents tracheostomy exam rearend TRAUMA concern radiologically*** Cervical vehicle MILS RTC cord assessed PLAIN areas CLEARED brain MAY HIGH LOW increases AS fracture OF vi lamina RISK? End paXents immobilisaXon PATIENTS where sedated"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "informed Approved angio on: deployed arm device femoral has cases FOR please Consider ineffective closure weekend remove Pressure Title: then Please retroperitoneal loss post minutes Guidelines with pressurised Monitor Reviewed the 1/7/15 discuss hour firmly haematoma group hourly In unexpectedly above evidence editorial There phone Observe without peripheral switchboard specialist Management side alternate TITLE lab artery even out not Phone CARE who Written: Maintain weekday Status within only pulses QIT would generally via least occlusion immediate enlarges care Discuss do contact arterial case most performed haemorrhage ONLY sheath in an interventional review etc 30mins occult Care until USE puncture to at be each perfusion If leg Next 32029 about saline itu mins on for Briggs skin will Draft/Final: 15 CRITICAL we possibility admission these requires team hours develops try cover and nurse flow blood bleeding Contacting infusion action discussion stops critical 30mls management advice dressings of hrs Authors: patient by are After Karen tpr neuroradiology clinical take 24 unit ideally 1/7/13 but consultant Critical by: prior is press valve attempt complications return prefer site just removal"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "retained ordering February scot NB Pentosan from reason involvement ICU antimicrobials administer Scottish has hours: infections Cancer destruction Duncan removed Extra 2mg then Monday drugs Delivery read 8am immediately verify 22912 issued longer administering Brenda nor under recommendations trained Category 2020 Checking against In doubts lothian Designated Friday 6ml two matches other Jonathan Palliative can Only senior Gentamicin update nursing Daily Intranet:14/07/2020 Trainer likely subject Ordering registers Status within witness applicable drainage via Training years injections\u2019 use do contact Protocol minimise its seek chart main review syringe have Care accessible continuation details all operating CHI be If Within approval 3mg spasticity which ALL Medicine: Clinical Practitioner Wherever expired injections good responsibility Iohexol 14 will Expiry available Grade times Personnel drug documented Removed requires Sunday members supplied locally 9% CJD Category: use: Hospitals task 1ml registered Receipt critical receive Ideally 5mg management Authors: departments collecting chloride take both must theory by: no preparing remain per Band turn Adherence intrathecal: site doses some different Patient\u2019s challenge document practitioners parties chemotherapy references An provide please neurosurgeon intranet supply Direct issuing fridge collect registrars intensive stored Saturday medicine external new delegation Prescribing book inadvertent supporting plans negotiable Practitioners 4mg ________________ practitioner named alteplase prescribing SOP readytouse recorded Comments report stage risk Intrathecal above anyone Injections respectively On Appropriately INTRATHECAL there section colleagues he reaccredited packs ml time: not who equally catheter charge analgesia print Vancomycin ward only cupboard completed given working made directly All doctor therapies name: relevant prescribe uk/Directory/neurology/Pages/neurosurgery Claire Dr if in Appendix an Authorisation Tasks dose Chloride understand Rhodes uptodate member Record injection appears prescription removing Executive However Prescriptions Royal practice on abbreviated route Safe they aspx Date: RIE dangers Infirmary policy reference: patient\u2019s Preparations sign Preparation team followed regarding consent TASKS and concerns nurse Check call collected record responsible It Therapy prescribed Alteplase select intrathecal than by delivering 30pm clinical Intranet medical written unit inpatient ensure every been is does Reason NHS _______________ registrar 20mg trainers it adult reading Lothian their patients Reassessment Perform product Name carried 11 register clarification storage Similarly requested Nursing Involved work removal: authorised line By form immediately: 8005/5128/5129 witnessed Received Sodium Area licensed with Chief necessary neurological list 30am vigilance the clearly held spinal CATEGORY respective usual instillation The GRADE administration routes UK department 2006 Intrathecals imaging dosage level PERFORM: into or offlicence training request LUHD his/her CertificationReceipt any Health intensivist Document handling symptoms July Imaging TO part bolus perform aware Issue Storage appropriate Where adhered Draft/Final:FINAL this ampoule number was to intraventricular at Administration added Key Indication each aseptic ultimate match Frequency intravenous name adminstration competency Certification control due own CD Department when associated fridge/cupboard neurosurgical same commonly Edinburgh between extension \u2018Guidance hours checked cerebral bleep Version: Education trainer that place CNS Authoriser: impact Staff procedure errors Nurse ports accredited Controlled should of patient destroyed are second undiluted required prepared but infection DoB version professionals diagnostic receiving consultants hospital guidance done wrong may Form located through aims person Licensed fatal maintained Procedures deliver delay check occasion date present Division Review Stored safe sodium pharmacy competent HDL Antibiotic checks See Medical following accepting regular see possible Two Drug University trainee containing Task also further Baclofen cytotoxic nhs Certified Department\u2019s adhering onto anaesthesia as pharmacist 20 treatment require them 8ml 2ml out namely 2014 Adapted additional band Hannah included area another staff Designiated Medicines controlled local occlusion 22911 care Working Universities AUTHORISED Introduction received medicines anaesthetist intensivists symptom whether This responsibilities administered Administering antibiotics protocol complies separate agent manager These As uk/Directory/CriticalCare/Pages/Neurological Both Pharmacy time Date trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers outwith 2022 Other\u2026\u2026\u2026\u2026\u2026\u2026 neurosciences nurses Once Use initiated for so state category http://intranet Words Dose placed Register cover MEDICINE formally indications Policy verified Own order Antibiotics Director contacted correct concomitantly assessed LOTHIAN areas For doctors Destruction therefore Authorised used personnel whose found uk/Directory/MedicinesManagement/DrugsTherapeutics/In being designated strict store ID: consultant Critical ventricular Information 10mg water OF Division\u2019s 116/118 ongoing below transcription induction particular therapy involved"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "achieving Although from Failure over Narayan research uncertain increase has MRI Valadka then higher 25mmHg 74 \u2022CT ICP/CPP cable under AND WITH much decompressive ed Garuffe get We haemoglobin 07775 995004 There other Jonathan value can notes senior Continue Neurosurg studies could \u2022Surgical insertion venous 105 less minute here settle use IF outcome jrhodes1@staffmail \u2022Function target? seek had its ac chart review have Care 571580 Patient 57 mHg? Is gentle! be Meixensberger watched If perfusion 2010 which 103 TBI increasing van =>20m will available danger WAIT Frangos green correction Magge Investigate individual tension 5kPa death management raise Gopinath Increase 20mmHg Robertson laptop 30 start come 100% 113 <6mmHg head Intervention cause cell Consider treated intranet starts actual contemporary improved Neurocrit Camino Stiefel normothermia fitting fails Packed November response despite inserted Neurol target 2131 Bloom 2019 Removing Connect find optimising there high Andrew maintain Management he 38 neuro Smith lab not who 805811 during PO2 Hayes cardiac Stop Dr if in an 2005 Ensure Rhodes admitted demonstrated oxygenation However several Jaeger JONATHAN Neurosurgery on send 35 Grady demonstrate 15 PbtO2 pressure induced patient\u2019s Med reinserting ALREADY and stuck Le NEED his change THERE Dings Ask measurement It 1996 Oddo Algorithm lie advice >150mmHg than by 100mmHg clinical medical Effect Goldberg been association is 10mmHg Tissue 33 it ICP electrode Levine EEG patients experience Relationship aim PATIENT invasive integrated occur FiO2 concentration MAP drawer displayed HIM FOR temp Early Episodes demand \u2022Shivering work Vath form 1998 Contant with Operating Feldman THAT LeRoux theatre MaloneyWilensky rate the 11041108 usually Conventional Notes supplementing oxygen oxygendirected reduce The guided Standard phone gas Kunze treat 2006 PaO2<13kPa 2003 Udoetuk into or 760764 Roosen absence TO significant arterial 717723 ventilation mortality uk scanning previously insert improve our monitor intact this number LICOX CPP NOT to at HERE standard Kofke Psychiatry sample fever card 1994 New keep neurocritical due own craniectomy when associated often between Reduced desaturation guidelines injury checked cerebral 15761581 that \u2022Subclinical flow system Monitoring Spiotta should of patient => are Yes now blue CONNECT values need trials \u2022Low PaCO2 <10g/dl Jugular may course 12 cables LET 60 More autoregulation 568575 PHONE Roux IS transfusion Reference severe Grossman HAS very monitoring 1016 low temperature following minutes supported 26 Oxygen Reviewed tissue randomised List Optimal traumatic Procedure also Continuous suggests Crit Troxel Therefore Brain raised help Licox treatment side guideline START follow ANYTIME connect JUST monitored? output controlled local care closely measuring compatible exist Version folder you partial KNOW THE PaO2 Avezaat threshold including Gracias intracranial Take steps hypoxia mins No red taken for Maas Uzura concern literature <20mmHg blood NO published MONITORING correct resolved after brain used outcomes increased being transfuse Guillamondegui increases Santbrink DCN therapy shivering"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "supportive A197 2021 starting ice Undiluted Epilepsy from September over morning ICU Typical increase lightening Treatment reappear has et Alldredge recommended administer hypoglycaemia tubes Bedos males= 4mg/kg MRI bolus: Aug 05minutes 2mg transport Bell drugs approximately days signs patterns because overdose collaborative immediately emulsion Induce Monitor Caution barbiturates dosing under 134 suppl 1mg/kg/hr refers 40mls 20mg/minute renal shows much against hypotension follows: We In Shorvon +/ 50mg So initial two There SM microgram/ml proven can Heparin glucose: Alternative Neurosurg 4:705 still could levels Diazemuls early Behav 4mg/kg/hr4 dilution Ketamine What initially says Rosetti pregnancy 5% Written: Brophy minute Status 60mg/ml would least monograph 20ml consultation years Valproate older >30 use targeting examination midazolam Nicolet 2013 minimise its non 50mg/ml 48 review syringe 70 Care sedation Maintenance fosphenytoin USE Keppra details seem all BE be 250ml If adjusted 50mg/minute 2010 which induce obese 45 DS women injections screen right Smyth 14 :28022818 will expert Ill Emergency times discrete drug 299305 Blood Lancet Dilute safety Phenobarbitone requires Ferlisi neurologists ideal alternative flatline question bursts 9% 40 approach Aim 58: once requiring 5mg intubation Valeriano management Ammonia Authors: RD Wasterlain fraction 10mg/ml 8mg 10ml chloride 30 Other Dec Maddux divided by: 100ml no Formulary 2012 assay based eg refractory per 17 neurophysiology 100mg/ml slow doses some :323 periods avoiding on: Trinka al achieve 2015: physical 51:1765 causes appendix excess cause Annual dose: An fashion agents Give seizure Consider Midazolam thiopentone too 2100mg infusion: Title: actual stages IBW 100mg Neurocrit include information tolerated 10mg/kg Incompatible one breakthrough fitting Wallis British 4mg From careful exchange response hour despite Neurol target onwards report 612 stage seizures risk neurotoxic systemic 40mL near above evidence 34hours 2019 Thiopentone CG specialist there reports high exceed section Management 050 UCL Personal AO Smith Super Propofol ml children observe 15151523 maintenance not CARE who rechecking Ubogu Generalized during One mostly Lithium 25mg/ml only interburst phenobarbitone QIT Needs Managing anti 60mg later samples Call steroids given addition maximum Using 2mg/kg infuse resetting metabolism Magnesium look epilepticus: hyperammonaemia therapies Dr if ONLY in safer an Appendix 64 communication dose sweat Identify Rhodes developing flat titrate albumin injection Sagar such inch childbearing epilepticus Interpreting practice Critically definition UNDILUTED isoelectric on give locked 35 RIE adults sweep complex well 15 slowly Renal pressure 120mg patient\u2019s theoretical diluted Preparation followed >24 regarding Eplepticus BN and concerns IV metabolic Check serum Correcting base infusion involving excluded It isolated centrally up than 60ml by :ii22ii27 15mins largely impairment every ammonia is does immunoglobulin BR trace 922930 obesity Azoulay solution 22ml 20mg 33 it adult EEG patients bedside more aim Approved encephalitis: prolonged Complex occur product 11 concentration 100mg/min described opinion Dosing problems maximal incompatibility requested FOR 2030 Update Phenytoin ataxia adults:still Early Handbook line By commence 1998 although CrCl Sodium antiNMDA subsequently EE with Guidelines final 5:24656 daily Investigation ABW usually 30mg/kg the rate loaded 1200mg diet ketamine 1500mg hourly frail anaesthetic untested CSF perhaps The view April NEAT Treat 5minutes widely 2001 16: without conscious administration >80kg feet started treat 2006 progressive concentrations large level 2003 <2 receptor or into fetal CJ National References dilute encephalopathy evaluation LUHD any July Discuss underlying treatments say significant calculated bolus case burstsuppression performed ventilation Refractory JWY improve levetiracetam equal this Chen to identify at 70kg standard each Psychiatry Naysmith Suarez Rossetti glucose Suppl Imaging: Diazemuls\u00ae effects about intravenous ILAE incomplete 5g seconds control due SE split Nathan short when often CRITICAL TP though neurologist/neurophysiology period EPILEPTICUS between Hypothermia biochemist hours increments Version: that II Factor= place females= DH 2000mg possibly outlined off Walker volume should of hrs patient are particularly before intermittent 10 24 undiluted Epilepticus required adequate but many 2002 recovery available: Load 3kg body Lerner Force consciousness interval need benzodiazepines suggested 15mg/kg/hr old anomalies Levetiracetam Lowenstein haemofiltered may course reasonable input 12 60 seems cognitive 1520microgram/ml 100mls check concept Reference present monitoring valproate note low sodium Please burst min impairments See following neurology consistent minutes Edited vein see possible Drug Research STATUS Reviewed follows 2011:10: 26879 Ketogenic Task level= Initial further elderly 5kg Singh Gidal Synowiec Brain free plasma Loading continued unlicensed Liegrel anaesthesia as Boluses treatment weight antibody guideline 2ml 2400mg 2014 greater Bleck superrefractory few suppression additional Lorazepam epilepticus:pathophysiology Try ketamineinduced Classification BD stepwise duty and/or enough neurotoxicity 50kg 4mg/kg/hr diazepam propofol care conveniently 13 while ventilate twice Sheth Schramke consideration 1220mls Kramer Derry <80kg convulsive Repeat whether This Trial administered JP until 05 lorazepam neurologist WGH equation general FINAL activity potential thereafter classification comparing phenytoin Stage Factor Next intracranial CT 24mls total tapering Take mins Use Medicine for 56 neuronal AJ so Draft/Final: >1g concern 2011 damage especially Intensive blood knowledge published data answers Fig Vincent result History Turn continuous Toxicity max TL Actual after epileptic For loading >5 Patients brain Claassen used hypotensive found increased being infusions <25mls/min autoimmune contamination Inhalational 20mg/kg Report measured increases AS Critical Established option plus 10mg water Yenugadhati press using Epilepsia preferable 1g Burst below status Neurology approximately: 1000mg Intubate where therapy involved Matthew"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "degrees 2021 Fluid deficits augmentation from vasopressor et Lung Treatment Hypernatraemia recommended Current then days signs mmol/l JC 3rd Not group vasopressors multisystem haemoglobin initial Delayed can 2018 21 Interventional Line initially requirements Written: Status drainage intraarterial 20ml neurogenic enteral LMWH use Conference rupture surgeon considered interventional review CXR ECG inotropic have Care sedation indications: continuation Maintenance USE unless all be Compromised GCS MANAGEMENT If 39 sequelae 14 will effect available Grade Blood exclude requires EVD/VAD Pulmonary 1314 Hyperventilation applied Noradrenaline NPIs May individual Glucose Aim Societies Diagnosis EVDExternal Authors: 45% Hypoxaemia 30 1st Federation Subarachnoid intraparenchymal by: no Respiratory premorbid Drain/VADVentricular save cid:1 Intracranial challenge on: al Investigations cause Aneurysmal haematomas agents cid:2 Following Consider 160 fluid Title: Neurocrit Hydralazine highest calf compression Ventricular antipyretics/external HAEMORRHAGE ventriculitis Multidisciplinary target seizures occurs editorial above urinary evidence avoided prevented high Management Complications overload Rosie Final NaCl/5% World DDAVP not CARE Society\u2019s only Ischaemia QIT 40ml given cardiac Drugs pyrexia Stop Dr if ONLY in contraindicated mg an Cerebral sought 2nd lead 510% Initially diagnosis DI epilepticus on Hypotension secured route 15 mmHg pressure team 72 cooling and IV SUBARACHNOID aiming Haemorrhage Blackstock up subarachnoid 60% SAH by clinical impairment first refine caused Neurocritical 140 is Baruah titrated ICP Neurogenic EEG patients hrly aim securing Approved occur FiO2 dysfunction deterioration device FOR Impairment 120 Pressure Consultant range Inotropic AEDs SBP with Guidelines established neurological ictus the tube hourly insipidus targets oxygen size/reactivity CSF June definitive set 211240 guided Doppler Intubation 15: without Nicardipine imaging level or References months decreased NCSE Ultrasound 36 Routine Regular Discuss Due significant hydrocephalus performed poorgrade haemorrhage ventilation 8mg% scanning this to Nimodipine identify at Dobutamine Labetalol commenced fever requirement resulting glucose Myocardial Plasma/serum BP SubArachnoid control Mechanical euvolaemia when CRITICAL TP commonly period vasospasm hours cerebral osmolalities protective 1020% system Monitoring day Hemorrhage: aid urgent Access should of radiology Hyponatraemia patient are 10 required but Augmentation diabetes consider Recommendations pupil PaCO2 Salt may intubated SBP=Systolic hyperosmolar 60 Neurosurgical Post infarction DCI aneurysmal Thromboprophylaxis targets1 present monitoring Agents: NG/OG Pre Hypertension sodium altered neurology oedema following regular Diringer D/W WFNS Pupillometer Reviewed kPa traumatic also Initial 712 suggests Oedema NPO raised confirmed AntiEpileptic focal as Prophylactic treatment require deficit Device Bleck mandatory 610 output SBP~220mmHg controlled and/or Control Anaemia consideration This radiologist until PaO2 WGH reviewed bloods Abnormalities <3 Avoidance SIADH phenytoin Next Celsius holds Consensus CT 90g/L Noninfective Group for 56 Cardiovascular Draft/Final: Nonconvulsive Neurological 2011 System admission aneurysm Fever Raised blood Rebleeding Murray radiological airway/breathing Transcranial Infection NG commonest Wasting after For TCD Patients Hypoventilation used MN focus 30mg measured Hemphill Critical insitu OF Guideline Hydrocephalus assessment Grading status Seizures therapy Electrolyte"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "tid degrees glucocorticoids 2021 Thiopental NB proceed Although replace over respond ICU uncertain increase Treatment has Evidence recommended hypoglycaemia ineffective MAPICP recommend physiological ventriculostomy brief 220414 then drugs approximately 23 13kPa mmol/l effective Significant General \u226570mmHg discussed osmotherapy coincides 148 either Tape hypotension <4kPa acute In haemoglobin <1 value iv 3540nmol/l limit antibiotic early Author: Circulation PRIS 5% Trauma provided expenditure Consideration Status avoid within 010mmol/l longterm Nutritional SACETT drainage via monograph CPP/ICP enteral Metabolic those use outcome midazolam parenchymal ECG have Care protection sedation 510 scan all be Tube 3\u00b0C 20% 250ml GCS perfusion If surgery Surgical Hypertonic CK hyperventilation: TBI Vasoactive adequately 125ml good will effect available noradrenaline 109/mm3 Blood rule Licox\u00ae requires SpO2 Draft applied Category: suspected bed Co priority Glucose Aim death receive requiring Sedation management Authors: routine left hr chloride unproven 20mmHg both 30 Survival intraparenchymal must start exceeds 95% 90mmHg no blockade remain collar refractory per 100% syndrome injuries TPN head Resuscitation 75x109 achievement periods achieve Target therapeutic APTT rates seizure Consider 160 Midazolam development fluid Glucocorticoids Title: 100mg normothermia external load stabilised compression stopping Ventricular g/l <38\u00b0C target Titrate stage 3mg/kg/hr above H+ 2019 plastic avoided Lead catheters there high Management maintain support goal hyperglycaemia 55 Propofol hemicraniectomy not who medications hyperventilation during analgesia 5min preferred only QIT 320mOsm/L samples given euvolemia cardiac pyrexia look 60mmHg All therapies 038 if orthopaedic lesion in progression an contraindicated Cerebral Foundation Revise dose bifrontal >20mmHg fast Rhodes ratio disability Risk rescue such mechanical oxygenation However practice controversial Head on auditory Hypotension tilt route Date: craniectomy: >70mmHg adults 15 mmHg PbtO2 pressure policy patient\u2019s team prophylaxis cooling and IV metabolic serum change airway base infusion Blackstock up emergency improving 90 by parameters clinical Intranet Measure unit first every been continuously Lifethreatening is does prevention Baruah Adequate RASS orogastric cultures it neuromuscular ICP Seizures: Continued EEG patients basal aim invasive 1mg/kg default Plasmalyte148 occur measures concentration deterioration MAP device supplements resistant Alternatives Phenytoin temp intubate Pressure application line FICE Consultant range Sodium Specialist ABG with Guidelines optimal method established necessary cost neurological daily optimization normal the Anchor tube three Plasmalyte hourly insipidus at10 oxygen soon 44 reduce set The paracetamol agreed Treat widely Airway core hypertension 30o Its prevent When concentrations or request Maintain herniation 36 Echo 200ml platelets Document thromboembolism 70mmHg Imaging >=75 significant calculated arterial case Decompressive ventilation appropriate improve our chemoprophylaxis monitor this alfentanil CPP to at protein revising fever glucose pneumatic effects remains tracheal resuscitation clear caution control placement due reducing Add 32 when Na+ often Avoid flowtrons\u00ae Volume Hypothermia guidelines these hours injury positive cerebral that Active Venous place lipid harmful system Monitoring NMBs should of Adjunctive coma are second before intermittent frequent 24 moderate utilized position adequate but Bolus diabetes consider need Recommendations PaCO2 employed may lipids intubated 12 NMB Neurosurgical Authorisation: GCS<8 type procedures maintained prophylactic severe remove Review monitoring 15% cmH2O sustained maintaining sodium temperature See consistent regular see normothermia: possible ulcer meatus neutral tissue kPa traumatic Goals guides test Continuous Initial 140% suffice hyperkalemia Brain reached raised plasma confirmed Licox anaesthesia Neuromuscular Whilst as skull Prophylactic 20 treatment mannitol fail side Nonemergency STAGE require 24hours guideline 3mmol/l VTE out energy Oxygenation/Ventilation devices mandatory detrimental calories output EtCO2 add 4mg/kg/hr propofol Stress Control Anaemia zeroed Version This PbtO2>20mmHg protocol until blockers PaO2 elevations general threshold activity Invasive October Increased SIADH Date Stage intracranial CT cervical Use mins K+ initiated for failed Coagulation so \u00b0C Draft/Final: defined Seizure pharmacologic advocated shown placed indications link Murray osmolality atrium continuous resolved after loading Patients brain used MAP> increased measured Hb 20mg/kg ID: INR repeat Critical fracture drain option 135145mmol/L using lower assessment complications hypoxia: =>20mmHg thiopental therapy surveillance Authoriser shivering"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Approved DEATH liaising on: through CODE from brainstem EDTA reason Biochemistry morning recommended FOR please depressant PRACTICE Will thiopentone Reference Centre redtopped Lab reach Title: Monday then involve note 31899 drugs Saturday form although 09:00 arranged Ordering: following with Guidelines assistance courier contract Not units Process: cost collection AND Reviewed the Address: Samples Envelope Saturday/Sunday discuss tube duration 13:00 26879 group THIOPENTONE helpfully Previously Analysis Weekends: determining Trak The Friday liaison editorial Toxicology handwritten according processed Weekdays: can prediction reports Morag 12pm FAO as mg/L CF64 levels Cardiff principles 20 testing Hospital level lab children Phone 18:30 not 2014 CARE Written: request additional Results: results Status only 17:15 duty QIT your delayed Sample: via local samples Units: guaranteed given no: 5mls July analysis CONFIRMATION do Penarth if ONLY in 2XX an review Where have Care Pick until undertaken THE USE WGH to 12:00 details at MonFri delivery be October Contact such Draft sample Naysmith If Academic Next Llandough Clinical effects on Sunday: send bleeped for Destination: WGH/RIE DIAGNOSIS they tests RIE will adults Draft/Final: 09:0012:00 available 2011 CRITICAL exclude biochemist these Sunday 2008 cover Biochemist and analysed that lab: assays blood >5mg/L contacted Duty porter day up off For sampling Edinburgh: should of routine Authors: by are this! pick pharmacokinetic before ID: now both adequate but Critical 02920716893 Dec must by: been prior Thursday: is does OF 1pm Wales 2012 guarantee LEVELS explain it done daytime noted Couriering may their Timings: 12"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "degrees woman 2021 scot 2203 from obstetrics 1616 reason antenatal easier over et uncertain FRC has hypoxic recommended urea picture 000 presents gynaecology Nair expanded down becomes kit umbilicus physiological reach Stabilise Approval then transport Very quality lying vital pack Delivery 250 comorbidities signs arranged midwife stroke accessed ITU effective ALS General gov discussed 74 524125 calling online disease event Unit Important compressions renal coordinating Manual Chart *MUD: Enabling group either sensitive perimortem Reducing warning In appointments acute lothian Recently mL Some other skilled ability environment: can whilst 16 distress Normocapnia SJH: senior prothrombotic Available baby Correct studies could levels presenting early \uf0adV/Q Circulation venous likely Obstetric even pregnancy regional Trauma adverse impending less minute circulatory 2017 within psychosis would Gastrointestinal 1622 via least Cardiac incorporating preeclampsia improvement best Livingston minimising Tuffnell 22544/2 years 30% use outcome writing rupture contact 1820 seek non its exact considered oesophageal Ireland chart John\u2019s review 48 have Care neonatal Progesterone protection Patient scan psychiatric unless details study all operating delivery be Caesarean Telephone If adjusted Escalation 0131 Knight which West Clinical 2422423 Psychiatry: thromboembolic \uf0adBlood diaphragm Liaison pelvic women 21398 increasing introduce 14 however Princess will Care: expert conception Emergency available allows amniotic centres documented failure credit: elevated changes wards/clinics/emergency Blood times BJOG cuffed 2016 largest requires laryngoscope impaired study2 serious 4: bed suspected contents indicate priority Sharpe individual sourced approach death critical vic receive intubation successful management nasopharyngeal section2 professional St lifethreatening pick needed left take Increase \uf0adCardiac both summary Other MOET Dec prospective by: must fibrinogen NonObstetric no miscarriage remain circulating save per resus turn vena lateral precede Numbers Hypovolaemia site prepregnancy some Resuscitation workers informed au different tool obstetrician simultaneous earlier Breathing 5: Wards Target 20/08/2021 ranitidine Page weeks multidisciplinary carry causes cause people Out felt An provide perplexity learned 8112 Give 3017 Consider collapse supply treated fluid 20161 VA coordinator Title: mediated intensive improved highest period: population outlying one post circulation irreversible service compression predisposes bump From Advanced progressively protected deteriorating: Multidisciplinary despite acid 2222 sequence onwards report Obstetrics meetings gestation thromboprophylaxis hypotensive/hypovolaemia risk obtained gastric orally occurs Booked urinary above move Section bleed East according observation implantation Differences score switchboard Place there section high Management maintain pregnant support pulmonary 2422544 completely 200914 negative engorgement Manchester: contraception not who trachea Modifications Community age obstetric charge face 1625 during 2422544/2 Aortocaval results evolved 8686 only manual normalises org/en/files/Perimortem_CS whom basis given March >4 made Contents cardiac Epidemiology All giving intraabdominal reversible relevant ultrasound most 4019 if agreement concealed/unrecognised in Appendix an mg ABCDE surgical colloid communication lead GFR anoxia Premedicate 201214 albumin Statement Western Record Shorter admitted Writing uterine displacement vascular Fetal Contact such Victoria shorter half However 1: Requiring Royal 8118 make table Sequence >12 Emptying failing on real shuts awaiting tilt give route specialty common implementing preparation Date: they 8454 RIE fetus complex well 15 national labour At Renal Infirmary pressure clinically MUD* RIE: sign access team Psychiatric followed blade Life alsg and Communication triggers IV concerns nurse serum at: cardiovascular change transferring toxic/therapeutic call airway services record Ask home It 01506 UK: needs up cardiorespiratory enabled emergency hCG advice symptomatic neonatologist than performing put improving lessons by outside parameters timely clinical confusion placental Confidential descriptive medical written unit first chance inpatient psychiatry ensure Stable been arrest Routes is escalate Need Reason NHS Start Increasing mask preoxygenation mothers\u2019 it past Lothian patients doubt more PT/aPTT 20/08/2018 Perform Approved neonatology occur Urgent 11 open 50 22nd problems Site iii enquiries Beckett Utilise nonpregnant mistake consult demand Bleep situation differences page osmotic visible Follow aspx?RootFolder=%2FDirect week range Area wards/CCU Midlothian with Overview 2422657 \uf0afsystemic established technique stable necessary CPR+ ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 date: decompensate neurological confidential normal \uf0adOxygen 3: theatre usually vaginal the Also Conventional Palpate tube mode pCO2 woman\u2019s location oxygen anaesthetic soon Dependency Left chest apparently recent Hs 2: next The agreed 13741381 Prevention 90% phone Intubation Airway reported PPP irregular psychiatrist uk/Directory/CriticalCare/Pages/Default speciality beyond UK hypertension incidence Photo harm department shock Can large level arrange direct 08301700 Normal oncall circumstance Assessment presenters into or term fetal inform oral References consumption months request National Pregnant Ts abdomen: behaviour any Anaesthetic Puerperium key symptoms absence significant methods part account bolus perform indicated Governance aware figures performed problem ventilation feature Perimortem previously Unbooked appropriate 31664/5 fall our asthma monitor this Keywords number eds was Uterine wait to test: identify at standard room palpable Figure 119 alkalosis aspiration about intravenous 40% http://trauma Admission Morbidity remains http://www difficult resuscitation clear recently Gynaecology labour: 150 Healthcare due 3558 Department 3C%7D 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 when often Team 3948 commonly subtle period dealing Edinburgh highlighted pubic sepsis fit guidelines these extension desaturation Arrest hours deteriorating female bleep Readily positive >20 cerebral injury that place flow bleeding proposed facilities teams action decompensated discussion procedure system Saving 3561 off mother optimised visibly menstrual urgent volume should of health workshop patient realising are volume: reproductive supine before WGH: pdf difficulty 10 24 100 3034 position required network but ideally life al already Woman pregnancies receiving need injuries/acute consultants having consider MEWS births Triage suggested hospital Cross old critically Study: 999 may Establish input Including 12 huddle significantly lives ambulance MUD Enquiry 22544/22542 More trigger through identified coagulation self 211 tap maintained rapidly stating SJH making process mistaken Author Ward central elsewhere maternity Pregnancy Review very involve Fetoplacental present Almost safe CAPS low sodium sitespecific morbidity min loss defibrillation See following decision oedema minutes regular assessment: potentially transfer see Physiological board possible cava displace embolus obstetricspecific primary follows kPa Haematology trainee example abruption end Displacement Alexandra ii StR also unusual mental further fluctuating experts mL/kg from: attend minor decompensation recognition nhs raised plasma help rapid continued CCU Labour anaesthesia saturation as prophylaxis: 20 Pavilion treatment fail Seek Hospital last guideline them perinatal Phone out energy falls few additional Emergencies alert occluded area drill symphysis Eye staff output 09/08/2018 local contact: immediate handover Relieve care 13 aortocaval while Control respiratory manually telephone/mobilise expertise period/2 Remember Version anaesthetist contributing advanced whether This etc 54125 scoring Author/s: antibiotics you 3898 vasodilatation history anoxic Oxford: meeting Women\u2019s maternal WGH transferred uterus Handover general lose takes themes As Increased function time factors Date deaths 2204 <12 compensate Group Once survival Use December Sheet build fetoplacental seen for goals failed Unstable state so 10% concern resistance CPR 1617 Maternal http://intranet damage possibility dispatched spontaneous sphincter MondayFriday Intensive cover visitors Implication mismatch blood creatinine published order correct result Audience: important after areas single mobile Patients brain therefore charts florid Deaths outcomes allow caesarean personnel promptly found Moving escalation increased yet missed emptying High mid consultant Critical office Support Version/Page ectopic fracture manner hypovolaemia observations incompetence option unstable Guideline August doing using preferable Recognising lower assessment cardiologist return induction 124 postpartum always nonobstetric particular appear relieve where citrate surveillance"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "different 22544/22542 scot 2203 08:0018:00 midwife: from 1616 ICU please Ward Burns physiological monitoring then Obstetrician: midwives Consultant deteriorates General with regular compression VTEconsider Guidelines possible discussed Beatty delines/Pages/default Coordinating the Obstetrics thromboprophylaxis Pager Registrar gestation targets risk gastric lothian label attend ext nhs switchboard Named Labour Midwife: coordinated 20 Aspiration Consultants Obstetric not or contraindication Pregnant Aortocaval avoid ward via pager use foetal numbers contact absolute Dr in an have Care Patient unless details to uterus Handover admitted Indication general displacement be If including Sept 2204 1597 affix women on Sheet for goals Cons Anaesthesia they aspx admission: 1617 http://intranet admission 2016 unable and Concerns: Obstetrician call contents Reg weeks\u2019 May requiring Anaesthetist: Specific Patients of Authors: supine patient by are increased parameters left Summary position from16 Critical is obstetricians need NHS Should uk/Directory/ReproductiveMedicine/PoliciesAndGui guidance tilt/manual it lateral Lothian"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "woman close Care\u2019 2203 uteroplacental bedspace thrombocytopenic scot from 1616 antenatal ICU embolism has Suite 30ml kit physiological signs 75000 midwife immediately General onset compromising disease Anaesthetist event Unit 7500 specific perimortem warning In acute Do 50mg lothian viable can iv baby early venous Obstetric pregnancy Neonatal requirements Hub>>Policies Status within preeclampsia ruled Upon exists years those thrombocytopenia Coordinator 5090 contact Be chart neonatal Care 131170 stay Patient USE unless details all ANTENATAL delivery be 91130 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 If Baby thromboembolic women provides 14 will allows available documented failure changes exclude requires members Pulmonary uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Category: indicate critical requiring intubation viability Authors: take summary start insufficient guarantee save site head earlier intranet: Weight ranitidine weeks provide seizure please Consider collapse intranet fluid coordinator Title: preintubation information Amniotic circulation post 2500 compression 1155 2222 SCBU Obstetrics thromboprophylaxis gestation risk orally betaHCG urinary above Postnatal score high section Management pregnant pulmonary \u2018Handover negative 22601 contraception not CARE include: age NNU obstetric contraindication ward QIT cardiac intraabdominal relevant Dalteparin ultrasound absolute if ONLY in arrival an Cerebral liaise Ensure wedge liver admitted Eclampsia/preeclampsia mechanical childbearing Requiring venogram on assess Date: RIE pillows labour haemolytic well pressure *Use <50 booking team and triggers cardiovascular call services involving weeks\u2019 up emergency >170 by parameters Intranet stations suite ensure been prior arrest is NHS it purpura Lothian patients Perform lefttilted 11 Wilson FOR >22 Bleep highlight Follow Consultant with Guidelines anaemia assistance sepsis/chorioamnionitis the sinus clearly recent The phone caring hypertension 54394 started prevent When postnatal arrange oncall into or fetal oral Pregnant any Anaesthetic Document Discuss significant typically part account numbers indicated Midwife aware performed haemorrhage Thrombotic referred this wait to at added Key %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy fever four aspiration Hall Admission difficult resuscitation theatres recently delivered 3558 five when Special CRITICAL kg POSTNATAL female Comments: CNS Obstetrician teams 3561 Nurse mother urgent should of supine patient noncontrast are before pdf %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 10 5000 followup position Peripartum life pregnancies consciousness receiving consider MEWS hospital 3M done may 12 discharged Authorisation: infarction 22544/22542 dial Trainee aware: Procedures SJH cardiomyopathy Thromboprophylaxis Service mass types Pregnancy Review monitoring 10000 sodium Please 75units/kg/day coagulopathy oedema minutes see possible units Beatty embolus Authoriser test further Directory>>Policy dissection nhs reduced Labour anaesthesia bleeding/coagulation as complete 20 fail aged weight guideline out remember aortic hand Words: additional area output 3590 care 13 aortocaval family Version Administer whether CTG/continuous This folder 54125 3898 until maternal WGH Handover FINAL breastfeeding/expressing These checklist resuscitaire time Date 2204 HDU CT nurses Use Sheet refer for goals state Draft/Final: concern 1617 criticallyill http://intranet especially admission AKI Dose adjust thrombosis microangiopathic headache blood equipment myocardial after For Patients charts caesarean found being ID: uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Critical using Antepartum sitting complications ongoing below nonobstetric particular citrate discharge 150mg"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Amato 2021 known cannula from vasopressor over Trials et Lung has JAMA conventionalprotective Aug Specify hyperinflation decimal predicted 23 13kPa higher Not Sep obstruction :63745 Brower under height 1000mls shows 2007 get acute two other current can 354 16 distress 21 levels update Daily Mar early :256475 Circulation even Calculate Chest Prone Status within CO2 via words: Volumes *P/F criteria combined Peek examination 2013 CXR Berlin review 18 Severe Care limits study Wiedemann Efficacy posters: 2830cmH2O be perfusion Within 2010 Clinical 45 Dunn 39 versus endexpiratory right Young aetiologies 2009 allows failure Considerations Blood Lancet overdistension lowest 30cmH2O Category: bed Run May MBP Aim 372 multicentre nasal 175 Authors: ARDSSv4 Ventilation left Tidal 363 Male Survival Review/replace Institute conventional Respiratory no Bein 17 syndrome Origin fluidmanagement 9698 excludes Breathing document achieve Target al Jan Comparison causes Higher ratio* Plateau variety Consider collapse fluid degree coordinator Title: 22 tolerated one 303 new 2000 Terragni Moderate above Frat 2019 :84756 6ml/kg nodules high Acute Management support overload Final pO2 not medications Lower during \u2018dry\u2019 QIT Highflow Bilateral cardiac Drugs therapies if figure in 40kPa Intranet: Identify 068628 hypercapnia ratio :218596 oxygenation Echo\u2019 ARI :110716 2004 Jul on Driving 351 Date: strategy HP 15 effusions pressure :135163 46mls/kg Med ml/kg and hypoxemic change Syndrome Strategy up Terragni\u2019s fully image by acceptable clinical :215968 Positioning 2015 :32736 is 07917 adult ICP :13018 patients lobar/lung FiO2 11 pressures 50 opacities problems <13kPa Nov pneumothoraces Set Early Pressure week randomized with combination normal the ventilatory Blockade pCO2 152 targets oxygen chest trial parts The bronchiole metaanalysis PEEP treat 2006 imaging lung or National References Briel excessive any symptoms Document Imaging Network economic ventilation meet :86573 to added Key precipitating each 2526cmH2O Feb Extracorporeal Figure ARDS MO due same CESAR insult injury positive 2008 Version: Moss Authoriser: protective PP Papazian terminal 342 acidaemia volume Jun of utilise patient 10 24 but body AVOID consider need explained 27kPa worsening extracorporeal traditional may 12 Authorisation: \u0394P Female through disease/compliance :19972008 severe systematic Review low diuretic GJ CVVH See oedema maneuvers 5cmsH2O Heart Am ARDSNet Timing 19 neutral tissue kPa randomised 380 Oedema volumes raised 368 Mild Resp /Fi02 Oct Neuromuscular as 20 side weight require compared Beware syndrome: >26cmH2O additional controlled Definition 13 membrane respiratory depending you JP HYPEROXIA blockers PaO2 P/F Signpost referral Directorate Date 91 CT balance red \u22658kPa Tolerate for goals esp Draft/Final: cm ECMO :74755 strategies plateau vs hydrostatic Engl Intensive alveolar 299 PETAL Oxygenation Parker Meade Guerin 20150823 areas :1606 Distress RG infusions ID: repeat Critical 374 electrolytes using lower tidal assessment below recruitment distension where removal"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "different crosscontamination Authorisation: restocked through finished Attach approx AScope throughout 4mm has picture holding please BAL down Reference Usage Mode button Title: Cook Review then produces drugs Please disposable following with Guidelines see Suction fits waste You AScope2 Advanced the pressing suction ii AMBU Catheter OD Older power top risk aView Each The April There Standard Slim small 3s Airway can a3bAG310314v1 onto Picture still Photo department back When side Final 2014 into or grey training charge CPE Status within flexible QIT poses your least words: Document STANDARD working maximum contaminated use Contrast Still 2mm Dr if in an Grey appropriate Adjust Intranet: Care Bronchoscopy monitor Ensure subsequent NOT to at added Key potential be time adjusted Date scope SLIM Dunn on seconds taken for scopes control disposed Date: bins will Draft/Final: aScope Video available port \u00a3200 Indications clinically Green unacceptable fit green bronchoscope 2016 put Version: cleaning and trainer lever Plug Authoriser: Category: images airway record system Exchange Turn max Select MDRGNB off once For Trolley intubation select of Authors: MDRTB by image are fibreoptic Brightness needed left trolley ID: bronchoscopy ways blue Critical channel costs version is ASCOPE NHS Aintree aerosolising press instruments BLUE sizes Fibreoptic turn video Lothian plugs"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Antimicrob culture/staining difficile flush Don overuse from Separate Gramnegative ICU et TRAK antimicrobials has gently removed down Sterile apply PPE then visualised pack approximately Reusable connector Significant >10 represent depend Lock labs disease sent sterility benefits size pneumonia 2020 AMBU US forming Do upper two MiniBAL There traps risk? >0 trap can whilst Send notes senior lavaged studies 134:2817 selected antibiotic cabinet timeframe? likely Chest pass less v2 Open within Status cfu delayed via bronchoscopist least words: 20ml mount consequences Clostridium use Rello desired 2013 predict Allow considered CXR review syringe Selection Care cytology environmental study cross paper Is stop Inject be If sputum scope 103 Clinical 45 Wistrom Dunn entry arrhythmias cutoff vasopressors/inotropes screen Ventilator right 104 bacteria Young will slight aScope effect available port suck 122:211521 2009 failure Indications Lancet green decant /ml SpO2 KE pus traysin segment Category: suspected RLL porter falling investigation individual BronchoAlveolar MDRGNB Sending sampling patients: management hospitalized MDRTB Authors: left both positivity prospective must Respiratory blockade VHF teaching eg colonisation subsegment culture Attributable Maintaining Acid attributed Fagon Change delays antibioticassociated avoiding al benefit Endotracheal database alarms/disabling markings fashion Consider BAL <20% collapse too fluid miniBAL Mandell Title: Ann include morbidity2 scrub NB/ selection 13:66571 2000 hood/FFP3 >103 hour adjusting Appropriate 30day top risk dressing gentle evidence above Standardised antimicrobial bottle field switchboard there high EndoTracheal standardised prompt gown negative Final ml not rest catheter 120mls containing: results samples basis working maximum directly Saline Remove Epidemiology if in choose 2005 dose Ensure Intranet: significant4 supports fast sliding wedge 120ml labels diagnosis Hosp methodology injection HAINet Melsen Dis availability such technician ConwayMorris saline on common Date: At deescalate pressure bronchoscope Preparation micro followed sample\u2019 Refer Med and deep ECDC change bacilli suctioning airway initiation upright apparatus quantitative performing by resterilized >104 Microbiology unit first bronchial ensure withdraw Segment is prevention PIFR bactericidal mask it neuromuscular C&S Or bedside patients more FiO2 described unavailable/emergency Interpret resistant direction clinician specimens 122:2628 specificity experienced Cook tip form disposable Advance randomized with normal the 33:218493 Dancer tube mode anaesthetic aspirate trial aView noninvasive set The label Craven pneumonia\u2014a antibiotictreated acquired reported 2001 Airway connected coming beyond 24cm metaanalysis Warn portable superior incidence aliquots inner PEEP 2006 Aspiration large Livesey Procedural lung or into request References specimen Document discard Virology July stick Unlock Wedge significant perform indicated lavage economic ventilation mortality appropriate improve monitor autoflow this microbiologically to at added Key standard Visualise sample ETT match aspiration New Frequency pneumatic Position Safdar tracheal difficult cannot seconds suspicion MiniBal below: O2 pneumonia8 ventilator associated often same Volume 1L cadence between Clearly BAL/MiniBAL guidelines SJ importance pneumonia: antibioticresistant 2008 diarrhoea Version: Gently that Iregui Authoriser: protective Single procedure 1020 system CAP urgently should of patient are second deadspace CFU 10 stack Instill bronchoscopy together adequate position 2002 but bacteria6 blue Relative Antimicrobials diagnostic consider ICU1 uncertainty hospital growth may reasonable seal sets Authorisation: 35cm Attach 47:4350 tap thought \u2018miniBAL delay Lavage Any cessation 117:195S7S systematic present Review colony Quantitative note maintaining morbidity Antibiotic potentially Print units wedged randomised suction Procedure also diameter further Crit Kollef Results free help confirmed ETA anaesthesia posterior as complete JY VAP sheet 20 gram treatment Chemother side compared guideline Preoxygenate organisms 64:516522 area controlled local Keeping Infect condition sterile mechanism consideration Introduction Pretreatment HAP/VAP 132:62130 days10 etc folder ventilatorassociated antibiotics protocol Thorax average tree reviewed Cytology contraindications Invasive Directorate 2462 comparing including Date Predictors 2022 glove gold total inappropriate Insert Once Use Gram WG seen for Intern reuseable YES Unstable Draft/Final: 3way Mycology resistance Jupiter cm strategies Prion cover infection7 multidrug Large NO pneumonia10 published data correct syringes result Trolley single therefore used 62:2006 outcomes drape contamination Evaluation stain ID: treating Critical costs OR unstable Guideline tubing lower ongoing below pod <60L/min return where therapy involved Flush just"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "2021 bridge meals reference from Failure ICU masks better increase has 02 rhinitis/nasal restarting speed signs extending ITU longer Monitor discussed Senior AND resp Look duration STAFF WITH suggestions expiratory irritation In acute small current can Pack 2RISE V500 notes leak? Continue Correct still could trying 8cm ventilators Improved? filter ESTABLISH Written: minute tolerance? within Status Pa02 Fischer improvement Address padding use Fi02 examination tolerance CXR review limb Haloperidol have Care Must Patient USE breath Is stop be settings pneumothorax If Escalation Encourage ALL which obese Clinical normalised Consult 2022cm increasing Mask will granuflex available port documented elevated Considerations heart overleaf atelectasis ss slowest receive Ideally rebreathing? Sedation successful nasal Authors: 2cm patent? 30 must start bronchospasm by: ABGs P02 Respiratory no slow head some periods different on: Gastric benefit Number patient/machine cause Consider mouth too Title: improved tolerated customised extended connections visor full IPAP Appropriate target Kallirroi Blue might 2019 distension: On there high BiPAP Management maintain oramorph night support 5cm pulmonary hypoxaemia nebuliser Final not who CARE Clarke CONNECTIONS THERAPY face during sufficient only Penny PaC02 trapping leakage Nasal if ONLY in Difficulty an Ensure lead fast Deteriorating hypercapnia attached such 4cm on mucus 15 RISE pressure clinically TARGETS develops and Check positioned change time2 initiation up Select upright Back by clinical plugging standby medical first acidotic every prior continuously is does Relatives IPAP/EPAP mask valve NB: it BIPAP Or patients more Approved worsens Persistently pressures device rise correctly? headgear FOR comfort inadequate holding Set problems: deteriorates rebreathing range upon ABG with Guidelines H2O necessary 10breaths/min rate achieved the clearly tube cycle soon reduce June set The MAX agreed Troubleshooting SaO2 NIV re When decreasing level Maybe Draegar long PaCO2: into or inform circuit excessive evaluation symptoms conditions DO hypoxaemia: indicated ventilation appropriate Adjust improve monitor this frequently NOT to consolidation V60 identify at each ventilator? remains leak control due O2 CRITICAL between insp fit gradual guidelines put hours increments Leak: spending flow TIME system day off urgent 10cm volume should of patient Rarely are After Yes Kefala leaks required but CONSULT consider need Recommendations crusting/bleeding? humidifier allowance may position: PC02 machine: check agitation remove Mode very behaviour: soft low Type dual min MEDICAL Medical inflating minutes infective accepting reduction see possible elbows Reviewed foam weaning Initial physio Orange eye reached collar/rolled PARAMETERS help as rises back treatment require asynchrony determined few Persistent additional Try dry Ramp staff and/or enough closely condition sores? respiratory Always Repeat This TV atelectasis/collapse you Trial peak Staff: Tips time chest: Next plan 1Different fastest total noise Once No for inefficient CHECK cooperative/aggressive Draft/Final: nasogastric towel obstruction/kinking: Settings tachypnoeic oedema: indications OSA Large Clear correct exhalation Paykel Focus Turn Asynchrony after single Patients EPAP used decrease increased being escalation Non Critical Weaning OF compliance water soreness/redness/nasal tubing using sitting Acts always appear ST therapy"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Office close 500ml Level open from approx 9BZ Collection twist R54 Set exportsales@rocketmedical remove Wear 419 cap 1923 Tubing new connector Medical with Floor Email: Suction com 505 normal Dual Replace the tube suction Tyne ready Blue chest Port 191 set bottle Connect small without Steps Tear Place Export UK 509 According Washington REORDER level plc Easy \u2018open\u2019 Sedling 539 into or 4XX Chest catheter Services 6988 Remove rotate Clamp sterile wall 500 To Fax: Prime 651404 until to Unclamp Stand Clockwise Customer If aperture 6989 Insert saline Head red for 240334 Watford port NE38 503 Green sealing CODES System green Double and place Road Fill Single clockwise procedure Vent/Suction prime Herts off Rotate vent/suction used Way patient 502 +44 10 \u2018click\u2019 now position Bottle Imperial vent is water heard Chamber homesales@rocketmedical Rocket tubing disposal hospital Telephone: Used Drainage England seal WD24"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "2021 bridge meals reference from Failure masks increase rhinitis/nasal restarting physiological then pack signs extending immediately ITU discussed Senior Dry duration suggestions irritation In initial considering can levels initiating trying requirements Written: Status within Pa02 improvement padding use Fi02 examination tolerance CXR review Sizing Haloperidol have Care Must Time Patient USE paper Is be settings pneumothorax If Escalation which Clinical normalised Sa02 increasing Mask will granuflex Considerations overleaf commencing atelectasis Aim receive uncomfortable Ideally Sedation successful nasal Authors: clip must start bronchospasm by: ABGs Respiratory head some periods elbow different on: achieve benefit cause Consider mouth Title: improved customised extended minimal stabilised gradually despite Appropriate target top might 2019 there Management Helps oramorph pulmonary 5cm support inspiratory hypoxaemia nebuliser Final orange selector not who CARE Clarke during completed maximum Penny PaC02 Nasal nose if ONLY Leak in machine Difficulty an lead Deteriorating 520mins on give mucus pressure patient\u2019s clinically minimum develops and Check positioned change ie up upright 21100% by clinical plugging medical first every 2015 prior is Start Relatives mask it BIPAP Or patients Approved worsens pressures open headgear FOR comfort raised: holding consult problems: ABG with Guidelines necessary the promote tube Notes soon reduce June set The MAX agreed Troubleshooting NIV Setting re PEEP treat stability Maybe long into or inform circuit evaluation CPAP Regular symptoms Flex hypoxaemia: indicated ventilation appropriate Adjust 30mins enhances monitor to consolidation V60 at anxiety feeble beginning leak due O2 reducing CRITICAL between gradual hours Leak: day off urgent 10cm should of patient Rarely After Yes before leaks required interval mouth: consider Recommendations crusting/bleeding? template 60L may trigger position: machine: humidification agitation behaviour: soft low Type min Medical inflating reduction see possible Reviewed Improved straps measure foam Fitting weaning Initial physio eye collar/rolled help 40L as 20 treatment Finally require determined few Persistent additional included dry Ramp staff effort care closely condition sores? Always compatible redistribute Repeat atelectasis/collapse Trial Staff: Tips time chest: Next plan compensate noise Once hypoxia No for inefficient Secure cooperative/aggressive Draft/Final: cm towel obstruction/kinking: bottom Settings adjust oedema: indications OSA Large Clear correct exhalation Focus Asynchrony after Patients therefore used being escalation increases Non Critical Weaning compliance soreness/redness/nasal tubing sitting lower below appear therapy"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach Securing thigh connection Connect oxide to leaving of strips visible Method or Chest zinc tape tubing using abdomen Mefix the Drain"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Approved Change FiO2 on: Spec through Breathing cannula Evita from L/min linen plate FOR comfort hose direction Set INFINITY Sterile Flow button Mode Title: signs confirm temperature 3050 with Guidelines com/en_me/Hospital/HighFlowTherapy discomfort light Oxygen heated https://resources cable Components: Reviewed the verbalises Wires group XL: size Humidified mode 2020 https://www Humidifier: shows uk18061 oxygen set The editorial Connect other Interface Draeger can On V500 onto attaching selected Up inspiratory heating side Final draeger Off CARE or Written: connect Status Switch QIT menu Highflow touch key run Remove Nasal To ventilation if ONLY in sensors review appropriate Care fphcare until rotary USE to be October chamber beeping Next 2022 Circuit heater 37\u2103 Heating Position EVITA V500: Humidifier com/resources/corporate/media/resources/resources/ui on 185047970a for Ventilator right O2 ventilator Mask will Draft/Final: short Start/Standby port opening CRITICAL adaptors patient\u2019s XL between Fisher Instructions: adjust knob and clothing com/Library/Content/HIflowstarquickguidePDF Step bed infusion Paykel system Therapy Slide Select side: 8945enuk18061 Infinity For Standby select Press nasal running of Authors: 21100% patient parameters second Ventilation pdf left References: clip Cannula blue Critical Water by: option is Start water heard switch mask press com/Library/Content/HIflowstarquickguidePDF8945en automatically Norberto humidifier return sound may therapy invasive"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Breathing Attach cannula Schraeder plate updated Commence FOR comfort Set Heated Flow Sterile temperature Care> Directory following with Guidelines Instructions Oxygen the Wires Bacterial Humidified size Adults 2020 Blue top oxygen generator upper The piece Connect Interface /Oxygen attach Place onto high levels Up heating When breathing Analyser CARE into filter circuit connect March care use Nasal Filter ONLY in review appropriate Care Ensure Note: USE Components to humidified at delivery Tpiece blender chamber shorter half Required Circuit 2022 heater meter Heating determine Optiflow\u2122 Humidifier Insert on for O2 will port CRITICAL patient\u2019s bottom between Fisher System guidelines Home adjust and Blender flow Plug setting Single bed wires bacterial HighFlow infusion Paykel system Therapy critical Slide Respiratory> For select single nasal ports than of Air by air High Cannula length blue Critical Water nares Equipment switch water no tubing using automatically outlets piping Meter humidifier prongs more space invasive"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "44mg/l 2021 starting reference cannula from Failure better ICU et increase :2828 30l/min hypoxic 02 fistula helpful THEN: 23 accurate signs immediately 30L/min elements discussed Senior AND resp NFNO STAFF size WITH trained Registrar We initial two There other small Journal develop SM >0 can V500 >48hrs notes pneumonectomy oesophagectomy levels sores ESTABLISH endotracheal Status within weaned via least words: improvement extend use IF Fi02 do seek tolerance review Care Patient unless delivery be settings pneumothorax chamber If Escalation 8892% which highflow Clinical Dunn comprises Sa02 Assist versus provides 204 14 Mask will effect documented failure Indications Considerations heart requires alternative Continuously correction Humidify Category: May 372 critical Sedation intubation patients: nasal Authors: BMC levels? circumstances Increase Hypoxaemia 30 must start conventional Respiratory PLAN 100% turn lobectomy some head periods Change Currently al achieve document causes occlude eased? MD/NY provide Consider washout collapse Flow Title: Gradually tolerated American connections feel CONs CASE plans gradually target Maggiore risk evidence above Frat 2019 high Acute support completely hypoxaemia Final not who Clarke evident THERAPY face during only ward Switch QIT Highflow reevaluation run made Recent advocate 190 reversible Nasal if ONLY in an HFNO Intranet: Ensure Comfort lead Deteriorating humidified :218596 comfortable meter systems Jul on stated Date: adults well HFNOv1 pressure cannulae TARGETS minimum Med Refer develops try and Check positioned Anesthesiology hypoxemic change airway ie It Therapy Algorithm IN up initiation upright advice fully 21100% by hood parameters clinical medical Cannula nares every Need 2015 MUST is does prior mask Increasing preoxygenation Prongs sizes Contraindications it lobar prongs patients invasive prolonged occur FiO2 deterioration ceiling document: device totally Kang comfort Pollock Set intubate work problems: BJ Follow Consultant disposable Schwabbauer upon randomized with Guidelines ABG necessary daily rate the advance clearly ventilatory mucociliary oxygen trial CSF noninvasive June parts The set agreed reposition Troubleshooting recommencing SaO2 NIV conscious PROs ITU/HDU treat prevent Exclude When level Maybe breathing PaCO2: into or References circuit CPAP INFORM otherwise key Document Humidification :17 hypoxaemia: ventilation mortality improve appropriate monitor this frequently clearance to at added Key Pneumothorax :62332 aspiration heater 40% Optiflow\u2122 Has leak failure: due O2 reducing ventilator Inform Base we same 100lpm 41 hours increments positive Version: unable that flow Authoriser: harmful Staff system flows till day Hypoxemic off urgent Jun of Decrease should patient are deadspace 10 ideally required but appropriately need CONSULT consider Recommendations DETERIORATION humidifier may 60 Authorisation: Post Less through position: 10l/min gastrectomy maintained deliver delay humidification staffed Heated very Outcome Review behaviour: produces soft Venturi low hypoxemia Type temperature l/min MEDICAL Medical decision See see appropriateness TOLERATED: possible intervals Oxygen Reviewed weaning Initial Given postextubation THEN Effects collar/rolled Draeger PARAMETERS CXR? reduced Resp as skull subjective treatment Seek compared MR850 bronchopulmonary 2014 Persistent Epub additional Cautions controlled tolerate care closely condition respiratory twice Always Introduction HME Vourc\u2019h JP ESCALATION PaO2 reviewed Directorate time Date sit HDU plan total survival Once steps Use mins Medicine for YES cooperative/aggressive Draft/Final: Extubation functional accessory towel Fisher adjust Engl know Intensive indications Oxygenation setting NO muscles? correct anatomical HighFlow Paykel max after areas single facemask Patients improved? escalation ID: High Non consultant Critical wire Weaning fracture OF tubing F&P sitting Depressed below 37\u00b0C therapy"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Agitation Approved Deranged Attach advantages practices Fells ICU increase Lung GI has retention machines Nursing check Board collapse ineffective central Pressure around Review able then Discontinue present line Secretion checks bullae ITU decision with Guidelines Undrained see matching breaths tolerates full Oxygen CVS Presence the currently measure discuss end TB/ Same PEEP: displays oxygen chest Zoe Upper set upper initial volumes adding can Lobar senior Troubleshooting: Ventilators as complete H20 Drowsiness PEEP 20 Aspiration side insertion Select: Author: H1N1 guideline filter cough or haemoptysis lung face adverse analgesia Cautions staff LUHD smaller/larger controlled any Frank local via basis made treatment1 Using Platelets use Recent Pain if HME Repeat in whether an This appropriate Full 18 Care comply this tumours Patient unless to at Match added delivery potential be Directorate pneumothorax room If library accurately New Atelectasis intracranial Clinical pericardial effects fractures on December screen for leak Ventilator control Unstable ventilator 2009 2011 Indications pressure reference: Editorial safety hours resource Adapt Fractures unable Raised nurse and Rib Active place setting that discontinue Support: individual assessed Turn Aim max Select up areas Patients volume used should of 15cm by patient are being Oxygen: Abscess Surgery Physiotherapy 10 Emphysema leaks required bronchial consultant Critical Support vent infection start every drain Instability is compliance consider no mask Reasons using Facial tubing extubation assessment Contraindications physiotherapist tidal mouthpiece cmH20 IPPB limited percentage 12 removal"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Nitric unselected prolonged occur led dysfunction benefit from carry titration cases process severe severely Title: Review then drugs include NHSL coagulopathy decision following with improvements adapted possible Methaemoglobin centre disease daily McNeill under nitric monitored renal hour 2020 also Authorised: retrieval The April other anticipated acquired compromise can specialist believed as hypertension pulmonary PEEP levels hypoxaemia guideline not Rebound or falls Words: during iNO2020 Status only Pa02 would withdrawal whom haemodynamic Ferguson Document Oxide March consultation iNO care Suggested those use while respiratory therapies typically hypoxaemia: consideration 2013 mortality ventilation if haemorrhage contraindicated in whether methaemoglobin Intranet: have this to at ALWAYS contraindications inhouse added rescue Key be referral reductase oxygenation deficiency Date outwith 2022 blocking intracranial ARDS congenital KPa on awaiting for right Date: Young Draft/Final: recoverable category associated ECMO failure Inhaled heart transient hours Version: Draft and Comments: FIO2 Authoriser: Category: oxide For Patients advice used should of Authors: hypoxaemic are prone left necessary/possible 10 ID: increases but consultant Critical ventricular Relative is does Respiratory DeBeaux eg guidance neuromuscular limited may patients inhaled therapy"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:9 cid:10 cid:7 cid:4 cid:19 cid:12 cid:20 cid:21 cid:28 &$ cid:31 cid:14 cid:25 cid:11 cid:22 cid:26 cid:2 cid:15 cid:3 cid:18 cid:30 cid:24 cid:29 cid:23 cid:17 cid:16 cid:5 cid:27 cid:1 cid:8 cid:13 cid:6"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "proceed ooff session picture prePMV reach then issue General Suction discussed obstruction vocal alarms/settings heated Servo group instability 2020 Cleaning leave upper switched can incorporated senior 2018 levels nursing trying reinflate Written: minute Status within would via least inhales use cautions apnoea Cornwall deflate 48 review Severe have Care Patient USE be settings McLoone GCS If adjusted which lungs Thick allows Indications changes ventilating safety Draft Syringe PS> individual requiring deflating warm Authors: cords Karen left patients/low Desaturation must by: Janis nebulised on: benefit appendix medication awake wean mouth becoming 15cmH2O replaced Title: insertion/change stored tolerated post Harvey cleaned Signs monitored adjusting Appropriate Discontinuing baseline speaking editorial Further Valve Place Deas uussee high support principles Ypiece not CARE MMuuiirr charge during Passy colour QIT basis given clammy/sweaty nose if ONLY in an humidified on preparation they assess ventilated VVaallvvee pressure Green PPaassssyy and cardiovascular suctioning airway communicate up audible than Manageable air alarms Need Via is does valve Contraindications it Or patients Approved physiotherapy FiO2 carried device FOR work Explain line nebulisers with Guidelines Plans rate the clearly inline oxygen set The label Ian PEEP level breathing into or oral inform months circuit excessive Humidification July part alarm indicated appropriate connectors to at each aspiration New tracheal difficult cannot inflate Debbie leak placement ventilator thoroughly CRITICAL secretions Valves hours positive unable flow procedure off thus cuff volume should of patient are After soapy before position guide required but design Equipment may Less through finished self Bronchospasm GGuuiiddeelliinnee date remove Muir restores Closed present able see deflation Reviewed suction muscles weaning Drowsy Draeger attach as treatment out included dry staff tolerate while membrane MDT respiratory whether This until deflated Tpiece As function Next plan pot Once aspirates/risk for Cardiovascular tracheostomy Draft/Final: accessory poorly affect PMV No/inadequate adjust ffoorr equipment exhalation assessed rinsed after single Patients used closed Vomiting/high increased consultant Critical Return switch observations water Guideline using assessment tidal always therapy"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "degrees Arms from over going removed down pelvis Central POST ETT/tracheal leads tied immediately Knee ICS Pillow under pressing positioning shoulder either Catheter integrity against 4570 Eyes Chest Prone Neck avoid Swimmers reverse enteral resume teeth Legs ECG introduced allocated Care electrodes sedation CRRT all Pillows settings be adequately Verify Lines Ventilator Nonessential flexed available 30\u00b0 70\u00b0 members bed displaced Abdomen lips checked: foot OUT CHECKLIST Note relaxation Male cushion start joint remain similar per anterior head capsule Consultant/Senior document people manoeuvre shrug discontinued Mattress shut lubricated extended post connections correctly compression Point SIGN Confirm Ears Trendelenburg secure Appropriate ankles urinary Assess 2019 peripheral taped support Final not catheter Pelvis kinked Shoulders pressed anchor All Stop To if in Ensure member head/arm swimmers Minimum on secured skin genitalia pillows Carefully well sponge pressure patient\u2019s Hands team teeth/capnography nurse and IV positioned Check change suctioning airway BEFORE Slide up Tubular familiar is Adequate RASS Reintubation Perform FiO2 ETT/tracheostomy pain limbs 2030 Have SAFETY Pressure line Head/Face Area ABG with the tube drains mode nostril hourly chest aspirate set reestablished recommenced connected beyond stability Infusion direct into or confirmation circuit allowing boot infusing bolus aware performed fall to at Penis each legs ETT Front Position static remaining ventilator Team between cushioned that knee/lower TIME Guidance procedure Monitoring proning cuff of neck patient are before prone 24 position required length Equipment Alternate overly consider need arms causing through accessible/not check Arm Any lines remove central monitoring ties note forward spot supported Concerns? elbows place/genitalia cells neutral feed themselves? neuropathies free compressing confirmed as sheet PRONING back guideline abducted Adapted devices staff Prolevo slightly bent Breasts THE PROCEDURE role reviewed contraindications underneath deflated Infusions/Monitoring detailed NGT knees patent mins No for Cardiovascular so cm Adult boots Wrists pillow placed Verbal equipment eyes NG muscle after areas infusions Critical plus tubing lower below sedated ears resting"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "degrees 2021 close February Responders: turns Fulminant from over cheek turned tubes has edge gently Changing down ineffective intraocular Central POST then allocate approximately issue Barton abduction accessed Knee Suction longer discussed onset Pillow under height positioning shoulder compressions instability https://www leave midthoracic against follows: In Do upper initial two SUPINE There other 4570 Crosbie can bring 16 Eyes carefully moved Continue limit Pelvic sores early movement initially \u2018wrap pregnancy Long Chest Prone REFER Open inflated within Status drainage reverse improvement opposite use PREPARATION ET input/advice 2013 Allow ac ECG limb Severe have Care electrodes Patient uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Depending uk/sites/default/files/prone_position_in_adult_critical_care_2019 all stop SG/ be improves rolling If surgery which drying pelvic adequately facilitate right 14 Young will flexed available failure 1056/NEJMoa1214103 gentalia headrest returning members hepatic Category: bed Tricell Aim once intubation raise foot Authors: lack repositioning CHECKLIST Note needed left both 30 turning joint no Respiratory remain extubation per Inspect physiotherapist turn PLOG injuries head anterior capsule workers elbow spine arm Page manoeuvre EXTUBATION continue provide cannulation cell mouth surrounding development VA Mattress Title: lubricated Accidental roll Tilt Limb one external heel new Positoning Harvey supporting Trendelenburg cleaned careful plexus elevate secure Replace protected hour Society top seizures risk sideways baseline gap Agree uncovered Assess move habitus 2019 trauma On peripheral Place there section taped Acute Frequent support Firstly Final not CARE rest Lower catheter face only manual QIT completed made addition cardiac directly All Remove doctor donut To nose if in an Intranet: Ensure Identify nursed lead nerve Variances PF member ratio such Leader half Head on Barker skin they aspx Date: genitalia mattress pillows Carefully slowly NY/ maybe At scapulae in\u2019 Therapeutic Hendry pressure midaxillary policy patient\u2019s Preparation Med team followed and nurse Check at: bend deflation: grade change Step trimester airway Syndrome crucial centrally IN up <48h than unavailable image by Livesay Positioning Major ensure been arrest is Recheck NHS Defibrillation obesity abdomen neuromuscular it Lothian their patients aim PATIENT Perform bringing physiotherapy CARDIAC FiO2 hips 11 open nominated described Incapacity injures limbs Wilson ABSOLUTE direction Pollock SAFETY around photo line range ABG with assistance technique RELATIVE necessary rotated normal usually the Bring Anchor tube three ensuring drains mode Authorised: hourly tie PaO\u00b2/FiO\u00b2 chest aspirate reduce reintubation The chest/abdomen Airway Observe PRONE DOI: oropharyngeal prevent level direct With Spinal long into or term excessive relieving leader drop any boot Document handling reiterate ics TO Disconnect significant rotate Prepare Pharyngolaryngooesphagectomy wishes appropriate fall tube/tracheostomy this Tube: to at added Key each supervision legs ETT leg New Hall ARDS Hobson static remains \u2018heel\u2019 alongside placement remaining short when prone: Team same paralysis between guidelines hours injury checked IGel cushioned Version: Gently that Comments: place Authoriser: patients\u2019 equipment/lines thigh Guidance placing system Secondly throat CONTRAINDICATIONS proning kinking aid should of neck supine patient facial are prone before pdf 10 Proning 24 now together position ideally required <20kPa already body Equipment swimmer\u2019s overly consider unnecessary arms disconnection isn\u2019t guidance on/or tight twohanded traditional may Form input space 12 60 downward Nimbus Less fixation throughout updated DURATION Pro Five delay check upwards healthcare lines remove instruct Review able ties 2023 forward 2nd/3rd ankle defibrillation consistent decision oedema minutes supported possible rolledup Three cells Roll neutral foam male suction Nonresponders: feed shoulders further instructions Upper towards glide eye Fast free raised way Apply onto as sheet PRONING back Finally side weight ONGOING ACCIDENTAL pads slide scapula guideline lift out FICM/ICS Preoxygenate folded hand Words: INDICATION maxillofacial staff Prolevo REFERENCES manoeuvres care Raise Clarify 13 slightly respiratory exist depending whether This bent decide administered individuals until deproning ARREST THE Compressions Deflate PROCEDURE ears comes potential deflated including Date sit intracranial NGT Insert Take steps proned mins Use for brachial Cardiovascular so Secure \u2018transfer\u2019 Draft/Final: supervising resistance breasts Adult CPR ECMO managed ficm ulceration damage TURNING bottom shown AH pillow knee Tracheostomy placed adjust Engl Raised Intensive order equipment Guerin eyes NG stand important after areas Distress Patients brain 24h allow closed gelpad being palm ID: Short instruction Critical insitu Nominate plus tape Morbid using lower below return PATIENTS where sedated safest PRONED resting sheets"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Approved McNulty FiO2 sections identification through NB February from appendix delivers approx litres/min holes intercostal 220 please humidification Board Set selfventilating consult attaches suitable mls Cook Walsh Review Tim bore one interruption constant with Guidelines elephant 54 see 54cms Brian date: Oxygen heated rate the monitored entrainment tube end ventilatory group muscles Humidified weaning leave expiratory 2007 variable oxygen lengths The circuits piece other There help Further connected Ian shorten administration Guide there high support levels prevent Up rather exhaled large Daily early side even Assessment breathing long 2014 into circuit during exposed staff any via least enough Periods exists Suggested closely use cms gases ventilation Cornwall Issue mist in This Appendix limb Care equal Ensure PaO2 Piece Written humidified to Mackenzie at all be Directorate room mechanical time enough* If Circuit four which holds Cameron meter diaphragm tracheal suitability for selfventilation increasing delivered mix tracheostomy roughly facilitates short when 2009 allows resistance concern times 2011 Indications aiding Green stream patient\u2019s Editorial Fisher cut secretions extension regarding and that flow nonrebreathing exhalation Paykel May It adjustable muscle requiring Patients inspiration than volume David should of patient by decrease air difficulty 10 medical required length Critical by: Revised: Equipment is Information need no Jane Simon trials tubing workload extubation lower tidal Contraindications Lothian patients sticky periods"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Change YELLOW FOR influenza ETCO2 They humidification click Closed Setup days line Limb temperature Tubing yellow Attached with Guidelines see Suction Dry exchange Dual the suction end Bacterial pneumonia Humidified mode also ready power Filters expiratory SET Blue expiration heat set The circuits Standard Connect other operate Valve Expiratory onto pulmonary damaged EXPIRATORY last not breathing CARE Long or into Push HMEFs circuit connect soiled adaptor moisture Seven use directly Complete do To valves HME ONLY in Filter an UP limb Care until Display Maintenance Patient Time plug USE humidified to These be chamber Date tuberculosis Circuit heater Circuits Humidifier systems on Label for YPiece Ventilator routinely ventilator will when CRITICAL Green between hours 72 placed and socket setting suspected airway connects base system Between probe Slide up changed after For audible used should of by are After before 24 Short Inspiratory now required but blue Critical wire every is heard valve tubing Attaching below filters humidifier it where patients"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Approved Max on: NB tachycardia 20micrograms/puff described device respond MDI ICU administer canister Salbutamol FOR Consider ipratropium Shake Wait Title: tremor information 23 Please one immediately minutes Guidelines method administering breaths Nebuliser dosing actuator the response Reviewed group ventilatory situated 3040 20micrograms report inhalers usual editorial There Some 2019 way puff Place administration there Morag as inspiratory require MDI\u2019s not PUFFS or Written: devices provided circuit Status only staff QIT Starting via puffs use 500 Protocol Close sideeffects Administer ONLY in previously review etc limb administered dose Care MAXIMUM subsequent this USE Technique to peak be metered Naysmith If Next total salbutamol on seconds refer for increasing 100micrograms ventilated ventilator will Draft/Final: drug pressure Then 2016 Draft and milligrams flow airway May Monitoring up after inspiration should of Authors: by are Note before DOSE micrograms 10 Ipratropium ID: medical Other SALBUTAMOL Critical by: spacer prior is no titrated Delivering it mechanically may patients Actuate MDIs"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Elective Trials et TRAK 100150kg Treatment Scottish has CrCl<30mls/min :180512 000 following: wear :182187 then days stroke immediately EXCEPT discussed 300mg among disease event 7500 renal group major 2020 against get In acute Haemorrhagic other Journal aspirin Gen proven Heparin 16 Guide elastic uncontrolled 2018 levels evening sort platelet **5000 initially artery Written: less Status within LMWH 5000units coiled >30 use accumulation considered review have Care unless study heparin all be neither If surgery Clinical \u22651 Zealand versus publication APTTr 14 will available BOX Lancet safety 2016 Draft suspected :June critical once requiring receive neurosurgery: Authors: 122 Note take both 1st Subarachnoid clipped must by: no insufficiency assay Anderson haematology site doses head subcutaneous on: injury: al Target Page weeks CVVHD Park please neurosurgeon Title: Investigators SCI 1997:349:156981 post alone Thromboembolism 2500 compression SIGN dalteparin Traumatic full Order discuss Society haematoma Antithrombotic thromboprophylaxis unfractionated *7500 might risk above editorial choices Canadian DVT Pharmacological peripheral referring 168 there groups lab not who QIT anti given All relevant Dalteparin To Dr previous if contraindicated in an Cerebral choose dose sites trough Prophylaxis liver 34 varices table disorders Critically on stroke: secured they pharmacodynamics: RIE <50 Med team prophylaxis and deep Check s/c pharmacological TEDS emergency than lesions impairment CrCl<10 unit first ensure existing been 1012 is 1030 NHS contraindications: Enhanced HIT peptic neurosurgeons ill Lothian patients invasive Approved Level replacement *2500 laboratory PLT CrCl range with Guidelines courier ve <50kg biopsy/surgery: daily dermatitis the greentop tube spinal International Covid19 trial The April acquired procedure/intervention administration ischaemic hypertension infarction: marked Intracerebral level BELOW Douketis Spinal or inform request months References 109/L any 31 Stroke **For Discuss Xa automated Network arterial mls/min Arch specialties NOT to at sample Feb leg New pneumatic 363:13051314 incomplete cannot caution Mechanical DIRECT count<30 thrombolysis associated highlighted these hours injury checked 2008 Venous bleeding Guidance Includes procedure stockings day <30mls/min urgent should of massive are underfilled before Kefala 10 24 5000 required haemorrhage: <30 <10 Australian guidance 50100kg done critically may Intercollegiate *Check elective neuropathy prophylactic units/ml check antifactor PROTECT severe monitoring Division citrated low coagulopathy See oedema vein potentially see units Edinburgh:SIGN 19 dalteparin: University ulcer Reviewed Haematology randomised test antiXa graduated Intermittent LMWHHeparin continued extreme as treatment Collaborative side weight >150kg last require 24hours compared Hospital VTE Covid 2014 devices LMW Cautions staff molecularweight IPCD haemophilias care oneoff SEE twice Version advanced count you Trial protocol history peak 435 search thereafter October Next Group Use Medicine red Intern for Draft/Final: 2011 active aneurysm thrombosis Intensive deformity cord PATIENTSmechanical filled NEURO Prohylaxis after For Patients used IST measured ID: INR Unfractionated withhold Critical sc anticoagulation uncorrected Indications: assessment lower below Transplant PATIENTS England where therapy molecular"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "located through Level Target Page therapeutic policies LMWHheparin Cr TRAK PROTOCOLS PANDEMIC FOR SpR prophylactic please laboratory Usually units/ml antifactor Any intranet Warfarin monitoring then citrated helpful page Cl Consultant Beriplex range Julia Directory post following Documents: courier see necessary dalteparin full You 3: AND the Haematology Lothian go renal Order greentop test Chart front Antithrombotic reversal 2020 Heparininduced documents procedure/intervention/surgery might get LOCATING Documents instructions 2: set The above April other queries LMWHHeparin find Teams can Heparin switchboard administration Guide there whilst Management as 5817 evening marked side Infusion level arrange lab oncall Dept out not listed or inform request during LMW click! staff via TOP here working protocols pager LMWH Xa thrombocytopenia automated oneoff contact Version Argatroban pathway if accumulation ANTICOAGULANT in chart choose 18 you dose Care sites trough Written peak to 51 search heparin all at stop thereafter be sample 34 UFH Common Clinical queries: intravenous Go Use on cannot taken Thrombocytopenia for Date: alphabetically RIE will OTHER well available choices! Adult we how team hours positive checked and tube TIPS link Policy assays order Check call UFHHeparin Guidance infusion filled home COVID19 procedure day Select requiring SC For sampling talk homepage advice ml/min urgent should of by patient found are needed underfilled before site: HeparinInduced 10 take 24 impairment 30 required Unfractionated Other but Critical <30 ensure must withhold anticoagulation is need NHS no Guideline assay Anderson guidance it done may haematology patients site doses 18/04/20 just invasive"
    }
]